Journal List HHS Author Manuscripts PMC library NLM provides access scientific literature Inclusion NLM database imply endorsement agreement contents NLM National Institutes Health Learn disclaimer J Cell Physiol Author manuscript available PMC Apr Published final edited form J Cell Physiol Apr doi jcp PMCID PMC NIHMSID NIHMS PMID Protein Kinase C Expression Oncogenic Signaling Mechanisms Cancer Nicole R Murray Krishna R Kalari Alan P Fields Nicole R Murray Department Cancer Biology Mayo Clinic Comprehensive Cancer Center Jacksonville Florida Find articles Nicole R Murray Krishna R Kalari Department Cancer Biology Mayo Clinic Comprehensive Cancer Center Jacksonville Florida Find articles Krishna R Kalari Alan P Fields Department Cancer Biology Mayo Clinic Comprehensive Cancer Center Jacksonville Florida Find articles Alan P Fields Author information Copyright License information Disclaimer Department Cancer Biology Mayo Clinic Comprehensive Cancer Center Jacksonville Florida correspondences addressed Alan P Fields PhD Mayo Clinic College Medicine Griffin Cancer Research Building Rm San Pablo Road Jacksonville Florida office fax udeoyamnalasdleif Copyright notice Abstract Accumulating evidence demonstrates PKC oncogene prognostic marker frequently targeted genetic alteration many major forms human cancer Functional data demonstrate PKC required transformed phenotype NSCLC pancreatic ovarian prostate colon brain cancer cells Future studies required determine whether PKC also oncogene many cancer types also overexpress PKC Studies PKC using genetically defined models tumorigenesis revealed critical role PKC multiple stages tumorigenesis including tumor initiation progression metastasis Recent studies genetic model lung adenocarcinoma suggest role PKC transformation lung cancer stem cells studies important implications therapeutic use aurothiomalate ATM highly selective PKC signaling inhibitor currently undergoing clinical evaluation Significant progress made determining molecular mechanisms PKC drives transformed phenotype particularly central role played oncogenic PKCPar complex transformed growth invasion several PKCdependent survival pathways chemoresistance Future studies required determine composition dynamics PKCPar complex mechanisms oncogenic signaling complex regulated Likewise better understanding critical downstream effectors PKC various human tumor types holds promise identifying novel prognostic surrogate markers oncogenic PKC activity may clinically useful ongoing clinical trials ATM Keywords tumorigenesis gene amplification signal trandsuction invasion metastasis aurothiomalate Introduction Protein kinase C PKC family structurally related serinethreonine protein kinases whose catalytic activity regulated interaction phospholipid cofactors inter intramolecular phosphorylation specific proteinprotein interactions PKC enzyme family divided three subgroups conventional calciumdependent cPKCs alpha beta beta II II gamma novel calciumindependent nPKCs delta epsilon eta theta atypical aPKCs zeta iota also known lambda mice grouping based presence absence functional domains confer specific cofactor activator requirements Conventional PKCs calcium diacylglycerol DAG phosphatidylserinedependent due presence conserved modular C C domains within regulatory region enzyme Novel PKCs DAG phosphatidylserinedependent require calcium Due unique structure Nterminal regulatory region atypical PKCs require calcium DAG phosphatidylserine activation Biochemical immunologic studies indicate multiple PKC isozymes expressed virtually cell tissue types reviewed Fields Murray expression individual PKC isozymes developmentally regulated responsive differentiation state cells tissues reasons PKC isozymes thought fulfill distinct nonredundant functions within cell reviewed Dempsey et al Reyland However similar activator requirements substrate specificities PKC isozymes vitro complicated identification physiologically relevant isozymespecific substrates cellular functions ability genetically manipulate expression specific PKC isozyme express mutant forms individual PKC isozymes altered kinase activity proven successful identifying PKC isozymespecific functions Using genetic techniques many laboratories including demonstrated isozyme cell typespecific roles PKC cellular proliferation differentiation apoptosis cell polarity Chalmers et al GokmenPolar Fields Jansen et al Mischak et al Murray et al Oster Leitges discovery PKC cellular receptor tumorpromoting phorbol esters led intense interest role individual PKC isozymes cancer development Castagna et al Kikkawa et al Indeed expression level cellular localization individual PKC isozymes shown altered carcinogenesis numerous tissue types reviewed Fields Gustafson However despite exhaustive investigation somatic germline mutations found coding regions PKCs associated human cancers diseases date one PKC isozyme atypical PKC shown satisfy criteria human oncogene minireview details work laboratory others characterizing role oncogenic PKC rodent carcinogenesis models human cancer also discuss status efforts therapeutically target critical oncogene treatment cancer patients PKC Expression Primary Human Tumors PKC overexpressed prognostic multiple human cancer types Overexpression PKC demonstrated many human cancers Table PKC frequently overexpressed cancers lung Regala et al b pancreas Scotti et al stomach Takagawa et al colon Murray et al esophagus Yang et al liver Du et al bile duct Li et al breast Kojima et al ovary Eder et al Weichert et al Zhang et al prostate Ishiguro et al brain Patel et al addition published reports metaanalysis publicly available microarray data provides additional support overexpression PKC many tumor types including lung Landi et al breast Richardson et al pancreas Segara et al prostate Wallace et al ovary Cancer Genome Atlas liver Wurmbach et al Table Interestingly increased PKC brain cancer supported available genomic data sets Lee et al Table Analysis available microarray datasets revealed addition lung cancer Landi et al several squamoustype cancers also express elevated PKC including head neck Ginos et al tongue cancer Ye et al Significant overexpression PKC also detected renal cancer Gumz et al bladder cancer Dyrskjot et al SanchezCarbayo et al melanoma Talantov et al leukemia Valk et al Table studies strongly indicate role PKC many major forms human cancer TABLE PKC Expression Human Tumor Types Tumor type Tumor Control ppaired Type Analysis Result Reference Lung p blot qPCR IHC Elevated Amplified High PKC predicts poor survival Regala et al b PDAC p qPCR IHC Elevated High PKC predicts poor survival Scotti et al Gastric IHC Elevated High PKC predicts disease recurrence Takagawa et al Colon p blot Elevated Murray et al Esophageal IHC FISH Elevated Amplified gene amplification correlates tumor size stage LN metastasis High PKC predicts metastasis Yang et al Hepatocellular carcinoma p RTPCR IHC Elevated High PKC correlates size metastasis invasion stage Du et al Cholangiocarcinoma IHC Elevated High PKC correlates differentiation invasion LN metastasis stage Prognostic poor survival Li et al Breast IHC Elevated Kojima et al Ovarian IHC mRNA array CGH Elevated Amplified High PKC correlates stage Zhang et al Ovarian Array CGH qPCR IHC Elevated Amplified serous tumors high copy predicts poor survival nonserous tumors high PKC predicts poor survival Eder et al Ovarian IHC Elevated High PKC predicts poor survival Weichert et al Prostate p qPCR blot Elevated High PKC predicts poor recurrence free survival Ishiguro et al Brain blot Elevated Patel et al Open separate window TABLE PKC Expression Publicly Available Human Tumor Microarray Datasets Cancer Type Tumor Control Significant Tumor Pvalue Reference Head Neck Yes Ginos et al Tongue Yes Ye et al Lung Yes Landi et al Superficial Bladder Cancer SanChezCarbayo et al Infiltrating Bladder Urothelial Carcinoma Yes E SanChezCarbayo et al Superficial Bladder Cancer Yes E Dyrskjot et al Infiltrating Bladder Urothelial Carcinoma Yes E Dyrskjot et al Brain Lee et al Pancreas Yes E Segara et al Melanoma Yes E Talantov et al Ovarian Yes E TCGA Ovarian Published Liver HCC Yes E Wurmbach et al Breast Yes Richardson et al Prostate Yes Wallace et al Acute Myeloid Leukemia Yes Valk et al Renal Yes Gumz et al Open separate window tumor types examined PKC expression also shown prognostic significance High PKC predicts poor patient survival lung Regala et al b pancreatic Scotti et al bile duct Li et al ovarian Eder et al Weichert et al prostate Ishiguro et al cancer Elevated PKC expression predicts disease recurrence gastric cancer Takagawa et al metastasis esophageal cancer Yang et al analysis PKC expression lung cancer PKC emerged prognostic indicator comparable tumor stage prognostic value Interestingly PKC expression correlate tumor stage nonsmall cell lung cancer NSCLC rather PKC levels comparable early late stage disease indicating elevated PKC expression early event lung tumor development Regala et al b contrast PKC expression correlates tumor stage ovarian bile duct liver cancer suggesting PKC may regulate disease progression tumor types Du et al Li et al Zhang et al Thus PKC expression elevated variety tumor types many cases predictive poor clinical outcome Therefore PKC expression profiling may identify patients elevated risk relapse disease progression Since many patients diagnosed early stage cancer eventually relapse PKC expression profiling may useful identifying high risk patients would candidates aggressive clinical management perhaps discussed PKCtargeted therapy PKC target frequent tumorspecific gene amplification DNA amplification one mechanism oncogenes activated neoplastic tissue PKC gene PRKCI resides chromosome q chromosomal region frequently amplified human cancers particularly squamous cell carcinomas Brass et al Heselmeyer et al Lin et al Racz et al Singh et al Therefore examined NSCLC tumors evidence changes PRKCI gene copy number Regala et al b PRKCI found amplified tumorspecific fashion NSCLC tumors examined Furthermore PRKCI amplification correlates PKC mRNA protein expression poor outcome NSCLC tumors Regala et al b Interestingly PRKCI amplification frequently found lung squamous cell carcinoma SCC rarely lung adenomcarcinoma LAC Regala et al b consistent distribution chromosome q amplification tumor types confined SCC Balsara et al Brass et al Similar tumorspecific PRKCI amplification also observed ovarian cancers serous subtype Eder et al Zhang et al esophageal squamous cell cancer Yang et al PKC expression PRKCI copy number also correlate chromosome q gains tumors Eder et al Yang et al Zhang et al indicating PKC relevant target tumorspecific chromosome q amplification Since chromosome q amplification one common chromosomal changes human cancers including SCC head neck Snaddon et al cervix Sugita et al likely PKC expression gene copy number prognostic significance tumors well PRKCI amplification mechanism PKC expression elevated human tumors PKC expression elevated degree frequency lung SCC LAC tumors despite fact PKC gene amplification largely confined SCC tumors Regala et al b Furthermore PKC frequently overexpressed tumor types including colon cancers Murray et al pancreatic cancers Scotti et al leukemia Gustafson et al harbor frequent chromosome q amplification recently demonstrated BcrAbl transcriptionally activates PKC RasMekdependent activation specific Elk element within proximal PKC promoter chronic myelogenous leukemia CML cells Gustafson et al similar mechanism likely play LAC pancreatic ductal adenocarcinoma PDAC tumors harbor oncogenic KRAS mutations Indeed observed statistically significant positive correlation presence KRAS mutation PKC expression primary LAC tumors unpublished observations Likewise PDAC tumors harbor KRAS mutation Klimstra Longnecker detected PKC overexpressed tumors Scotti et al Another potential mechanism oncogenic activation PKC somatic mutation However sequence analysis exons PKC gene LAC cases SCC cases failed detect mutations suggesting somatic mutation PKC either occur extremely rare NSCLC unpublished observations summary PKC first date PKC isozyme shown bonafide human oncogene Regala et al b Current evidence strongly supports oncogenic role PKC NSCLC PDAC ovarian cancer glioma Given widespread overexpression PKC major tumor types appears likely PKC shown oncogene many tumor types well II PKC Cellular Transformation PKC survival gene human cancer first demonstration PKC important transformed phenotype human cancer cells came studies CML cells Murray Fields CML cells highly resistant apoptotic effects numerous chemotherapeutic agents result expression chimeric tyrosine kinase oncogene BcrAbl transforming activity causes CML Bedi et al found BcrAblpositive CML cells express high levels PKC PKC activated response apoptotic stimuli treatment chemotherapeutic agent paclitaxel Jamieson et al Disruption PKC expression activity sensitized CML cells induction paclitaxelinduced apoptosis Murray Fields Subsequent studies established similar role PKC survival chemoresistance tumor cell types including prostate Win AcevedoDuncan NSCLC Jin et al glioblastoma Baldwin et al PKC oncogenic ras mediated transformation intestinal epithelial cells Studies mouse fibroblasts first established functional link aPKCs cellular Ras Ras activate aPKCs DiazMeco et al aPKC activity necessary Rasmediated effects actinbased cytoskeleton fibroblasts Bjorkoy et al Coghlan et al Kampfer et al Uberall et al Since oncogenic Ras signaling drive colon carcinogenesis oncogenic Ras mutations detected colon cancers Slattery et al Takayama et al investigated role PKC Ras mediated transformation rat intestinal epithelial RIE cells Murray et al found oncogenic Ras activates PKC introduced nontransformed RIE cells expression kinasedeficient dominant negative PKC mutant kdPKC Ras transformed RIE cells inhibits Ras mediated invasion anchorageindependent growth Murray et al results provided direct evidence PKC involved establishment transformed phenotype Ras epithelial cells PKC required maintenance transformed phenotype cancer cells PKC plays key role transformation induced introduction oncogenic Ras nontransformed epithelial cells also maintenance transformed phenotype established human cancer cells harboring oncogenic KRAS mutations Frederick et al Regala et al Scotti et al Expression kdPKC knock PKC expression using lentiviralmediated shRNA blocked transformed anchorageindependent growth invasion human NSCLC cells Frederick et al Regala et al human PDAC cells Scotti et al Genetic disruption PKC also blocks proliferative invasive properties prostate glioma cell lines vitro Baldwin et al Ishiguro et al Patel et al Disruption PKC expression also blocks tumorigenicity NSCLC PDAC cell tumors injected either subcutaneously orthotopically lung pancreas respectively Regala et al Scotti et al Analysis human PDAC cells orthotopic injection mouse pancreas revealed PKCdeficient tumor cells yielded significantly smaller tumors significantly fewer metastases kidney liver diaphragm mesentery providing first evidence PKC important tumor metastasis vivo Scotti et al role PKC transformed growth restricted cell harboring oncogenic KRAS mutations since NSCLC cell lines expressing wildtype KRAS harboring PRKCI amplification also require PKC transformed phenotype Regala et al Regala et al b III PKC Tumorigenesis vivo PKC necessary oncogenic Kras mutant APC mediated intestinal tumorigenesis Several transgenic models tumorigenesis revealed PKC plays critical promotive role tumorigenesis vivo established mice either kdPKC constitutively active caPKC PKC expressed specifically intestinal epithelium Murray et al Expression either PKC mutant demonstrable effect basal proliferation differentiation colonic epithelium Murray Fields Murray et al However expression caPKC colon increased susceptibility carcinogen azoxymethane AOMinduced formation colonic preneoplastic lesions aberrant crypt foci ACF whereas expression kdPKC significantly inhibited AOMinduced ACF formation Murray et al addition caPKC mice exhibited increase number AOMinduced colon tumors majority tumors mice progressed benign adenoma malignant intramucosal carcinoma Murray et al Similar results obtained vivo model oncogenic Kras mediated colon carcinogenesis Kras LA mouse Johnson et al Expression kdPKC colonic epithelium mice inhibited oncogenic Kras mediated ACF formation Murray et al data demonstrated PKC required oncogenic Kras mediated transformation intestinal epithelium vivo constitute first evidence function role PKC tumorigenesis vivo Interestingly PKC also elevated intestinal tumors formed Apc Min mice Murray et al Oster Leitges determine PKC plays role tumor development Apc Min mice mouse PKC gene Prkci inactivated intestinal epithelium triple transgenic Apc Min Prkci ff villinCre mice Cremediated recombination Apc Min Prkci ff villinCre mice exhibited loss intestinal epithelial PKC expression significant decrease number intestinal tumors compared Apc Min Prkci ff mice harbor intact alleles Prkci gene Murray et al Thus PKC important Apc Min induced intestinal epithelial tumorigenesis indicating role PKC colon tumorigenesis vivo limited Kras mediated tumors Role PKC initiation lung tumorigenesis PKC cancer stem cell gene PKC oncogene required maintenance transformed phenotype nonsmall cell lung cancer NSCLC cells Frederick et al Regala et al Regala et al b address whether PKC involved lung tumor development established mouse model oncogenic Kras GD activated Cremediated recombination lung without simultaneous genetic loss mouse PKC gene Prkci Regala et al Genetic loss Prkci dramatically inhibits Kras initiated hyperplasia subsequent lung tumor formation vivo effect correlates defect ability Prkci deficient bronchioalveolar stem cells BASCs undergo Kras mediated expansion morphological transformation vitro vivo Regala et al BASC exhibit stemlike properties thought tumorinitiating cells model Kras mediated lung tumorigenesis Jackson et al Thus Prkci required oncogeneinduced expansion transformation tumorinitiating lung stemlike cells studies suggest PKC may serve critical role cancer stem cell biology Whether PKC plays similar role maintenance cancer stem cell niche human cancers remains important topic future study IV Oncogenic PKC Signaling Mechanisms PKCmediated survival signaling PKC activates multiple survival pathways confer resistance apoptosis induced many stimuli including TNF carcinogens chemotherapeutic agents Figure PKC sufficient mediate antiapoptotic effects BcrAbl via transactivation NFB Jamieson et al Lu et al Interestingly CML cells BcrAbl induces PKC expression RasMekdependent pathway involving functional Elk transcription factor binding site within proximal promoter PKC Gustafson et al Thus BcrAbl appears regulate PKC multiple levels induce chemoresistant phenotype BcrAbl induce PKC expression PKC key effector BcrAblmediated survival signaling PKCmediated survival TNFtreated prostate cancer cells also mediated NFBdependent mechanism prostate cancer cells PKCmediated phosphorylation IK leads activation canonical NFB pathway cell survival Win AcevedoDuncan glioblastoma cells PKCmediated survival appears result PKCinduced attenuation p mitogenactivated protein kinase signaling protects cells cytotoxicity caused chemotherapeutic agents Baldwin et al NSCLC cells ability PKC enhance resistance NNKinduced apoptosis appears mediated Srcdependent activation PKC phosphorylates proapoptotic protein BAD Jin et al Therefore PKC activate multiple signaling pathways promote cell survival different tumor cell types Open separate window Figure Schematic representation key oncogenic PKC signaling pathways PKC resides within several major signaling pathways implicated human cancer PKC activated known oncogenes Ras BcrAbl Src PIK cytokines TNF IL growth factors NGF EGF PKC signals downstream effectors Rac NFB important different aspects transformed phenotype Many components PKCdependent signal pathways mutated often multiple mechanisms ie gene amplification somatic mutation human tumors indicated yellow boxes Arrows indicate flow signaling pathways touching boxes indicate direct binding signaling components Phosphorylation events indicated circled Ps Rac critical downstream effector oncogenic PKC Rho family GTPase Rac activated oncogenic Ras essential Ras mediated transformed growth cellular invasion fibroblasts KhosraviFar et al Qiu et al PKC necessary Ras mediated Rac activation RIE cells Murray et al thus kdPKC blocks oncogenic Ras mediated Rac activation expression constitutively active Rac allele RacV overcomes dnPKCmediated inhibition cellular invasion Murray et al studies placed PKC downstream oncogenic Kras upstream critical Kras effector Rac activates MekErk signaling axis drive transformed growth also mediates cytoskeletal rearrangement involved cellular invasion Murray et al Figure Rac also critical downstream target Kras mediated PKCdependent transformation NSCLC Regala et al PDAC Scotti et al NSCLC PDAC cells KRAS activates PKCRacPakMekErk signaling axis drives transformed growth vitro tumorigenicity vivo Regala et al Scotti et al Interestingly Rac also plays critical role downstream oncogenic PKC NSCLC cells harbor mutant KRAS indicating PKCRac signaling specific mutant KRAS mediated transformation Regala et al Regala et al b Expression RacV reconstituted cellular invasion anchorageindependent growth PKCdeficient NSCLC PDAC cells Mekdependent manner Regala et al Scotti et al Thus Rac critical downstream effector oncogenic PKC multiple cancer cell types restricted tumor cells harboring KRAS mutations role PB domain PKC oncogenic signaling Nterminal regulatory domain aPKCs unique contains PhoxBem PB domain mediates homo heterotypic proteinprotein interactions critical activation intracellular localization Lamark et al Par PB domaincontaining protein binds atypical PKCs via PBPB domain interactions EtienneManneville Hall Wilson et al Par links atypical PKC cell polarity forming complex atypical PKC Rho family GTPase Rac cdc EtienneManneville Hall Joberty et al Lin et al Noda et al Qiu et al Suzuki et al Suzuki et al Since Rac critical downstream effector oncogenic PKC multiple cell types including colon lung pancreas Murray et al Regala et al Scotti et al assessed role PB domain PKC Rac activation NSCLC cell transformation Regala et al Expression PB domain PKC NSCLC cells uncouples PKC Par Rac activation inhibits transformed growth Likewise RNAimediated knock PKC Par Rac inhibits transformed growth cellular invasion NSCLC cancer cells Frederick et al Expression wildtype PKC PKC knock cells restores transformation whereas expression PB domain mutant PKC PKCDA bind Par Frederick et al Similarly expression wild type Par Par knock cells restores transformation whereas expression Par mutants either bind PKC ParKA couple Rac ParCRIB Frederick et al Expression RacV PKC Pardepleted NSCLC cells restores transformed growth cellular invasion Frederick et al PKCPar complex functions activate RacMekErk signaling axis drives transformed growth NSCLC cells Frederick et al studies defined novel PKCPar complex required NSCLC transformation Figure Ect binds activates PKCPar complex identified Rac critical downstream effector oncogenic PKCPar complex key question became complex activate Rac address question utilized proteomics approach identify proteins associate PKCPar complex NSCLC cells Justilien Fields Rho family GTPase guanine nucleotide exchange factor GEF Ect identified prominent component PKCPar complex Fields Justilien Justilien Fields RNAimediated knock Ect inhibits Rac activity blocks transformed growth invasion tumorigenicity NSCLC cells whereas expression RacV restores transformation Ectdeficient cells Justilien Fields Interestingly role Ect NSCLC transformation distinct wellestablished role cytokinesis fact NSCLC cells appear acquired Ectindependent cytokinesis mechanism resembles described fibrosarcoma H cells Kanada et al Rather NSCLC cells Ect mislocalized cytoplasm binds PKCPar complex Knock either PKC Par causes redistribution Ect nucleus loss transformed growth invasion Therefore Ect PKC drive tumor cell proliferation formation oncogenic PKCParEct complex Interestingly Ect gene ECT resides chromosome q close proximity PRKCI Studies primary NSCLC tumors demonstrated PRKCI ECT coamplified overexpressed NSCLC Justilien Fields Thus Ect PKC genetically linked coordinate gene amplification NSCLC tumors biochemically functionally linked NSCLC transformation formation oncogenic PKCParEct complex drives NSCLC cell transformation activating Rac Figure Justilien Fields MMP critical downstream effector oncogenic PKCParRac signaling axis recently carried genomic analysis identify genes whose expression modulated RNAimediated knock PKC NSCLC cells matrix metalloproteinase MMP stromolysin emerged analysis genomic target PKC Frederick et al Depletion PKC Par Rac RNAi inhibits MMP expression NSCLC cells expression exogenous wildtype Par Par knock cells restored MMP expression whereas expression Par mutants either bind PKC Rac indicating role PKCParRac complex MMP expression RNAimediated knock MMP blocks anchorageindependent growth cell invasion NSCLC cells loss transformed growth invasion PKC knock Par knock NSCLC cells rescued addition catalytically active MMP Frederick et al Taken together data defined PKCParRacPakMekErk signaling axis drives anchorageindependent growth invasion NSCLC cells least part induction MMP expression Frederick et al Interestingly analysis primary human lung tumor specimens demonstrated strong correlation PKC MMP expression primary NSCLC tumors suggesting role PKCParRacPakMekErkMMP signaling axis primary human lung cancers Frederick et al molecular mechanism PKCmediated overexpression MMP promotes transformation currently unexplored merits investigation second genomic study conducted metaanalysis gene expression primary lung adenocarcinomas LAC three independent public domain datasets Erdogan et al analysis identified four genes COPB ELF RFC PLS whose expression correlates positively PKC primary LAC tumors three databases QPCR analysis primary LAC samples showed four genes highly overexpressed tumors exhibit strong positive correlation PKC expression Erdogan et al RNAimediated knock PKC LAC cell lines demonstrated PKC regulates expression genes Furthermore RNAimediated knock genes led significant inhibition anchorageindependent growth cellular invasion demonstrating important transformation LAC cells Erdogan et al Finally metaanalysis revealed subsets PKCregulated genes coordinately overexpressed PKC major tumor types including lung squamous cell carcinoma breast colon prostate pancreatic glioblastoma cancers Erdogan et al analysis revealed novel signaling mechanisms participate PKCmediated transformation Figure provide potentially useful biomarkers PKCmediated signaling may serve targets development novel prognostic markers andor therapeutic agents V PKC Therapeutic Target Treatment Cancer PBPB domain interaction PKC Par highly specific required oncogenic PKCParRacMMP signaling axis mediates anchorageindependent growth invasion human NSCLC cells vitro tumorigenicity vivo Frederick et al Therefore reasoned interaction attractive target development novel mechanismbased therapeutics treatment NSCLC Using novel fluorescence resonance energy transfer FRETbased assay identified small molecular weight compounds disrupt PBPB domain interaction PKC Par StallingsMann et al Among potent inhibitors identified goldcontaining compounds aurothioglucose ATG aurothiomalate ATM FDAapproved treatments rheumatoid arthritis Messori Marcon ATG ATM exhibit dosedependent inhibition PKCPar binding IC StallingsMann et al Treatment NSCLC cells compounds inhibits PKCmediated Rac activation blocks anchorageindependent growth NSCLC cells vitro tumorigenicity vivo StallingsMann et al inhibition rescued expression RacV indicating ATM targets interaction PKC Par couples PKC Rac StallingsMann et al precise mechanism action ATG ATM RA still unknown however proposed mechanism action formation goldcysteine adducts target cellular proteins Bratt et al Jeon et al Pia Rigobello et al Yamashita et al PB domain atypical PKCs contains unique cysteine residue Cys within conserved OPR PC AID OPCA motif crystal structure PKCPar complex resides binding interface PKC Par Hirano et al Lamark et al Mutation Cys isoleucine CI valine CV amino acids frequently reside position PB domains preserves Par binding makes PKC resistant inhibitory effects ATM Par binding vitro Erdogan et al Expression CI PKC mutant NSCLC cells supports transformed growth renders cells resistant inhibitory effects ATM transformed growth Erdogan et al Thus ATM inhibits PKCPar interactions vitro vivo blocks NSCLC cell transformation targeting Cys within PB domain PKC Given clinical potential ATM therapeutic agent assessed inhibitory efficacy ATM transformed growth cell lines representing major subtypes lung cancer including lung adenocarcinoma LAC lung squamous cell carcinoma LSCC large cell carcinoma LCC small cell lung carcinoma SCLC Regala et al ATM potently inhibited anchorageindependent growth lines tested IC ranging nM lung cancer cell lines clustered highly sensitive ATM IC relatively insensitive ATM IC Interestingly ATM sensitivity correlate tumor subtype KRAS mutation status sensitivity panel standard chemotherapeutic agents frequently used treat lung cancer patients including cisplatin placitaxel gemcitabine Regala et al Rather elevated PKC expression major molecular characteristic exhibited lung cancer cells responsive ATM Regala et al Consistent vitro observations ATM inhibits tumorigenicity sensitive insensitive lung cell tumors vivo plasma drug concentrations consistent ATM IC cell lines vitro Furthermore measurements plasma drug concentrations demonstrated sensitive well insensitive cell lines exhibit antitumor response ATM plasma levels routinely achieved RA patients undergoing ATM therapy Regala et al Thus ATM exhibits antitumor activity major lung cancer subtypes particularly tumor cells express high levels PKC PKC expression profiling revealed significant subset primary NSCLC tumors express PKC level associated ATM sensitivity vitro Regala et al Therefore PKC expression profiling lung tumor samples may useful identifying lung cancer patients likely respond ATM therapy addition fact PKC overexpressed many tumor types see Table suggest ATM may effective treatment option tumor types well Several phase phase II clinical trials currently accruing Mayo Clinic determine appropriate dosing regimen ATM assess antitumor activity ATM alone combination targeted therapeutic agents NSCLC ovarian cancer pancreatic cancer SummaryFuture Directions Accumulating evidence demonstrates PKC oncogene frequently targeted genetic alteration many major forms human cancer Tables Functional data indicate PKC required transformed phenotype NSCLC pancreatic ovarian prostate colon brain cancer cells Future studies required determine whether PKC also oncogene cancers Studies PKC using genetically defined models tumorigenesis revealed critical role PKC multiple stages tumorigenesis including tumor initiation progression metastasis Recent studies genetic model lung adenocarcinoma suggest role PKC transformation lung cancer stem cells studies important implications therapeutic use ATM particularly future studies validate PKC important gene critical cancer stem cell niche Significant progress made determining molecular mechanisms PKC drives transformed phenotype particularly central role played oncogenic PKCPar complex transformed growth invasion several PKCdependent survival pathways chemoresistance Future studies required determine composition dynamics PKCPar complex mechanisms oncogenic signaling complex regulated Likewise better understanding critical downstream effectors PKC various human tumor types holds promise identification novel prognostic surrogate markers oncogenic PKC activity may clinically useful ongoing clinical trials ATM studies also hold promise revealing novel therapeutic targets Similarly complete understanding signaling mechanisms Kras possibly oncogenes regulate PKC expression human tumors may reveal new therapeutic intervention strategies Ultimately ongoing future clinical trials required establish usefulness ATM antitumor agent allow validation potential surrogate markers predictors therapeutic response PKCdirected therapy identified preclinical models Acknowledgments authors wish thank members Fields Murray laboratories key contributions data described review authors apologize colleagues whose important contributions area cited though attempted cite much relevant literature possible space limitations made comprehensive citation impossible Work laboratories discussed article supported grants APF National Institutes Health CA American Lung AssociationLUNGevity V Foundation Cancer Research James Esther King Biomedical Research Program Mayo Foundation NRM National Institutes Health CA Mayo Clinic SPORE Pancreatic Cancer Career Development award P CA NR Murray References Baldwin RM GarrattLalonde Parolin DA Krzyzanowski PM Andrade Lorimer IA Protection glioblastoma cells cisplatin cytotoxicity via protein kinase Ciotamediated attenuation p MAP kinase signaling Oncogene PubMed Google Scholar Baldwin RM Parolin DAE Lorimer IAJ Regulation glioblastoma cell invasion PKCiota RhoB Oncogene PubMed Google Scholar Balsara BR Sonoda G du Manoir Siegfried JM Gabrielson E Testa JR Comparative genomic hybridization analysis detects frequent often highlevel overrepresentation DNA sequences q p p q human nonsmall cell lung carcinomas Cancer Res PubMed Google Scholar Bedi Barber JP Bedi GC elDeiry WS Sidransky Vala MS Akhtar AJ Hilton J Jones RJ BCRABLmediated inhibition apoptosis delay GM transition DNA damage mechanism resistance multiple anticancer agents Blood PubMed Google Scholar Bjorkoy G Perander Overvatn Johansen Reversion Ras phosphatidylcholinehydrolyzing phospholipase Cmediated transformation NIH cells dominant interfering mutant protein kinase C lambda accompanied loss constitutive nuclear mitogenactivated protein kinaseextracellular signalregulated kinase activity J Biol Chem PubMed Google Scholar Brass N Racz Heckel Remberger K Sybrecht GW Meese EU Amplification genes BCHE SLCA squamous cell carcinoma lung Cancer Res PubMed Google Scholar Brass N Ukena Remberger K Mack U Sybrecht GW Meese EU DNA amplification chromosome qq squamous cell carcinoma lung detected reverse chromosome painting Eur J Cancer PubMed Google Scholar Bratt J Belcher J Vercellotti GM Palmblad J Effects antirheumatic gold salts NFkappa B mobilization tumour necrosis factoralpha TNFalphainduced neutrophildependent cytotoxicity human endothelial cells Clin Exp Immunol PMC free article PubMed Google Scholar Castagna Takai Kaibuchi K Sano K Kikkawa U Nishizuka Direct activation calciumactivated phospholipiddependent protein kinase tumorpromoting phorbol esters J Biol Chem PubMed Google Scholar Chalmers AD Pambos Mason J Lang Wylie C Papalopulu N aPKC Crumbs Lgl control apicobasal polarity early vertebrate development Development PubMed Google Scholar Coghlan MP Chou MM Carpenter CL Atypical protein kinases Clambda zeta associate GTPbinding protein Cdc mediate stress fiber loss Mol Cell Biol PMC free article PubMed Google Scholar Dempsey EC Newton AC MochlyRosen Fields AP Reyland Insel PA Protein kinase C isozymes regulation diverse cell responses J Physiol PubMed Google Scholar DiazMeco MT Lozano J Municio MM Berra E Frutos Sanz L Moscat J Evidence vitro vivo interaction Ras protein kinase C zeta J Biol Chem PubMed Google Scholar Du GS Wang JM Lu JX Li Q CQ Du JT Zou SQ Expression PaPKCiota Ecadherin betacatenin related invasion metastasis hepatocellular carcinoma Ann Surg Oncol PubMed Google Scholar Dyrskjot L Kruhoffer Thykjaer Marcussen N Jensen JL Moller K Orntoft TF Gene expression urinary bladder common carcinoma situ gene expression signature exists disregarding histopathological classification Cancer Res PubMed Google Scholar Eder Sui X Rosen DG Nolden LK Cheng KW Lahad JP KangoSingh Lu KH Warneke CL Atkinson EN Bedrosian Keyomarsi K Kuo Wl Gray JW Yin JCP Liu J Halder G Mills GB Atypical PKCiota contributes poor prognosis loss apicalbasal polarity Cyclin E overexpression ovarian cancer PNAS PMC free article PubMed Google Scholar Erdogan E Klee EW Thompson EA Fields AP Metaanalysis oncogenic protein kinase Ciota signaling lung adenocarcinoma Clin Cancer Res PMC free article PubMed Google Scholar Erdogan E Lamark StallingsMann Lee J Pellecchia Thompson EA Johansen Fields AP Aurothiomalate inhibits transformed growth targeting PB domain protein kinase Ciota J Biol Chem PubMed Google Scholar EtienneManneville Hall Cell polarity Par aPKC cytoskeletal crosstalk Curr Opin Cell Biol PubMed Google Scholar Fields AP Gustafson WC Protein kinase C disease cancer Methods Mol Biol PubMed Google Scholar Fields AP Justilien V guanine nucleotide exchange factor GEF Ect oncogene human cancer Adv Enzyme Regul PMC free article PubMed Google Scholar Fields AP Murray NR Protein kinase C isozymes therapeutic targets treatment human cancers Adv Enzyme Regul PMC free article PubMed Google Scholar Frederick LA Matthews JA Jamieson L Justilien V Thompson EA Radisky DC Fields AP Matrix metalloproteinase critical effector protein kinase CiotaParalphamediated lung cancer Oncogene PMC free article PubMed Google Scholar Ginos Page GP Michalowicz BS Patel KJ Volker SE Pambuccian SE Ondrey FG Adams GL Gaffney PM Identification gene expression signature associated recurrent disease squamous cell carcinoma head neck Cancer Res PubMed Google Scholar GokmenPolar Fields AP Mapping molecular determinant protein kinase C betaII isozyme function J Biol Chem PubMed Google Scholar Gumz ML Zou H Kreinest PA Childs AC Belmonte LS LeGrand SN Wu KJ Luxon BA Sinha Parker Sun LZ Ahlquist DA Wood CG Copland JA Secreted frizzledrelated protein loss contributes tumor phenotype clear cell renal cell carcinoma Clin Cancer Res PubMed Google Scholar Gustafson WC Ray Jamieson L Thompson EA Brasier AR Fields AP BcrAbl regulates protein kinase Ciota PKCiota transcription via Elk site PKCiota promoter J Biol Chem PubMed Google Scholar Heselmeyer K Macville Schrock E Blegen H Hellstrom AC Shah K Auer G Ried Advancedstage cervical carcinomas defined recurrent pattern chromosomal aberrations revealing high genetic instability consistent gain chromosome arm q Genes Chromosomes Cancer PubMed Google Scholar Hirano Yoshinaga Ogura K Yokochi Noda Sumimoto H Inagaki F Solution structure atypical protein kinase C PB domain mode interaction ZIPp MEK J Biol Chem PubMed Google Scholar Ishiguro H Akimoto K Nagashima Kojima Sasaki IshiguroImagawa Nakaigawa N Ohno Kubota Uemura H aPKClambdaiota promotes growth prostate cancer cells autocrine manner transcriptional activation interleukin Proc Natl Acad Sci U PMC free article PubMed Google Scholar Jackson EL Willis N Mercer K Bronson RT Crowley Montoya R Jacks Tuveson DA Analysis lung tumor initiation progression using conditional expression oncogenic Kras Genes Dev PMC free article PubMed Google Scholar Jamieson L Carpenter L Biden TJ Fields AP Protein kinase Ciota activity necessary BcrAblmediated resistance druginduced apoptosis J Biol Chem PubMed Google Scholar Jansen AP Verwiebe EG Dreckschmidt NE Wheeler DL Oberley TD Verma AK Protein kinase Cepsilon transgenic mice unique model metastatic squamous cell carcinoma Cancer Res PubMed Google Scholar Jeon KI Jeong JY Jue DM Thiolreactive metal compounds inhibit NFkappa B activation blocking kappa B kinase J Immunol PubMed Google Scholar Jin Z Xin Deng X Survival function protein kinase Ciota novel nitrosamine methylnitrosaminopyridylbutanoneactivated bad kinase J Biol Chem PubMed Google Scholar Joberty G Petersen C Gao L Macara IG cellpolarity protein Par links Par atypical protein kinase C Cdc Nat Cell Biol PubMed Google Scholar Johnson L Mercer K Greenbaum Bronson RT Crowley Tuveson DA Jacks Somatic activation Kras oncogene causes early onset lung cancer mice Nature PubMed Google Scholar Justilien V Fields AP Ect links PKCiotaParalpha complex Rac activation cellular transformation Oncogene PMC free article PubMed Google Scholar Kampfer Windegger Hochholdinger F Schwaiger W Pestell RG Baier G Grunicke HH Uberall F Protein kinase C isoforms involved transcriptional activation cyclin transforming HaRas J Biol Chem PubMed Google Scholar Kanada Nagasaki Uyeda TQ Novel functions Ect polar lamellipodia formation polarity maintenance contractile ringindependent cytokinesis adherent cells Mol Biol Cell PMC free article PubMed Google Scholar KhosraviFar R Solski PA Clark GJ Kinch MS Der CJ Activation Rac RhoA mitogenactivated protein kinases required Ras transformation Mol Cell Biol PMC free article PubMed Google Scholar Kikkawa U Takai Tanaka Miyake R Nishizuka Protein kinase C possible receptor protein tumorpromoting phorbol esters J Biol Chem PubMed Google Scholar Klimstra DS Longnecker DS Kras mutations pancreatic ductal proliferative lesions J Pathol PMC free article PubMed Google Scholar Kojima Akimoto K Nagashima Ishiguro H Shirai Chishima Ichikawa Ishikawa Sasaki Kubota Inayama Aoki Ohno Shimada H overexpression altered localization atypical protein kinase C lambdaiota breast cancer correlates pathologic type tumors Hum Pathol PubMed Google Scholar Lamark Perander Outzen H Kristiansen K Overvatn Michaelsen E Bjorkoy G Johansen Interaction codes within family mammalian Phox Bemp domaincontaining proteins J Biol Chem PubMed Google Scholar Landi MT Dracheva Rotunno Figueroa JD Liu H Dasgupta Mann FE Fukuoka J Hames Bergen AW Murphy SE Yang P Pesatori AC Consonni Bertazzi PA Wacholder Shih JH Caporaso NE Jen J Gene expression signature cigarette smoking role lung adenocarcinoma development survival PLoS ONE e PMC free article PubMed Google Scholar Lee J Kotliarova Kotliarov Li Su Q Donin NM Pastorino Purow BW Christopher N Zhang W Park JK Fine HA Tumor stem cells derived glioblastomas cultured bFGF EGF closely mirror phenotype genotype primary tumors serumcultured cell lines Cancer Cell PubMed Google Scholar Li Q Wang JM Liu C Xiao BL Lu JX Zou SQ Correlation aPKCiota Ecadherin expression invasion prognosis cholangiocarcinoma Hepatobiliary Pancreat Dis Int PubMed Google Scholar Lin Edwards Fawcett JP Mbamalu G Scott JD Pawson mammalian PARPAR complex implicated CdcRac aPKC signalling cell polarity Nat Cell Biol PubMed Google Scholar Lin Smith LT Smiraglia DJ KazhiyurMannar R Lang JC Schuller DE Kornacker K Wenger R Plass C DNA copy number gains head neck squamous cell carcinoma Oncogene PubMed Google Scholar Lu Jamieson L Brasier AR Fields AP NFkappaBRelA transactivation required atypical protein kinase C iotamediated cell survival Oncogene PubMed Google Scholar Messori L Marcon G Gold complexes treatment rheumatoid arthritis Met Ions Biol Syst PubMed Google Scholar Mischak H Goodnight JA Kolch W MartinyBaron G Schaechtle C Kazanietz MG Blumberg PM Pierce JH Mushinski JF Overexpression protein kinase Cdelta epsilon NIH cells induces opposite effects growth morphology anchorage dependence tumorigenicity J Biol Chem PubMed Google Scholar Murray NR Davidson LA Chapkin RS Gustafson WC Schattenberg DG Fields AP Overexpression protein kinase C betaII induces colonic hyperproliferation increased sensitivity colon carcinogenesis J Cell Biol PMC free article PubMed Google Scholar Murray NR Fields AP Atypical protein kinase C iota protects human leukemia cells druginduced apoptosis J Biol Chem PubMed Google Scholar Murray NR Jamieson L Yu W Zhang J GokmenPolar Sier Anastasiadis P Gatalica Z Thompson EA Fields AP Protein kinase Ciota required Ras transformation colon carcinogenesis vivo J Cell Biol PMC free article PubMed Google Scholar Murray NR Weems J Braun U Leitges Fields AP Protein kinase C betaII PKCiotalambda collaborating partners colon cancer promotion progression Cancer Res PMC free article PubMed Google Scholar Noda Takeya R Ohno Naito Ito Sumimoto H Human homologues Caenorhabditis elegans cell polarity protein PAR adaptor links small GTPases Rac Cdc atypical protein kinase C Genes Cells PubMed Google Scholar Oster H Leitges Protein kinase C alpha PKCzeta suppresses intestinal tumor formation ApcMin mice Cancer Res PubMed Google Scholar Patel R Win H Desai Patel K Matthews JA AcevedoDuncan Involvement PKCiota glioma proliferation Cell Prolif PMC free article PubMed Google Scholar Pia Rigobello Messori L Marcon G Agostina Cinellu Bragadin Folda Scutari G Bindoli Gold complexes inhibit mitochondrial thioredoxin reductase consequences mitochondrial functions J Inorg Biochem PubMed Google Scholar Qiu RG Abo Steven Martin G human homolog C elegans polarity determinant Par links Rac Cdc PKCzeta signaling cell transformation Curr Biol PubMed Google Scholar Qiu RG Chen J Kirn McCormick F Symons essential role Rac Ras transformation Nature PubMed Google Scholar Racz Brass N Heckel Pahl Remberger K Meese E Expression analysis genes qq involved frequent amplification squamous cell lung carcinoma Eur J Cancer PubMed Google Scholar Regala RP Davis RK Kunz Khoor Leitges Fields AP Atypical protein kinase Ciota required bronchioalveolar stem cell expansion lung tumorigenesis Cancer Res PMC free article PubMed Google Scholar Regala RP Thompson EA Fields AP Atypical protein kinase C iota expression aurothiomalate sensitivity human lung cancer cells Cancer Res PMC free article PubMed Google Scholar Regala RP Weems C Jamieson L Copland JA Thompson EA Fields AP Atypical protein kinase Ciota plays critical role human lung cancer cell growth tumorigenicity J Biol Chem PubMed Google Scholar Regala RP Weems C Jamieson L Khoor Edell ES Lohse CM Fields AP Atypical protein kinase C iota oncogene human nonsmall cell lung cancer Cancer Res b PubMed Google Scholar Reyland Protein kinase C isoforms Multifunctional regulators cell life death Front Biosci PMC free article PubMed Google Scholar Richardson AL Wang ZC De Nicolo Lu X Brown Miron Liao X Iglehart JD Livingston DM Ganesan X chromosomal abnormalities basallike human breast cancer Cancer Cell PubMed Google Scholar SanchezCarbayo Socci ND Lozano J Saint F CordonCardo C Defining molecular profiles poor outcome patients invasive bladder cancer using oligonucleotide microarrays J Clin Oncol PubMed Google Scholar Scotti ML Bamlet W Smyrk TC Fields AP Murray NR Protein kinase C iota required pancreatic cancer cell transformed growth tumorigenesis Cancer Res PMC free article PubMed Google Scholar Segara Biankin AV Kench JG Langusch CC Dawson AC Skalicky DA Gotley DC Coleman MJ Sutherland RL Henshall SM Expression HOXB retinoic acid signaling target pancreatic cancer pancreatic intraepithelial neoplasia Clin Cancer Res PubMed Google Scholar Singh B Stoffel Gogineni Poluri Pfister DG Shaha AR Pathak Bosl G CordonCardo C Shah JP Rao PH Amplification q locus associated progression invasive cancer negative prognostic factor head neck squamous cell carcinomas J Pathol PMC free article PubMed Google Scholar Slattery ML Anderson K Curtin K K Schaffer Edwards Samowitz W Lifestyle factors Kiras mutations colon cancer tumors Mutat Res PubMed Google Scholar Snaddon J Parkinson EK Craft JA Bartholomew C Fulton R Detection functional PTEN lipid phosphatase protein enzyme activity squamous cell carcinomas head neck despite loss heterozygosity locus Br J Cancer PMC free article PubMed Google Scholar StallingsMann Jamieson L Regala RP Weems C Murray NR Fields AP novel smallmolecule inhibitor protein kinase Ciota blocks transformed growth nonsmallcell lung cancer cells Cancer Res PubMed Google Scholar Sugita Tanaka N Davidson Sekiya VarellaGarcia West J Drabkin HA Gemmill RM Molecular definition small amplification domain within q tumors cervix ovary lung Cancer Genet Cytogenet PubMed Google Scholar Suzuki Akimoto K Ohno Protein kinase C lambdaiota PKClambdaiota PKC isotype essential development multicellular organisms J Biochem Tokyo PubMed Google Scholar Suzuki Yamanaka Hirose Manabe N Mizuno K Shimizu Akimoto K Izumi Ohnishi Ohno Atypical protein kinase C involved evolutionarily conserved par protein complex plays critical role establishing epitheliaspecific junctional structures J Cell Biol PMC free article PubMed Google Scholar Takagawa R Akimoto K Ichikawa Akiyama H Kojima Ishiguro H Inayama Aoki Kunisaki C Endo Nagashima Ohno High expression atypical protein kinase C lambdaiota gastric cancer prognostic factor recurrence Ann Surg Oncol PubMed Google Scholar Takayama Ohi Hayashi Miyanishi K Nobuoka Nakajima Satoh Takimoto R Kato J Sakamaki Niitsu Analysis Kras APC betacatenin aberrant crypt foci sporadic adenoma cancer familial adenomatous polyposis Gastroenterology PubMed Google Scholar Talantov Mazumder Yu JX Briggs Jiang Backus J Atkins Wang Novel genes associated malignant melanoma benign melanocytic lesions Clin Cancer Res PubMed Google Scholar Uberall F Hellbert K Kampfer Maly K Villunger Spitaler Mwanjewe J BaierBitterlich G Baier G Grunicke HH Evidence atypical protein kinase Clambda atypical protein kinase Czeta participate Rasmediated reorganization Factin cytoskeleton J Cell Biol PMC free article PubMed Google Scholar Valk PJ Verhaak RG Beijen Erpelinck CA Barjesteh van Waalwijk van DoornKhosrovani Boer JM Beverloo HB Moorhouse MJ van der Spek PJ Lowenberg B Delwel R Prognostically useful geneexpression profiles acute myeloid leukemia N Engl J Med PubMed Google Scholar Wallace TA Prueitt RL Yi Howe TM Gillespie JW Yfantis HG Stephens RM Caporaso NE Loffredo CA Ambs Tumor immunobiological differences prostate cancer AfricanAmerican EuropeanAmerican men Cancer Res PubMed Google Scholar Weichert W Gekeler V Denkert C Dietel Hauptmann Protein kinase C isoform expression ovarian carcinoma correlates indicators poor prognosis Int J Oncol PubMed Google Scholar Wilson MI Gill DJ Perisic Quinn MT Williams RL PB domainmediated heterodimerization NADPH oxidase signaling complexes atypical protein kinase C Par p Mol Cell PubMed Google Scholar Win HY AcevedoDuncan Atypical protein kinase C phosphorylates IKKalphabeta transformed nonmalignant malignant prostate cell survival Cancer Lett PubMed Google Scholar Wurmbach E Chen YB Khitrov G Zhang W Roayaie Schwartz Fiel Thung Mazzaferro V Bruix J Bottinger E Friedman Waxman Llovet JM Genomewide molecular profiles HCVinduced dysplasia hepatocellular carcinoma Hepatology PubMed Google Scholar Yamashita Ashino Oshima Kawamura Ohuchi K Takayanagi Inhibition TPAinduced NFkappaB nuclear translocation production PGE antirheumatic gold compounds J Pharm Pharmacol PubMed Google Scholar Yang YL Chu JY Luo ML Wu YP Zhang Feng YB Shi ZZ Xu X Han YL Cai Dong JT Zhan QM Wu Wang MR Amplification PRKCI located q associated lymph node metastasis esophageal squamous cell carcinoma Genes Chromosomes Cancer PubMed Google Scholar Ye H Yu Temam Ziober BL Wang J Schwartz JL Mao L Wong DT Zhou X Transcriptomic dissection tongue squamous cell carcinoma BMC Genomics PMC free article PubMed Google Scholar Zhang L Huang J Yang N Liang Barchetti Giannakakis Cadungog MG OBrienJenkins Massobrio Roby KF Katsaros Gimotty P Butzow R Weber BL Coukos G Integrative genomic analysis protein kinase C PKC family identifies PKCiota biomarker potential oncogene ovarian carcinoma Cancer Res PubMed Google Scholar Journal List HHS Author Manuscripts PMC Journal List HHS Author Manuscripts PMC Journal List Journal List HHS Author Manuscripts HHS Author Manuscripts PMC library NLM provides access scientific literature Inclusion NLM database imply endorsement agreement contents NLM National Institutes Health Learn disclaimer Learn disclaimer J Cell Physiol Author manuscript available PMC Apr Published final edited form J Cell Physiol Apr doi jcp PMCID PMC NIHMSID NIHMS PMID Protein Kinase C Expression Oncogenic Signaling Mechanisms Cancer Nicole R Murray Krishna R Kalari Alan P Fields Nicole R Murray Department Cancer Biology Mayo Clinic Comprehensive Cancer Center Jacksonville Florida Find articles Nicole R Murray Krishna R Kalari Department Cancer Biology Mayo Clinic Comprehensive Cancer Center Jacksonville Florida Find articles Krishna R Kalari Alan P Fields Department Cancer Biology Mayo Clinic Comprehensive Cancer Center Jacksonville Florida Find articles Alan P Fields Author information Copyright License information Disclaimer Department Cancer Biology Mayo Clinic Comprehensive Cancer Center Jacksonville Florida correspondences addressed Alan P Fields PhD Mayo Clinic College Medicine Griffin Cancer Research Building Rm San Pablo Road Jacksonville Florida office fax udeoyamnalasdleif Copyright notice Abstract Accumulating evidence demonstrates PKC oncogene prognostic marker frequently targeted genetic alteration many major forms human cancer Functional data demonstrate PKC required transformed phenotype NSCLC pancreatic ovarian prostate colon brain cancer cells Future studies required determine whether PKC also oncogene many cancer types also overexpress PKC Studies PKC using genetically defined models tumorigenesis revealed critical role PKC multiple stages tumorigenesis including tumor initiation progression metastasis Recent studies genetic model lung adenocarcinoma suggest role PKC transformation lung cancer stem cells studies important implications therapeutic use aurothiomalate ATM highly selective PKC signaling inhibitor currently undergoing clinical evaluation Significant progress made determining molecular mechanisms PKC drives transformed phenotype particularly central role played oncogenic PKCPar complex transformed growth invasion several PKCdependent survival pathways chemoresistance Future studies required determine composition dynamics PKCPar complex mechanisms oncogenic signaling complex regulated Likewise better understanding critical downstream effectors PKC various human tumor types holds promise identifying novel prognostic surrogate markers oncogenic PKC activity may clinically useful ongoing clinical trials ATM Keywords tumorigenesis gene amplification signal trandsuction invasion metastasis aurothiomalate Introduction Protein kinase C PKC family structurally related serinethreonine protein kinases whose catalytic activity regulated interaction phospholipid cofactors inter intramolecular phosphorylation specific proteinprotein interactions PKC enzyme family divided three subgroups conventional calciumdependent cPKCs alpha beta beta II II gamma novel calciumindependent nPKCs delta epsilon eta theta atypical aPKCs zeta iota also known lambda mice grouping based presence absence functional domains confer specific cofactor activator requirements Conventional PKCs calcium diacylglycerol DAG phosphatidylserinedependent due presence conserved modular C C domains within regulatory region enzyme Novel PKCs DAG phosphatidylserinedependent require calcium Due unique structure Nterminal regulatory region atypical PKCs require calcium DAG phosphatidylserine activation Biochemical immunologic studies indicate multiple PKC isozymes expressed virtually cell tissue types reviewed Fields Murray expression individual PKC isozymes developmentally regulated responsive differentiation state cells tissues reasons PKC isozymes thought fulfill distinct nonredundant functions within cell reviewed Dempsey et al Reyland However similar activator requirements substrate specificities PKC isozymes vitro complicated identification physiologically relevant isozymespecific substrates cellular functions ability genetically manipulate expression specific PKC isozyme express mutant forms individual PKC isozymes altered kinase activity proven successful identifying PKC isozymespecific functions Using genetic techniques many laboratories including demonstrated isozyme cell typespecific roles PKC cellular proliferation differentiation apoptosis cell polarity Chalmers et al GokmenPolar Fields Jansen et al Mischak et al Murray et al Oster Leitges discovery PKC cellular receptor tumorpromoting phorbol esters led intense interest role individual PKC isozymes cancer development Castagna et al Kikkawa et al Indeed expression level cellular localization individual PKC isozymes shown altered carcinogenesis numerous tissue types reviewed Fields Gustafson However despite exhaustive investigation somatic germline mutations found coding regions PKCs associated human cancers diseases date one PKC isozyme atypical PKC shown satisfy criteria human oncogene minireview details work laboratory others characterizing role oncogenic PKC rodent carcinogenesis models human cancer also discuss status efforts therapeutically target critical oncogene treatment cancer patients PKC Expression Primary Human Tumors PKC overexpressed prognostic multiple human cancer types Overexpression PKC demonstrated many human cancers Table PKC frequently overexpressed cancers lung Regala et al b pancreas Scotti et al stomach Takagawa et al colon Murray et al esophagus Yang et al liver Du et al bile duct Li et al breast Kojima et al ovary Eder et al Weichert et al Zhang et al prostate Ishiguro et al brain Patel et al addition published reports metaanalysis publicly available microarray data provides additional support overexpression PKC many tumor types including lung Landi et al breast Richardson et al pancreas Segara et al prostate Wallace et al ovary Cancer Genome Atlas liver Wurmbach et al Table Interestingly increased PKC brain cancer supported available genomic data sets Lee et al Table Analysis available microarray datasets revealed addition lung cancer Landi et al several squamoustype cancers also express elevated PKC including head neck Ginos et al tongue cancer Ye et al Significant overexpression PKC also detected renal cancer Gumz et al bladder cancer Dyrskjot et al SanchezCarbayo et al melanoma Talantov et al leukemia Valk et al Table studies strongly indicate role PKC many major forms human cancer TABLE PKC Expression Human Tumor Types Tumor type Tumor Control ppaired Type Analysis Result Reference Lung p blot qPCR IHC Elevated Amplified High PKC predicts poor survival Regala et al b PDAC p qPCR IHC Elevated High PKC predicts poor survival Scotti et al Gastric IHC Elevated High PKC predicts disease recurrence Takagawa et al Colon p blot Elevated Murray et al Esophageal IHC FISH Elevated Amplified gene amplification correlates tumor size stage LN metastasis High PKC predicts metastasis Yang et al Hepatocellular carcinoma p RTPCR IHC Elevated High PKC correlates size metastasis invasion stage Du et al Cholangiocarcinoma IHC Elevated High PKC correlates differentiation invasion LN metastasis stage Prognostic poor survival Li et al Breast IHC Elevated Kojima et al Ovarian IHC mRNA array CGH Elevated Amplified High PKC correlates stage Zhang et al Ovarian Array CGH qPCR IHC Elevated Amplified serous tumors high copy predicts poor survival nonserous tumors high PKC predicts poor survival Eder et al Ovarian IHC Elevated High PKC predicts poor survival Weichert et al Prostate p qPCR blot Elevated High PKC predicts poor recurrence free survival Ishiguro et al Brain blot Elevated Patel et al Open separate window TABLE PKC Expression Publicly Available Human Tumor Microarray Datasets Cancer Type Tumor Control Significant Tumor Pvalue Reference Head Neck Yes Ginos et al Tongue Yes Ye et al Lung Yes Landi et al Superficial Bladder Cancer SanChezCarbayo et al Infiltrating Bladder Urothelial Carcinoma Yes E SanChezCarbayo et al Superficial Bladder Cancer Yes E Dyrskjot et al Infiltrating Bladder Urothelial Carcinoma Yes E Dyrskjot et al Brain Lee et al Pancreas Yes E Segara et al Melanoma Yes E Talantov et al Ovarian Yes E TCGA Ovarian Published Liver HCC Yes E Wurmbach et al Breast Yes Richardson et al Prostate Yes Wallace et al Acute Myeloid Leukemia Yes Valk et al Renal Yes Gumz et al Open separate window tumor types examined PKC expression also shown prognostic significance High PKC predicts poor patient survival lung Regala et al b pancreatic Scotti et al bile duct Li et al ovarian Eder et al Weichert et al prostate Ishiguro et al cancer Elevated PKC expression predicts disease recurrence gastric cancer Takagawa et al metastasis esophageal cancer Yang et al analysis PKC expression lung cancer PKC emerged prognostic indicator comparable tumor stage prognostic value Interestingly PKC expression correlate tumor stage nonsmall cell lung cancer NSCLC rather PKC levels comparable early late stage disease indicating elevated PKC expression early event lung tumor development Regala et al b contrast PKC expression correlates tumor stage ovarian bile duct liver cancer suggesting PKC may regulate disease progression tumor types Du et al Li et al Zhang et al Thus PKC expression elevated variety tumor types many cases predictive poor clinical outcome Therefore PKC expression profiling may identify patients elevated risk relapse disease progression Since many patients diagnosed early stage cancer eventually relapse PKC expression profiling may useful identifying high risk patients would candidates aggressive clinical management perhaps discussed PKCtargeted therapy PKC target frequent tumorspecific gene amplification DNA amplification one mechanism oncogenes activated neoplastic tissue PKC gene PRKCI resides chromosome q chromosomal region frequently amplified human cancers particularly squamous cell carcinomas Brass et al Heselmeyer et al Lin et al Racz et al Singh et al Therefore examined NSCLC tumors evidence changes PRKCI gene copy number Regala et al b PRKCI found amplified tumorspecific fashion NSCLC tumors examined Furthermore PRKCI amplification correlates PKC mRNA protein expression poor outcome NSCLC tumors Regala et al b Interestingly PRKCI amplification frequently found lung squamous cell carcinoma SCC rarely lung adenomcarcinoma LAC Regala et al b consistent distribution chromosome q amplification tumor types confined SCC Balsara et al Brass et al Similar tumorspecific PRKCI amplification also observed ovarian cancers serous subtype Eder et al Zhang et al esophageal squamous cell cancer Yang et al PKC expression PRKCI copy number also correlate chromosome q gains tumors Eder et al Yang et al Zhang et al indicating PKC relevant target tumorspecific chromosome q amplification Since chromosome q amplification one common chromosomal changes human cancers including SCC head neck Snaddon et al cervix Sugita et al likely PKC expression gene copy number prognostic significance tumors well PRKCI amplification mechanism PKC expression elevated human tumors PKC expression elevated degree frequency lung SCC LAC tumors despite fact PKC gene amplification largely confined SCC tumors Regala et al b Furthermore PKC frequently overexpressed tumor types including colon cancers Murray et al pancreatic cancers Scotti et al leukemia Gustafson et al harbor frequent chromosome q amplification recently demonstrated BcrAbl transcriptionally activates PKC RasMekdependent activation specific Elk element within proximal PKC promoter chronic myelogenous leukemia CML cells Gustafson et al similar mechanism likely play LAC pancreatic ductal adenocarcinoma PDAC tumors harbor oncogenic KRAS mutations Indeed observed statistically significant positive correlation presence KRAS mutation PKC expression primary LAC tumors unpublished observations Likewise PDAC tumors harbor KRAS mutation Klimstra Longnecker detected PKC overexpressed tumors Scotti et al Another potential mechanism oncogenic activation PKC somatic mutation However sequence analysis exons PKC gene LAC cases SCC cases failed detect mutations suggesting somatic mutation PKC either occur extremely rare NSCLC unpublished observations summary PKC first date PKC isozyme shown bonafide human oncogene Regala et al b Current evidence strongly supports oncogenic role PKC NSCLC PDAC ovarian cancer glioma Given widespread overexpression PKC major tumor types appears likely PKC shown oncogene many tumor types well II PKC Cellular Transformation PKC survival gene human cancer first demonstration PKC important transformed phenotype human cancer cells came studies CML cells Murray Fields CML cells highly resistant apoptotic effects numerous chemotherapeutic agents result expression chimeric tyrosine kinase oncogene BcrAbl transforming activity causes CML Bedi et al found BcrAblpositive CML cells express high levels PKC PKC activated response apoptotic stimuli treatment chemotherapeutic agent paclitaxel Jamieson et al Disruption PKC expression activity sensitized CML cells induction paclitaxelinduced apoptosis Murray Fields Subsequent studies established similar role PKC survival chemoresistance tumor cell types including prostate Win AcevedoDuncan NSCLC Jin et al glioblastoma Baldwin et al PKC oncogenic ras mediated transformation intestinal epithelial cells Studies mouse fibroblasts first established functional link aPKCs cellular Ras Ras activate aPKCs DiazMeco et al aPKC activity necessary Rasmediated effects actinbased cytoskeleton fibroblasts Bjorkoy et al Coghlan et al Kampfer et al Uberall et al Since oncogenic Ras signaling drive colon carcinogenesis oncogenic Ras mutations detected colon cancers Slattery et al Takayama et al investigated role PKC Ras mediated transformation rat intestinal epithelial RIE cells Murray et al found oncogenic Ras activates PKC introduced nontransformed RIE cells expression kinasedeficient dominant negative PKC mutant kdPKC Ras transformed RIE cells inhibits Ras mediated invasion anchorageindependent growth Murray et al results provided direct evidence PKC involved establishment transformed phenotype Ras epithelial cells PKC required maintenance transformed phenotype cancer cells PKC plays key role transformation induced introduction oncogenic Ras nontransformed epithelial cells also maintenance transformed phenotype established human cancer cells harboring oncogenic KRAS mutations Frederick et al Regala et al Scotti et al Expression kdPKC knock PKC expression using lentiviralmediated shRNA blocked transformed anchorageindependent growth invasion human NSCLC cells Frederick et al Regala et al human PDAC cells Scotti et al Genetic disruption PKC also blocks proliferative invasive properties prostate glioma cell lines vitro Baldwin et al Ishiguro et al Patel et al Disruption PKC expression also blocks tumorigenicity NSCLC PDAC cell tumors injected either subcutaneously orthotopically lung pancreas respectively Regala et al Scotti et al Analysis human PDAC cells orthotopic injection mouse pancreas revealed PKCdeficient tumor cells yielded significantly smaller tumors significantly fewer metastases kidney liver diaphragm mesentery providing first evidence PKC important tumor metastasis vivo Scotti et al role PKC transformed growth restricted cell harboring oncogenic KRAS mutations since NSCLC cell lines expressing wildtype KRAS harboring PRKCI amplification also require PKC transformed phenotype Regala et al Regala et al b III PKC Tumorigenesis vivo PKC necessary oncogenic Kras mutant APC mediated intestinal tumorigenesis Several transgenic models tumorigenesis revealed PKC plays critical promotive role tumorigenesis vivo established mice either kdPKC constitutively active caPKC PKC expressed specifically intestinal epithelium Murray et al Expression either PKC mutant demonstrable effect basal proliferation differentiation colonic epithelium Murray Fields Murray et al However expression caPKC colon increased susceptibility carcinogen azoxymethane AOMinduced formation colonic preneoplastic lesions aberrant crypt foci ACF whereas expression kdPKC significantly inhibited AOMinduced ACF formation Murray et al addition caPKC mice exhibited increase number AOMinduced colon tumors majority tumors mice progressed benign adenoma malignant intramucosal carcinoma Murray et al Similar results obtained vivo model oncogenic Kras mediated colon carcinogenesis Kras LA mouse Johnson et al Expression kdPKC colonic epithelium mice inhibited oncogenic Kras mediated ACF formation Murray et al data demonstrated PKC required oncogenic Kras mediated transformation intestinal epithelium vivo constitute first evidence function role PKC tumorigenesis vivo Interestingly PKC also elevated intestinal tumors formed Apc Min mice Murray et al Oster Leitges determine PKC plays role tumor development Apc Min mice mouse PKC gene Prkci inactivated intestinal epithelium triple transgenic Apc Min Prkci ff villinCre mice Cremediated recombination Apc Min Prkci ff villinCre mice exhibited loss intestinal epithelial PKC expression significant decrease number intestinal tumors compared Apc Min Prkci ff mice harbor intact alleles Prkci gene Murray et al Thus PKC important Apc Min induced intestinal epithelial tumorigenesis indicating role PKC colon tumorigenesis vivo limited Kras mediated tumors Role PKC initiation lung tumorigenesis PKC cancer stem cell gene PKC oncogene required maintenance transformed phenotype nonsmall cell lung cancer NSCLC cells Frederick et al Regala et al Regala et al b address whether PKC involved lung tumor development established mouse model oncogenic Kras GD activated Cremediated recombination lung without simultaneous genetic loss mouse PKC gene Prkci Regala et al Genetic loss Prkci dramatically inhibits Kras initiated hyperplasia subsequent lung tumor formation vivo effect correlates defect ability Prkci deficient bronchioalveolar stem cells BASCs undergo Kras mediated expansion morphological transformation vitro vivo Regala et al BASC exhibit stemlike properties thought tumorinitiating cells model Kras mediated lung tumorigenesis Jackson et al Thus Prkci required oncogeneinduced expansion transformation tumorinitiating lung stemlike cells studies suggest PKC may serve critical role cancer stem cell biology Whether PKC plays similar role maintenance cancer stem cell niche human cancers remains important topic future study IV Oncogenic PKC Signaling Mechanisms PKCmediated survival signaling PKC activates multiple survival pathways confer resistance apoptosis induced many stimuli including TNF carcinogens chemotherapeutic agents Figure PKC sufficient mediate antiapoptotic effects BcrAbl via transactivation NFB Jamieson et al Lu et al Interestingly CML cells BcrAbl induces PKC expression RasMekdependent pathway involving functional Elk transcription factor binding site within proximal promoter PKC Gustafson et al Thus BcrAbl appears regulate PKC multiple levels induce chemoresistant phenotype BcrAbl induce PKC expression PKC key effector BcrAblmediated survival signaling PKCmediated survival TNFtreated prostate cancer cells also mediated NFBdependent mechanism prostate cancer cells PKCmediated phosphorylation IK leads activation canonical NFB pathway cell survival Win AcevedoDuncan glioblastoma cells PKCmediated survival appears result PKCinduced attenuation p mitogenactivated protein kinase signaling protects cells cytotoxicity caused chemotherapeutic agents Baldwin et al NSCLC cells ability PKC enhance resistance NNKinduced apoptosis appears mediated Srcdependent activation PKC phosphorylates proapoptotic protein BAD Jin et al Therefore PKC activate multiple signaling pathways promote cell survival different tumor cell types Open separate window Figure Schematic representation key oncogenic PKC signaling pathways PKC resides within several major signaling pathways implicated human cancer PKC activated known oncogenes Ras BcrAbl Src PIK cytokines TNF IL growth factors NGF EGF PKC signals downstream effectors Rac NFB important different aspects transformed phenotype Many components PKCdependent signal pathways mutated often multiple mechanisms ie gene amplification somatic mutation human tumors indicated yellow boxes Arrows indicate flow signaling pathways touching boxes indicate direct binding signaling components Phosphorylation events indicated circled Ps Rac critical downstream effector oncogenic PKC Rho family GTPase Rac activated oncogenic Ras essential Ras mediated transformed growth cellular invasion fibroblasts KhosraviFar et al Qiu et al PKC necessary Ras mediated Rac activation RIE cells Murray et al thus kdPKC blocks oncogenic Ras mediated Rac activation expression constitutively active Rac allele RacV overcomes dnPKCmediated inhibition cellular invasion Murray et al studies placed PKC downstream oncogenic Kras upstream critical Kras effector Rac activates MekErk signaling axis drive transformed growth also mediates cytoskeletal rearrangement involved cellular invasion Murray et al Figure Rac also critical downstream target Kras mediated PKCdependent transformation NSCLC Regala et al PDAC Scotti et al NSCLC PDAC cells KRAS activates PKCRacPakMekErk signaling axis drives transformed growth vitro tumorigenicity vivo Regala et al Scotti et al Interestingly Rac also plays critical role downstream oncogenic PKC NSCLC cells harbor mutant KRAS indicating PKCRac signaling specific mutant KRAS mediated transformation Regala et al Regala et al b Expression RacV reconstituted cellular invasion anchorageindependent growth PKCdeficient NSCLC PDAC cells Mekdependent manner Regala et al Scotti et al Thus Rac critical downstream effector oncogenic PKC multiple cancer cell types restricted tumor cells harboring KRAS mutations role PB domain PKC oncogenic signaling Nterminal regulatory domain aPKCs unique contains PhoxBem PB domain mediates homo heterotypic proteinprotein interactions critical activation intracellular localization Lamark et al Par PB domaincontaining protein binds atypical PKCs via PBPB domain interactions EtienneManneville Hall Wilson et al Par links atypical PKC cell polarity forming complex atypical PKC Rho family GTPase Rac cdc EtienneManneville Hall Joberty et al Lin et al Noda et al Qiu et al Suzuki et al Suzuki et al Since Rac critical downstream effector oncogenic PKC multiple cell types including colon lung pancreas Murray et al Regala et al Scotti et al assessed role PB domain PKC Rac activation NSCLC cell transformation Regala et al Expression PB domain PKC NSCLC cells uncouples PKC Par Rac activation inhibits transformed growth Likewise RNAimediated knock PKC Par Rac inhibits transformed growth cellular invasion NSCLC cancer cells Frederick et al Expression wildtype PKC PKC knock cells restores transformation whereas expression PB domain mutant PKC PKCDA bind Par Frederick et al Similarly expression wild type Par Par knock cells restores transformation whereas expression Par mutants either bind PKC ParKA couple Rac ParCRIB Frederick et al Expression RacV PKC Pardepleted NSCLC cells restores transformed growth cellular invasion Frederick et al PKCPar complex functions activate RacMekErk signaling axis drives transformed growth NSCLC cells Frederick et al studies defined novel PKCPar complex required NSCLC transformation Figure Ect binds activates PKCPar complex identified Rac critical downstream effector oncogenic PKCPar complex key question became complex activate Rac address question utilized proteomics approach identify proteins associate PKCPar complex NSCLC cells Justilien Fields Rho family GTPase guanine nucleotide exchange factor GEF Ect identified prominent component PKCPar complex Fields Justilien Justilien Fields RNAimediated knock Ect inhibits Rac activity blocks transformed growth invasion tumorigenicity NSCLC cells whereas expression RacV restores transformation Ectdeficient cells Justilien Fields Interestingly role Ect NSCLC transformation distinct wellestablished role cytokinesis fact NSCLC cells appear acquired Ectindependent cytokinesis mechanism resembles described fibrosarcoma H cells Kanada et al Rather NSCLC cells Ect mislocalized cytoplasm binds PKCPar complex Knock either PKC Par causes redistribution Ect nucleus loss transformed growth invasion Therefore Ect PKC drive tumor cell proliferation formation oncogenic PKCParEct complex Interestingly Ect gene ECT resides chromosome q close proximity PRKCI Studies primary NSCLC tumors demonstrated PRKCI ECT coamplified overexpressed NSCLC Justilien Fields Thus Ect PKC genetically linked coordinate gene amplification NSCLC tumors biochemically functionally linked NSCLC transformation formation oncogenic PKCParEct complex drives NSCLC cell transformation activating Rac Figure Justilien Fields MMP critical downstream effector oncogenic PKCParRac signaling axis recently carried genomic analysis identify genes whose expression modulated RNAimediated knock PKC NSCLC cells matrix metalloproteinase MMP stromolysin emerged analysis genomic target PKC Frederick et al Depletion PKC Par Rac RNAi inhibits MMP expression NSCLC cells expression exogenous wildtype Par Par knock cells restored MMP expression whereas expression Par mutants either bind PKC Rac indicating role PKCParRac complex MMP expression RNAimediated knock MMP blocks anchorageindependent growth cell invasion NSCLC cells loss transformed growth invasion PKC knock Par knock NSCLC cells rescued addition catalytically active MMP Frederick et al Taken together data defined PKCParRacPakMekErk signaling axis drives anchorageindependent growth invasion NSCLC cells least part induction MMP expression Frederick et al Interestingly analysis primary human lung tumor specimens demonstrated strong correlation PKC MMP expression primary NSCLC tumors suggesting role PKCParRacPakMekErkMMP signaling axis primary human lung cancers Frederick et al molecular mechanism PKCmediated overexpression MMP promotes transformation currently unexplored merits investigation second genomic study conducted metaanalysis gene expression primary lung adenocarcinomas LAC three independent public domain datasets Erdogan et al analysis identified four genes COPB ELF RFC PLS whose expression correlates positively PKC primary LAC tumors three databases QPCR analysis primary LAC samples showed four genes highly overexpressed tumors exhibit strong positive correlation PKC expression Erdogan et al RNAimediated knock PKC LAC cell lines demonstrated PKC regulates expression genes Furthermore RNAimediated knock genes led significant inhibition anchorageindependent growth cellular invasion demonstrating important transformation LAC cells Erdogan et al Finally metaanalysis revealed subsets PKCregulated genes coordinately overexpressed PKC major tumor types including lung squamous cell carcinoma breast colon prostate pancreatic glioblastoma cancers Erdogan et al analysis revealed novel signaling mechanisms participate PKCmediated transformation Figure provide potentially useful biomarkers PKCmediated signaling may serve targets development novel prognostic markers andor therapeutic agents V PKC Therapeutic Target Treatment Cancer PBPB domain interaction PKC Par highly specific required oncogenic PKCParRacMMP signaling axis mediates anchorageindependent growth invasion human NSCLC cells vitro tumorigenicity vivo Frederick et al Therefore reasoned interaction attractive target development novel mechanismbased therapeutics treatment NSCLC Using novel fluorescence resonance energy transfer FRETbased assay identified small molecular weight compounds disrupt PBPB domain interaction PKC Par StallingsMann et al Among potent inhibitors identified goldcontaining compounds aurothioglucose ATG aurothiomalate ATM FDAapproved treatments rheumatoid arthritis Messori Marcon ATG ATM exhibit dosedependent inhibition PKCPar binding IC StallingsMann et al Treatment NSCLC cells compounds inhibits PKCmediated Rac activation blocks anchorageindependent growth NSCLC cells vitro tumorigenicity vivo StallingsMann et al inhibition rescued expression RacV indicating ATM targets interaction PKC Par couples PKC Rac StallingsMann et al precise mechanism action ATG ATM RA still unknown however proposed mechanism action formation goldcysteine adducts target cellular proteins Bratt et al Jeon et al Pia Rigobello et al Yamashita et al PB domain atypical PKCs contains unique cysteine residue Cys within conserved OPR PC AID OPCA motif crystal structure PKCPar complex resides binding interface PKC Par Hirano et al Lamark et al Mutation Cys isoleucine CI valine CV amino acids frequently reside position PB domains preserves Par binding makes PKC resistant inhibitory effects ATM Par binding vitro Erdogan et al Expression CI PKC mutant NSCLC cells supports transformed growth renders cells resistant inhibitory effects ATM transformed growth Erdogan et al Thus ATM inhibits PKCPar interactions vitro vivo blocks NSCLC cell transformation targeting Cys within PB domain PKC Given clinical potential ATM therapeutic agent assessed inhibitory efficacy ATM transformed growth cell lines representing major subtypes lung cancer including lung adenocarcinoma LAC lung squamous cell carcinoma LSCC large cell carcinoma LCC small cell lung carcinoma SCLC Regala et al ATM potently inhibited anchorageindependent growth lines tested IC ranging nM lung cancer cell lines clustered highly sensitive ATM IC relatively insensitive ATM IC Interestingly ATM sensitivity correlate tumor subtype KRAS mutation status sensitivity panel standard chemotherapeutic agents frequently used treat lung cancer patients including cisplatin placitaxel gemcitabine Regala et al Rather elevated PKC expression major molecular characteristic exhibited lung cancer cells responsive ATM Regala et al Consistent vitro observations ATM inhibits tumorigenicity sensitive insensitive lung cell tumors vivo plasma drug concentrations consistent ATM IC cell lines vitro Furthermore measurements plasma drug concentrations demonstrated sensitive well insensitive cell lines exhibit antitumor response ATM plasma levels routinely achieved RA patients undergoing ATM therapy Regala et al Thus ATM exhibits antitumor activity major lung cancer subtypes particularly tumor cells express high levels PKC PKC expression profiling revealed significant subset primary NSCLC tumors express PKC level associated ATM sensitivity vitro Regala et al Therefore PKC expression profiling lung tumor samples may useful identifying lung cancer patients likely respond ATM therapy addition fact PKC overexpressed many tumor types see Table suggest ATM may effective treatment option tumor types well Several phase phase II clinical trials currently accruing Mayo Clinic determine appropriate dosing regimen ATM assess antitumor activity ATM alone combination targeted therapeutic agents NSCLC ovarian cancer pancreatic cancer SummaryFuture Directions Accumulating evidence demonstrates PKC oncogene frequently targeted genetic alteration many major forms human cancer Tables Functional data indicate PKC required transformed phenotype NSCLC pancreatic ovarian prostate colon brain cancer cells Future studies required determine whether PKC also oncogene cancers Studies PKC using genetically defined models tumorigenesis revealed critical role PKC multiple stages tumorigenesis including tumor initiation progression metastasis Recent studies genetic model lung adenocarcinoma suggest role PKC transformation lung cancer stem cells studies important implications therapeutic use ATM particularly future studies validate PKC important gene critical cancer stem cell niche Significant progress made determining molecular mechanisms PKC drives transformed phenotype particularly central role played oncogenic PKCPar complex transformed growth invasion several PKCdependent survival pathways chemoresistance Future studies required determine composition dynamics PKCPar complex mechanisms oncogenic signaling complex regulated Likewise better understanding critical downstream effectors PKC various human tumor types holds promise identification novel prognostic surrogate markers oncogenic PKC activity may clinically useful ongoing clinical trials ATM studies also hold promise revealing novel therapeutic targets Similarly complete understanding signaling mechanisms Kras possibly oncogenes regulate PKC expression human tumors may reveal new therapeutic intervention strategies Ultimately ongoing future clinical trials required establish usefulness ATM antitumor agent allow validation potential surrogate markers predictors therapeutic response PKCdirected therapy identified preclinical models Acknowledgments authors wish thank members Fields Murray laboratories key contributions data described review authors apologize colleagues whose important contributions area cited though attempted cite much relevant literature possible space limitations made comprehensive citation impossible Work laboratories discussed article supported grants APF National Institutes Health CA American Lung AssociationLUNGevity V Foundation Cancer Research James Esther King Biomedical Research Program Mayo Foundation NRM National Institutes Health CA Mayo Clinic SPORE Pancreatic Cancer Career Development award P CA NR Murray References Baldwin RM GarrattLalonde Parolin DA Krzyzanowski PM Andrade Lorimer IA Protection glioblastoma cells cisplatin cytotoxicity via protein kinase Ciotamediated attenuation p MAP kinase signaling Oncogene PubMed Google Scholar Baldwin RM Parolin DAE Lorimer IAJ Regulation glioblastoma cell invasion PKCiota RhoB Oncogene PubMed Google Scholar Balsara BR Sonoda G du Manoir Siegfried JM Gabrielson E Testa JR Comparative genomic hybridization analysis detects frequent often highlevel overrepresentation DNA sequences q p p q human nonsmall cell lung carcinomas Cancer Res PubMed Google Scholar Bedi Barber JP Bedi GC elDeiry WS Sidransky Vala MS Akhtar AJ Hilton J Jones RJ BCRABLmediated inhibition apoptosis delay GM transition DNA damage mechanism resistance multiple anticancer agents Blood PubMed Google Scholar Bjorkoy G Perander Overvatn Johansen Reversion Ras phosphatidylcholinehydrolyzing phospholipase Cmediated transformation NIH cells dominant interfering mutant protein kinase C lambda accompanied loss constitutive nuclear mitogenactivated protein kinaseextracellular signalregulated kinase activity J Biol Chem PubMed Google Scholar Brass N Racz Heckel Remberger K Sybrecht GW Meese EU Amplification genes BCHE SLCA squamous cell carcinoma lung Cancer Res PubMed Google Scholar Brass N Ukena Remberger K Mack U Sybrecht GW Meese EU DNA amplification chromosome qq squamous cell carcinoma lung detected reverse chromosome painting Eur J Cancer PubMed Google Scholar Bratt J Belcher J Vercellotti GM Palmblad J Effects antirheumatic gold salts NFkappa B mobilization tumour necrosis factoralpha TNFalphainduced neutrophildependent cytotoxicity human endothelial cells Clin Exp Immunol PMC free article PubMed Google Scholar Castagna Takai Kaibuchi K Sano K Kikkawa U Nishizuka Direct activation calciumactivated phospholipiddependent protein kinase tumorpromoting phorbol esters J Biol Chem PubMed Google Scholar Chalmers AD Pambos Mason J Lang Wylie C Papalopulu N aPKC Crumbs Lgl control apicobasal polarity early vertebrate development Development PubMed Google Scholar Coghlan MP Chou MM Carpenter CL Atypical protein kinases Clambda zeta associate GTPbinding protein Cdc mediate stress fiber loss Mol Cell Biol PMC free article PubMed Google Scholar Dempsey EC Newton AC MochlyRosen Fields AP Reyland Insel PA Protein kinase C isozymes regulation diverse cell responses J Physiol PubMed Google Scholar DiazMeco MT Lozano J Municio MM Berra E Frutos Sanz L Moscat J Evidence vitro vivo interaction Ras protein kinase C zeta J Biol Chem PubMed Google Scholar Du GS Wang JM Lu JX Li Q CQ Du JT Zou SQ Expression PaPKCiota Ecadherin betacatenin related invasion metastasis hepatocellular carcinoma Ann Surg Oncol PubMed Google Scholar Dyrskjot L Kruhoffer Thykjaer Marcussen N Jensen JL Moller K Orntoft TF Gene expression urinary bladder common carcinoma situ gene expression signature exists disregarding histopathological classification Cancer Res PubMed Google Scholar Eder Sui X Rosen DG Nolden LK Cheng KW Lahad JP KangoSingh Lu KH Warneke CL Atkinson EN Bedrosian Keyomarsi K Kuo Wl Gray JW Yin JCP Liu J Halder G Mills GB Atypical PKCiota contributes poor prognosis loss apicalbasal polarity Cyclin E overexpression ovarian cancer PNAS PMC free article PubMed Google Scholar Erdogan E Klee EW Thompson EA Fields AP Metaanalysis oncogenic protein kinase Ciota signaling lung adenocarcinoma Clin Cancer Res PMC free article PubMed Google Scholar Erdogan E Lamark StallingsMann Lee J Pellecchia Thompson EA Johansen Fields AP Aurothiomalate inhibits transformed growth targeting PB domain protein kinase Ciota J Biol Chem PubMed Google Scholar EtienneManneville Hall Cell polarity Par aPKC cytoskeletal crosstalk Curr Opin Cell Biol PubMed Google Scholar Fields AP Gustafson WC Protein kinase C disease cancer Methods Mol Biol PubMed Google Scholar Fields AP Justilien V guanine nucleotide exchange factor GEF Ect oncogene human cancer Adv Enzyme Regul PMC free article PubMed Google Scholar Fields AP Murray NR Protein kinase C isozymes therapeutic targets treatment human cancers Adv Enzyme Regul PMC free article PubMed Google Scholar Frederick LA Matthews JA Jamieson L Justilien V Thompson EA Radisky DC Fields AP Matrix metalloproteinase critical effector protein kinase CiotaParalphamediated lung cancer Oncogene PMC free article PubMed Google Scholar Ginos Page GP Michalowicz BS Patel KJ Volker SE Pambuccian SE Ondrey FG Adams GL Gaffney PM Identification gene expression signature associated recurrent disease squamous cell carcinoma head neck Cancer Res PubMed Google Scholar GokmenPolar Fields AP Mapping molecular determinant protein kinase C betaII isozyme function J Biol Chem PubMed Google Scholar Gumz ML Zou H Kreinest PA Childs AC Belmonte LS LeGrand SN Wu KJ Luxon BA Sinha Parker Sun LZ Ahlquist DA Wood CG Copland JA Secreted frizzledrelated protein loss contributes tumor phenotype clear cell renal cell carcinoma Clin Cancer Res PubMed Google Scholar Gustafson WC Ray Jamieson L Thompson EA Brasier AR Fields AP BcrAbl regulates protein kinase Ciota PKCiota transcription via Elk site PKCiota promoter J Biol Chem PubMed Google Scholar Heselmeyer K Macville Schrock E Blegen H Hellstrom AC Shah K Auer G Ried Advancedstage cervical carcinomas defined recurrent pattern chromosomal aberrations revealing high genetic instability consistent gain chromosome arm q Genes Chromosomes Cancer PubMed Google Scholar Hirano Yoshinaga Ogura K Yokochi Noda Sumimoto H Inagaki F Solution structure atypical protein kinase C PB domain mode interaction ZIPp MEK J Biol Chem PubMed Google Scholar Ishiguro H Akimoto K Nagashima Kojima Sasaki IshiguroImagawa Nakaigawa N Ohno Kubota Uemura H aPKClambdaiota promotes growth prostate cancer cells autocrine manner transcriptional activation interleukin Proc Natl Acad Sci U PMC free article PubMed Google Scholar Jackson EL Willis N Mercer K Bronson RT Crowley Montoya R Jacks Tuveson DA Analysis lung tumor initiation progression using conditional expression oncogenic Kras Genes Dev PMC free article PubMed Google Scholar Jamieson L Carpenter L Biden TJ Fields AP Protein kinase Ciota activity necessary BcrAblmediated resistance druginduced apoptosis J Biol Chem PubMed Google Scholar Jansen AP Verwiebe EG Dreckschmidt NE Wheeler DL Oberley TD Verma AK Protein kinase Cepsilon transgenic mice unique model metastatic squamous cell carcinoma Cancer Res PubMed Google Scholar Jeon KI Jeong JY Jue DM Thiolreactive metal compounds inhibit NFkappa B activation blocking kappa B kinase J Immunol PubMed Google Scholar Jin Z Xin Deng X Survival function protein kinase Ciota novel nitrosamine methylnitrosaminopyridylbutanoneactivated bad kinase J Biol Chem PubMed Google Scholar Joberty G Petersen C Gao L Macara IG cellpolarity protein Par links Par atypical protein kinase C Cdc Nat Cell Biol PubMed Google Scholar Johnson L Mercer K Greenbaum Bronson RT Crowley Tuveson DA Jacks Somatic activation Kras oncogene causes early onset lung cancer mice Nature PubMed Google Scholar Justilien V Fields AP Ect links PKCiotaParalpha complex Rac activation cellular transformation Oncogene PMC free article PubMed Google Scholar Kampfer Windegger Hochholdinger F Schwaiger W Pestell RG Baier G Grunicke HH Uberall F Protein kinase C isoforms involved transcriptional activation cyclin transforming HaRas J Biol Chem PubMed Google Scholar Kanada Nagasaki Uyeda TQ Novel functions Ect polar lamellipodia formation polarity maintenance contractile ringindependent cytokinesis adherent cells Mol Biol Cell PMC free article PubMed Google Scholar KhosraviFar R Solski PA Clark GJ Kinch MS Der CJ Activation Rac RhoA mitogenactivated protein kinases required Ras transformation Mol Cell Biol PMC free article PubMed Google Scholar Kikkawa U Takai Tanaka Miyake R Nishizuka Protein kinase C possible receptor protein tumorpromoting phorbol esters J Biol Chem PubMed Google Scholar Klimstra DS Longnecker DS Kras mutations pancreatic ductal proliferative lesions J Pathol PMC free article PubMed Google Scholar Kojima Akimoto K Nagashima Ishiguro H Shirai Chishima Ichikawa Ishikawa Sasaki Kubota Inayama Aoki Ohno Shimada H overexpression altered localization atypical protein kinase C lambdaiota breast cancer correlates pathologic type tumors Hum Pathol PubMed Google Scholar Lamark Perander Outzen H Kristiansen K Overvatn Michaelsen E Bjorkoy G Johansen Interaction codes within family mammalian Phox Bemp domaincontaining proteins J Biol Chem PubMed Google Scholar Landi MT Dracheva Rotunno Figueroa JD Liu H Dasgupta Mann FE Fukuoka J Hames Bergen AW Murphy SE Yang P Pesatori AC Consonni Bertazzi PA Wacholder Shih JH Caporaso NE Jen J Gene expression signature cigarette smoking role lung adenocarcinoma development survival PLoS ONE e PMC free article PubMed Google Scholar Lee J Kotliarova Kotliarov Li Su Q Donin NM Pastorino Purow BW Christopher N Zhang W Park JK Fine HA Tumor stem cells derived glioblastomas cultured bFGF EGF closely mirror phenotype genotype primary tumors serumcultured cell lines Cancer Cell PubMed Google Scholar Li Q Wang JM Liu C Xiao BL Lu JX Zou SQ Correlation aPKCiota Ecadherin expression invasion prognosis cholangiocarcinoma Hepatobiliary Pancreat Dis Int PubMed Google Scholar Lin Edwards Fawcett JP Mbamalu G Scott JD Pawson mammalian PARPAR complex implicated CdcRac aPKC signalling cell polarity Nat Cell Biol PubMed Google Scholar Lin Smith LT Smiraglia DJ KazhiyurMannar R Lang JC Schuller DE Kornacker K Wenger R Plass C DNA copy number gains head neck squamous cell carcinoma Oncogene PubMed Google Scholar Lu Jamieson L Brasier AR Fields AP NFkappaBRelA transactivation required atypical protein kinase C iotamediated cell survival Oncogene PubMed Google Scholar Messori L Marcon G Gold complexes treatment rheumatoid arthritis Met Ions Biol Syst PubMed Google Scholar Mischak H Goodnight JA Kolch W MartinyBaron G Schaechtle C Kazanietz MG Blumberg PM Pierce JH Mushinski JF Overexpression protein kinase Cdelta epsilon NIH cells induces opposite effects growth morphology anchorage dependence tumorigenicity J Biol Chem PubMed Google Scholar Murray NR Davidson LA Chapkin RS Gustafson WC Schattenberg DG Fields AP Overexpression protein kinase C betaII induces colonic hyperproliferation increased sensitivity colon carcinogenesis J Cell Biol PMC free article PubMed Google Scholar Murray NR Fields AP Atypical protein kinase C iota protects human leukemia cells druginduced apoptosis J Biol Chem PubMed Google Scholar Murray NR Jamieson L Yu W Zhang J GokmenPolar Sier Anastasiadis P Gatalica Z Thompson EA Fields AP Protein kinase Ciota required Ras transformation colon carcinogenesis vivo J Cell Biol PMC free article PubMed Google Scholar Murray NR Weems J Braun U Leitges Fields AP Protein kinase C betaII PKCiotalambda collaborating partners colon cancer promotion progression Cancer Res PMC free article PubMed Google Scholar Noda Takeya R Ohno Naito Ito Sumimoto H Human homologues Caenorhabditis elegans cell polarity protein PAR adaptor links small GTPases Rac Cdc atypical protein kinase C Genes Cells PubMed Google Scholar Oster H Leitges Protein kinase C alpha PKCzeta suppresses intestinal tumor formation ApcMin mice Cancer Res PubMed Google Scholar Patel R Win H Desai Patel K Matthews JA AcevedoDuncan Involvement PKCiota glioma proliferation Cell Prolif PMC free article PubMed Google Scholar Pia Rigobello Messori L Marcon G Agostina Cinellu Bragadin Folda Scutari G Bindoli Gold complexes inhibit mitochondrial thioredoxin reductase consequences mitochondrial functions J Inorg Biochem PubMed Google Scholar Qiu RG Abo Steven Martin G human homolog C elegans polarity determinant Par links Rac Cdc PKCzeta signaling cell transformation Curr Biol PubMed Google Scholar Qiu RG Chen J Kirn McCormick F Symons essential role Rac Ras transformation Nature PubMed Google Scholar Racz Brass N Heckel Pahl Remberger K Meese E Expression analysis genes qq involved frequent amplification squamous cell lung carcinoma Eur J Cancer PubMed Google Scholar Regala RP Davis RK Kunz Khoor Leitges Fields AP Atypical protein kinase Ciota required bronchioalveolar stem cell expansion lung tumorigenesis Cancer Res PMC free article PubMed Google Scholar Regala RP Thompson EA Fields AP Atypical protein kinase C iota expression aurothiomalate sensitivity human lung cancer cells Cancer Res PMC free article PubMed Google Scholar Regala RP Weems C Jamieson L Copland JA Thompson EA Fields AP Atypical protein kinase Ciota plays critical role human lung cancer cell growth tumorigenicity J Biol Chem PubMed Google Scholar Regala RP Weems C Jamieson L Khoor Edell ES Lohse CM Fields AP Atypical protein kinase C iota oncogene human nonsmall cell lung cancer Cancer Res b PubMed Google Scholar Reyland Protein kinase C isoforms Multifunctional regulators cell life death Front Biosci PMC free article PubMed Google Scholar Richardson AL Wang ZC De Nicolo Lu X Brown Miron Liao X Iglehart JD Livingston DM Ganesan X chromosomal abnormalities basallike human breast cancer Cancer Cell PubMed Google Scholar SanchezCarbayo Socci ND Lozano J Saint F CordonCardo C Defining molecular profiles poor outcome patients invasive bladder cancer using oligonucleotide microarrays J Clin Oncol PubMed Google Scholar Scotti ML Bamlet W Smyrk TC Fields AP Murray NR Protein kinase C iota required pancreatic cancer cell transformed growth tumorigenesis Cancer Res PMC free article PubMed Google Scholar Segara Biankin AV Kench JG Langusch CC Dawson AC Skalicky DA Gotley DC Coleman MJ Sutherland RL Henshall SM Expression HOXB retinoic acid signaling target pancreatic cancer pancreatic intraepithelial neoplasia Clin Cancer Res PubMed Google Scholar Singh B Stoffel Gogineni Poluri Pfister DG Shaha AR Pathak Bosl G CordonCardo C Shah JP Rao PH Amplification q locus associated progression invasive cancer negative prognostic factor head neck squamous cell carcinomas J Pathol PMC free article PubMed Google Scholar Slattery ML Anderson K Curtin K K Schaffer Edwards Samowitz W Lifestyle factors Kiras mutations colon cancer tumors Mutat Res PubMed Google Scholar Snaddon J Parkinson EK Craft JA Bartholomew C Fulton R Detection functional PTEN lipid phosphatase protein enzyme activity squamous cell carcinomas head neck despite loss heterozygosity locus Br J Cancer PMC free article PubMed Google Scholar StallingsMann Jamieson L Regala RP Weems C Murray NR Fields AP novel smallmolecule inhibitor protein kinase Ciota blocks transformed growth nonsmallcell lung cancer cells Cancer Res PubMed Google Scholar Sugita Tanaka N Davidson Sekiya VarellaGarcia West J Drabkin HA Gemmill RM Molecular definition small amplification domain within q tumors cervix ovary lung Cancer Genet Cytogenet PubMed Google Scholar Suzuki Akimoto K Ohno Protein kinase C lambdaiota PKClambdaiota PKC isotype essential development multicellular organisms J Biochem Tokyo PubMed Google Scholar Suzuki Yamanaka Hirose Manabe N Mizuno K Shimizu Akimoto K Izumi Ohnishi Ohno Atypical protein kinase C involved evolutionarily conserved par protein complex plays critical role establishing epitheliaspecific junctional structures J Cell Biol PMC free article PubMed Google Scholar Takagawa R Akimoto K Ichikawa Akiyama H Kojima Ishiguro H Inayama Aoki Kunisaki C Endo Nagashima Ohno High expression atypical protein kinase C lambdaiota gastric cancer prognostic factor recurrence Ann Surg Oncol PubMed Google Scholar Takayama Ohi Hayashi Miyanishi K Nobuoka Nakajima Satoh Takimoto R Kato J Sakamaki Niitsu Analysis Kras APC betacatenin aberrant crypt foci sporadic adenoma cancer familial adenomatous polyposis Gastroenterology PubMed Google Scholar Talantov Mazumder Yu JX Briggs Jiang Backus J Atkins Wang Novel genes associated malignant melanoma benign melanocytic lesions Clin Cancer Res PubMed Google Scholar Uberall F Hellbert K Kampfer Maly K Villunger Spitaler Mwanjewe J BaierBitterlich G Baier G Grunicke HH Evidence atypical protein kinase Clambda atypical protein kinase Czeta participate Rasmediated reorganization Factin cytoskeleton J Cell Biol PMC free article PubMed Google Scholar Valk PJ Verhaak RG Beijen Erpelinck CA Barjesteh van Waalwijk van DoornKhosrovani Boer JM Beverloo HB Moorhouse MJ van der Spek PJ Lowenberg B Delwel R Prognostically useful geneexpression profiles acute myeloid leukemia N Engl J Med PubMed Google Scholar Wallace TA Prueitt RL Yi Howe TM Gillespie JW Yfantis HG Stephens RM Caporaso NE Loffredo CA Ambs Tumor immunobiological differences prostate cancer AfricanAmerican EuropeanAmerican men Cancer Res PubMed Google Scholar Weichert W Gekeler V Denkert C Dietel Hauptmann Protein kinase C isoform expression ovarian carcinoma correlates indicators poor prognosis Int J Oncol PubMed Google Scholar Wilson MI Gill DJ Perisic Quinn MT Williams RL PB domainmediated heterodimerization NADPH oxidase signaling complexes atypical protein kinase C Par p Mol Cell PubMed Google Scholar Win HY AcevedoDuncan Atypical protein kinase C phosphorylates IKKalphabeta transformed nonmalignant malignant prostate cell survival Cancer Lett PubMed Google Scholar Wurmbach E Chen YB Khitrov G Zhang W Roayaie Schwartz Fiel Thung Mazzaferro V Bruix J Bottinger E Friedman Waxman Llovet JM Genomewide molecular profiles HCVinduced dysplasia hepatocellular carcinoma Hepatology PubMed Google Scholar Yamashita Ashino Oshima Kawamura Ohuchi K Takayanagi Inhibition TPAinduced NFkappaB nuclear translocation production PGE antirheumatic gold compounds J Pharm Pharmacol PubMed Google Scholar Yang YL Chu JY Luo ML Wu YP Zhang Feng YB Shi ZZ Xu X Han YL Cai Dong JT Zhan QM Wu Wang MR Amplification PRKCI located q associated lymph node metastasis esophageal squamous cell carcinoma Genes Chromosomes Cancer PubMed Google Scholar Ye H Yu Temam Ziober BL Wang J Schwartz JL Mao L Wong DT Zhou X Transcriptomic dissection tongue squamous cell carcinoma BMC Genomics PMC free article PubMed Google Scholar Zhang L Huang J Yang N Liang Barchetti Giannakakis Cadungog MG OBrienJenkins Massobrio Roby KF Katsaros Gimotty P Butzow R Weber BL Coukos G Integrative genomic analysis protein kinase C PKC family identifies PKCiota biomarker potential oncogene ovarian carcinoma Cancer Res PubMed Google Scholar J Cell Physiol Author manuscript available PMC Apr Published final edited form J Cell Physiol Apr doi jcp PMCID PMC NIHMSID NIHMS PMID Protein Kinase C Expression Oncogenic Signaling Mechanisms Cancer Nicole R Murray Krishna R Kalari Alan P Fields Nicole R Murray Department Cancer Biology Mayo Clinic Comprehensive Cancer Center Jacksonville Florida Find articles Nicole R Murray Krishna R Kalari Department Cancer Biology Mayo Clinic Comprehensive Cancer Center Jacksonville Florida Find articles Krishna R Kalari Alan P Fields Department Cancer Biology Mayo Clinic Comprehensive Cancer Center Jacksonville Florida Find articles Alan P Fields Author information Copyright License information Disclaimer Department Cancer Biology Mayo Clinic Comprehensive Cancer Center Jacksonville Florida correspondences addressed Alan P Fields PhD Mayo Clinic College Medicine Griffin Cancer Research Building Rm San Pablo Road Jacksonville Florida office fax udeoyamnalasdleif Copyright notice Abstract Accumulating evidence demonstrates PKC oncogene prognostic marker frequently targeted genetic alteration many major forms human cancer Functional data demonstrate PKC required transformed phenotype NSCLC pancreatic ovarian prostate colon brain cancer cells Future studies required determine whether PKC also oncogene many cancer types also overexpress PKC Studies PKC using genetically defined models tumorigenesis revealed critical role PKC multiple stages tumorigenesis including tumor initiation progression metastasis Recent studies genetic model lung adenocarcinoma suggest role PKC transformation lung cancer stem cells studies important implications therapeutic use aurothiomalate ATM highly selective PKC signaling inhibitor currently undergoing clinical evaluation Significant progress made determining molecular mechanisms PKC drives transformed phenotype particularly central role played oncogenic PKCPar complex transformed growth invasion several PKCdependent survival pathways chemoresistance Future studies required determine composition dynamics PKCPar complex mechanisms oncogenic signaling complex regulated Likewise better understanding critical downstream effectors PKC various human tumor types holds promise identifying novel prognostic surrogate markers oncogenic PKC activity may clinically useful ongoing clinical trials ATM Keywords tumorigenesis gene amplification signal trandsuction invasion metastasis aurothiomalate Introduction Protein kinase C PKC family structurally related serinethreonine protein kinases whose catalytic activity regulated interaction phospholipid cofactors inter intramolecular phosphorylation specific proteinprotein interactions PKC enzyme family divided three subgroups conventional calciumdependent cPKCs alpha beta beta II II gamma novel calciumindependent nPKCs delta epsilon eta theta atypical aPKCs zeta iota also known lambda mice grouping based presence absence functional domains confer specific cofactor activator requirements Conventional PKCs calcium diacylglycerol DAG phosphatidylserinedependent due presence conserved modular C C domains within regulatory region enzyme Novel PKCs DAG phosphatidylserinedependent require calcium Due unique structure Nterminal regulatory region atypical PKCs require calcium DAG phosphatidylserine activation Biochemical immunologic studies indicate multiple PKC isozymes expressed virtually cell tissue types reviewed Fields Murray expression individual PKC isozymes developmentally regulated responsive differentiation state cells tissues reasons PKC isozymes thought fulfill distinct nonredundant functions within cell reviewed Dempsey et al Reyland However similar activator requirements substrate specificities PKC isozymes vitro complicated identification physiologically relevant isozymespecific substrates cellular functions ability genetically manipulate expression specific PKC isozyme express mutant forms individual PKC isozymes altered kinase activity proven successful identifying PKC isozymespecific functions Using genetic techniques many laboratories including demonstrated isozyme cell typespecific roles PKC cellular proliferation differentiation apoptosis cell polarity Chalmers et al GokmenPolar Fields Jansen et al Mischak et al Murray et al Oster Leitges discovery PKC cellular receptor tumorpromoting phorbol esters led intense interest role individual PKC isozymes cancer development Castagna et al Kikkawa et al Indeed expression level cellular localization individual PKC isozymes shown altered carcinogenesis numerous tissue types reviewed Fields Gustafson However despite exhaustive investigation somatic germline mutations found coding regions PKCs associated human cancers diseases date one PKC isozyme atypical PKC shown satisfy criteria human oncogene minireview details work laboratory others characterizing role oncogenic PKC rodent carcinogenesis models human cancer also discuss status efforts therapeutically target critical oncogene treatment cancer patients PKC Expression Primary Human Tumors PKC overexpressed prognostic multiple human cancer types Overexpression PKC demonstrated many human cancers Table PKC frequently overexpressed cancers lung Regala et al b pancreas Scotti et al stomach Takagawa et al colon Murray et al esophagus Yang et al liver Du et al bile duct Li et al breast Kojima et al ovary Eder et al Weichert et al Zhang et al prostate Ishiguro et al brain Patel et al addition published reports metaanalysis publicly available microarray data provides additional support overexpression PKC many tumor types including lung Landi et al breast Richardson et al pancreas Segara et al prostate Wallace et al ovary Cancer Genome Atlas liver Wurmbach et al Table Interestingly increased PKC brain cancer supported available genomic data sets Lee et al Table Analysis available microarray datasets revealed addition lung cancer Landi et al several squamoustype cancers also express elevated PKC including head neck Ginos et al tongue cancer Ye et al Significant overexpression PKC also detected renal cancer Gumz et al bladder cancer Dyrskjot et al SanchezCarbayo et al melanoma Talantov et al leukemia Valk et al Table studies strongly indicate role PKC many major forms human cancer TABLE PKC Expression Human Tumor Types Tumor type Tumor Control ppaired Type Analysis Result Reference Lung p blot qPCR IHC Elevated Amplified High PKC predicts poor survival Regala et al b PDAC p qPCR IHC Elevated High PKC predicts poor survival Scotti et al Gastric IHC Elevated High PKC predicts disease recurrence Takagawa et al Colon p blot Elevated Murray et al Esophageal IHC FISH Elevated Amplified gene amplification correlates tumor size stage LN metastasis High PKC predicts metastasis Yang et al Hepatocellular carcinoma p RTPCR IHC Elevated High PKC correlates size metastasis invasion stage Du et al Cholangiocarcinoma IHC Elevated High PKC correlates differentiation invasion LN metastasis stage Prognostic poor survival Li et al Breast IHC Elevated Kojima et al Ovarian IHC mRNA array CGH Elevated Amplified High PKC correlates stage Zhang et al Ovarian Array CGH qPCR IHC Elevated Amplified serous tumors high copy predicts poor survival nonserous tumors high PKC predicts poor survival Eder et al Ovarian IHC Elevated High PKC predicts poor survival Weichert et al Prostate p qPCR blot Elevated High PKC predicts poor recurrence free survival Ishiguro et al Brain blot Elevated Patel et al Open separate window TABLE PKC Expression Publicly Available Human Tumor Microarray Datasets Cancer Type Tumor Control Significant Tumor Pvalue Reference Head Neck Yes Ginos et al Tongue Yes Ye et al Lung Yes Landi et al Superficial Bladder Cancer SanChezCarbayo et al Infiltrating Bladder Urothelial Carcinoma Yes E SanChezCarbayo et al Superficial Bladder Cancer Yes E Dyrskjot et al Infiltrating Bladder Urothelial Carcinoma Yes E Dyrskjot et al Brain Lee et al Pancreas Yes E Segara et al Melanoma Yes E Talantov et al Ovarian Yes E TCGA Ovarian Published Liver HCC Yes E Wurmbach et al Breast Yes Richardson et al Prostate Yes Wallace et al Acute Myeloid Leukemia Yes Valk et al Renal Yes Gumz et al Open separate window tumor types examined PKC expression also shown prognostic significance High PKC predicts poor patient survival lung Regala et al b pancreatic Scotti et al bile duct Li et al ovarian Eder et al Weichert et al prostate Ishiguro et al cancer Elevated PKC expression predicts disease recurrence gastric cancer Takagawa et al metastasis esophageal cancer Yang et al analysis PKC expression lung cancer PKC emerged prognostic indicator comparable tumor stage prognostic value Interestingly PKC expression correlate tumor stage nonsmall cell lung cancer NSCLC rather PKC levels comparable early late stage disease indicating elevated PKC expression early event lung tumor development Regala et al b contrast PKC expression correlates tumor stage ovarian bile duct liver cancer suggesting PKC may regulate disease progression tumor types Du et al Li et al Zhang et al Thus PKC expression elevated variety tumor types many cases predictive poor clinical outcome Therefore PKC expression profiling may identify patients elevated risk relapse disease progression Since many patients diagnosed early stage cancer eventually relapse PKC expression profiling may useful identifying high risk patients would candidates aggressive clinical management perhaps discussed PKCtargeted therapy PKC target frequent tumorspecific gene amplification DNA amplification one mechanism oncogenes activated neoplastic tissue PKC gene PRKCI resides chromosome q chromosomal region frequently amplified human cancers particularly squamous cell carcinomas Brass et al Heselmeyer et al Lin et al Racz et al Singh et al Therefore examined NSCLC tumors evidence changes PRKCI gene copy number Regala et al b PRKCI found amplified tumorspecific fashion NSCLC tumors examined Furthermore PRKCI amplification correlates PKC mRNA protein expression poor outcome NSCLC tumors Regala et al b Interestingly PRKCI amplification frequently found lung squamous cell carcinoma SCC rarely lung adenomcarcinoma LAC Regala et al b consistent distribution chromosome q amplification tumor types confined SCC Balsara et al Brass et al Similar tumorspecific PRKCI amplification also observed ovarian cancers serous subtype Eder et al Zhang et al esophageal squamous cell cancer Yang et al PKC expression PRKCI copy number also correlate chromosome q gains tumors Eder et al Yang et al Zhang et al indicating PKC relevant target tumorspecific chromosome q amplification Since chromosome q amplification one common chromosomal changes human cancers including SCC head neck Snaddon et al cervix Sugita et al likely PKC expression gene copy number prognostic significance tumors well PRKCI amplification mechanism PKC expression elevated human tumors PKC expression elevated degree frequency lung SCC LAC tumors despite fact PKC gene amplification largely confined SCC tumors Regala et al b Furthermore PKC frequently overexpressed tumor types including colon cancers Murray et al pancreatic cancers Scotti et al leukemia Gustafson et al harbor frequent chromosome q amplification recently demonstrated BcrAbl transcriptionally activates PKC RasMekdependent activation specific Elk element within proximal PKC promoter chronic myelogenous leukemia CML cells Gustafson et al similar mechanism likely play LAC pancreatic ductal adenocarcinoma PDAC tumors harbor oncogenic KRAS mutations Indeed observed statistically significant positive correlation presence KRAS mutation PKC expression primary LAC tumors unpublished observations Likewise PDAC tumors harbor KRAS mutation Klimstra Longnecker detected PKC overexpressed tumors Scotti et al Another potential mechanism oncogenic activation PKC somatic mutation However sequence analysis exons PKC gene LAC cases SCC cases failed detect mutations suggesting somatic mutation PKC either occur extremely rare NSCLC unpublished observations summary PKC first date PKC isozyme shown bonafide human oncogene Regala et al b Current evidence strongly supports oncogenic role PKC NSCLC PDAC ovarian cancer glioma Given widespread overexpression PKC major tumor types appears likely PKC shown oncogene many tumor types well II PKC Cellular Transformation PKC survival gene human cancer first demonstration PKC important transformed phenotype human cancer cells came studies CML cells Murray Fields CML cells highly resistant apoptotic effects numerous chemotherapeutic agents result expression chimeric tyrosine kinase oncogene BcrAbl transforming activity causes CML Bedi et al found BcrAblpositive CML cells express high levels PKC PKC activated response apoptotic stimuli treatment chemotherapeutic agent paclitaxel Jamieson et al Disruption PKC expression activity sensitized CML cells induction paclitaxelinduced apoptosis Murray Fields Subsequent studies established similar role PKC survival chemoresistance tumor cell types including prostate Win AcevedoDuncan NSCLC Jin et al glioblastoma Baldwin et al PKC oncogenic ras mediated transformation intestinal epithelial cells Studies mouse fibroblasts first established functional link aPKCs cellular Ras Ras activate aPKCs DiazMeco et al aPKC activity necessary Rasmediated effects actinbased cytoskeleton fibroblasts Bjorkoy et al Coghlan et al Kampfer et al Uberall et al Since oncogenic Ras signaling drive colon carcinogenesis oncogenic Ras mutations detected colon cancers Slattery et al Takayama et al investigated role PKC Ras mediated transformation rat intestinal epithelial RIE cells Murray et al found oncogenic Ras activates PKC introduced nontransformed RIE cells expression kinasedeficient dominant negative PKC mutant kdPKC Ras transformed RIE cells inhibits Ras mediated invasion anchorageindependent growth Murray et al results provided direct evidence PKC involved establishment transformed phenotype Ras epithelial cells PKC required maintenance transformed phenotype cancer cells PKC plays key role transformation induced introduction oncogenic Ras nontransformed epithelial cells also maintenance transformed phenotype established human cancer cells harboring oncogenic KRAS mutations Frederick et al Regala et al Scotti et al Expression kdPKC knock PKC expression using lentiviralmediated shRNA blocked transformed anchorageindependent growth invasion human NSCLC cells Frederick et al Regala et al human PDAC cells Scotti et al Genetic disruption PKC also blocks proliferative invasive properties prostate glioma cell lines vitro Baldwin et al Ishiguro et al Patel et al Disruption PKC expression also blocks tumorigenicity NSCLC PDAC cell tumors injected either subcutaneously orthotopically lung pancreas respectively Regala et al Scotti et al Analysis human PDAC cells orthotopic injection mouse pancreas revealed PKCdeficient tumor cells yielded significantly smaller tumors significantly fewer metastases kidney liver diaphragm mesentery providing first evidence PKC important tumor metastasis vivo Scotti et al role PKC transformed growth restricted cell harboring oncogenic KRAS mutations since NSCLC cell lines expressing wildtype KRAS harboring PRKCI amplification also require PKC transformed phenotype Regala et al Regala et al b III PKC Tumorigenesis vivo PKC necessary oncogenic Kras mutant APC mediated intestinal tumorigenesis Several transgenic models tumorigenesis revealed PKC plays critical promotive role tumorigenesis vivo established mice either kdPKC constitutively active caPKC PKC expressed specifically intestinal epithelium Murray et al Expression either PKC mutant demonstrable effect basal proliferation differentiation colonic epithelium Murray Fields Murray et al However expression caPKC colon increased susceptibility carcinogen azoxymethane AOMinduced formation colonic preneoplastic lesions aberrant crypt foci ACF whereas expression kdPKC significantly inhibited AOMinduced ACF formation Murray et al addition caPKC mice exhibited increase number AOMinduced colon tumors majority tumors mice progressed benign adenoma malignant intramucosal carcinoma Murray et al Similar results obtained vivo model oncogenic Kras mediated colon carcinogenesis Kras LA mouse Johnson et al Expression kdPKC colonic epithelium mice inhibited oncogenic Kras mediated ACF formation Murray et al data demonstrated PKC required oncogenic Kras mediated transformation intestinal epithelium vivo constitute first evidence function role PKC tumorigenesis vivo Interestingly PKC also elevated intestinal tumors formed Apc Min mice Murray et al Oster Leitges determine PKC plays role tumor development Apc Min mice mouse PKC gene Prkci inactivated intestinal epithelium triple transgenic Apc Min Prkci ff villinCre mice Cremediated recombination Apc Min Prkci ff villinCre mice exhibited loss intestinal epithelial PKC expression significant decrease number intestinal tumors compared Apc Min Prkci ff mice harbor intact alleles Prkci gene Murray et al Thus PKC important Apc Min induced intestinal epithelial tumorigenesis indicating role PKC colon tumorigenesis vivo limited Kras mediated tumors Role PKC initiation lung tumorigenesis PKC cancer stem cell gene PKC oncogene required maintenance transformed phenotype nonsmall cell lung cancer NSCLC cells Frederick et al Regala et al Regala et al b address whether PKC involved lung tumor development established mouse model oncogenic Kras GD activated Cremediated recombination lung without simultaneous genetic loss mouse PKC gene Prkci Regala et al Genetic loss Prkci dramatically inhibits Kras initiated hyperplasia subsequent lung tumor formation vivo effect correlates defect ability Prkci deficient bronchioalveolar stem cells BASCs undergo Kras mediated expansion morphological transformation vitro vivo Regala et al BASC exhibit stemlike properties thought tumorinitiating cells model Kras mediated lung tumorigenesis Jackson et al Thus Prkci required oncogeneinduced expansion transformation tumorinitiating lung stemlike cells studies suggest PKC may serve critical role cancer stem cell biology Whether PKC plays similar role maintenance cancer stem cell niche human cancers remains important topic future study IV Oncogenic PKC Signaling Mechanisms PKCmediated survival signaling PKC activates multiple survival pathways confer resistance apoptosis induced many stimuli including TNF carcinogens chemotherapeutic agents Figure PKC sufficient mediate antiapoptotic effects BcrAbl via transactivation NFB Jamieson et al Lu et al Interestingly CML cells BcrAbl induces PKC expression RasMekdependent pathway involving functional Elk transcription factor binding site within proximal promoter PKC Gustafson et al Thus BcrAbl appears regulate PKC multiple levels induce chemoresistant phenotype BcrAbl induce PKC expression PKC key effector BcrAblmediated survival signaling PKCmediated survival TNFtreated prostate cancer cells also mediated NFBdependent mechanism prostate cancer cells PKCmediated phosphorylation IK leads activation canonical NFB pathway cell survival Win AcevedoDuncan glioblastoma cells PKCmediated survival appears result PKCinduced attenuation p mitogenactivated protein kinase signaling protects cells cytotoxicity caused chemotherapeutic agents Baldwin et al NSCLC cells ability PKC enhance resistance NNKinduced apoptosis appears mediated Srcdependent activation PKC phosphorylates proapoptotic protein BAD Jin et al Therefore PKC activate multiple signaling pathways promote cell survival different tumor cell types Open separate window Figure Schematic representation key oncogenic PKC signaling pathways PKC resides within several major signaling pathways implicated human cancer PKC activated known oncogenes Ras BcrAbl Src PIK cytokines TNF IL growth factors NGF EGF PKC signals downstream effectors Rac NFB important different aspects transformed phenotype Many components PKCdependent signal pathways mutated often multiple mechanisms ie gene amplification somatic mutation human tumors indicated yellow boxes Arrows indicate flow signaling pathways touching boxes indicate direct binding signaling components Phosphorylation events indicated circled Ps Rac critical downstream effector oncogenic PKC Rho family GTPase Rac activated oncogenic Ras essential Ras mediated transformed growth cellular invasion fibroblasts KhosraviFar et al Qiu et al PKC necessary Ras mediated Rac activation RIE cells Murray et al thus kdPKC blocks oncogenic Ras mediated Rac activation expression constitutively active Rac allele RacV overcomes dnPKCmediated inhibition cellular invasion Murray et al studies placed PKC downstream oncogenic Kras upstream critical Kras effector Rac activates MekErk signaling axis drive transformed growth also mediates cytoskeletal rearrangement involved cellular invasion Murray et al Figure Rac also critical downstream target Kras mediated PKCdependent transformation NSCLC Regala et al PDAC Scotti et al NSCLC PDAC cells KRAS activates PKCRacPakMekErk signaling axis drives transformed growth vitro tumorigenicity vivo Regala et al Scotti et al Interestingly Rac also plays critical role downstream oncogenic PKC NSCLC cells harbor mutant KRAS indicating PKCRac signaling specific mutant KRAS mediated transformation Regala et al Regala et al b Expression RacV reconstituted cellular invasion anchorageindependent growth PKCdeficient NSCLC PDAC cells Mekdependent manner Regala et al Scotti et al Thus Rac critical downstream effector oncogenic PKC multiple cancer cell types restricted tumor cells harboring KRAS mutations role PB domain PKC oncogenic signaling Nterminal regulatory domain aPKCs unique contains PhoxBem PB domain mediates homo heterotypic proteinprotein interactions critical activation intracellular localization Lamark et al Par PB domaincontaining protein binds atypical PKCs via PBPB domain interactions EtienneManneville Hall Wilson et al Par links atypical PKC cell polarity forming complex atypical PKC Rho family GTPase Rac cdc EtienneManneville Hall Joberty et al Lin et al Noda et al Qiu et al Suzuki et al Suzuki et al Since Rac critical downstream effector oncogenic PKC multiple cell types including colon lung pancreas Murray et al Regala et al Scotti et al assessed role PB domain PKC Rac activation NSCLC cell transformation Regala et al Expression PB domain PKC NSCLC cells uncouples PKC Par Rac activation inhibits transformed growth Likewise RNAimediated knock PKC Par Rac inhibits transformed growth cellular invasion NSCLC cancer cells Frederick et al Expression wildtype PKC PKC knock cells restores transformation whereas expression PB domain mutant PKC PKCDA bind Par Frederick et al Similarly expression wild type Par Par knock cells restores transformation whereas expression Par mutants either bind PKC ParKA couple Rac ParCRIB Frederick et al Expression RacV PKC Pardepleted NSCLC cells restores transformed growth cellular invasion Frederick et al PKCPar complex functions activate RacMekErk signaling axis drives transformed growth NSCLC cells Frederick et al studies defined novel PKCPar complex required NSCLC transformation Figure Ect binds activates PKCPar complex identified Rac critical downstream effector oncogenic PKCPar complex key question became complex activate Rac address question utilized proteomics approach identify proteins associate PKCPar complex NSCLC cells Justilien Fields Rho family GTPase guanine nucleotide exchange factor GEF Ect identified prominent component PKCPar complex Fields Justilien Justilien Fields RNAimediated knock Ect inhibits Rac activity blocks transformed growth invasion tumorigenicity NSCLC cells whereas expression RacV restores transformation Ectdeficient cells Justilien Fields Interestingly role Ect NSCLC transformation distinct wellestablished role cytokinesis fact NSCLC cells appear acquired Ectindependent cytokinesis mechanism resembles described fibrosarcoma H cells Kanada et al Rather NSCLC cells Ect mislocalized cytoplasm binds PKCPar complex Knock either PKC Par causes redistribution Ect nucleus loss transformed growth invasion Therefore Ect PKC drive tumor cell proliferation formation oncogenic PKCParEct complex Interestingly Ect gene ECT resides chromosome q close proximity PRKCI Studies primary NSCLC tumors demonstrated PRKCI ECT coamplified overexpressed NSCLC Justilien Fields Thus Ect PKC genetically linked coordinate gene amplification NSCLC tumors biochemically functionally linked NSCLC transformation formation oncogenic PKCParEct complex drives NSCLC cell transformation activating Rac Figure Justilien Fields MMP critical downstream effector oncogenic PKCParRac signaling axis recently carried genomic analysis identify genes whose expression modulated RNAimediated knock PKC NSCLC cells matrix metalloproteinase MMP stromolysin emerged analysis genomic target PKC Frederick et al Depletion PKC Par Rac RNAi inhibits MMP expression NSCLC cells expression exogenous wildtype Par Par knock cells restored MMP expression whereas expression Par mutants either bind PKC Rac indicating role PKCParRac complex MMP expression RNAimediated knock MMP blocks anchorageindependent growth cell invasion NSCLC cells loss transformed growth invasion PKC knock Par knock NSCLC cells rescued addition catalytically active MMP Frederick et al Taken together data defined PKCParRacPakMekErk signaling axis drives anchorageindependent growth invasion NSCLC cells least part induction MMP expression Frederick et al Interestingly analysis primary human lung tumor specimens demonstrated strong correlation PKC MMP expression primary NSCLC tumors suggesting role PKCParRacPakMekErkMMP signaling axis primary human lung cancers Frederick et al molecular mechanism PKCmediated overexpression MMP promotes transformation currently unexplored merits investigation second genomic study conducted metaanalysis gene expression primary lung adenocarcinomas LAC three independent public domain datasets Erdogan et al analysis identified four genes COPB ELF RFC PLS whose expression correlates positively PKC primary LAC tumors three databases QPCR analysis primary LAC samples showed four genes highly overexpressed tumors exhibit strong positive correlation PKC expression Erdogan et al RNAimediated knock PKC LAC cell lines demonstrated PKC regulates expression genes Furthermore RNAimediated knock genes led significant inhibition anchorageindependent growth cellular invasion demonstrating important transformation LAC cells Erdogan et al Finally metaanalysis revealed subsets PKCregulated genes coordinately overexpressed PKC major tumor types including lung squamous cell carcinoma breast colon prostate pancreatic glioblastoma cancers Erdogan et al analysis revealed novel signaling mechanisms participate PKCmediated transformation Figure provide potentially useful biomarkers PKCmediated signaling may serve targets development novel prognostic markers andor therapeutic agents V PKC Therapeutic Target Treatment Cancer PBPB domain interaction PKC Par highly specific required oncogenic PKCParRacMMP signaling axis mediates anchorageindependent growth invasion human NSCLC cells vitro tumorigenicity vivo Frederick et al Therefore reasoned interaction attractive target development novel mechanismbased therapeutics treatment NSCLC Using novel fluorescence resonance energy transfer FRETbased assay identified small molecular weight compounds disrupt PBPB domain interaction PKC Par StallingsMann et al Among potent inhibitors identified goldcontaining compounds aurothioglucose ATG aurothiomalate ATM FDAapproved treatments rheumatoid arthritis Messori Marcon ATG ATM exhibit dosedependent inhibition PKCPar binding IC StallingsMann et al Treatment NSCLC cells compounds inhibits PKCmediated Rac activation blocks anchorageindependent growth NSCLC cells vitro tumorigenicity vivo StallingsMann et al inhibition rescued expression RacV indicating ATM targets interaction PKC Par couples PKC Rac StallingsMann et al precise mechanism action ATG ATM RA still unknown however proposed mechanism action formation goldcysteine adducts target cellular proteins Bratt et al Jeon et al Pia Rigobello et al Yamashita et al PB domain atypical PKCs contains unique cysteine residue Cys within conserved OPR PC AID OPCA motif crystal structure PKCPar complex resides binding interface PKC Par Hirano et al Lamark et al Mutation Cys isoleucine CI valine CV amino acids frequently reside position PB domains preserves Par binding makes PKC resistant inhibitory effects ATM Par binding vitro Erdogan et al Expression CI PKC mutant NSCLC cells supports transformed growth renders cells resistant inhibitory effects ATM transformed growth Erdogan et al Thus ATM inhibits PKCPar interactions vitro vivo blocks NSCLC cell transformation targeting Cys within PB domain PKC Given clinical potential ATM therapeutic agent assessed inhibitory efficacy ATM transformed growth cell lines representing major subtypes lung cancer including lung adenocarcinoma LAC lung squamous cell carcinoma LSCC large cell carcinoma LCC small cell lung carcinoma SCLC Regala et al ATM potently inhibited anchorageindependent growth lines tested IC ranging nM lung cancer cell lines clustered highly sensitive ATM IC relatively insensitive ATM IC Interestingly ATM sensitivity correlate tumor subtype KRAS mutation status sensitivity panel standard chemotherapeutic agents frequently used treat lung cancer patients including cisplatin placitaxel gemcitabine Regala et al Rather elevated PKC expression major molecular characteristic exhibited lung cancer cells responsive ATM Regala et al Consistent vitro observations ATM inhibits tumorigenicity sensitive insensitive lung cell tumors vivo plasma drug concentrations consistent ATM IC cell lines vitro Furthermore measurements plasma drug concentrations demonstrated sensitive well insensitive cell lines exhibit antitumor response ATM plasma levels routinely achieved RA patients undergoing ATM therapy Regala et al Thus ATM exhibits antitumor activity major lung cancer subtypes particularly tumor cells express high levels PKC PKC expression profiling revealed significant subset primary NSCLC tumors express PKC level associated ATM sensitivity vitro Regala et al Therefore PKC expression profiling lung tumor samples may useful identifying lung cancer patients likely respond ATM therapy addition fact PKC overexpressed many tumor types see Table suggest ATM may effective treatment option tumor types well Several phase phase II clinical trials currently accruing Mayo Clinic determine appropriate dosing regimen ATM assess antitumor activity ATM alone combination targeted therapeutic agents NSCLC ovarian cancer pancreatic cancer SummaryFuture Directions Accumulating evidence demonstrates PKC oncogene frequently targeted genetic alteration many major forms human cancer Tables Functional data indicate PKC required transformed phenotype NSCLC pancreatic ovarian prostate colon brain cancer cells Future studies required determine whether PKC also oncogene cancers Studies PKC using genetically defined models tumorigenesis revealed critical role PKC multiple stages tumorigenesis including tumor initiation progression metastasis Recent studies genetic model lung adenocarcinoma suggest role PKC transformation lung cancer stem cells studies important implications therapeutic use ATM particularly future studies validate PKC important gene critical cancer stem cell niche Significant progress made determining molecular mechanisms PKC drives transformed phenotype particularly central role played oncogenic PKCPar complex transformed growth invasion several PKCdependent survival pathways chemoresistance Future studies required determine composition dynamics PKCPar complex mechanisms oncogenic signaling complex regulated Likewise better understanding critical downstream effectors PKC various human tumor types holds promise identification novel prognostic surrogate markers oncogenic PKC activity may clinically useful ongoing clinical trials ATM studies also hold promise revealing novel therapeutic targets Similarly complete understanding signaling mechanisms Kras possibly oncogenes regulate PKC expression human tumors may reveal new therapeutic intervention strategies Ultimately ongoing future clinical trials required establish usefulness ATM antitumor agent allow validation potential surrogate markers predictors therapeutic response PKCdirected therapy identified preclinical models Acknowledgments authors wish thank members Fields Murray laboratories key contributions data described review authors apologize colleagues whose important contributions area cited though attempted cite much relevant literature possible space limitations made comprehensive citation impossible Work laboratories discussed article supported grants APF National Institutes Health CA American Lung AssociationLUNGevity V Foundation Cancer Research James Esther King Biomedical Research Program Mayo Foundation NRM National Institutes Health CA Mayo Clinic SPORE Pancreatic Cancer Career Development award P CA NR Murray References Baldwin RM GarrattLalonde Parolin DA Krzyzanowski PM Andrade Lorimer IA Protection glioblastoma cells cisplatin cytotoxicity via protein kinase Ciotamediated attenuation p MAP kinase signaling Oncogene PubMed Google Scholar Baldwin RM Parolin DAE Lorimer IAJ Regulation glioblastoma cell invasion PKCiota RhoB Oncogene PubMed Google Scholar Balsara BR Sonoda G du Manoir Siegfried JM Gabrielson E Testa JR Comparative genomic hybridization analysis detects frequent often highlevel overrepresentation DNA sequences q p p q human nonsmall cell lung carcinomas Cancer Res PubMed Google Scholar Bedi Barber JP Bedi GC elDeiry WS Sidransky Vala MS Akhtar AJ Hilton J Jones RJ BCRABLmediated inhibition apoptosis delay GM transition DNA damage mechanism resistance multiple anticancer agents Blood PubMed Google Scholar Bjorkoy G Perander Overvatn Johansen Reversion Ras phosphatidylcholinehydrolyzing phospholipase Cmediated transformation NIH cells dominant interfering mutant protein kinase C lambda accompanied loss constitutive nuclear mitogenactivated protein kinaseextracellular signalregulated kinase activity J Biol Chem PubMed Google Scholar Brass N Racz Heckel Remberger K Sybrecht GW Meese EU Amplification genes BCHE SLCA squamous cell carcinoma lung Cancer Res PubMed Google Scholar Brass N Ukena Remberger K Mack U Sybrecht GW Meese EU DNA amplification chromosome qq squamous cell carcinoma lung detected reverse chromosome painting Eur J Cancer PubMed Google Scholar Bratt J Belcher J Vercellotti GM Palmblad J Effects antirheumatic gold salts NFkappa B mobilization tumour necrosis factoralpha TNFalphainduced neutrophildependent cytotoxicity human endothelial cells Clin Exp Immunol PMC free article PubMed Google Scholar Castagna Takai Kaibuchi K Sano K Kikkawa U Nishizuka Direct activation calciumactivated phospholipiddependent protein kinase tumorpromoting phorbol esters J Biol Chem PubMed Google Scholar Chalmers AD Pambos Mason J Lang Wylie C Papalopulu N aPKC Crumbs Lgl control apicobasal polarity early vertebrate development Development PubMed Google Scholar Coghlan MP Chou MM Carpenter CL Atypical protein kinases Clambda zeta associate GTPbinding protein Cdc mediate stress fiber loss Mol Cell Biol PMC free article PubMed Google Scholar Dempsey EC Newton AC MochlyRosen Fields AP Reyland Insel PA Protein kinase C isozymes regulation diverse cell responses J Physiol PubMed Google Scholar DiazMeco MT Lozano J Municio MM Berra E Frutos Sanz L Moscat J Evidence vitro vivo interaction Ras protein kinase C zeta J Biol Chem PubMed Google Scholar Du GS Wang JM Lu JX Li Q CQ Du JT Zou SQ Expression PaPKCiota Ecadherin betacatenin related invasion metastasis hepatocellular carcinoma Ann Surg Oncol PubMed Google Scholar Dyrskjot L Kruhoffer Thykjaer Marcussen N Jensen JL Moller K Orntoft TF Gene expression urinary bladder common carcinoma situ gene expression signature exists disregarding histopathological classification Cancer Res PubMed Google Scholar Eder Sui X Rosen DG Nolden LK Cheng KW Lahad JP KangoSingh Lu KH Warneke CL Atkinson EN Bedrosian Keyomarsi K Kuo Wl Gray JW Yin JCP Liu J Halder G Mills GB Atypical PKCiota contributes poor prognosis loss apicalbasal polarity Cyclin E overexpression ovarian cancer PNAS PMC free article PubMed Google Scholar Erdogan E Klee EW Thompson EA Fields AP Metaanalysis oncogenic protein kinase Ciota signaling lung adenocarcinoma Clin Cancer Res PMC free article PubMed Google Scholar Erdogan E Lamark StallingsMann Lee J Pellecchia Thompson EA Johansen Fields AP Aurothiomalate inhibits transformed growth targeting PB domain protein kinase Ciota J Biol Chem PubMed Google Scholar EtienneManneville Hall Cell polarity Par aPKC cytoskeletal crosstalk Curr Opin Cell Biol PubMed Google Scholar Fields AP Gustafson WC Protein kinase C disease cancer Methods Mol Biol PubMed Google Scholar Fields AP Justilien V guanine nucleotide exchange factor GEF Ect oncogene human cancer Adv Enzyme Regul PMC free article PubMed Google Scholar Fields AP Murray NR Protein kinase C isozymes therapeutic targets treatment human cancers Adv Enzyme Regul PMC free article PubMed Google Scholar Frederick LA Matthews JA Jamieson L Justilien V Thompson EA Radisky DC Fields AP Matrix metalloproteinase critical effector protein kinase CiotaParalphamediated lung cancer Oncogene PMC free article PubMed Google Scholar Ginos Page GP Michalowicz BS Patel KJ Volker SE Pambuccian SE Ondrey FG Adams GL Gaffney PM Identification gene expression signature associated recurrent disease squamous cell carcinoma head neck Cancer Res PubMed Google Scholar GokmenPolar Fields AP Mapping molecular determinant protein kinase C betaII isozyme function J Biol Chem PubMed Google Scholar Gumz ML Zou H Kreinest PA Childs AC Belmonte LS LeGrand SN Wu KJ Luxon BA Sinha Parker Sun LZ Ahlquist DA Wood CG Copland JA Secreted frizzledrelated protein loss contributes tumor phenotype clear cell renal cell carcinoma Clin Cancer Res PubMed Google Scholar Gustafson WC Ray Jamieson L Thompson EA Brasier AR Fields AP BcrAbl regulates protein kinase Ciota PKCiota transcription via Elk site PKCiota promoter J Biol Chem PubMed Google Scholar Heselmeyer K Macville Schrock E Blegen H Hellstrom AC Shah K Auer G Ried Advancedstage cervical carcinomas defined recurrent pattern chromosomal aberrations revealing high genetic instability consistent gain chromosome arm q Genes Chromosomes Cancer PubMed Google Scholar Hirano Yoshinaga Ogura K Yokochi Noda Sumimoto H Inagaki F Solution structure atypical protein kinase C PB domain mode interaction ZIPp MEK J Biol Chem PubMed Google Scholar Ishiguro H Akimoto K Nagashima Kojima Sasaki IshiguroImagawa Nakaigawa N Ohno Kubota Uemura H aPKClambdaiota promotes growth prostate cancer cells autocrine manner transcriptional activation interleukin Proc Natl Acad Sci U PMC free article PubMed Google Scholar Jackson EL Willis N Mercer K Bronson RT Crowley Montoya R Jacks Tuveson DA Analysis lung tumor initiation progression using conditional expression oncogenic Kras Genes Dev PMC free article PubMed Google Scholar Jamieson L Carpenter L Biden TJ Fields AP Protein kinase Ciota activity necessary BcrAblmediated resistance druginduced apoptosis J Biol Chem PubMed Google Scholar Jansen AP Verwiebe EG Dreckschmidt NE Wheeler DL Oberley TD Verma AK Protein kinase Cepsilon transgenic mice unique model metastatic squamous cell carcinoma Cancer Res PubMed Google Scholar Jeon KI Jeong JY Jue DM Thiolreactive metal compounds inhibit NFkappa B activation blocking kappa B kinase J Immunol PubMed Google Scholar Jin Z Xin Deng X Survival function protein kinase Ciota novel nitrosamine methylnitrosaminopyridylbutanoneactivated bad kinase J Biol Chem PubMed Google Scholar Joberty G Petersen C Gao L Macara IG cellpolarity protein Par links Par atypical protein kinase C Cdc Nat Cell Biol PubMed Google Scholar Johnson L Mercer K Greenbaum Bronson RT Crowley Tuveson DA Jacks Somatic activation Kras oncogene causes early onset lung cancer mice Nature PubMed Google Scholar Justilien V Fields AP Ect links PKCiotaParalpha complex Rac activation cellular transformation Oncogene PMC free article PubMed Google Scholar Kampfer Windegger Hochholdinger F Schwaiger W Pestell RG Baier G Grunicke HH Uberall F Protein kinase C isoforms involved transcriptional activation cyclin transforming HaRas J Biol Chem PubMed Google Scholar Kanada Nagasaki Uyeda TQ Novel functions Ect polar lamellipodia formation polarity maintenance contractile ringindependent cytokinesis adherent cells Mol Biol Cell PMC free article PubMed Google Scholar KhosraviFar R Solski PA Clark GJ Kinch MS Der CJ Activation Rac RhoA mitogenactivated protein kinases required Ras transformation Mol Cell Biol PMC free article PubMed Google Scholar Kikkawa U Takai Tanaka Miyake R Nishizuka Protein kinase C possible receptor protein tumorpromoting phorbol esters J Biol Chem PubMed Google Scholar Klimstra DS Longnecker DS Kras mutations pancreatic ductal proliferative lesions J Pathol PMC free article PubMed Google Scholar Kojima Akimoto K Nagashima Ishiguro H Shirai Chishima Ichikawa Ishikawa Sasaki Kubota Inayama Aoki Ohno Shimada H overexpression altered localization atypical protein kinase C lambdaiota breast cancer correlates pathologic type tumors Hum Pathol PubMed Google Scholar Lamark Perander Outzen H Kristiansen K Overvatn Michaelsen E Bjorkoy G Johansen Interaction codes within family mammalian Phox Bemp domaincontaining proteins J Biol Chem PubMed Google Scholar Landi MT Dracheva Rotunno Figueroa JD Liu H Dasgupta Mann FE Fukuoka J Hames Bergen AW Murphy SE Yang P Pesatori AC Consonni Bertazzi PA Wacholder Shih JH Caporaso NE Jen J Gene expression signature cigarette smoking role lung adenocarcinoma development survival PLoS ONE e PMC free article PubMed Google Scholar Lee J Kotliarova Kotliarov Li Su Q Donin NM Pastorino Purow BW Christopher N Zhang W Park JK Fine HA Tumor stem cells derived glioblastomas cultured bFGF EGF closely mirror phenotype genotype primary tumors serumcultured cell lines Cancer Cell PubMed Google Scholar Li Q Wang JM Liu C Xiao BL Lu JX Zou SQ Correlation aPKCiota Ecadherin expression invasion prognosis cholangiocarcinoma Hepatobiliary Pancreat Dis Int PubMed Google Scholar Lin Edwards Fawcett JP Mbamalu G Scott JD Pawson mammalian PARPAR complex implicated CdcRac aPKC signalling cell polarity Nat Cell Biol PubMed Google Scholar Lin Smith LT Smiraglia DJ KazhiyurMannar R Lang JC Schuller DE Kornacker K Wenger R Plass C DNA copy number gains head neck squamous cell carcinoma Oncogene PubMed Google Scholar Lu Jamieson L Brasier AR Fields AP NFkappaBRelA transactivation required atypical protein kinase C iotamediated cell survival Oncogene PubMed Google Scholar Messori L Marcon G Gold complexes treatment rheumatoid arthritis Met Ions Biol Syst PubMed Google Scholar Mischak H Goodnight JA Kolch W MartinyBaron G Schaechtle C Kazanietz MG Blumberg PM Pierce JH Mushinski JF Overexpression protein kinase Cdelta epsilon NIH cells induces opposite effects growth morphology anchorage dependence tumorigenicity J Biol Chem PubMed Google Scholar Murray NR Davidson LA Chapkin RS Gustafson WC Schattenberg DG Fields AP Overexpression protein kinase C betaII induces colonic hyperproliferation increased sensitivity colon carcinogenesis J Cell Biol PMC free article PubMed Google Scholar Murray NR Fields AP Atypical protein kinase C iota protects human leukemia cells druginduced apoptosis J Biol Chem PubMed Google Scholar Murray NR Jamieson L Yu W Zhang J GokmenPolar Sier Anastasiadis P Gatalica Z Thompson EA Fields AP Protein kinase Ciota required Ras transformation colon carcinogenesis vivo J Cell Biol PMC free article PubMed Google Scholar Murray NR Weems J Braun U Leitges Fields AP Protein kinase C betaII PKCiotalambda collaborating partners colon cancer promotion progression Cancer Res PMC free article PubMed Google Scholar Noda Takeya R Ohno Naito Ito Sumimoto H Human homologues Caenorhabditis elegans cell polarity protein PAR adaptor links small GTPases Rac Cdc atypical protein kinase C Genes Cells PubMed Google Scholar Oster H Leitges Protein kinase C alpha PKCzeta suppresses intestinal tumor formation ApcMin mice Cancer Res PubMed Google Scholar Patel R Win H Desai Patel K Matthews JA AcevedoDuncan Involvement PKCiota glioma proliferation Cell Prolif PMC free article PubMed Google Scholar Pia Rigobello Messori L Marcon G Agostina Cinellu Bragadin Folda Scutari G Bindoli Gold complexes inhibit mitochondrial thioredoxin reductase consequences mitochondrial functions J Inorg Biochem PubMed Google Scholar Qiu RG Abo Steven Martin G human homolog C elegans polarity determinant Par links Rac Cdc PKCzeta signaling cell transformation Curr Biol PubMed Google Scholar Qiu RG Chen J Kirn McCormick F Symons essential role Rac Ras transformation Nature PubMed Google Scholar Racz Brass N Heckel Pahl Remberger K Meese E Expression analysis genes qq involved frequent amplification squamous cell lung carcinoma Eur J Cancer PubMed Google Scholar Regala RP Davis RK Kunz Khoor Leitges Fields AP Atypical protein kinase Ciota required bronchioalveolar stem cell expansion lung tumorigenesis Cancer Res PMC free article PubMed Google Scholar Regala RP Thompson EA Fields AP Atypical protein kinase C iota expression aurothiomalate sensitivity human lung cancer cells Cancer Res PMC free article PubMed Google Scholar Regala RP Weems C Jamieson L Copland JA Thompson EA Fields AP Atypical protein kinase Ciota plays critical role human lung cancer cell growth tumorigenicity J Biol Chem PubMed Google Scholar Regala RP Weems C Jamieson L Khoor Edell ES Lohse CM Fields AP Atypical protein kinase C iota oncogene human nonsmall cell lung cancer Cancer Res b PubMed Google Scholar Reyland Protein kinase C isoforms Multifunctional regulators cell life death Front Biosci PMC free article PubMed Google Scholar Richardson AL Wang ZC De Nicolo Lu X Brown Miron Liao X Iglehart JD Livingston DM Ganesan X chromosomal abnormalities basallike human breast cancer Cancer Cell PubMed Google Scholar SanchezCarbayo Socci ND Lozano J Saint F CordonCardo C Defining molecular profiles poor outcome patients invasive bladder cancer using oligonucleotide microarrays J Clin Oncol PubMed Google Scholar Scotti ML Bamlet W Smyrk TC Fields AP Murray NR Protein kinase C iota required pancreatic cancer cell transformed growth tumorigenesis Cancer Res PMC free article PubMed Google Scholar Segara Biankin AV Kench JG Langusch CC Dawson AC Skalicky DA Gotley DC Coleman MJ Sutherland RL Henshall SM Expression HOXB retinoic acid signaling target pancreatic cancer pancreatic intraepithelial neoplasia Clin Cancer Res PubMed Google Scholar Singh B Stoffel Gogineni Poluri Pfister DG Shaha AR Pathak Bosl G CordonCardo C Shah JP Rao PH Amplification q locus associated progression invasive cancer negative prognostic factor head neck squamous cell carcinomas J Pathol PMC free article PubMed Google Scholar Slattery ML Anderson K Curtin K K Schaffer Edwards Samowitz W Lifestyle factors Kiras mutations colon cancer tumors Mutat Res PubMed Google Scholar Snaddon J Parkinson EK Craft JA Bartholomew C Fulton R Detection functional PTEN lipid phosphatase protein enzyme activity squamous cell carcinomas head neck despite loss heterozygosity locus Br J Cancer PMC free article PubMed Google Scholar StallingsMann Jamieson L Regala RP Weems C Murray NR Fields AP novel smallmolecule inhibitor protein kinase Ciota blocks transformed growth nonsmallcell lung cancer cells Cancer Res PubMed Google Scholar Sugita Tanaka N Davidson Sekiya VarellaGarcia West J Drabkin HA Gemmill RM Molecular definition small amplification domain within q tumors cervix ovary lung Cancer Genet Cytogenet PubMed Google Scholar Suzuki Akimoto K Ohno Protein kinase C lambdaiota PKClambdaiota PKC isotype essential development multicellular organisms J Biochem Tokyo PubMed Google Scholar Suzuki Yamanaka Hirose Manabe N Mizuno K Shimizu Akimoto K Izumi Ohnishi Ohno Atypical protein kinase C involved evolutionarily conserved par protein complex plays critical role establishing epitheliaspecific junctional structures J Cell Biol PMC free article PubMed Google Scholar Takagawa R Akimoto K Ichikawa Akiyama H Kojima Ishiguro H Inayama Aoki Kunisaki C Endo Nagashima Ohno High expression atypical protein kinase C lambdaiota gastric cancer prognostic factor recurrence Ann Surg Oncol PubMed Google Scholar Takayama Ohi Hayashi Miyanishi K Nobuoka Nakajima Satoh Takimoto R Kato J Sakamaki Niitsu Analysis Kras APC betacatenin aberrant crypt foci sporadic adenoma cancer familial adenomatous polyposis Gastroenterology PubMed Google Scholar Talantov Mazumder Yu JX Briggs Jiang Backus J Atkins Wang Novel genes associated malignant melanoma benign melanocytic lesions Clin Cancer Res PubMed Google Scholar Uberall F Hellbert K Kampfer Maly K Villunger Spitaler Mwanjewe J BaierBitterlich G Baier G Grunicke HH Evidence atypical protein kinase Clambda atypical protein kinase Czeta participate Rasmediated reorganization Factin cytoskeleton J Cell Biol PMC free article PubMed Google Scholar Valk PJ Verhaak RG Beijen Erpelinck CA Barjesteh van Waalwijk van DoornKhosrovani Boer JM Beverloo HB Moorhouse MJ van der Spek PJ Lowenberg B Delwel R Prognostically useful geneexpression profiles acute myeloid leukemia N Engl J Med PubMed Google Scholar Wallace TA Prueitt RL Yi Howe TM Gillespie JW Yfantis HG Stephens RM Caporaso NE Loffredo CA Ambs Tumor immunobiological differences prostate cancer AfricanAmerican EuropeanAmerican men Cancer Res PubMed Google Scholar Weichert W Gekeler V Denkert C Dietel Hauptmann Protein kinase C isoform expression ovarian carcinoma correlates indicators poor prognosis Int J Oncol PubMed Google Scholar Wilson MI Gill DJ Perisic Quinn MT Williams RL PB domainmediated heterodimerization NADPH oxidase signaling complexes atypical protein kinase C Par p Mol Cell PubMed Google Scholar Win HY AcevedoDuncan Atypical protein kinase C phosphorylates IKKalphabeta transformed nonmalignant malignant prostate cell survival Cancer Lett PubMed Google Scholar Wurmbach E Chen YB Khitrov G Zhang W Roayaie Schwartz Fiel Thung Mazzaferro V Bruix J Bottinger E Friedman Waxman Llovet JM Genomewide molecular profiles HCVinduced dysplasia hepatocellular carcinoma Hepatology PubMed Google Scholar Yamashita Ashino Oshima Kawamura Ohuchi K Takayanagi Inhibition TPAinduced NFkappaB nuclear translocation production PGE antirheumatic gold compounds J Pharm Pharmacol PubMed Google Scholar Yang YL Chu JY Luo ML Wu YP Zhang Feng YB Shi ZZ Xu X Han YL Cai Dong JT Zhan QM Wu Wang MR Amplification PRKCI located q associated lymph node metastasis esophageal squamous cell carcinoma Genes Chromosomes Cancer PubMed Google Scholar Ye H Yu Temam Ziober BL Wang J Schwartz JL Mao L Wong DT Zhou X Transcriptomic dissection tongue squamous cell carcinoma BMC Genomics PMC free article PubMed Google Scholar Zhang L Huang J Yang N Liang Barchetti Giannakakis Cadungog MG OBrienJenkins Massobrio Roby KF Katsaros Gimotty P Butzow R Weber BL Coukos G Integrative genomic analysis protein kinase C PKC family identifies PKCiota biomarker potential oncogene ovarian carcinoma Cancer Res PubMed Google Scholar J Cell Physiol Author manuscript available PMC Apr Published final edited form J Cell Physiol Apr doi jcp PMCID PMC NIHMSID NIHMS PMID Protein Kinase C Expression Oncogenic Signaling Mechanisms Cancer Nicole R Murray Krishna R Kalari Alan P Fields Nicole R Murray Department Cancer Biology Mayo Clinic Comprehensive Cancer Center Jacksonville Florida Find articles Nicole R Murray Krishna R Kalari Department Cancer Biology Mayo Clinic Comprehensive Cancer Center Jacksonville Florida Find articles Krishna R Kalari Alan P Fields Department Cancer Biology Mayo Clinic Comprehensive Cancer Center Jacksonville Florida Find articles Alan P Fields Author information Copyright License information Disclaimer Department Cancer Biology Mayo Clinic Comprehensive Cancer Center Jacksonville Florida correspondences addressed Alan P Fields PhD Mayo Clinic College Medicine Griffin Cancer Research Building Rm San Pablo Road Jacksonville Florida office fax udeoyamnalasdleif Copyright notice Abstract Accumulating evidence demonstrates PKC oncogene prognostic marker frequently targeted genetic alteration many major forms human cancer Functional data demonstrate PKC required transformed phenotype NSCLC pancreatic ovarian prostate colon brain cancer cells Future studies required determine whether PKC also oncogene many cancer types also overexpress PKC Studies PKC using genetically defined models tumorigenesis revealed critical role PKC multiple stages tumorigenesis including tumor initiation progression metastasis Recent studies genetic model lung adenocarcinoma suggest role PKC transformation lung cancer stem cells studies important implications therapeutic use aurothiomalate ATM highly selective PKC signaling inhibitor currently undergoing clinical evaluation Significant progress made determining molecular mechanisms PKC drives transformed phenotype particularly central role played oncogenic PKCPar complex transformed growth invasion several PKCdependent survival pathways chemoresistance Future studies required determine composition dynamics PKCPar complex mechanisms oncogenic signaling complex regulated Likewise better understanding critical downstream effectors PKC various human tumor types holds promise identifying novel prognostic surrogate markers oncogenic PKC activity may clinically useful ongoing clinical trials ATM Keywords tumorigenesis gene amplification signal trandsuction invasion metastasis aurothiomalate Introduction Protein kinase C PKC family structurally related serinethreonine protein kinases whose catalytic activity regulated interaction phospholipid cofactors inter intramolecular phosphorylation specific proteinprotein interactions PKC enzyme family divided three subgroups conventional calciumdependent cPKCs alpha beta beta II II gamma novel calciumindependent nPKCs delta epsilon eta theta atypical aPKCs zeta iota also known lambda mice grouping based presence absence functional domains confer specific cofactor activator requirements Conventional PKCs calcium diacylglycerol DAG phosphatidylserinedependent due presence conserved modular C C domains within regulatory region enzyme Novel PKCs DAG phosphatidylserinedependent require calcium Due unique structure Nterminal regulatory region atypical PKCs require calcium DAG phosphatidylserine activation Biochemical immunologic studies indicate multiple PKC isozymes expressed virtually cell tissue types reviewed Fields Murray expression individual PKC isozymes developmentally regulated responsive differentiation state cells tissues reasons PKC isozymes thought fulfill distinct nonredundant functions within cell reviewed Dempsey et al Reyland However similar activator requirements substrate specificities PKC isozymes vitro complicated identification physiologically relevant isozymespecific substrates cellular functions ability genetically manipulate expression specific PKC isozyme express mutant forms individual PKC isozymes altered kinase activity proven successful identifying PKC isozymespecific functions Using genetic techniques many laboratories including demonstrated isozyme cell typespecific roles PKC cellular proliferation differentiation apoptosis cell polarity Chalmers et al GokmenPolar Fields Jansen et al Mischak et al Murray et al Oster Leitges discovery PKC cellular receptor tumorpromoting phorbol esters led intense interest role individual PKC isozymes cancer development Castagna et al Kikkawa et al Indeed expression level cellular localization individual PKC isozymes shown altered carcinogenesis numerous tissue types reviewed Fields Gustafson However despite exhaustive investigation somatic germline mutations found coding regions PKCs associated human cancers diseases date one PKC isozyme atypical PKC shown satisfy criteria human oncogene minireview details work laboratory others characterizing role oncogenic PKC rodent carcinogenesis models human cancer also discuss status efforts therapeutically target critical oncogene treatment cancer patients PKC Expression Primary Human Tumors PKC overexpressed prognostic multiple human cancer types Overexpression PKC demonstrated many human cancers Table PKC frequently overexpressed cancers lung Regala et al b pancreas Scotti et al stomach Takagawa et al colon Murray et al esophagus Yang et al liver Du et al bile duct Li et al breast Kojima et al ovary Eder et al Weichert et al Zhang et al prostate Ishiguro et al brain Patel et al addition published reports metaanalysis publicly available microarray data provides additional support overexpression PKC many tumor types including lung Landi et al breast Richardson et al pancreas Segara et al prostate Wallace et al ovary Cancer Genome Atlas liver Wurmbach et al Table Interestingly increased PKC brain cancer supported available genomic data sets Lee et al Table Analysis available microarray datasets revealed addition lung cancer Landi et al several squamoustype cancers also express elevated PKC including head neck Ginos et al tongue cancer Ye et al Significant overexpression PKC also detected renal cancer Gumz et al bladder cancer Dyrskjot et al SanchezCarbayo et al melanoma Talantov et al leukemia Valk et al Table studies strongly indicate role PKC many major forms human cancer TABLE PKC Expression Human Tumor Types Tumor type Tumor Control ppaired Type Analysis Result Reference Lung p blot qPCR IHC Elevated Amplified High PKC predicts poor survival Regala et al b PDAC p qPCR IHC Elevated High PKC predicts poor survival Scotti et al Gastric IHC Elevated High PKC predicts disease recurrence Takagawa et al Colon p blot Elevated Murray et al Esophageal IHC FISH Elevated Amplified gene amplification correlates tumor size stage LN metastasis High PKC predicts metastasis Yang et al Hepatocellular carcinoma p RTPCR IHC Elevated High PKC correlates size metastasis invasion stage Du et al Cholangiocarcinoma IHC Elevated High PKC correlates differentiation invasion LN metastasis stage Prognostic poor survival Li et al Breast IHC Elevated Kojima et al Ovarian IHC mRNA array CGH Elevated Amplified High PKC correlates stage Zhang et al Ovarian Array CGH qPCR IHC Elevated Amplified serous tumors high copy predicts poor survival nonserous tumors high PKC predicts poor survival Eder et al Ovarian IHC Elevated High PKC predicts poor survival Weichert et al Prostate p qPCR blot Elevated High PKC predicts poor recurrence free survival Ishiguro et al Brain blot Elevated Patel et al Open separate window TABLE PKC Expression Publicly Available Human Tumor Microarray Datasets Cancer Type Tumor Control Significant Tumor Pvalue Reference Head Neck Yes Ginos et al Tongue Yes Ye et al Lung Yes Landi et al Superficial Bladder Cancer SanChezCarbayo et al Infiltrating Bladder Urothelial Carcinoma Yes E SanChezCarbayo et al Superficial Bladder Cancer Yes E Dyrskjot et al Infiltrating Bladder Urothelial Carcinoma Yes E Dyrskjot et al Brain Lee et al Pancreas Yes E Segara et al Melanoma Yes E Talantov et al Ovarian Yes E TCGA Ovarian Published Liver HCC Yes E Wurmbach et al Breast Yes Richardson et al Prostate Yes Wallace et al Acute Myeloid Leukemia Yes Valk et al Renal Yes Gumz et al Open separate window tumor types examined PKC expression also shown prognostic significance High PKC predicts poor patient survival lung Regala et al b pancreatic Scotti et al bile duct Li et al ovarian Eder et al Weichert et al prostate Ishiguro et al cancer Elevated PKC expression predicts disease recurrence gastric cancer Takagawa et al metastasis esophageal cancer Yang et al analysis PKC expression lung cancer PKC emerged prognostic indicator comparable tumor stage prognostic value Interestingly PKC expression correlate tumor stage nonsmall cell lung cancer NSCLC rather PKC levels comparable early late stage disease indicating elevated PKC expression early event lung tumor development Regala et al b contrast PKC expression correlates tumor stage ovarian bile duct liver cancer suggesting PKC may regulate disease progression tumor types Du et al Li et al Zhang et al Thus PKC expression elevated variety tumor types many cases predictive poor clinical outcome Therefore PKC expression profiling may identify patients elevated risk relapse disease progression Since many patients diagnosed early stage cancer eventually relapse PKC expression profiling may useful identifying high risk patients would candidates aggressive clinical management perhaps discussed PKCtargeted therapy PKC target frequent tumorspecific gene amplification DNA amplification one mechanism oncogenes activated neoplastic tissue PKC gene PRKCI resides chromosome q chromosomal region frequently amplified human cancers particularly squamous cell carcinomas Brass et al Heselmeyer et al Lin et al Racz et al Singh et al Therefore examined NSCLC tumors evidence changes PRKCI gene copy number Regala et al b PRKCI found amplified tumorspecific fashion NSCLC tumors examined Furthermore PRKCI amplification correlates PKC mRNA protein expression poor outcome NSCLC tumors Regala et al b Interestingly PRKCI amplification frequently found lung squamous cell carcinoma SCC rarely lung adenomcarcinoma LAC Regala et al b consistent distribution chromosome q amplification tumor types confined SCC Balsara et al Brass et al Similar tumorspecific PRKCI amplification also observed ovarian cancers serous subtype Eder et al Zhang et al esophageal squamous cell cancer Yang et al PKC expression PRKCI copy number also correlate chromosome q gains tumors Eder et al Yang et al Zhang et al indicating PKC relevant target tumorspecific chromosome q amplification Since chromosome q amplification one common chromosomal changes human cancers including SCC head neck Snaddon et al cervix Sugita et al likely PKC expression gene copy number prognostic significance tumors well PRKCI amplification mechanism PKC expression elevated human tumors PKC expression elevated degree frequency lung SCC LAC tumors despite fact PKC gene amplification largely confined SCC tumors Regala et al b Furthermore PKC frequently overexpressed tumor types including colon cancers Murray et al pancreatic cancers Scotti et al leukemia Gustafson et al harbor frequent chromosome q amplification recently demonstrated BcrAbl transcriptionally activates PKC RasMekdependent activation specific Elk element within proximal PKC promoter chronic myelogenous leukemia CML cells Gustafson et al similar mechanism likely play LAC pancreatic ductal adenocarcinoma PDAC tumors harbor oncogenic KRAS mutations Indeed observed statistically significant positive correlation presence KRAS mutation PKC expression primary LAC tumors unpublished observations Likewise PDAC tumors harbor KRAS mutation Klimstra Longnecker detected PKC overexpressed tumors Scotti et al Another potential mechanism oncogenic activation PKC somatic mutation However sequence analysis exons PKC gene LAC cases SCC cases failed detect mutations suggesting somatic mutation PKC either occur extremely rare NSCLC unpublished observations summary PKC first date PKC isozyme shown bonafide human oncogene Regala et al b Current evidence strongly supports oncogenic role PKC NSCLC PDAC ovarian cancer glioma Given widespread overexpression PKC major tumor types appears likely PKC shown oncogene many tumor types well II PKC Cellular Transformation PKC survival gene human cancer first demonstration PKC important transformed phenotype human cancer cells came studies CML cells Murray Fields CML cells highly resistant apoptotic effects numerous chemotherapeutic agents result expression chimeric tyrosine kinase oncogene BcrAbl transforming activity causes CML Bedi et al found BcrAblpositive CML cells express high levels PKC PKC activated response apoptotic stimuli treatment chemotherapeutic agent paclitaxel Jamieson et al Disruption PKC expression activity sensitized CML cells induction paclitaxelinduced apoptosis Murray Fields Subsequent studies established similar role PKC survival chemoresistance tumor cell types including prostate Win AcevedoDuncan NSCLC Jin et al glioblastoma Baldwin et al PKC oncogenic ras mediated transformation intestinal epithelial cells Studies mouse fibroblasts first established functional link aPKCs cellular Ras Ras activate aPKCs DiazMeco et al aPKC activity necessary Rasmediated effects actinbased cytoskeleton fibroblasts Bjorkoy et al Coghlan et al Kampfer et al Uberall et al Since oncogenic Ras signaling drive colon carcinogenesis oncogenic Ras mutations detected colon cancers Slattery et al Takayama et al investigated role PKC Ras mediated transformation rat intestinal epithelial RIE cells Murray et al found oncogenic Ras activates PKC introduced nontransformed RIE cells expression kinasedeficient dominant negative PKC mutant kdPKC Ras transformed RIE cells inhibits Ras mediated invasion anchorageindependent growth Murray et al results provided direct evidence PKC involved establishment transformed phenotype Ras epithelial cells PKC required maintenance transformed phenotype cancer cells PKC plays key role transformation induced introduction oncogenic Ras nontransformed epithelial cells also maintenance transformed phenotype established human cancer cells harboring oncogenic KRAS mutations Frederick et al Regala et al Scotti et al Expression kdPKC knock PKC expression using lentiviralmediated shRNA blocked transformed anchorageindependent growth invasion human NSCLC cells Frederick et al Regala et al human PDAC cells Scotti et al Genetic disruption PKC also blocks proliferative invasive properties prostate glioma cell lines vitro Baldwin et al Ishiguro et al Patel et al Disruption PKC expression also blocks tumorigenicity NSCLC PDAC cell tumors injected either subcutaneously orthotopically lung pancreas respectively Regala et al Scotti et al Analysis human PDAC cells orthotopic injection mouse pancreas revealed PKCdeficient tumor cells yielded significantly smaller tumors significantly fewer metastases kidney liver diaphragm mesentery providing first evidence PKC important tumor metastasis vivo Scotti et al role PKC transformed growth restricted cell harboring oncogenic KRAS mutations since NSCLC cell lines expressing wildtype KRAS harboring PRKCI amplification also require PKC transformed phenotype Regala et al Regala et al b III PKC Tumorigenesis vivo PKC necessary oncogenic Kras mutant APC mediated intestinal tumorigenesis Several transgenic models tumorigenesis revealed PKC plays critical promotive role tumorigenesis vivo established mice either kdPKC constitutively active caPKC PKC expressed specifically intestinal epithelium Murray et al Expression either PKC mutant demonstrable effect basal proliferation differentiation colonic epithelium Murray Fields Murray et al However expression caPKC colon increased susceptibility carcinogen azoxymethane AOMinduced formation colonic preneoplastic lesions aberrant crypt foci ACF whereas expression kdPKC significantly inhibited AOMinduced ACF formation Murray et al addition caPKC mice exhibited increase number AOMinduced colon tumors majority tumors mice progressed benign adenoma malignant intramucosal carcinoma Murray et al Similar results obtained vivo model oncogenic Kras mediated colon carcinogenesis Kras LA mouse Johnson et al Expression kdPKC colonic epithelium mice inhibited oncogenic Kras mediated ACF formation Murray et al data demonstrated PKC required oncogenic Kras mediated transformation intestinal epithelium vivo constitute first evidence function role PKC tumorigenesis vivo Interestingly PKC also elevated intestinal tumors formed Apc Min mice Murray et al Oster Leitges determine PKC plays role tumor development Apc Min mice mouse PKC gene Prkci inactivated intestinal epithelium triple transgenic Apc Min Prkci ff villinCre mice Cremediated recombination Apc Min Prkci ff villinCre mice exhibited loss intestinal epithelial PKC expression significant decrease number intestinal tumors compared Apc Min Prkci ff mice harbor intact alleles Prkci gene Murray et al Thus PKC important Apc Min induced intestinal epithelial tumorigenesis indicating role PKC colon tumorigenesis vivo limited Kras mediated tumors Role PKC initiation lung tumorigenesis PKC cancer stem cell gene PKC oncogene required maintenance transformed phenotype nonsmall cell lung cancer NSCLC cells Frederick et al Regala et al Regala et al b address whether PKC involved lung tumor development established mouse model oncogenic Kras GD activated Cremediated recombination lung without simultaneous genetic loss mouse PKC gene Prkci Regala et al Genetic loss Prkci dramatically inhibits Kras initiated hyperplasia subsequent lung tumor formation vivo effect correlates defect ability Prkci deficient bronchioalveolar stem cells BASCs undergo Kras mediated expansion morphological transformation vitro vivo Regala et al BASC exhibit stemlike properties thought tumorinitiating cells model Kras mediated lung tumorigenesis Jackson et al Thus Prkci required oncogeneinduced expansion transformation tumorinitiating lung stemlike cells studies suggest PKC may serve critical role cancer stem cell biology Whether PKC plays similar role maintenance cancer stem cell niche human cancers remains important topic future study IV Oncogenic PKC Signaling Mechanisms PKCmediated survival signaling PKC activates multiple survival pathways confer resistance apoptosis induced many stimuli including TNF carcinogens chemotherapeutic agents Figure PKC sufficient mediate antiapoptotic effects BcrAbl via transactivation NFB Jamieson et al Lu et al Interestingly CML cells BcrAbl induces PKC expression RasMekdependent pathway involving functional Elk transcription factor binding site within proximal promoter PKC Gustafson et al Thus BcrAbl appears regulate PKC multiple levels induce chemoresistant phenotype BcrAbl induce PKC expression PKC key effector BcrAblmediated survival signaling PKCmediated survival TNFtreated prostate cancer cells also mediated NFBdependent mechanism prostate cancer cells PKCmediated phosphorylation IK leads activation canonical NFB pathway cell survival Win AcevedoDuncan glioblastoma cells PKCmediated survival appears result PKCinduced attenuation p mitogenactivated protein kinase signaling protects cells cytotoxicity caused chemotherapeutic agents Baldwin et al NSCLC cells ability PKC enhance resistance NNKinduced apoptosis appears mediated Srcdependent activation PKC phosphorylates proapoptotic protein BAD Jin et al Therefore PKC activate multiple signaling pathways promote cell survival different tumor cell types Open separate window Figure Schematic representation key oncogenic PKC signaling pathways PKC resides within several major signaling pathways implicated human cancer PKC activated known oncogenes Ras BcrAbl Src PIK cytokines TNF IL growth factors NGF EGF PKC signals downstream effectors Rac NFB important different aspects transformed phenotype Many components PKCdependent signal pathways mutated often multiple mechanisms ie gene amplification somatic mutation human tumors indicated yellow boxes Arrows indicate flow signaling pathways touching boxes indicate direct binding signaling components Phosphorylation events indicated circled Ps Rac critical downstream effector oncogenic PKC Rho family GTPase Rac activated oncogenic Ras essential Ras mediated transformed growth cellular invasion fibroblasts KhosraviFar et al Qiu et al PKC necessary Ras mediated Rac activation RIE cells Murray et al thus kdPKC blocks oncogenic Ras mediated Rac activation expression constitutively active Rac allele RacV overcomes dnPKCmediated inhibition cellular invasion Murray et al studies placed PKC downstream oncogenic Kras upstream critical Kras effector Rac activates MekErk signaling axis drive transformed growth also mediates cytoskeletal rearrangement involved cellular invasion Murray et al Figure Rac also critical downstream target Kras mediated PKCdependent transformation NSCLC Regala et al PDAC Scotti et al NSCLC PDAC cells KRAS activates PKCRacPakMekErk signaling axis drives transformed growth vitro tumorigenicity vivo Regala et al Scotti et al Interestingly Rac also plays critical role downstream oncogenic PKC NSCLC cells harbor mutant KRAS indicating PKCRac signaling specific mutant KRAS mediated transformation Regala et al Regala et al b Expression RacV reconstituted cellular invasion anchorageindependent growth PKCdeficient NSCLC PDAC cells Mekdependent manner Regala et al Scotti et al Thus Rac critical downstream effector oncogenic PKC multiple cancer cell types restricted tumor cells harboring KRAS mutations role PB domain PKC oncogenic signaling Nterminal regulatory domain aPKCs unique contains PhoxBem PB domain mediates homo heterotypic proteinprotein interactions critical activation intracellular localization Lamark et al Par PB domaincontaining protein binds atypical PKCs via PBPB domain interactions EtienneManneville Hall Wilson et al Par links atypical PKC cell polarity forming complex atypical PKC Rho family GTPase Rac cdc EtienneManneville Hall Joberty et al Lin et al Noda et al Qiu et al Suzuki et al Suzuki et al Since Rac critical downstream effector oncogenic PKC multiple cell types including colon lung pancreas Murray et al Regala et al Scotti et al assessed role PB domain PKC Rac activation NSCLC cell transformation Regala et al Expression PB domain PKC NSCLC cells uncouples PKC Par Rac activation inhibits transformed growth Likewise RNAimediated knock PKC Par Rac inhibits transformed growth cellular invasion NSCLC cancer cells Frederick et al Expression wildtype PKC PKC knock cells restores transformation whereas expression PB domain mutant PKC PKCDA bind Par Frederick et al Similarly expression wild type Par Par knock cells restores transformation whereas expression Par mutants either bind PKC ParKA couple Rac ParCRIB Frederick et al Expression RacV PKC Pardepleted NSCLC cells restores transformed growth cellular invasion Frederick et al PKCPar complex functions activate RacMekErk signaling axis drives transformed growth NSCLC cells Frederick et al studies defined novel PKCPar complex required NSCLC transformation Figure Ect binds activates PKCPar complex identified Rac critical downstream effector oncogenic PKCPar complex key question became complex activate Rac address question utilized proteomics approach identify proteins associate PKCPar complex NSCLC cells Justilien Fields Rho family GTPase guanine nucleotide exchange factor GEF Ect identified prominent component PKCPar complex Fields Justilien Justilien Fields RNAimediated knock Ect inhibits Rac activity blocks transformed growth invasion tumorigenicity NSCLC cells whereas expression RacV restores transformation Ectdeficient cells Justilien Fields Interestingly role Ect NSCLC transformation distinct wellestablished role cytokinesis fact NSCLC cells appear acquired Ectindependent cytokinesis mechanism resembles described fibrosarcoma H cells Kanada et al Rather NSCLC cells Ect mislocalized cytoplasm binds PKCPar complex Knock either PKC Par causes redistribution Ect nucleus loss transformed growth invasion Therefore Ect PKC drive tumor cell proliferation formation oncogenic PKCParEct complex Interestingly Ect gene ECT resides chromosome q close proximity PRKCI Studies primary NSCLC tumors demonstrated PRKCI ECT coamplified overexpressed NSCLC Justilien Fields Thus Ect PKC genetically linked coordinate gene amplification NSCLC tumors biochemically functionally linked NSCLC transformation formation oncogenic PKCParEct complex drives NSCLC cell transformation activating Rac Figure Justilien Fields MMP critical downstream effector oncogenic PKCParRac signaling axis recently carried genomic analysis identify genes whose expression modulated RNAimediated knock PKC NSCLC cells matrix metalloproteinase MMP stromolysin emerged analysis genomic target PKC Frederick et al Depletion PKC Par Rac RNAi inhibits MMP expression NSCLC cells expression exogenous wildtype Par Par knock cells restored MMP expression whereas expression Par mutants either bind PKC Rac indicating role PKCParRac complex MMP expression RNAimediated knock MMP blocks anchorageindependent growth cell invasion NSCLC cells loss transformed growth invasion PKC knock Par knock NSCLC cells rescued addition catalytically active MMP Frederick et al Taken together data defined PKCParRacPakMekErk signaling axis drives anchorageindependent growth invasion NSCLC cells least part induction MMP expression Frederick et al Interestingly analysis primary human lung tumor specimens demonstrated strong correlation PKC MMP expression primary NSCLC tumors suggesting role PKCParRacPakMekErkMMP signaling axis primary human lung cancers Frederick et al molecular mechanism PKCmediated overexpression MMP promotes transformation currently unexplored merits investigation second genomic study conducted metaanalysis gene expression primary lung adenocarcinomas LAC three independent public domain datasets Erdogan et al analysis identified four genes COPB ELF RFC PLS whose expression correlates positively PKC primary LAC tumors three databases QPCR analysis primary LAC samples showed four genes highly overexpressed tumors exhibit strong positive correlation PKC expression Erdogan et al RNAimediated knock PKC LAC cell lines demonstrated PKC regulates expression genes Furthermore RNAimediated knock genes led significant inhibition anchorageindependent growth cellular invasion demonstrating important transformation LAC cells Erdogan et al Finally metaanalysis revealed subsets PKCregulated genes coordinately overexpressed PKC major tumor types including lung squamous cell carcinoma breast colon prostate pancreatic glioblastoma cancers Erdogan et al analysis revealed novel signaling mechanisms participate PKCmediated transformation Figure provide potentially useful biomarkers PKCmediated signaling may serve targets development novel prognostic markers andor therapeutic agents V PKC Therapeutic Target Treatment Cancer PBPB domain interaction PKC Par highly specific required oncogenic PKCParRacMMP signaling axis mediates anchorageindependent growth invasion human NSCLC cells vitro tumorigenicity vivo Frederick et al Therefore reasoned interaction attractive target development novel mechanismbased therapeutics treatment NSCLC Using novel fluorescence resonance energy transfer FRETbased assay identified small molecular weight compounds disrupt PBPB domain interaction PKC Par StallingsMann et al Among potent inhibitors identified goldcontaining compounds aurothioglucose ATG aurothiomalate ATM FDAapproved treatments rheumatoid arthritis Messori Marcon ATG ATM exhibit dosedependent inhibition PKCPar binding IC StallingsMann et al Treatment NSCLC cells compounds inhibits PKCmediated Rac activation blocks anchorageindependent growth NSCLC cells vitro tumorigenicity vivo StallingsMann et al inhibition rescued expression RacV indicating ATM targets interaction PKC Par couples PKC Rac StallingsMann et al precise mechanism action ATG ATM RA still unknown however proposed mechanism action formation goldcysteine adducts target cellular proteins Bratt et al Jeon et al Pia Rigobello et al Yamashita et al PB domain atypical PKCs contains unique cysteine residue Cys within conserved OPR PC AID OPCA motif crystal structure PKCPar complex resides binding interface PKC Par Hirano et al Lamark et al Mutation Cys isoleucine CI valine CV amino acids frequently reside position PB domains preserves Par binding makes PKC resistant inhibitory effects ATM Par binding vitro Erdogan et al Expression CI PKC mutant NSCLC cells supports transformed growth renders cells resistant inhibitory effects ATM transformed growth Erdogan et al Thus ATM inhibits PKCPar interactions vitro vivo blocks NSCLC cell transformation targeting Cys within PB domain PKC Given clinical potential ATM therapeutic agent assessed inhibitory efficacy ATM transformed growth cell lines representing major subtypes lung cancer including lung adenocarcinoma LAC lung squamous cell carcinoma LSCC large cell carcinoma LCC small cell lung carcinoma SCLC Regala et al ATM potently inhibited anchorageindependent growth lines tested IC ranging nM lung cancer cell lines clustered highly sensitive ATM IC relatively insensitive ATM IC Interestingly ATM sensitivity correlate tumor subtype KRAS mutation status sensitivity panel standard chemotherapeutic agents frequently used treat lung cancer patients including cisplatin placitaxel gemcitabine Regala et al Rather elevated PKC expression major molecular characteristic exhibited lung cancer cells responsive ATM Regala et al Consistent vitro observations ATM inhibits tumorigenicity sensitive insensitive lung cell tumors vivo plasma drug concentrations consistent ATM IC cell lines vitro Furthermore measurements plasma drug concentrations demonstrated sensitive well insensitive cell lines exhibit antitumor response ATM plasma levels routinely achieved RA patients undergoing ATM therapy Regala et al Thus ATM exhibits antitumor activity major lung cancer subtypes particularly tumor cells express high levels PKC PKC expression profiling revealed significant subset primary NSCLC tumors express PKC level associated ATM sensitivity vitro Regala et al Therefore PKC expression profiling lung tumor samples may useful identifying lung cancer patients likely respond ATM therapy addition fact PKC overexpressed many tumor types see Table suggest ATM may effective treatment option tumor types well Several phase phase II clinical trials currently accruing Mayo Clinic determine appropriate dosing regimen ATM assess antitumor activity ATM alone combination targeted therapeutic agents NSCLC ovarian cancer pancreatic cancer SummaryFuture Directions Accumulating evidence demonstrates PKC oncogene frequently targeted genetic alteration many major forms human cancer Tables Functional data indicate PKC required transformed phenotype NSCLC pancreatic ovarian prostate colon brain cancer cells Future studies required determine whether PKC also oncogene cancers Studies PKC using genetically defined models tumorigenesis revealed critical role PKC multiple stages tumorigenesis including tumor initiation progression metastasis Recent studies genetic model lung adenocarcinoma suggest role PKC transformation lung cancer stem cells studies important implications therapeutic use ATM particularly future studies validate PKC important gene critical cancer stem cell niche Significant progress made determining molecular mechanisms PKC drives transformed phenotype particularly central role played oncogenic PKCPar complex transformed growth invasion several PKCdependent survival pathways chemoresistance Future studies required determine composition dynamics PKCPar complex mechanisms oncogenic signaling complex regulated Likewise better understanding critical downstream effectors PKC various human tumor types holds promise identification novel prognostic surrogate markers oncogenic PKC activity may clinically useful ongoing clinical trials ATM studies also hold promise revealing novel therapeutic targets Similarly complete understanding signaling mechanisms Kras possibly oncogenes regulate PKC expression human tumors may reveal new therapeutic intervention strategies Ultimately ongoing future clinical trials required establish usefulness ATM antitumor agent allow validation potential surrogate markers predictors therapeutic response PKCdirected therapy identified preclinical models Acknowledgments authors wish thank members Fields Murray laboratories key contributions data described review authors apologize colleagues whose important contributions area cited though attempted cite much relevant literature possible space limitations made comprehensive citation impossible Work laboratories discussed article supported grants APF National Institutes Health CA American Lung AssociationLUNGevity V Foundation Cancer Research James Esther King Biomedical Research Program Mayo Foundation NRM National Institutes Health CA Mayo Clinic SPORE Pancreatic Cancer Career Development award P CA NR Murray References Baldwin RM GarrattLalonde Parolin DA Krzyzanowski PM Andrade Lorimer IA Protection glioblastoma cells cisplatin cytotoxicity via protein kinase Ciotamediated attenuation p MAP kinase signaling Oncogene PubMed Google Scholar Baldwin RM Parolin DAE Lorimer IAJ Regulation glioblastoma cell invasion PKCiota RhoB Oncogene PubMed Google Scholar Balsara BR Sonoda G du Manoir Siegfried JM Gabrielson E Testa JR Comparative genomic hybridization analysis detects frequent often highlevel overrepresentation DNA sequences q p p q human nonsmall cell lung carcinomas Cancer Res PubMed Google Scholar Bedi Barber JP Bedi GC elDeiry WS Sidransky Vala MS Akhtar AJ Hilton J Jones RJ BCRABLmediated inhibition apoptosis delay GM transition DNA damage mechanism resistance multiple anticancer agents Blood PubMed Google Scholar Bjorkoy G Perander Overvatn Johansen Reversion Ras phosphatidylcholinehydrolyzing phospholipase Cmediated transformation NIH cells dominant interfering mutant protein kinase C lambda accompanied loss constitutive nuclear mitogenactivated protein kinaseextracellular signalregulated kinase activity J Biol Chem PubMed Google Scholar Brass N Racz Heckel Remberger K Sybrecht GW Meese EU Amplification genes BCHE SLCA squamous cell carcinoma lung Cancer Res PubMed Google Scholar Brass N Ukena Remberger K Mack U Sybrecht GW Meese EU DNA amplification chromosome qq squamous cell carcinoma lung detected reverse chromosome painting Eur J Cancer PubMed Google Scholar Bratt J Belcher J Vercellotti GM Palmblad J Effects antirheumatic gold salts NFkappa B mobilization tumour necrosis factoralpha TNFalphainduced neutrophildependent cytotoxicity human endothelial cells Clin Exp Immunol PMC free article PubMed Google Scholar Castagna Takai Kaibuchi K Sano K Kikkawa U Nishizuka Direct activation calciumactivated phospholipiddependent protein kinase tumorpromoting phorbol esters J Biol Chem PubMed Google Scholar Chalmers AD Pambos Mason J Lang Wylie C Papalopulu N aPKC Crumbs Lgl control apicobasal polarity early vertebrate development Development PubMed Google Scholar Coghlan MP Chou MM Carpenter CL Atypical protein kinases Clambda zeta associate GTPbinding protein Cdc mediate stress fiber loss Mol Cell Biol PMC free article PubMed Google Scholar Dempsey EC Newton AC MochlyRosen Fields AP Reyland Insel PA Protein kinase C isozymes regulation diverse cell responses J Physiol PubMed Google Scholar DiazMeco MT Lozano J Municio MM Berra E Frutos Sanz L Moscat J Evidence vitro vivo interaction Ras protein kinase C zeta J Biol Chem PubMed Google Scholar Du GS Wang JM Lu JX Li Q CQ Du JT Zou SQ Expression PaPKCiota Ecadherin betacatenin related invasion metastasis hepatocellular carcinoma Ann Surg Oncol PubMed Google Scholar Dyrskjot L Kruhoffer Thykjaer Marcussen N Jensen JL Moller K Orntoft TF Gene expression urinary bladder common carcinoma situ gene expression signature exists disregarding histopathological classification Cancer Res PubMed Google Scholar Eder Sui X Rosen DG Nolden LK Cheng KW Lahad JP KangoSingh Lu KH Warneke CL Atkinson EN Bedrosian Keyomarsi K Kuo Wl Gray JW Yin JCP Liu J Halder G Mills GB Atypical PKCiota contributes poor prognosis loss apicalbasal polarity Cyclin E overexpression ovarian cancer PNAS PMC free article PubMed Google Scholar Erdogan E Klee EW Thompson EA Fields AP Metaanalysis oncogenic protein kinase Ciota signaling lung adenocarcinoma Clin Cancer Res PMC free article PubMed Google Scholar Erdogan E Lamark StallingsMann Lee J Pellecchia Thompson EA Johansen Fields AP Aurothiomalate inhibits transformed growth targeting PB domain protein kinase Ciota J Biol Chem PubMed Google Scholar EtienneManneville Hall Cell polarity Par aPKC cytoskeletal crosstalk Curr Opin Cell Biol PubMed Google Scholar Fields AP Gustafson WC Protein kinase C disease cancer Methods Mol Biol PubMed Google Scholar Fields AP Justilien V guanine nucleotide exchange factor GEF Ect oncogene human cancer Adv Enzyme Regul PMC free article PubMed Google Scholar Fields AP Murray NR Protein kinase C isozymes therapeutic targets treatment human cancers Adv Enzyme Regul PMC free article PubMed Google Scholar Frederick LA Matthews JA Jamieson L Justilien V Thompson EA Radisky DC Fields AP Matrix metalloproteinase critical effector protein kinase CiotaParalphamediated lung cancer Oncogene PMC free article PubMed Google Scholar Ginos Page GP Michalowicz BS Patel KJ Volker SE Pambuccian SE Ondrey FG Adams GL Gaffney PM Identification gene expression signature associated recurrent disease squamous cell carcinoma head neck Cancer Res PubMed Google Scholar GokmenPolar Fields AP Mapping molecular determinant protein kinase C betaII isozyme function J Biol Chem PubMed Google Scholar Gumz ML Zou H Kreinest PA Childs AC Belmonte LS LeGrand SN Wu KJ Luxon BA Sinha Parker Sun LZ Ahlquist DA Wood CG Copland JA Secreted frizzledrelated protein loss contributes tumor phenotype clear cell renal cell carcinoma Clin Cancer Res PubMed Google Scholar Gustafson WC Ray Jamieson L Thompson EA Brasier AR Fields AP BcrAbl regulates protein kinase Ciota PKCiota transcription via Elk site PKCiota promoter J Biol Chem PubMed Google Scholar Heselmeyer K Macville Schrock E Blegen H Hellstrom AC Shah K Auer G Ried Advancedstage cervical carcinomas defined recurrent pattern chromosomal aberrations revealing high genetic instability consistent gain chromosome arm q Genes Chromosomes Cancer PubMed Google Scholar Hirano Yoshinaga Ogura K Yokochi Noda Sumimoto H Inagaki F Solution structure atypical protein kinase C PB domain mode interaction ZIPp MEK J Biol Chem PubMed Google Scholar Ishiguro H Akimoto K Nagashima Kojima Sasaki IshiguroImagawa Nakaigawa N Ohno Kubota Uemura H aPKClambdaiota promotes growth prostate cancer cells autocrine manner transcriptional activation interleukin Proc Natl Acad Sci U PMC free article PubMed Google Scholar Jackson EL Willis N Mercer K Bronson RT Crowley Montoya R Jacks Tuveson DA Analysis lung tumor initiation progression using conditional expression oncogenic Kras Genes Dev PMC free article PubMed Google Scholar Jamieson L Carpenter L Biden TJ Fields AP Protein kinase Ciota activity necessary BcrAblmediated resistance druginduced apoptosis J Biol Chem PubMed Google Scholar Jansen AP Verwiebe EG Dreckschmidt NE Wheeler DL Oberley TD Verma AK Protein kinase Cepsilon transgenic mice unique model metastatic squamous cell carcinoma Cancer Res PubMed Google Scholar Jeon KI Jeong JY Jue DM Thiolreactive metal compounds inhibit NFkappa B activation blocking kappa B kinase J Immunol PubMed Google Scholar Jin Z Xin Deng X Survival function protein kinase Ciota novel nitrosamine methylnitrosaminopyridylbutanoneactivated bad kinase J Biol Chem PubMed Google Scholar Joberty G Petersen C Gao L Macara IG cellpolarity protein Par links Par atypical protein kinase C Cdc Nat Cell Biol PubMed Google Scholar Johnson L Mercer K Greenbaum Bronson RT Crowley Tuveson DA Jacks Somatic activation Kras oncogene causes early onset lung cancer mice Nature PubMed Google Scholar Justilien V Fields AP Ect links PKCiotaParalpha complex Rac activation cellular transformation Oncogene PMC free article PubMed Google Scholar Kampfer Windegger Hochholdinger F Schwaiger W Pestell RG Baier G Grunicke HH Uberall F Protein kinase C isoforms involved transcriptional activation cyclin transforming HaRas J Biol Chem PubMed Google Scholar Kanada Nagasaki Uyeda TQ Novel functions Ect polar lamellipodia formation polarity maintenance contractile ringindependent cytokinesis adherent cells Mol Biol Cell PMC free article PubMed Google Scholar KhosraviFar R Solski PA Clark GJ Kinch MS Der CJ Activation Rac RhoA mitogenactivated protein kinases required Ras transformation Mol Cell Biol PMC free article PubMed Google Scholar Kikkawa U Takai Tanaka Miyake R Nishizuka Protein kinase C possible receptor protein tumorpromoting phorbol esters J Biol Chem PubMed Google Scholar Klimstra DS Longnecker DS Kras mutations pancreatic ductal proliferative lesions J Pathol PMC free article PubMed Google Scholar Kojima Akimoto K Nagashima Ishiguro H Shirai Chishima Ichikawa Ishikawa Sasaki Kubota Inayama Aoki Ohno Shimada H overexpression altered localization atypical protein kinase C lambdaiota breast cancer correlates pathologic type tumors Hum Pathol PubMed Google Scholar Lamark Perander Outzen H Kristiansen K Overvatn Michaelsen E Bjorkoy G Johansen Interaction codes within family mammalian Phox Bemp domaincontaining proteins J Biol Chem PubMed Google Scholar Landi MT Dracheva Rotunno Figueroa JD Liu H Dasgupta Mann FE Fukuoka J Hames Bergen AW Murphy SE Yang P Pesatori AC Consonni Bertazzi PA Wacholder Shih JH Caporaso NE Jen J Gene expression signature cigarette smoking role lung adenocarcinoma development survival PLoS ONE e PMC free article PubMed Google Scholar Lee J Kotliarova Kotliarov Li Su Q Donin NM Pastorino Purow BW Christopher N Zhang W Park JK Fine HA Tumor stem cells derived glioblastomas cultured bFGF EGF closely mirror phenotype genotype primary tumors serumcultured cell lines Cancer Cell PubMed Google Scholar Li Q Wang JM Liu C Xiao BL Lu JX Zou SQ Correlation aPKCiota Ecadherin expression invasion prognosis cholangiocarcinoma Hepatobiliary Pancreat Dis Int PubMed Google Scholar Lin Edwards Fawcett JP Mbamalu G Scott JD Pawson mammalian PARPAR complex implicated CdcRac aPKC signalling cell polarity Nat Cell Biol PubMed Google Scholar Lin Smith LT Smiraglia DJ KazhiyurMannar R Lang JC Schuller DE Kornacker K Wenger R Plass C DNA copy number gains head neck squamous cell carcinoma Oncogene PubMed Google Scholar Lu Jamieson L Brasier AR Fields AP NFkappaBRelA transactivation required atypical protein kinase C iotamediated cell survival Oncogene PubMed Google Scholar Messori L Marcon G Gold complexes treatment rheumatoid arthritis Met Ions Biol Syst PubMed Google Scholar Mischak H Goodnight JA Kolch W MartinyBaron G Schaechtle C Kazanietz MG Blumberg PM Pierce JH Mushinski JF Overexpression protein kinase Cdelta epsilon NIH cells induces opposite effects growth morphology anchorage dependence tumorigenicity J Biol Chem PubMed Google Scholar Murray NR Davidson LA Chapkin RS Gustafson WC Schattenberg DG Fields AP Overexpression protein kinase C betaII induces colonic hyperproliferation increased sensitivity colon carcinogenesis J Cell Biol PMC free article PubMed Google Scholar Murray NR Fields AP Atypical protein kinase C iota protects human leukemia cells druginduced apoptosis J Biol Chem PubMed Google Scholar Murray NR Jamieson L Yu W Zhang J GokmenPolar Sier Anastasiadis P Gatalica Z Thompson EA Fields AP Protein kinase Ciota required Ras transformation colon carcinogenesis vivo J Cell Biol PMC free article PubMed Google Scholar Murray NR Weems J Braun U Leitges Fields AP Protein kinase C betaII PKCiotalambda collaborating partners colon cancer promotion progression Cancer Res PMC free article PubMed Google Scholar Noda Takeya R Ohno Naito Ito Sumimoto H Human homologues Caenorhabditis elegans cell polarity protein PAR adaptor links small GTPases Rac Cdc atypical protein kinase C Genes Cells PubMed Google Scholar Oster H Leitges Protein kinase C alpha PKCzeta suppresses intestinal tumor formation ApcMin mice Cancer Res PubMed Google Scholar Patel R Win H Desai Patel K Matthews JA AcevedoDuncan Involvement PKCiota glioma proliferation Cell Prolif PMC free article PubMed Google Scholar Pia Rigobello Messori L Marcon G Agostina Cinellu Bragadin Folda Scutari G Bindoli Gold complexes inhibit mitochondrial thioredoxin reductase consequences mitochondrial functions J Inorg Biochem PubMed Google Scholar Qiu RG Abo Steven Martin G human homolog C elegans polarity determinant Par links Rac Cdc PKCzeta signaling cell transformation Curr Biol PubMed Google Scholar Qiu RG Chen J Kirn McCormick F Symons essential role Rac Ras transformation Nature PubMed Google Scholar Racz Brass N Heckel Pahl Remberger K Meese E Expression analysis genes qq involved frequent amplification squamous cell lung carcinoma Eur J Cancer PubMed Google Scholar Regala RP Davis RK Kunz Khoor Leitges Fields AP Atypical protein kinase Ciota required bronchioalveolar stem cell expansion lung tumorigenesis Cancer Res PMC free article PubMed Google Scholar Regala RP Thompson EA Fields AP Atypical protein kinase C iota expression aurothiomalate sensitivity human lung cancer cells Cancer Res PMC free article PubMed Google Scholar Regala RP Weems C Jamieson L Copland JA Thompson EA Fields AP Atypical protein kinase Ciota plays critical role human lung cancer cell growth tumorigenicity J Biol Chem PubMed Google Scholar Regala RP Weems C Jamieson L Khoor Edell ES Lohse CM Fields AP Atypical protein kinase C iota oncogene human nonsmall cell lung cancer Cancer Res b PubMed Google Scholar Reyland Protein kinase C isoforms Multifunctional regulators cell life death Front Biosci PMC free article PubMed Google Scholar Richardson AL Wang ZC De Nicolo Lu X Brown Miron Liao X Iglehart JD Livingston DM Ganesan X chromosomal abnormalities basallike human breast cancer Cancer Cell PubMed Google Scholar SanchezCarbayo Socci ND Lozano J Saint F CordonCardo C Defining molecular profiles poor outcome patients invasive bladder cancer using oligonucleotide microarrays J Clin Oncol PubMed Google Scholar Scotti ML Bamlet W Smyrk TC Fields AP Murray NR Protein kinase C iota required pancreatic cancer cell transformed growth tumorigenesis Cancer Res PMC free article PubMed Google Scholar Segara Biankin AV Kench JG Langusch CC Dawson AC Skalicky DA Gotley DC Coleman MJ Sutherland RL Henshall SM Expression HOXB retinoic acid signaling target pancreatic cancer pancreatic intraepithelial neoplasia Clin Cancer Res PubMed Google Scholar Singh B Stoffel Gogineni Poluri Pfister DG Shaha AR Pathak Bosl G CordonCardo C Shah JP Rao PH Amplification q locus associated progression invasive cancer negative prognostic factor head neck squamous cell carcinomas J Pathol PMC free article PubMed Google Scholar Slattery ML Anderson K Curtin K K Schaffer Edwards Samowitz W Lifestyle factors Kiras mutations colon cancer tumors Mutat Res PubMed Google Scholar Snaddon J Parkinson EK Craft JA Bartholomew C Fulton R Detection functional PTEN lipid phosphatase protein enzyme activity squamous cell carcinomas head neck despite loss heterozygosity locus Br J Cancer PMC free article PubMed Google Scholar StallingsMann Jamieson L Regala RP Weems C Murray NR Fields AP novel smallmolecule inhibitor protein kinase Ciota blocks transformed growth nonsmallcell lung cancer cells Cancer Res PubMed Google Scholar Sugita Tanaka N Davidson Sekiya VarellaGarcia West J Drabkin HA Gemmill RM Molecular definition small amplification domain within q tumors cervix ovary lung Cancer Genet Cytogenet PubMed Google Scholar Suzuki Akimoto K Ohno Protein kinase C lambdaiota PKClambdaiota PKC isotype essential development multicellular organisms J Biochem Tokyo PubMed Google Scholar Suzuki Yamanaka Hirose Manabe N Mizuno K Shimizu Akimoto K Izumi Ohnishi Ohno Atypical protein kinase C involved evolutionarily conserved par protein complex plays critical role establishing epitheliaspecific junctional structures J Cell Biol PMC free article PubMed Google Scholar Takagawa R Akimoto K Ichikawa Akiyama H Kojima Ishiguro H Inayama Aoki Kunisaki C Endo Nagashima Ohno High expression atypical protein kinase C lambdaiota gastric cancer prognostic factor recurrence Ann Surg Oncol PubMed Google Scholar Takayama Ohi Hayashi Miyanishi K Nobuoka Nakajima Satoh Takimoto R Kato J Sakamaki Niitsu Analysis Kras APC betacatenin aberrant crypt foci sporadic adenoma cancer familial adenomatous polyposis Gastroenterology PubMed Google Scholar Talantov Mazumder Yu JX Briggs Jiang Backus J Atkins Wang Novel genes associated malignant melanoma benign melanocytic lesions Clin Cancer Res PubMed Google Scholar Uberall F Hellbert K Kampfer Maly K Villunger Spitaler Mwanjewe J BaierBitterlich G Baier G Grunicke HH Evidence atypical protein kinase Clambda atypical protein kinase Czeta participate Rasmediated reorganization Factin cytoskeleton J Cell Biol PMC free article PubMed Google Scholar Valk PJ Verhaak RG Beijen Erpelinck CA Barjesteh van Waalwijk van DoornKhosrovani Boer JM Beverloo HB Moorhouse MJ van der Spek PJ Lowenberg B Delwel R Prognostically useful geneexpression profiles acute myeloid leukemia N Engl J Med PubMed Google Scholar Wallace TA Prueitt RL Yi Howe TM Gillespie JW Yfantis HG Stephens RM Caporaso NE Loffredo CA Ambs Tumor immunobiological differences prostate cancer AfricanAmerican EuropeanAmerican men Cancer Res PubMed Google Scholar Weichert W Gekeler V Denkert C Dietel Hauptmann Protein kinase C isoform expression ovarian carcinoma correlates indicators poor prognosis Int J Oncol PubMed Google Scholar Wilson MI Gill DJ Perisic Quinn MT Williams RL PB domainmediated heterodimerization NADPH oxidase signaling complexes atypical protein kinase C Par p Mol Cell PubMed Google Scholar Win HY AcevedoDuncan Atypical protein kinase C phosphorylates IKKalphabeta transformed nonmalignant malignant prostate cell survival Cancer Lett PubMed Google Scholar Wurmbach E Chen YB Khitrov G Zhang W Roayaie Schwartz Fiel Thung Mazzaferro V Bruix J Bottinger E Friedman Waxman Llovet JM Genomewide molecular profiles HCVinduced dysplasia hepatocellular carcinoma Hepatology PubMed Google Scholar Yamashita Ashino Oshima Kawamura Ohuchi K Takayanagi Inhibition TPAinduced NFkappaB nuclear translocation production PGE antirheumatic gold compounds J Pharm Pharmacol PubMed Google Scholar Yang YL Chu JY Luo ML Wu YP Zhang Feng YB Shi ZZ Xu X Han YL Cai Dong JT Zhan QM Wu Wang MR Amplification PRKCI located q associated lymph node metastasis esophageal squamous cell carcinoma Genes Chromosomes Cancer PubMed Google Scholar Ye H Yu Temam Ziober BL Wang J Schwartz JL Mao L Wong DT Zhou X Transcriptomic dissection tongue squamous cell carcinoma BMC Genomics PMC free article PubMed Google Scholar Zhang L Huang J Yang N Liang Barchetti Giannakakis Cadungog MG OBrienJenkins Massobrio Roby KF Katsaros Gimotty P Butzow R Weber BL Coukos G Integrative genomic analysis protein kinase C PKC family identifies PKCiota biomarker potential oncogene ovarian carcinoma Cancer Res PubMed Google Scholar J Cell Physiol Author manuscript available PMC Apr Published final edited form J Cell Physiol Apr doi jcp PMCID PMC NIHMSID NIHMS PMID Protein Kinase C Expression Oncogenic Signaling Mechanisms Cancer Nicole R Murray Krishna R Kalari Alan P Fields Nicole R Murray Department Cancer Biology Mayo Clinic Comprehensive Cancer Center Jacksonville Florida Find articles Nicole R Murray Krishna R Kalari Department Cancer Biology Mayo Clinic Comprehensive Cancer Center Jacksonville Florida Find articles Krishna R Kalari Alan P Fields Department Cancer Biology Mayo Clinic Comprehensive Cancer Center Jacksonville Florida Find articles Alan P Fields Author information Copyright License information Disclaimer Department Cancer Biology Mayo Clinic Comprehensive Cancer Center Jacksonville Florida correspondences addressed Alan P Fields PhD Mayo Clinic College Medicine Griffin Cancer Research Building Rm San Pablo Road Jacksonville Florida office fax udeoyamnalasdleif Copyright notice J Cell Physiol Author manuscript available PMC Apr Published final edited form J Cell Physiol Apr doi jcp PMCID PMC NIHMSID NIHMS PMID J Cell Physiol Author manuscript available PMC Apr Published final edited form J Cell Physiol Apr doi jcpJ Cell Physiol Author manuscript available PMC Apr J Cell PhysiolPublished final edited form asPublished final edited form asJ Cell Physiol Apr doi jcpJ Cell Physiol Apr doi jcpdoi jcpPMCID PMC NIHMSID NIHMS PMID PMCID PMCPMCID PMCNIHMSID NIHMSNIHMSID NIHMSPMID Protein Kinase C Expression Oncogenic Signaling Mechanisms CancerNicole R Murray Krishna R Kalari Alan P Fields Nicole R Murray Department Cancer Biology Mayo Clinic Comprehensive Cancer Center Jacksonville Florida Find articles Nicole R Murray Krishna R Kalari Department Cancer Biology Mayo Clinic Comprehensive Cancer Center Jacksonville Florida Find articles Krishna R Kalari Alan P Fields Department Cancer Biology Mayo Clinic Comprehensive Cancer Center Jacksonville Florida Find articles Alan P FieldsNicole R Murray Krishna R Kalari Alan P Fields Nicole R MurrayKrishna R KalariAlan P FieldsNicole R Murray Department Cancer Biology Mayo Clinic Comprehensive Cancer Center Jacksonville Florida Find articles Nicole R Murray Krishna R Kalari Department Cancer Biology Mayo Clinic Comprehensive Cancer Center Jacksonville Florida Find articles Krishna R Kalari Alan P Fields Department Cancer Biology Mayo Clinic Comprehensive Cancer Center Jacksonville Florida Find articles Alan P FieldsNicole R Murray Department Cancer Biology Mayo Clinic Comprehensive Cancer Center Jacksonville Florida Find articles Nicole R MurrayNicole R Murray Department Cancer Biology Mayo Clinic Comprehensive Cancer Center Jacksonville Florida Find articles Nicole R MurrayNicole R MurrayKrishna R Kalari Department Cancer Biology Mayo Clinic Comprehensive Cancer Center Jacksonville Florida Find articles Krishna R KalariKrishna R Kalari Department Cancer Biology Mayo Clinic Comprehensive Cancer Center Jacksonville Florida Find articles Krishna R KalariKrishna R KalariAlan P Fields Department Cancer Biology Mayo Clinic Comprehensive Cancer Center Jacksonville Florida Find articles Alan P FieldsAlan P Fields Department Cancer Biology Mayo Clinic Comprehensive Cancer Center Jacksonville Florida Find articles Alan P FieldsAlan P FieldsAuthor information Copyright License information Disclaimer Department Cancer Biology Mayo Clinic Comprehensive Cancer Center Jacksonville Florida correspondences addressed Alan P Fields PhD Mayo Clinic College Medicine Griffin Cancer Research Building Rm San Pablo Road Jacksonville Florida office fax udeoyamnalasdleif Copyright notice Author information Copyright License information DisclaimerAuthor informationCopyright License informationDisclaimer Department Cancer Biology Mayo Clinic Comprehensive Cancer Center Jacksonville Florida correspondences addressed Alan P Fields PhD Mayo Clinic College Medicine Griffin Cancer Research Building Rm San Pablo Road Jacksonville Florida office fax udeoyamnalasdleif Department Cancer Biology Mayo Clinic Comprehensive Cancer Center Jacksonville Florida correspondences addressed Alan P Fields PhD Mayo Clinic College Medicine Griffin Cancer Research Building Rm San Pablo Road Jacksonville Florida office fax udeoyamnalasdleifudeoyamnalasdleifCopyright notice Copyright notice Copyright noticeAbstract Accumulating evidence demonstrates PKC oncogene prognostic marker frequently targeted genetic alteration many major forms human cancer Functional data demonstrate PKC required transformed phenotype NSCLC pancreatic ovarian prostate colon brain cancer cells Future studies required determine whether PKC also oncogene many cancer types also overexpress PKC Studies PKC using genetically defined models tumorigenesis revealed critical role PKC multiple stages tumorigenesis including tumor initiation progression metastasis Recent studies genetic model lung adenocarcinoma suggest role PKC transformation lung cancer stem cells studies important implications therapeutic use aurothiomalate ATM highly selective PKC signaling inhibitor currently undergoing clinical evaluation Significant progress made determining molecular mechanisms PKC drives transformed phenotype particularly central role played oncogenic PKCPar complex transformed growth invasion several PKCdependent survival pathways chemoresistance Future studies required determine composition dynamics PKCPar complex mechanisms oncogenic signaling complex regulated Likewise better understanding critical downstream effectors PKC various human tumor types holds promise identifying novel prognostic surrogate markers oncogenic PKC activity may clinically useful ongoing clinical trials ATM Keywords tumorigenesis gene amplification signal trandsuction invasion metastasis aurothiomalateAbstractAccumulating evidence demonstrates PKC oncogene prognostic marker frequently targeted genetic alteration many major forms human cancer Functional data demonstrate PKC required transformed phenotype NSCLC pancreatic ovarian prostate colon brain cancer cells Future studies required determine whether PKC also oncogene many cancer types also overexpress PKC Studies PKC using genetically defined models tumorigenesis revealed critical role PKC multiple stages tumorigenesis including tumor initiation progression metastasis Recent studies genetic model lung adenocarcinoma suggest role PKC transformation lung cancer stem cells studies important implications therapeutic use aurothiomalate ATM highly selective PKC signaling inhibitor currently undergoing clinical evaluation Significant progress made determining molecular mechanisms PKC drives transformed phenotype particularly central role played oncogenic PKCPar complex transformed growth invasion several PKCdependent survival pathways chemoresistance Future studies required determine composition dynamics PKCPar complex mechanisms oncogenic signaling complex regulated Likewise better understanding critical downstream effectors PKC various human tumor types holds promise identifying novel prognostic surrogate markers oncogenic PKC activity may clinically useful ongoing clinical trials ATMAccumulating evidence demonstrates PKC oncogene prognostic marker frequently targeted genetic alteration many major forms human cancer Functional data demonstrate PKC required transformed phenotype NSCLC pancreatic ovarian prostate colon brain cancer cells Future studies required determine whether PKC also oncogene many cancer types also overexpress PKC Studies PKC using genetically defined models tumorigenesis revealed critical role PKC multiple stages tumorigenesis including tumor initiation progression metastasis Recent studies genetic model lung adenocarcinoma suggest role PKC transformation lung cancer stem cells studies important implications therapeutic use aurothiomalate ATM highly selective PKC signaling inhibitor currently undergoing clinical evaluation Significant progress made determining molecular mechanisms PKC drives transformed phenotype particularly central role played oncogenic PKCPar complex transformed growth invasion several PKCdependent survival pathways chemoresistance Future studies required determine composition dynamics PKCPar complex mechanisms oncogenic signaling complex regulated Likewise better understanding critical downstream effectors PKC various human tumor types holds promise identifying novel prognostic surrogate markers oncogenic PKC activity may clinically useful ongoing clinical trials ATMKeywords tumorigenesis gene amplification signal trandsuction invasion metastasis aurothiomalateKeywords tumorigenesis gene amplification signal trandsuction invasion metastasis aurothiomalateIntroduction Protein kinase C PKC family structurally related serinethreonine protein kinases whose catalytic activity regulated interaction phospholipid cofactors inter intramolecular phosphorylation specific proteinprotein interactions PKC enzyme family divided three subgroups conventional calciumdependent cPKCs alpha beta beta II II gamma novel calciumindependent nPKCs delta epsilon eta theta atypical aPKCs zeta iota also known lambda mice grouping based presence absence functional domains confer specific cofactor activator requirements Conventional PKCs calcium diacylglycerol DAG phosphatidylserinedependent due presence conserved modular C C domains within regulatory region enzyme Novel PKCs DAG phosphatidylserinedependent require calcium Due unique structure Nterminal regulatory region atypical PKCs require calcium DAG phosphatidylserine activation Biochemical immunologic studies indicate multiple PKC isozymes expressed virtually cell tissue types reviewed Fields Murray expression individual PKC isozymes developmentally regulated responsive differentiation state cells tissues reasons PKC isozymes thought fulfill distinct nonredundant functions within cell reviewed Dempsey et al Reyland However similar activator requirements substrate specificities PKC isozymes vitro complicated identification physiologically relevant isozymespecific substrates cellular functions ability genetically manipulate expression specific PKC isozyme express mutant forms individual PKC isozymes altered kinase activity proven successful identifying PKC isozymespecific functions Using genetic techniques many laboratories including demonstrated isozyme cell typespecific roles PKC cellular proliferation differentiation apoptosis cell polarity Chalmers et al GokmenPolar Fields Jansen et al Mischak et al Murray et al Oster Leitges discovery PKC cellular receptor tumorpromoting phorbol esters led intense interest role individual PKC isozymes cancer development Castagna et al Kikkawa et al Indeed expression level cellular localization individual PKC isozymes shown altered carcinogenesis numerous tissue types reviewed Fields Gustafson However despite exhaustive investigation somatic germline mutations found coding regions PKCs associated human cancers diseases date one PKC isozyme atypical PKC shown satisfy criteria human oncogene minireview details work laboratory others characterizing role oncogenic PKC rodent carcinogenesis models human cancer also discuss status efforts therapeutically target critical oncogene treatment cancer patients PKC Expression Primary Human Tumors PKC overexpressed prognostic multiple human cancer types Overexpression PKC demonstrated many human cancers Table PKC frequently overexpressed cancers lung Regala et al b pancreas Scotti et al stomach Takagawa et al colon Murray et al esophagus Yang et al liver Du et al bile duct Li et al breast Kojima et al ovary Eder et al Weichert et al Zhang et al prostate Ishiguro et al brain Patel et al addition published reports metaanalysis publicly available microarray data provides additional support overexpression PKC many tumor types including lung Landi et al breast Richardson et al pancreas Segara et al prostate Wallace et al ovary Cancer Genome Atlas liver Wurmbach et al Table Interestingly increased PKC brain cancer supported available genomic data sets Lee et al Table Analysis available microarray datasets revealed addition lung cancer Landi et al several squamoustype cancers also express elevated PKC including head neck Ginos et al tongue cancer Ye et al Significant overexpression PKC also detected renal cancer Gumz et al bladder cancer Dyrskjot et al SanchezCarbayo et al melanoma Talantov et al leukemia Valk et al Table studies strongly indicate role PKC many major forms human cancer TABLE PKC Expression Human Tumor Types Tumor type Tumor Control ppaired Type Analysis Result Reference Lung p blot qPCR IHC Elevated Amplified High PKC predicts poor survival Regala et al b PDAC p qPCR IHC Elevated High PKC predicts poor survival Scotti et al Gastric IHC Elevated High PKC predicts disease recurrence Takagawa et al Colon p blot Elevated Murray et al Esophageal IHC FISH Elevated Amplified gene amplification correlates tumor size stage LN metastasis High PKC predicts metastasis Yang et al Hepatocellular carcinoma p RTPCR IHC Elevated High PKC correlates size metastasis invasion stage Du et al Cholangiocarcinoma IHC Elevated High PKC correlates differentiation invasion LN metastasis stage Prognostic poor survival Li et al Breast IHC Elevated Kojima et al Ovarian IHC mRNA array CGH Elevated Amplified High PKC correlates stage Zhang et al Ovarian Array CGH qPCR IHC Elevated Amplified serous tumors high copy predicts poor survival nonserous tumors high PKC predicts poor survival Eder et al Ovarian IHC Elevated High PKC predicts poor survival Weichert et al Prostate p qPCR blot Elevated High PKC predicts poor recurrence free survival Ishiguro et al Brain blot Elevated Patel et al Open separate window TABLE PKC Expression Publicly Available Human Tumor Microarray Datasets Cancer Type Tumor Control Significant Tumor Pvalue Reference Head Neck Yes Ginos et al Tongue Yes Ye et al Lung Yes Landi et al Superficial Bladder Cancer SanChezCarbayo et al Infiltrating Bladder Urothelial Carcinoma Yes E SanChezCarbayo et al Superficial Bladder Cancer Yes E Dyrskjot et al Infiltrating Bladder Urothelial Carcinoma Yes E Dyrskjot et al Brain Lee et al Pancreas Yes E Segara et al Melanoma Yes E Talantov et al Ovarian Yes E TCGA Ovarian Published Liver HCC Yes E Wurmbach et al Breast Yes Richardson et al Prostate Yes Wallace et al Acute Myeloid Leukemia Yes Valk et al Renal Yes Gumz et al Open separate window tumor types examined PKC expression also shown prognostic significance High PKC predicts poor patient survival lung Regala et al b pancreatic Scotti et al bile duct Li et al ovarian Eder et al Weichert et al prostate Ishiguro et al cancer Elevated PKC expression predicts disease recurrence gastric cancer Takagawa et al metastasis esophageal cancer Yang et al analysis PKC expression lung cancer PKC emerged prognostic indicator comparable tumor stage prognostic value Interestingly PKC expression correlate tumor stage nonsmall cell lung cancer NSCLC rather PKC levels comparable early late stage disease indicating elevated PKC expression early event lung tumor development Regala et al b contrast PKC expression correlates tumor stage ovarian bile duct liver cancer suggesting PKC may regulate disease progression tumor types Du et al Li et al Zhang et al Thus PKC expression elevated variety tumor types many cases predictive poor clinical outcome Therefore PKC expression profiling may identify patients elevated risk relapse disease progression Since many patients diagnosed early stage cancer eventually relapse PKC expression profiling may useful identifying high risk patients would candidates aggressive clinical management perhaps discussed PKCtargeted therapy PKC target frequent tumorspecific gene amplification DNA amplification one mechanism oncogenes activated neoplastic tissue PKC gene PRKCI resides chromosome q chromosomal region frequently amplified human cancers particularly squamous cell carcinomas Brass et al Heselmeyer et al Lin et al Racz et al Singh et al Therefore examined NSCLC tumors evidence changes PRKCI gene copy number Regala et al b PRKCI found amplified tumorspecific fashion NSCLC tumors examined Furthermore PRKCI amplification correlates PKC mRNA protein expression poor outcome NSCLC tumors Regala et al b Interestingly PRKCI amplification frequently found lung squamous cell carcinoma SCC rarely lung adenomcarcinoma LAC Regala et al b consistent distribution chromosome q amplification tumor types confined SCC Balsara et al Brass et al Similar tumorspecific PRKCI amplification also observed ovarian cancers serous subtype Eder et al Zhang et al esophageal squamous cell cancer Yang et al PKC expression PRKCI copy number also correlate chromosome q gains tumors Eder et al Yang et al Zhang et al indicating PKC relevant target tumorspecific chromosome q amplification Since chromosome q amplification one common chromosomal changes human cancers including SCC head neck Snaddon et al cervix Sugita et al likely PKC expression gene copy number prognostic significance tumors well PRKCI amplification mechanism PKC expression elevated human tumors PKC expression elevated degree frequency lung SCC LAC tumors despite fact PKC gene amplification largely confined SCC tumors Regala et al b Furthermore PKC frequently overexpressed tumor types including colon cancers Murray et al pancreatic cancers Scotti et al leukemia Gustafson et al harbor frequent chromosome q amplification recently demonstrated BcrAbl transcriptionally activates PKC RasMekdependent activation specific Elk element within proximal PKC promoter chronic myelogenous leukemia CML cells Gustafson et al similar mechanism likely play LAC pancreatic ductal adenocarcinoma PDAC tumors harbor oncogenic KRAS mutations Indeed observed statistically significant positive correlation presence KRAS mutation PKC expression primary LAC tumors unpublished observations Likewise PDAC tumors harbor KRAS mutation Klimstra Longnecker detected PKC overexpressed tumors Scotti et al Another potential mechanism oncogenic activation PKC somatic mutation However sequence analysis exons PKC gene LAC cases SCC cases failed detect mutations suggesting somatic mutation PKC either occur extremely rare NSCLC unpublished observations summary PKC first date PKC isozyme shown bonafide human oncogene Regala et al b Current evidence strongly supports oncogenic role PKC NSCLC PDAC ovarian cancer glioma Given widespread overexpression PKC major tumor types appears likely PKC shown oncogene many tumor types well II PKC Cellular Transformation PKC survival gene human cancer first demonstration PKC important transformed phenotype human cancer cells came studies CML cells Murray Fields CML cells highly resistant apoptotic effects numerous chemotherapeutic agents result expression chimeric tyrosine kinase oncogene BcrAbl transforming activity causes CML Bedi et al found BcrAblpositive CML cells express high levels PKC PKC activated response apoptotic stimuli treatment chemotherapeutic agent paclitaxel Jamieson et al Disruption PKC expression activity sensitized CML cells induction paclitaxelinduced apoptosis Murray Fields Subsequent studies established similar role PKC survival chemoresistance tumor cell types including prostate Win AcevedoDuncan NSCLC Jin et al glioblastoma Baldwin et al PKC oncogenic ras mediated transformation intestinal epithelial cells Studies mouse fibroblasts first established functional link aPKCs cellular Ras Ras activate aPKCs DiazMeco et al aPKC activity necessary Rasmediated effects actinbased cytoskeleton fibroblasts Bjorkoy et al Coghlan et al Kampfer et al Uberall et al Since oncogenic Ras signaling drive colon carcinogenesis oncogenic Ras mutations detected colon cancers Slattery et al Takayama et al investigated role PKC Ras mediated transformation rat intestinal epithelial RIE cells Murray et al found oncogenic Ras activates PKC introduced nontransformed RIE cells expression kinasedeficient dominant negative PKC mutant kdPKC Ras transformed RIE cells inhibits Ras mediated invasion anchorageindependent growth Murray et al results provided direct evidence PKC involved establishment transformed phenotype Ras epithelial cells PKC required maintenance transformed phenotype cancer cells PKC plays key role transformation induced introduction oncogenic Ras nontransformed epithelial cells also maintenance transformed phenotype established human cancer cells harboring oncogenic KRAS mutations Frederick et al Regala et al Scotti et al Expression kdPKC knock PKC expression using lentiviralmediated shRNA blocked transformed anchorageindependent growth invasion human NSCLC cells Frederick et al Regala et al human PDAC cells Scotti et al Genetic disruption PKC also blocks proliferative invasive properties prostate glioma cell lines vitro Baldwin et al Ishiguro et al Patel et al Disruption PKC expression also blocks tumorigenicity NSCLC PDAC cell tumors injected either subcutaneously orthotopically lung pancreas respectively Regala et al Scotti et al Analysis human PDAC cells orthotopic injection mouse pancreas revealed PKCdeficient tumor cells yielded significantly smaller tumors significantly fewer metastases kidney liver diaphragm mesentery providing first evidence PKC important tumor metastasis vivo Scotti et al role PKC transformed growth restricted cell harboring oncogenic KRAS mutations since NSCLC cell lines expressing wildtype KRAS harboring PRKCI amplification also require PKC transformed phenotype Regala et al Regala et al b III PKC Tumorigenesis vivo PKC necessary oncogenic Kras mutant APC mediated intestinal tumorigenesis Several transgenic models tumorigenesis revealed PKC plays critical promotive role tumorigenesis vivo established mice either kdPKC constitutively active caPKC PKC expressed specifically intestinal epithelium Murray et al Expression either PKC mutant demonstrable effect basal proliferation differentiation colonic epithelium Murray Fields Murray et al However expression caPKC colon increased susceptibility carcinogen azoxymethane AOMinduced formation colonic preneoplastic lesions aberrant crypt foci ACF whereas expression kdPKC significantly inhibited AOMinduced ACF formation Murray et al addition caPKC mice exhibited increase number AOMinduced colon tumors majority tumors mice progressed benign adenoma malignant intramucosal carcinoma Murray et al Similar results obtained vivo model oncogenic Kras mediated colon carcinogenesis Kras LA mouse Johnson et al Expression kdPKC colonic epithelium mice inhibited oncogenic Kras mediated ACF formation Murray et al data demonstrated PKC required oncogenic Kras mediated transformation intestinal epithelium vivo constitute first evidence function role PKC tumorigenesis vivo Interestingly PKC also elevated intestinal tumors formed Apc Min mice Murray et al Oster Leitges determine PKC plays role tumor development Apc Min mice mouse PKC gene Prkci inactivated intestinal epithelium triple transgenic Apc Min Prkci ff villinCre mice Cremediated recombination Apc Min Prkci ff villinCre mice exhibited loss intestinal epithelial PKC expression significant decrease number intestinal tumors compared Apc Min Prkci ff mice harbor intact alleles Prkci gene Murray et al Thus PKC important Apc Min induced intestinal epithelial tumorigenesis indicating role PKC colon tumorigenesis vivo limited Kras mediated tumors Role PKC initiation lung tumorigenesis PKC cancer stem cell gene PKC oncogene required maintenance transformed phenotype nonsmall cell lung cancer NSCLC cells Frederick et al Regala et al Regala et al b address whether PKC involved lung tumor development established mouse model oncogenic Kras GD activated Cremediated recombination lung without simultaneous genetic loss mouse PKC gene Prkci Regala et al Genetic loss Prkci dramatically inhibits Kras initiated hyperplasia subsequent lung tumor formation vivo effect correlates defect ability Prkci deficient bronchioalveolar stem cells BASCs undergo Kras mediated expansion morphological transformation vitro vivo Regala et al BASC exhibit stemlike properties thought tumorinitiating cells model Kras mediated lung tumorigenesis Jackson et al Thus Prkci required oncogeneinduced expansion transformation tumorinitiating lung stemlike cells studies suggest PKC may serve critical role cancer stem cell biology Whether PKC plays similar role maintenance cancer stem cell niche human cancers remains important topic future study IV Oncogenic PKC Signaling Mechanisms PKCmediated survival signaling PKC activates multiple survival pathways confer resistance apoptosis induced many stimuli including TNF carcinogens chemotherapeutic agents Figure PKC sufficient mediate antiapoptotic effects BcrAbl via transactivation NFB Jamieson et al Lu et al Interestingly CML cells BcrAbl induces PKC expression RasMekdependent pathway involving functional Elk transcription factor binding site within proximal promoter PKC Gustafson et al Thus BcrAbl appears regulate PKC multiple levels induce chemoresistant phenotype BcrAbl induce PKC expression PKC key effector BcrAblmediated survival signaling PKCmediated survival TNFtreated prostate cancer cells also mediated NFBdependent mechanism prostate cancer cells PKCmediated phosphorylation IK leads activation canonical NFB pathway cell survival Win AcevedoDuncan glioblastoma cells PKCmediated survival appears result PKCinduced attenuation p mitogenactivated protein kinase signaling protects cells cytotoxicity caused chemotherapeutic agents Baldwin et al NSCLC cells ability PKC enhance resistance NNKinduced apoptosis appears mediated Srcdependent activation PKC phosphorylates proapoptotic protein BAD Jin et al Therefore PKC activate multiple signaling pathways promote cell survival different tumor cell types Open separate window Figure Schematic representation key oncogenic PKC signaling pathways PKC resides within several major signaling pathways implicated human cancer PKC activated known oncogenes Ras BcrAbl Src PIK cytokines TNF IL growth factors NGF EGF PKC signals downstream effectors Rac NFB important different aspects transformed phenotype Many components PKCdependent signal pathways mutated often multiple mechanisms ie gene amplification somatic mutation human tumors indicated yellow boxes Arrows indicate flow signaling pathways touching boxes indicate direct binding signaling components Phosphorylation events indicated circled Ps Rac critical downstream effector oncogenic PKC Rho family GTPase Rac activated oncogenic Ras essential Ras mediated transformed growth cellular invasion fibroblasts KhosraviFar et al Qiu et al PKC necessary Ras mediated Rac activation RIE cells Murray et al thus kdPKC blocks oncogenic Ras mediated Rac activation expression constitutively active Rac allele RacV overcomes dnPKCmediated inhibition cellular invasion Murray et al studies placed PKC downstream oncogenic Kras upstream critical Kras effector Rac activates MekErk signaling axis drive transformed growth also mediates cytoskeletal rearrangement involved cellular invasion Murray et al Figure Rac also critical downstream target Kras mediated PKCdependent transformation NSCLC Regala et al PDAC Scotti et al NSCLC PDAC cells KRAS activates PKCRacPakMekErk signaling axis drives transformed growth vitro tumorigenicity vivo Regala et al Scotti et al Interestingly Rac also plays critical role downstream oncogenic PKC NSCLC cells harbor mutant KRAS indicating PKCRac signaling specific mutant KRAS mediated transformation Regala et al Regala et al b Expression RacV reconstituted cellular invasion anchorageindependent growth PKCdeficient NSCLC PDAC cells Mekdependent manner Regala et al Scotti et al Thus Rac critical downstream effector oncogenic PKC multiple cancer cell types restricted tumor cells harboring KRAS mutations role PB domain PKC oncogenic signaling Nterminal regulatory domain aPKCs unique contains PhoxBem PB domain mediates homo heterotypic proteinprotein interactions critical activation intracellular localization Lamark et al Par PB domaincontaining protein binds atypical PKCs via PBPB domain interactions EtienneManneville Hall Wilson et al Par links atypical PKC cell polarity forming complex atypical PKC Rho family GTPase Rac cdc EtienneManneville Hall Joberty et al Lin et al Noda et al Qiu et al Suzuki et al Suzuki et al Since Rac critical downstream effector oncogenic PKC multiple cell types including colon lung pancreas Murray et al Regala et al Scotti et al assessed role PB domain PKC Rac activation NSCLC cell transformation Regala et al Expression PB domain PKC NSCLC cells uncouples PKC Par Rac activation inhibits transformed growth Likewise RNAimediated knock PKC Par Rac inhibits transformed growth cellular invasion NSCLC cancer cells Frederick et al Expression wildtype PKC PKC knock cells restores transformation whereas expression PB domain mutant PKC PKCDA bind Par Frederick et al Similarly expression wild type Par Par knock cells restores transformation whereas expression Par mutants either bind PKC ParKA couple Rac ParCRIB Frederick et al Expression RacV PKC Pardepleted NSCLC cells restores transformed growth cellular invasion Frederick et al PKCPar complex functions activate RacMekErk signaling axis drives transformed growth NSCLC cells Frederick et al studies defined novel PKCPar complex required NSCLC transformation Figure Ect binds activates PKCPar complex identified Rac critical downstream effector oncogenic PKCPar complex key question became complex activate Rac address question utilized proteomics approach identify proteins associate PKCPar complex NSCLC cells Justilien Fields Rho family GTPase guanine nucleotide exchange factor GEF Ect identified prominent component PKCPar complex Fields Justilien Justilien Fields RNAimediated knock Ect inhibits Rac activity blocks transformed growth invasion tumorigenicity NSCLC cells whereas expression RacV restores transformation Ectdeficient cells Justilien Fields Interestingly role Ect NSCLC transformation distinct wellestablished role cytokinesis fact NSCLC cells appear acquired Ectindependent cytokinesis mechanism resembles described fibrosarcoma H cells Kanada et al Rather NSCLC cells Ect mislocalized cytoplasm binds PKCPar complex Knock either PKC Par causes redistribution Ect nucleus loss transformed growth invasion Therefore Ect PKC drive tumor cell proliferation formation oncogenic PKCParEct complex Interestingly Ect gene ECT resides chromosome q close proximity PRKCI Studies primary NSCLC tumors demonstrated PRKCI ECT coamplified overexpressed NSCLC Justilien Fields Thus Ect PKC genetically linked coordinate gene amplification NSCLC tumors biochemically functionally linked NSCLC transformation formation oncogenic PKCParEct complex drives NSCLC cell transformation activating Rac Figure Justilien Fields MMP critical downstream effector oncogenic PKCParRac signaling axis recently carried genomic analysis identify genes whose expression modulated RNAimediated knock PKC NSCLC cells matrix metalloproteinase MMP stromolysin emerged analysis genomic target PKC Frederick et al Depletion PKC Par Rac RNAi inhibits MMP expression NSCLC cells expression exogenous wildtype Par Par knock cells restored MMP expression whereas expression Par mutants either bind PKC Rac indicating role PKCParRac complex MMP expression RNAimediated knock MMP blocks anchorageindependent growth cell invasion NSCLC cells loss transformed growth invasion PKC knock Par knock NSCLC cells rescued addition catalytically active MMP Frederick et al Taken together data defined PKCParRacPakMekErk signaling axis drives anchorageindependent growth invasion NSCLC cells least part induction MMP expression Frederick et al Interestingly analysis primary human lung tumor specimens demonstrated strong correlation PKC MMP expression primary NSCLC tumors suggesting role PKCParRacPakMekErkMMP signaling axis primary human lung cancers Frederick et al molecular mechanism PKCmediated overexpression MMP promotes transformation currently unexplored merits investigation second genomic study conducted metaanalysis gene expression primary lung adenocarcinomas LAC three independent public domain datasets Erdogan et al analysis identified four genes COPB ELF RFC PLS whose expression correlates positively PKC primary LAC tumors three databases QPCR analysis primary LAC samples showed four genes highly overexpressed tumors exhibit strong positive correlation PKC expression Erdogan et al RNAimediated knock PKC LAC cell lines demonstrated PKC regulates expression genes Furthermore RNAimediated knock genes led significant inhibition anchorageindependent growth cellular invasion demonstrating important transformation LAC cells Erdogan et al Finally metaanalysis revealed subsets PKCregulated genes coordinately overexpressed PKC major tumor types including lung squamous cell carcinoma breast colon prostate pancreatic glioblastoma cancers Erdogan et al analysis revealed novel signaling mechanisms participate PKCmediated transformation Figure provide potentially useful biomarkers PKCmediated signaling may serve targets development novel prognostic markers andor therapeutic agents V PKC Therapeutic Target Treatment Cancer PBPB domain interaction PKC Par highly specific required oncogenic PKCParRacMMP signaling axis mediates anchorageindependent growth invasion human NSCLC cells vitro tumorigenicity vivo Frederick et al Therefore reasoned interaction attractive target development novel mechanismbased therapeutics treatment NSCLC Using novel fluorescence resonance energy transfer FRETbased assay identified small molecular weight compounds disrupt PBPB domain interaction PKC Par StallingsMann et al Among potent inhibitors identified goldcontaining compounds aurothioglucose ATG aurothiomalate ATM FDAapproved treatments rheumatoid arthritis Messori Marcon ATG ATM exhibit dosedependent inhibition PKCPar binding IC StallingsMann et al Treatment NSCLC cells compounds inhibits PKCmediated Rac activation blocks anchorageindependent growth NSCLC cells vitro tumorigenicity vivo StallingsMann et al inhibition rescued expression RacV indicating ATM targets interaction PKC Par couples PKC Rac StallingsMann et al precise mechanism action ATG ATM RA still unknown however proposed mechanism action formation goldcysteine adducts target cellular proteins Bratt et al Jeon et al Pia Rigobello et al Yamashita et al PB domain atypical PKCs contains unique cysteine residue Cys within conserved OPR PC AID OPCA motif crystal structure PKCPar complex resides binding interface PKC Par Hirano et al Lamark et al Mutation Cys isoleucine CI valine CV amino acids frequently reside position PB domains preserves Par binding makes PKC resistant inhibitory effects ATM Par binding vitro Erdogan et al Expression CI PKC mutant NSCLC cells supports transformed growth renders cells resistant inhibitory effects ATM transformed growth Erdogan et al Thus ATM inhibits PKCPar interactions vitro vivo blocks NSCLC cell transformation targeting Cys within PB domain PKC Given clinical potential ATM therapeutic agent assessed inhibitory efficacy ATM transformed growth cell lines representing major subtypes lung cancer including lung adenocarcinoma LAC lung squamous cell carcinoma LSCC large cell carcinoma LCC small cell lung carcinoma SCLC Regala et al ATM potently inhibited anchorageindependent growth lines tested IC ranging nM lung cancer cell lines clustered highly sensitive ATM IC relatively insensitive ATM IC Interestingly ATM sensitivity correlate tumor subtype KRAS mutation status sensitivity panel standard chemotherapeutic agents frequently used treat lung cancer patients including cisplatin placitaxel gemcitabine Regala et al Rather elevated PKC expression major molecular characteristic exhibited lung cancer cells responsive ATM Regala et al Consistent vitro observations ATM inhibits tumorigenicity sensitive insensitive lung cell tumors vivo plasma drug concentrations consistent ATM IC cell lines vitro Furthermore measurements plasma drug concentrations demonstrated sensitive well insensitive cell lines exhibit antitumor response ATM plasma levels routinely achieved RA patients undergoing ATM therapy Regala et al Thus ATM exhibits antitumor activity major lung cancer subtypes particularly tumor cells express high levels PKC PKC expression profiling revealed significant subset primary NSCLC tumors express PKC level associated ATM sensitivity vitro Regala et al Therefore PKC expression profiling lung tumor samples may useful identifying lung cancer patients likely respond ATM therapy addition fact PKC overexpressed many tumor types see Table suggest ATM may effective treatment option tumor types well Several phase phase II clinical trials currently accruing Mayo Clinic determine appropriate dosing regimen ATM assess antitumor activity ATM alone combination targeted therapeutic agents NSCLC ovarian cancer pancreatic cancerIntroductionProtein kinase C PKC family structurally related serinethreonine protein kinases whose catalytic activity regulated interaction phospholipid cofactors inter intramolecular phosphorylation specific proteinprotein interactions PKC enzyme family divided three subgroups conventional calciumdependent cPKCs alpha beta beta II II gamma novel calciumindependent nPKCs delta epsilon eta theta atypical aPKCs zeta iota also known lambda mice grouping based presence absence functional domains confer specific cofactor activator requirements Conventional PKCs calcium diacylglycerol DAG phosphatidylserinedependent due presence conserved modular C C domains within regulatory region enzyme Novel PKCs DAG phosphatidylserinedependent require calcium Due unique structure Nterminal regulatory region atypical PKCs require calcium DAG phosphatidylserine activationBiochemical immunologic studies indicate multiple PKC isozymes expressed virtually cell tissue types reviewed Fields Murray expression individual PKC isozymes developmentally regulated responsive differentiation state cells tissues reasons PKC isozymes thought fulfill distinct nonredundant functions within cell reviewed Dempsey et al Reyland However similar activator requirements substrate specificities PKC isozymes vitro complicated identification physiologically relevant isozymespecific substrates cellular functions ability genetically manipulate expression specific PKC isozyme express mutant forms individual PKC isozymes altered kinase activity proven successful identifying PKC isozymespecific functions Using genetic techniques many laboratories including demonstrated isozyme cell typespecific roles PKC cellular proliferation differentiation apoptosis cell polarity Chalmers et al GokmenPolar Fields Jansen et al Mischak et al Murray et al Oster Leitges discovery PKC cellular receptor tumorpromoting phorbol esters led intense interest role individual PKC isozymes cancer development Castagna et al Kikkawa et al Indeed expression level cellular localization individual PKC isozymes shown altered carcinogenesis numerous tissue types reviewed Fields Gustafson However despite exhaustive investigation somatic germline mutations found coding regions PKCs associated human cancers diseases date one PKC isozyme atypical PKC shown satisfy criteria human oncogene minireview details work laboratory others characterizing role oncogenic PKC rodent carcinogenesis models human cancer also discuss status efforts therapeutically target critical oncogene treatment cancer patientsFields Murray Dempsey et al Reyland vitroChalmers et al GokmenPolar Fields Jansen et al Mischak et al Murray et al Oster Leitges Castagna et al Kikkawa et al Fields Gustafson PKC Expression Primary Human Tumors PKC overexpressed prognostic multiple human cancer types Overexpression PKC demonstrated many human cancers Table PKC frequently overexpressed cancers lung Regala et al b pancreas Scotti et al stomach Takagawa et al colon Murray et al esophagus Yang et al liver Du et al bile duct Li et al breast Kojima et al ovary Eder et al Weichert et al Zhang et al prostate Ishiguro et al brain Patel et al addition published reports metaanalysis publicly available microarray data provides additional support overexpression PKC many tumor types including lung Landi et al breast Richardson et al pancreas Segara et al prostate Wallace et al ovary Cancer Genome Atlas liver Wurmbach et al Table Interestingly increased PKC brain cancer supported available genomic data sets Lee et al Table Analysis available microarray datasets revealed addition lung cancer Landi et al several squamoustype cancers also express elevated PKC including head neck Ginos et al tongue cancer Ye et al Significant overexpression PKC also detected renal cancer Gumz et al bladder cancer Dyrskjot et al SanchezCarbayo et al melanoma Talantov et al leukemia Valk et al Table studies strongly indicate role PKC many major forms human cancer TABLE PKC Expression Human Tumor Types Tumor type Tumor Control ppaired Type Analysis Result Reference Lung p blot qPCR IHC Elevated Amplified High PKC predicts poor survival Regala et al b PDAC p qPCR IHC Elevated High PKC predicts poor survival Scotti et al Gastric IHC Elevated High PKC predicts disease recurrence Takagawa et al Colon p blot Elevated Murray et al Esophageal IHC FISH Elevated Amplified gene amplification correlates tumor size stage LN metastasis High PKC predicts metastasis Yang et al Hepatocellular carcinoma p RTPCR IHC Elevated High PKC correlates size metastasis invasion stage Du et al Cholangiocarcinoma IHC Elevated High PKC correlates differentiation invasion LN metastasis stage Prognostic poor survival Li et al Breast IHC Elevated Kojima et al Ovarian IHC mRNA array CGH Elevated Amplified High PKC correlates stage Zhang et al Ovarian Array CGH qPCR IHC Elevated Amplified serous tumors high copy predicts poor survival nonserous tumors high PKC predicts poor survival Eder et al Ovarian IHC Elevated High PKC predicts poor survival Weichert et al Prostate p qPCR blot Elevated High PKC predicts poor recurrence free survival Ishiguro et al Brain blot Elevated Patel et al Open separate window TABLE PKC Expression Publicly Available Human Tumor Microarray Datasets Cancer Type Tumor Control Significant Tumor Pvalue Reference Head Neck Yes Ginos et al Tongue Yes Ye et al Lung Yes Landi et al Superficial Bladder Cancer SanChezCarbayo et al Infiltrating Bladder Urothelial Carcinoma Yes E SanChezCarbayo et al Superficial Bladder Cancer Yes E Dyrskjot et al Infiltrating Bladder Urothelial Carcinoma Yes E Dyrskjot et al Brain Lee et al Pancreas Yes E Segara et al Melanoma Yes E Talantov et al Ovarian Yes E TCGA Ovarian Published Liver HCC Yes E Wurmbach et al Breast Yes Richardson et al Prostate Yes Wallace et al Acute Myeloid Leukemia Yes Valk et al Renal Yes Gumz et al Open separate window tumor types examined PKC expression also shown prognostic significance High PKC predicts poor patient survival lung Regala et al b pancreatic Scotti et al bile duct Li et al ovarian Eder et al Weichert et al prostate Ishiguro et al cancer Elevated PKC expression predicts disease recurrence gastric cancer Takagawa et al metastasis esophageal cancer Yang et al analysis PKC expression lung cancer PKC emerged prognostic indicator comparable tumor stage prognostic value Interestingly PKC expression correlate tumor stage nonsmall cell lung cancer NSCLC rather PKC levels comparable early late stage disease indicating elevated PKC expression early event lung tumor development Regala et al b contrast PKC expression correlates tumor stage ovarian bile duct liver cancer suggesting PKC may regulate disease progression tumor types Du et al Li et al Zhang et al Thus PKC expression elevated variety tumor types many cases predictive poor clinical outcome Therefore PKC expression profiling may identify patients elevated risk relapse disease progression Since many patients diagnosed early stage cancer eventually relapse PKC expression profiling may useful identifying high risk patients would candidates aggressive clinical management perhaps discussed PKCtargeted therapy PKC target frequent tumorspecific gene amplification DNA amplification one mechanism oncogenes activated neoplastic tissue PKC gene PRKCI resides chromosome q chromosomal region frequently amplified human cancers particularly squamous cell carcinomas Brass et al Heselmeyer et al Lin et al Racz et al Singh et al Therefore examined NSCLC tumors evidence changes PRKCI gene copy number Regala et al b PRKCI found amplified tumorspecific fashion NSCLC tumors examined Furthermore PRKCI amplification correlates PKC mRNA protein expression poor outcome NSCLC tumors Regala et al b Interestingly PRKCI amplification frequently found lung squamous cell carcinoma SCC rarely lung adenomcarcinoma LAC Regala et al b consistent distribution chromosome q amplification tumor types confined SCC Balsara et al Brass et al Similar tumorspecific PRKCI amplification also observed ovarian cancers serous subtype Eder et al Zhang et al esophageal squamous cell cancer Yang et al PKC expression PRKCI copy number also correlate chromosome q gains tumors Eder et al Yang et al Zhang et al indicating PKC relevant target tumorspecific chromosome q amplification Since chromosome q amplification one common chromosomal changes human cancers including SCC head neck Snaddon et al cervix Sugita et al likely PKC expression gene copy number prognostic significance tumors well PRKCI amplification mechanism PKC expression elevated human tumors PKC expression elevated degree frequency lung SCC LAC tumors despite fact PKC gene amplification largely confined SCC tumors Regala et al b Furthermore PKC frequently overexpressed tumor types including colon cancers Murray et al pancreatic cancers Scotti et al leukemia Gustafson et al harbor frequent chromosome q amplification recently demonstrated BcrAbl transcriptionally activates PKC RasMekdependent activation specific Elk element within proximal PKC promoter chronic myelogenous leukemia CML cells Gustafson et al similar mechanism likely play LAC pancreatic ductal adenocarcinoma PDAC tumors harbor oncogenic KRAS mutations Indeed observed statistically significant positive correlation presence KRAS mutation PKC expression primary LAC tumors unpublished observations Likewise PDAC tumors harbor KRAS mutation Klimstra Longnecker detected PKC overexpressed tumors Scotti et al Another potential mechanism oncogenic activation PKC somatic mutation However sequence analysis exons PKC gene LAC cases SCC cases failed detect mutations suggesting somatic mutation PKC either occur extremely rare NSCLC unpublished observations summary PKC first date PKC isozyme shown bonafide human oncogene Regala et al b Current evidence strongly supports oncogenic role PKC NSCLC PDAC ovarian cancer glioma Given widespread overexpression PKC major tumor types appears likely PKC shown oncogene many tumor types wellI PKC Expression Primary Human TumorsPKC overexpressed prognostic multiple human cancer types Overexpression PKC demonstrated many human cancers Table PKC frequently overexpressed cancers lung Regala et al b pancreas Scotti et al stomach Takagawa et al colon Murray et al esophagus Yang et al liver Du et al bile duct Li et al breast Kojima et al ovary Eder et al Weichert et al Zhang et al prostate Ishiguro et al brain Patel et al addition published reports metaanalysis publicly available microarray data provides additional support overexpression PKC many tumor types including lung Landi et al breast Richardson et al pancreas Segara et al prostate Wallace et al ovary Cancer Genome Atlas liver Wurmbach et al Table Interestingly increased PKC brain cancer supported available genomic data sets Lee et al Table Analysis available microarray datasets revealed addition lung cancer Landi et al several squamoustype cancers also express elevated PKC including head neck Ginos et al tongue cancer Ye et al Significant overexpression PKC also detected renal cancer Gumz et al bladder cancer Dyrskjot et al SanchezCarbayo et al melanoma Talantov et al leukemia Valk et al Table studies strongly indicate role PKC many major forms human cancer TABLE PKC Expression Human Tumor Types Tumor type Tumor Control ppaired Type Analysis Result Reference Lung p blot qPCR IHC Elevated Amplified High PKC predicts poor survival Regala et al b PDAC p qPCR IHC Elevated High PKC predicts poor survival Scotti et al Gastric IHC Elevated High PKC predicts disease recurrence Takagawa et al Colon p blot Elevated Murray et al Esophageal IHC FISH Elevated Amplified gene amplification correlates tumor size stage LN metastasis High PKC predicts metastasis Yang et al Hepatocellular carcinoma p RTPCR IHC Elevated High PKC correlates size metastasis invasion stage Du et al Cholangiocarcinoma IHC Elevated High PKC correlates differentiation invasion LN metastasis stage Prognostic poor survival Li et al Breast IHC Elevated Kojima et al Ovarian IHC mRNA array CGH Elevated Amplified High PKC correlates stage Zhang et al Ovarian Array CGH qPCR IHC Elevated Amplified serous tumors high copy predicts poor survival nonserous tumors high PKC predicts poor survival Eder et al Ovarian IHC Elevated High PKC predicts poor survival Weichert et al Prostate p qPCR blot Elevated High PKC predicts poor recurrence free survival Ishiguro et al Brain blot Elevated Patel et al Open separate window TABLE PKC Expression Publicly Available Human Tumor Microarray Datasets Cancer Type Tumor Control Significant Tumor Pvalue Reference Head Neck Yes Ginos et al Tongue Yes Ye et al Lung Yes Landi et al Superficial Bladder Cancer SanChezCarbayo et al Infiltrating Bladder Urothelial Carcinoma Yes E SanChezCarbayo et al Superficial Bladder Cancer Yes E Dyrskjot et al Infiltrating Bladder Urothelial Carcinoma Yes E Dyrskjot et al Brain Lee et al Pancreas Yes E Segara et al Melanoma Yes E Talantov et al Ovarian Yes E TCGA Ovarian Published Liver HCC Yes E Wurmbach et al Breast Yes Richardson et al Prostate Yes Wallace et al Acute Myeloid Leukemia Yes Valk et al Renal Yes Gumz et al Open separate window tumor types examined PKC expression also shown prognostic significance High PKC predicts poor patient survival lung Regala et al b pancreatic Scotti et al bile duct Li et al ovarian Eder et al Weichert et al prostate Ishiguro et al cancer Elevated PKC expression predicts disease recurrence gastric cancer Takagawa et al metastasis esophageal cancer Yang et al analysis PKC expression lung cancer PKC emerged prognostic indicator comparable tumor stage prognostic value Interestingly PKC expression correlate tumor stage nonsmall cell lung cancer NSCLC rather PKC levels comparable early late stage disease indicating elevated PKC expression early event lung tumor development Regala et al b contrast PKC expression correlates tumor stage ovarian bile duct liver cancer suggesting PKC may regulate disease progression tumor types Du et al Li et al Zhang et al Thus PKC expression elevated variety tumor types many cases predictive poor clinical outcome Therefore PKC expression profiling may identify patients elevated risk relapse disease progression Since many patients diagnosed early stage cancer eventually relapse PKC expression profiling may useful identifying high risk patients would candidates aggressive clinical management perhaps discussed PKCtargeted therapyPKC overexpressed prognostic multiple human cancer types Overexpression PKC demonstrated many human cancers Table PKC frequently overexpressed cancers lung Regala et al b pancreas Scotti et al stomach Takagawa et al colon Murray et al esophagus Yang et al liver Du et al bile duct Li et al breast Kojima et al ovary Eder et al Weichert et al Zhang et al prostate Ishiguro et al brain Patel et al addition published reports metaanalysis publicly available microarray data provides additional support overexpression PKC many tumor types including lung Landi et al breast Richardson et al pancreas Segara et al prostate Wallace et al ovary Cancer Genome Atlas liver Wurmbach et al Table Interestingly increased PKC brain cancer supported available genomic data sets Lee et al Table Analysis available microarray datasets revealed addition lung cancer Landi et al several squamoustype cancers also express elevated PKC including head neck Ginos et al tongue cancer Ye et al Significant overexpression PKC also detected renal cancer Gumz et al bladder cancer Dyrskjot et al SanchezCarbayo et al melanoma Talantov et al leukemia Valk et al Table studies strongly indicate role PKC many major forms human cancerTable Table Regala et al bScotti et al Takagawa et al Murray et al Yang et al Du et al Li et al Kojima et al Eder et al Weichert et al Zhang et al Ishiguro et al Patel et al Landi et al Richardson et al Segara et al Wallace et al Wurmbach et al Table Table Lee et al Table Table Landi et al Ginos et al Ye et al Gumz et al Dyrskjot et al SanchezCarbayo et al Talantov et al Valk et al Table Table TABLE PKC Expression Human Tumor Types Tumor type Tumor Control ppaired Type Analysis Result Reference Lung p blot qPCR IHC Elevated Amplified High PKC predicts poor survival Regala et al b PDAC p qPCR IHC Elevated High PKC predicts poor survival Scotti et al Gastric IHC Elevated High PKC predicts disease recurrence Takagawa et al Colon p blot Elevated Murray et al Esophageal IHC FISH Elevated Amplified gene amplification correlates tumor size stage LN metastasis High PKC predicts metastasis Yang et al Hepatocellular carcinoma p RTPCR IHC Elevated High PKC correlates size metastasis invasion stage Du et al Cholangiocarcinoma IHC Elevated High PKC correlates differentiation invasion LN metastasis stage Prognostic poor survival Li et al Breast IHC Elevated Kojima et al Ovarian IHC mRNA array CGH Elevated Amplified High PKC correlates stage Zhang et al Ovarian Array CGH qPCR IHC Elevated Amplified serous tumors high copy predicts poor survival nonserous tumors high PKC predicts poor survival Eder et al Ovarian IHC Elevated High PKC predicts poor survival Weichert et al Prostate p qPCR blot Elevated High PKC predicts poor recurrence free survival Ishiguro et al Brain blot Elevated Patel et al Open separate windowTABLE PKC Expression Human Tumor TypesPKC Expression Human Tumor TypesTumor type Tumor Control ppaired Type Analysis Result Reference Lung p blot qPCR IHC Elevated Amplified High PKC predicts poor survival Regala et al b PDAC p qPCR IHC Elevated High PKC predicts poor survival Scotti et al Gastric IHC Elevated High PKC predicts disease recurrence Takagawa et al Colon p blot Elevated Murray et al Esophageal IHC FISH Elevated Amplified gene amplification correlates tumor size stage LN metastasis High PKC predicts metastasis Yang et al Hepatocellular carcinoma p RTPCR IHC Elevated High PKC correlates size metastasis invasion stage Du et al Cholangiocarcinoma IHC Elevated High PKC correlates differentiation invasion LN metastasis stage Prognostic poor survival Li et al Breast IHC Elevated Kojima et al Ovarian IHC mRNA array CGH Elevated Amplified High PKC correlates stage Zhang et al Ovarian Array CGH qPCR IHC Elevated Amplified serous tumors high copy predicts poor survival nonserous tumors high PKC predicts poor survival Eder et al Ovarian IHC Elevated High PKC predicts poor survival Weichert et al Prostate p qPCR blot Elevated High PKC predicts poor recurrence free survival Ishiguro et al Brain blot Elevated Patel et al Tumor type Tumor Control ppaired Type Analysis Result Reference Lung p blot qPCR IHC Elevated Amplified High PKC predicts poor survival Regala et al b PDAC p qPCR IHC Elevated High PKC predicts poor survival Scotti et al Gastric IHC Elevated High PKC predicts disease recurrence Takagawa et al Colon p blot Elevated Murray et al Esophageal IHC FISH Elevated Amplified gene amplification correlates tumor size stage LN metastasis High PKC predicts metastasis Yang et al Hepatocellular carcinoma p RTPCR IHC Elevated High PKC correlates size metastasis invasion stage Du et al Cholangiocarcinoma IHC Elevated High PKC correlates differentiation invasion LN metastasis stage Prognostic poor survival Li et al Breast IHC Elevated Kojima et al Ovarian IHC mRNA array CGH Elevated Amplified High PKC correlates stage Zhang et al Ovarian Array CGH qPCR IHC Elevated Amplified serous tumors high copy predicts poor survival nonserous tumors high PKC predicts poor survival Eder et al Ovarian IHC Elevated High PKC predicts poor survival Weichert et al Prostate p qPCR blot Elevated High PKC predicts poor recurrence free survival Ishiguro et al Brain blot Elevated Patel et al Tumor type Tumor Control ppaired Type Analysis Result ReferenceTumor type Tumor Control ppaired Type Analysis Result ReferenceTumor typeTumor Control ppairedType AnalysisResultReferenceLung p blot qPCR IHC Elevated Amplified High PKC predicts poor survival Regala et al b PDAC p qPCR IHC Elevated High PKC predicts poor survival Scotti et al Gastric IHC Elevated High PKC predicts disease recurrence Takagawa et al Colon p blot Elevated Murray et al Esophageal IHC FISH Elevated Amplified gene amplification correlates tumor size stage LN metastasis High PKC predicts metastasis Yang et al Hepatocellular carcinoma p RTPCR IHC Elevated High PKC correlates size metastasis invasion stage Du et al Cholangiocarcinoma IHC Elevated High PKC correlates differentiation invasion LN metastasis stage Prognostic poor survival Li et al Breast IHC Elevated Kojima et al Ovarian IHC mRNA array CGH Elevated Amplified High PKC correlates stage Zhang et al Ovarian Array CGH qPCR IHC Elevated Amplified serous tumors high copy predicts poor survival nonserous tumors high PKC predicts poor survival Eder et al Ovarian IHC Elevated High PKC predicts poor survival Weichert et al Prostate p qPCR blot Elevated High PKC predicts poor recurrence free survival Ishiguro et al Brain blot Elevated Patel et al Lung p blot qPCR IHC Elevated Amplified High PKC predicts poor survival Regala et al b Lung pblot qPCR IHCElevated Amplified High PKC predicts poor survival Regala et al b Regala et al bPDAC p qPCR IHC Elevated High PKC predicts poor survival Scotti et al PDAC pqPCR IHCElevated High PKC predicts poor survival Scotti et al Scotti et al Gastric IHC Elevated High PKC predicts disease recurrence Takagawa et al GastricIHCElevated High PKC predicts disease recurrence Takagawa et al Takagawa et al Colon p blot Elevated Murray et al Colon pblotElevated Murray et al Murray et al Esophageal IHC FISH Elevated Amplified gene amplification correlates tumor size stage LN metastasis High PKC predicts metastasis Yang et al EsophagealIHC FISHElevated Amplified gene amplification correlates tumor size stage LN metastasis High PKC predicts metastasis Yang et al Yang et al Hepatocellular carcinoma p RTPCR IHC Elevated High PKC correlates size metastasis invasion stage Du et al Hepatocellular carcinoma pRTPCR IHCElevated High PKC correlates size metastasis invasion stage Du et al Du et al Cholangiocarcinoma IHC Elevated High PKC correlates differentiation invasion LN metastasis stage Prognostic poor survival Li et al Cholangiocarcinoma IHCElevated High PKC correlates differentiation invasion LN metastasis stage Prognostic poor survival Li et al Li et al Breast IHC Elevated Kojima et al BreastIHCElevated Kojima et al Kojima et al Ovarian IHC mRNA array CGH Elevated Amplified High PKC correlates stage Zhang et al OvarianIHC mRNA array CGHElevated Amplified High PKC correlates stage Zhang et al Zhang et al Ovarian Array CGH qPCR IHC Elevated Amplified serous tumors high copy predicts poor survival nonserous tumors high PKC predicts poor survival Eder et al OvarianArray CGH qPCR IHCElevated Amplified serous tumors high copy predicts poor survival nonserous tumors high PKC predicts poor survival Eder et al Eder et al Ovarian IHC Elevated High PKC predicts poor survival Weichert et al Ovarian IHCElevated High PKC predicts poor survival Weichert et al Weichert et al Prostate p qPCR blot Elevated High PKC predicts poor recurrence free survival Ishiguro et al Prostate pqPCR blotElevated High PKC predicts poor recurrence free survival Ishiguro et al Ishiguro et al Brain blot Elevated Patel et al Brain blotElevated Patel et al Patel et al Open separate windowOpen separate windowTABLE PKC Expression Publicly Available Human Tumor Microarray Datasets Cancer Type Tumor Control Significant Tumor Pvalue Reference Head Neck Yes Ginos et al Tongue Yes Ye et al Lung Yes Landi et al Superficial Bladder Cancer SanChezCarbayo et al Infiltrating Bladder Urothelial Carcinoma Yes E SanChezCarbayo et al Superficial Bladder Cancer Yes E Dyrskjot et al Infiltrating Bladder Urothelial Carcinoma Yes E Dyrskjot et al Brain Lee et al Pancreas Yes E Segara et al Melanoma Yes E Talantov et al Ovarian Yes E TCGA Ovarian Published Liver HCC Yes E Wurmbach et al Breast Yes Richardson et al Prostate Yes Wallace et al Acute Myeloid Leukemia Yes Valk et al Renal Yes Gumz et al Open separate windowTABLE PKC Expression Publicly Available Human Tumor Microarray DatasetsPKC Expression Publicly Available Human Tumor Microarray DatasetsCancer Type Tumor Control Significant Tumor Pvalue Reference Head Neck Yes Ginos et al Tongue Yes Ye et al Lung Yes Landi et al Superficial Bladder Cancer SanChezCarbayo et al Infiltrating Bladder Urothelial Carcinoma Yes E SanChezCarbayo et al Superficial Bladder Cancer Yes E Dyrskjot et al Infiltrating Bladder Urothelial Carcinoma Yes E Dyrskjot et al Brain Lee et al Pancreas Yes E Segara et al Melanoma Yes E Talantov et al Ovarian Yes E TCGA Ovarian Published Liver HCC Yes E Wurmbach et al Breast Yes Richardson et al Prostate Yes Wallace et al Acute Myeloid Leukemia Yes Valk et al Renal Yes Gumz et al Cancer Type Tumor Control Significant Tumor Pvalue Reference Head Neck Yes Ginos et al Tongue Yes Ye et al Lung Yes Landi et al Superficial Bladder Cancer SanChezCarbayo et al Infiltrating Bladder Urothelial Carcinoma Yes E SanChezCarbayo et al Superficial Bladder Cancer Yes E Dyrskjot et al Infiltrating Bladder Urothelial Carcinoma Yes E Dyrskjot et al Brain Lee et al Pancreas Yes E Segara et al Melanoma Yes E Talantov et al Ovarian Yes E TCGA Ovarian Published Liver HCC Yes E Wurmbach et al Breast Yes Richardson et al Prostate Yes Wallace et al Acute Myeloid Leukemia Yes Valk et al Renal Yes Gumz et al Cancer Type Tumor Control Significant Tumor Pvalue ReferenceCancer Type Tumor Control Significant Tumor Pvalue ReferenceCancer TypeTumor ControlSignificant Tumor PvalueReferenceHead Neck Yes Ginos et al Tongue Yes Ye et al Lung Yes Landi et al Superficial Bladder Cancer SanChezCarbayo et al Infiltrating Bladder Urothelial Carcinoma Yes E SanChezCarbayo et al Superficial Bladder Cancer Yes E Dyrskjot et al Infiltrating Bladder Urothelial Carcinoma Yes E Dyrskjot et al Brain Lee et al Pancreas Yes E Segara et al Melanoma Yes E Talantov et al Ovarian Yes E TCGA Ovarian Published Liver HCC Yes E Wurmbach et al Breast Yes Richardson et al Prostate Yes Wallace et al Acute Myeloid Leukemia Yes Valk et al Renal Yes Gumz et al Head Neck Yes Ginos et al Head Neck Yes Ginos et al Ginos et al Tongue Yes Ye et al Tongue Yes Ye et al Ye et al Lung Yes Landi et al Lung Yes Landi et al Landi et al Superficial Bladder Cancer SanChezCarbayo et al Superficial Bladder Cancer SanChezCarbayo et al SanChezCarbayo et al Infiltrating Bladder Urothelial Carcinoma Yes E SanChezCarbayo et al Infiltrating Bladder Urothelial Carcinoma Yes E SanChezCarbayo et al SanChezCarbayo et al Superficial Bladder Cancer Yes E Dyrskjot et al Superficial Bladder Cancer Yes E Dyrskjot et al Dyrskjot et al Infiltrating Bladder Urothelial Carcinoma Yes E Dyrskjot et al Infiltrating Bladder Urothelial Carcinoma Yes E Dyrskjot et al Dyrskjot et al Brain Lee et al Brain Lee et al Lee et al Pancreas Yes E Segara et al Pancreas Yes E Segara et al Segara et al Melanoma Yes E Talantov et al Melanoma Yes E Talantov et al Talantov et al Ovarian Yes E TCGA Ovarian PublishedOvarian Yes ETCGA Ovarian PublishedLiver HCC Yes E Wurmbach et al Liver HCC Yes E Wurmbach et al Wurmbach et al Breast Yes Richardson et al Breast Yes Richardson et al Richardson et al Prostate Yes Wallace et al Prostate Yes Wallace et al Wallace et al Acute Myeloid Leukemia Yes Valk et al Acute Myeloid Leukemia Yes Valk et al Valk et al Renal Yes Gumz et al Renal Yes Gumz et al Gumz et al Open separate windowOpen separate windowIn tumor types examined PKC expression also shown prognostic significance High PKC predicts poor patient survival lung Regala et al b pancreatic Scotti et al bile duct Li et al ovarian Eder et al Weichert et al prostate Ishiguro et al cancer Elevated PKC expression predicts disease recurrence gastric cancer Takagawa et al metastasis esophageal cancer Yang et al analysis PKC expression lung cancer PKC emerged prognostic indicator comparable tumor stage prognostic value Interestingly PKC expression correlate tumor stage nonsmall cell lung cancer NSCLC rather PKC levels comparable early late stage disease indicating elevated PKC expression early event lung tumor development Regala et al b contrast PKC expression correlates tumor stage ovarian bile duct liver cancer suggesting PKC may regulate disease progression tumor types Du et al Li et al Zhang et al Regala et al bScotti et al Li et al Eder et al Weichert et al Ishiguro et al Takagawa et al Yang et al Regala et al bDu et al Li et al Zhang et al Thus PKC expression elevated variety tumor types many cases predictive poor clinical outcome Therefore PKC expression profiling may identify patients elevated risk relapse disease progression Since many patients diagnosed early stage cancer eventually relapse PKC expression profiling may useful identifying high risk patients would candidates aggressive clinical management perhaps discussed PKCtargeted therapyPKC target frequent tumorspecific gene amplification DNA amplification one mechanism oncogenes activated neoplastic tissue PKC gene PRKCI resides chromosome q chromosomal region frequently amplified human cancers particularly squamous cell carcinomas Brass et al Heselmeyer et al Lin et al Racz et al Singh et al Therefore examined NSCLC tumors evidence changes PRKCI gene copy number Regala et al b PRKCI found amplified tumorspecific fashion NSCLC tumors examined Furthermore PRKCI amplification correlates PKC mRNA protein expression poor outcome NSCLC tumors Regala et al b Interestingly PRKCI amplification frequently found lung squamous cell carcinoma SCC rarely lung adenomcarcinoma LAC Regala et al b consistent distribution chromosome q amplification tumor types confined SCC Balsara et al Brass et al Similar tumorspecific PRKCI amplification also observed ovarian cancers serous subtype Eder et al Zhang et al esophageal squamous cell cancer Yang et al PKC expression PRKCI copy number also correlate chromosome q gains tumors Eder et al Yang et al Zhang et al indicating PKC relevant target tumorspecific chromosome q amplification Since chromosome q amplification one common chromosomal changes human cancers including SCC head neck Snaddon et al cervix Sugita et al likely PKC expression gene copy number prognostic significance tumors well PRKCI amplification mechanism PKC expression elevated human tumors PKC expression elevated degree frequency lung SCC LAC tumors despite fact PKC gene amplification largely confined SCC tumors Regala et al b Furthermore PKC frequently overexpressed tumor types including colon cancers Murray et al pancreatic cancers Scotti et al leukemia Gustafson et al harbor frequent chromosome q amplification recently demonstrated BcrAbl transcriptionally activates PKC RasMekdependent activation specific Elk element within proximal PKC promoter chronic myelogenous leukemia CML cells Gustafson et al similar mechanism likely play LAC pancreatic ductal adenocarcinoma PDAC tumors harbor oncogenic KRAS mutations Indeed observed statistically significant positive correlation presence KRAS mutation PKC expression primary LAC tumors unpublished observations Likewise PDAC tumors harbor KRAS mutation Klimstra Longnecker detected PKC overexpressed tumors Scotti et al Another potential mechanism oncogenic activation PKC somatic mutation However sequence analysis exons PKC gene LAC cases SCC cases failed detect mutations suggesting somatic mutation PKC either occur extremely rare NSCLC unpublished observations summary PKC first date PKC isozyme shown bonafide human oncogene Regala et al b Current evidence strongly supports oncogenic role PKC NSCLC PDAC ovarian cancer glioma Given widespread overexpression PKC major tumor types appears likely PKC shown oncogene many tumor types wellPKC target frequent tumorspecific gene amplification DNA amplification one mechanism oncogenes activated neoplastic tissue PKC gene PRKCI resides chromosome q chromosomal region frequently amplified human cancers particularly squamous cell carcinomas Brass et al Heselmeyer et al Lin et al Racz et al Singh et al Therefore examined NSCLC tumors evidence changes PRKCI gene copy number Regala et al b PRKCI found amplified tumorspecific fashion NSCLC tumors examined Furthermore PRKCI amplification correlates PKC mRNA protein expression poor outcome NSCLC tumors Regala et al b Interestingly PRKCI amplification frequently found lung squamous cell carcinoma SCC rarely lung adenomcarcinoma LAC Regala et al b consistent distribution chromosome q amplification tumor types confined SCC Balsara et al Brass et al Similar tumorspecific PRKCI amplification also observed ovarian cancers serous subtype Eder et al Zhang et al esophageal squamous cell cancer Yang et al PKC expression PRKCI copy number also correlate chromosome q gains tumors Eder et al Yang et al Zhang et al indicating PKC relevant target tumorspecific chromosome q amplification Since chromosome q amplification one common chromosomal changes human cancers including SCC head neck Snaddon et al cervix Sugita et al likely PKC expression gene copy number prognostic significance tumors wellPRKCIBrass et al Heselmeyer et al Lin et al Racz et al Singh et al PRKCIRegala et al bPRKCIPRKCIRegala et al bPRKCIRegala et al bBalsara et al Brass et al PRKCIEder et al Zhang et al Yang et al PRKCIEder et al Yang et al Zhang et al Snaddon et al Sugita et al PRKCI amplification mechanism PKC expression elevated human tumors PKC expression elevated degree frequency lung SCC LAC tumors despite fact PKC gene amplification largely confined SCC tumors Regala et al b Furthermore PKC frequently overexpressed tumor types including colon cancers Murray et al pancreatic cancers Scotti et al leukemia Gustafson et al harbor frequent chromosome q amplification recently demonstrated BcrAbl transcriptionally activates PKC RasMekdependent activation specific Elk element within proximal PKC promoter chronic myelogenous leukemia CML cells Gustafson et al similar mechanism likely play LAC pancreatic ductal adenocarcinoma PDAC tumors harbor oncogenic KRAS mutations Indeed observed statistically significant positive correlation presence KRAS mutation PKC expression primary LAC tumors unpublished observations Likewise PDAC tumors harbor KRAS mutation Klimstra Longnecker detected PKC overexpressed tumors Scotti et al PRKCIRegala et al bMurray et al Scotti et al Gustafson et al Gustafson et al KRASKRASKRASKlimstra Longnecker Scotti et al Another potential mechanism oncogenic activation PKC somatic mutation However sequence analysis exons PKC gene LAC cases SCC cases failed detect mutations suggesting somatic mutation PKC either occur extremely rare NSCLC unpublished observations summary PKC first date PKC isozyme shown bonafide human oncogene Regala et al b Current evidence strongly supports oncogenic role PKC NSCLC PDAC ovarian cancer glioma Given widespread overexpression PKC major tumor types appears likely PKC shown oncogene many tumor types wellRegala et al bII PKC Cellular Transformation PKC survival gene human cancer first demonstration PKC important transformed phenotype human cancer cells came studies CML cells Murray Fields CML cells highly resistant apoptotic effects numerous chemotherapeutic agents result expression chimeric tyrosine kinase oncogene BcrAbl transforming activity causes CML Bedi et al found BcrAblpositive CML cells express high levels PKC PKC activated response apoptotic stimuli treatment chemotherapeutic agent paclitaxel Jamieson et al Disruption PKC expression activity sensitized CML cells induction paclitaxelinduced apoptosis Murray Fields Subsequent studies established similar role PKC survival chemoresistance tumor cell types including prostate Win AcevedoDuncan NSCLC Jin et al glioblastoma Baldwin et al PKC oncogenic ras mediated transformation intestinal epithelial cells Studies mouse fibroblasts first established functional link aPKCs cellular Ras Ras activate aPKCs DiazMeco et al aPKC activity necessary Rasmediated effects actinbased cytoskeleton fibroblasts Bjorkoy et al Coghlan et al Kampfer et al Uberall et al Since oncogenic Ras signaling drive colon carcinogenesis oncogenic Ras mutations detected colon cancers Slattery et al Takayama et al investigated role PKC Ras mediated transformation rat intestinal epithelial RIE cells Murray et al found oncogenic Ras activates PKC introduced nontransformed RIE cells expression kinasedeficient dominant negative PKC mutant kdPKC Ras transformed RIE cells inhibits Ras mediated invasion anchorageindependent growth Murray et al results provided direct evidence PKC involved establishment transformed phenotype Ras epithelial cells PKC required maintenance transformed phenotype cancer cells PKC plays key role transformation induced introduction oncogenic Ras nontransformed epithelial cells also maintenance transformed phenotype established human cancer cells harboring oncogenic KRAS mutations Frederick et al Regala et al Scotti et al Expression kdPKC knock PKC expression using lentiviralmediated shRNA blocked transformed anchorageindependent growth invasion human NSCLC cells Frederick et al Regala et al human PDAC cells Scotti et al Genetic disruption PKC also blocks proliferative invasive properties prostate glioma cell lines vitro Baldwin et al Ishiguro et al Patel et al Disruption PKC expression also blocks tumorigenicity NSCLC PDAC cell tumors injected either subcutaneously orthotopically lung pancreas respectively Regala et al Scotti et al Analysis human PDAC cells orthotopic injection mouse pancreas revealed PKCdeficient tumor cells yielded significantly smaller tumors significantly fewer metastases kidney liver diaphragm mesentery providing first evidence PKC important tumor metastasis vivo Scotti et al role PKC transformed growth restricted cell harboring oncogenic KRAS mutations since NSCLC cell lines expressing wildtype KRAS harboring PRKCI amplification also require PKC transformed phenotype Regala et al Regala et al b II PKC Cellular TransformationPKC survival gene human cancer first demonstration PKC important transformed phenotype human cancer cells came studies CML cells Murray Fields CML cells highly resistant apoptotic effects numerous chemotherapeutic agents result expression chimeric tyrosine kinase oncogene BcrAbl transforming activity causes CML Bedi et al found BcrAblpositive CML cells express high levels PKC PKC activated response apoptotic stimuli treatment chemotherapeutic agent paclitaxel Jamieson et al Disruption PKC expression activity sensitized CML cells induction paclitaxelinduced apoptosis Murray Fields Subsequent studies established similar role PKC survival chemoresistance tumor cell types including prostate Win AcevedoDuncan NSCLC Jin et al glioblastoma Baldwin et al PKC survival gene human cancer first demonstration PKC important transformed phenotype human cancer cells came studies CML cells Murray Fields CML cells highly resistant apoptotic effects numerous chemotherapeutic agents result expression chimeric tyrosine kinase oncogene BcrAbl transforming activity causes CML Bedi et al found BcrAblpositive CML cells express high levels PKC PKC activated response apoptotic stimuli treatment chemotherapeutic agent paclitaxel Jamieson et al Disruption PKC expression activity sensitized CML cells induction paclitaxelinduced apoptosis Murray Fields Subsequent studies established similar role PKC survival chemoresistance tumor cell types including prostate Win AcevedoDuncan NSCLC Jin et al glioblastoma Baldwin et al Murray Fields Bedi et al Jamieson et al Murray Fields Win AcevedoDuncan Jin et al Baldwin et al PKC oncogenic ras mediated transformation intestinal epithelial cells Studies mouse fibroblasts first established functional link aPKCs cellular Ras Ras activate aPKCs DiazMeco et al aPKC activity necessary Rasmediated effects actinbased cytoskeleton fibroblasts Bjorkoy et al Coghlan et al Kampfer et al Uberall et al Since oncogenic Ras signaling drive colon carcinogenesis oncogenic Ras mutations detected colon cancers Slattery et al Takayama et al investigated role PKC Ras mediated transformation rat intestinal epithelial RIE cells Murray et al found oncogenic Ras activates PKC introduced nontransformed RIE cells expression kinasedeficient dominant negative PKC mutant kdPKC Ras transformed RIE cells inhibits Ras mediated invasion anchorageindependent growth Murray et al results provided direct evidence PKC involved establishment transformed phenotype Ras epithelial cellsPKC oncogenic ras mediated transformation intestinal epithelial cells Studies mouse fibroblasts first established functional link aPKCs cellular Ras Ras activate aPKCs DiazMeco et al aPKC activity necessary Rasmediated effects actinbased cytoskeleton fibroblasts Bjorkoy et al Coghlan et al Kampfer et al Uberall et al Since oncogenic Ras signaling drive colon carcinogenesis oncogenic Ras mutations detected colon cancers Slattery et al Takayama et al investigated role PKC Ras mediated transformation rat intestinal epithelial RIE cells Murray et al found oncogenic Ras activates PKC introduced nontransformed RIE cells expression kinasedeficient dominant negative PKC mutant kdPKC Ras transformed RIE cells inhibits Ras mediated invasion anchorageindependent growth Murray et al results provided direct evidence PKC involved establishment transformed phenotype Ras epithelial cellsDiazMeco et al Bjorkoy et al Coghlan et al Kampfer et al Uberall et al RasRasSlattery et al Takayama et al RasMurray et al RasRasRasMurray et al RasPKC required maintenance transformed phenotype cancer cells PKC plays key role transformation induced introduction oncogenic Ras nontransformed epithelial cells also maintenance transformed phenotype established human cancer cells harboring oncogenic KRAS mutations Frederick et al Regala et al Scotti et al Expression kdPKC knock PKC expression using lentiviralmediated shRNA blocked transformed anchorageindependent growth invasion human NSCLC cells Frederick et al Regala et al human PDAC cells Scotti et al Genetic disruption PKC also blocks proliferative invasive properties prostate glioma cell lines vitro Baldwin et al Ishiguro et al Patel et al Disruption PKC expression also blocks tumorigenicity NSCLC PDAC cell tumors injected either subcutaneously orthotopically lung pancreas respectively Regala et al Scotti et al Analysis human PDAC cells orthotopic injection mouse pancreas revealed PKCdeficient tumor cells yielded significantly smaller tumors significantly fewer metastases kidney liver diaphragm mesentery providing first evidence PKC important tumor metastasis vivo Scotti et al role PKC transformed growth restricted cell harboring oncogenic KRAS mutations since NSCLC cell lines expressing wildtype KRAS harboring PRKCI amplification also require PKC transformed phenotype Regala et al Regala et al b PKC required maintenance transformed phenotype cancer cells PKC plays key role transformation induced introduction oncogenic Ras nontransformed epithelial cells also maintenance transformed phenotype established human cancer cells harboring oncogenic KRAS mutations Frederick et al Regala et al Scotti et al Expression kdPKC knock PKC expression using lentiviralmediated shRNA blocked transformed anchorageindependent growth invasion human NSCLC cells Frederick et al Regala et al human PDAC cells Scotti et al Genetic disruption PKC also blocks proliferative invasive properties prostate glioma cell lines vitro Baldwin et al Ishiguro et al Patel et al Disruption PKC expression also blocks tumorigenicity NSCLC PDAC cell tumors injected either subcutaneously orthotopically lung pancreas respectively Regala et al Scotti et al Analysis human PDAC cells orthotopic injection mouse pancreas revealed PKCdeficient tumor cells yielded significantly smaller tumors significantly fewer metastases kidney liver diaphragm mesentery providing first evidence PKC important tumor metastasis vivo Scotti et al role PKC transformed growth restricted cell harboring oncogenic KRAS mutations since NSCLC cell lines expressing wildtype KRAS harboring PRKCI amplification also require PKC transformed phenotype Regala et al Regala et al b RasKRASFrederick et al Regala et al aScotti et al Frederick et al Regala et al aScotti et al vitroBaldwin et al Ishiguro et al Patel et al Regala et al aScotti et al vivoScotti et al KRASKRASPRKCIRegala et al aRegala et al bIII PKC Tumorigenesis vivo PKC necessary oncogenic Kras mutant APC mediated intestinal tumorigenesis Several transgenic models tumorigenesis revealed PKC plays critical promotive role tumorigenesis vivo established mice either kdPKC constitutively active caPKC PKC expressed specifically intestinal epithelium Murray et al Expression either PKC mutant demonstrable effect basal proliferation differentiation colonic epithelium Murray Fields Murray et al However expression caPKC colon increased susceptibility carcinogen azoxymethane AOMinduced formation colonic preneoplastic lesions aberrant crypt foci ACF whereas expression kdPKC significantly inhibited AOMinduced ACF formation Murray et al addition caPKC mice exhibited increase number AOMinduced colon tumors majority tumors mice progressed benign adenoma malignant intramucosal carcinoma Murray et al Similar results obtained vivo model oncogenic Kras mediated colon carcinogenesis Kras LA mouse Johnson et al Expression kdPKC colonic epithelium mice inhibited oncogenic Kras mediated ACF formation Murray et al data demonstrated PKC required oncogenic Kras mediated transformation intestinal epithelium vivo constitute first evidence function role PKC tumorigenesis vivo Interestingly PKC also elevated intestinal tumors formed Apc Min mice Murray et al Oster Leitges determine PKC plays role tumor development Apc Min mice mouse PKC gene Prkci inactivated intestinal epithelium triple transgenic Apc Min Prkci ff villinCre mice Cremediated recombination Apc Min Prkci ff villinCre mice exhibited loss intestinal epithelial PKC expression significant decrease number intestinal tumors compared Apc Min Prkci ff mice harbor intact alleles Prkci gene Murray et al Thus PKC important Apc Min induced intestinal epithelial tumorigenesis indicating role PKC colon tumorigenesis vivo limited Kras mediated tumors Role PKC initiation lung tumorigenesis PKC cancer stem cell gene PKC oncogene required maintenance transformed phenotype nonsmall cell lung cancer NSCLC cells Frederick et al Regala et al Regala et al b address whether PKC involved lung tumor development established mouse model oncogenic Kras GD activated Cremediated recombination lung without simultaneous genetic loss mouse PKC gene Prkci Regala et al Genetic loss Prkci dramatically inhibits Kras initiated hyperplasia subsequent lung tumor formation vivo effect correlates defect ability Prkci deficient bronchioalveolar stem cells BASCs undergo Kras mediated expansion morphological transformation vitro vivo Regala et al BASC exhibit stemlike properties thought tumorinitiating cells model Kras mediated lung tumorigenesis Jackson et al Thus Prkci required oncogeneinduced expansion transformation tumorinitiating lung stemlike cells studies suggest PKC may serve critical role cancer stem cell biology Whether PKC plays similar role maintenance cancer stem cell niche human cancers remains important topic future studyIII PKC Tumorigenesis vivoin vivoPKC necessary oncogenic Kras mutant APC mediated intestinal tumorigenesis Several transgenic models tumorigenesis revealed PKC plays critical promotive role tumorigenesis vivo established mice either kdPKC constitutively active caPKC PKC expressed specifically intestinal epithelium Murray et al Expression either PKC mutant demonstrable effect basal proliferation differentiation colonic epithelium Murray Fields Murray et al However expression caPKC colon increased susceptibility carcinogen azoxymethane AOMinduced formation colonic preneoplastic lesions aberrant crypt foci ACF whereas expression kdPKC significantly inhibited AOMinduced ACF formation Murray et al addition caPKC mice exhibited increase number AOMinduced colon tumors majority tumors mice progressed benign adenoma malignant intramucosal carcinoma Murray et al Similar results obtained vivo model oncogenic Kras mediated colon carcinogenesis Kras LA mouse Johnson et al Expression kdPKC colonic epithelium mice inhibited oncogenic Kras mediated ACF formation Murray et al data demonstrated PKC required oncogenic Kras mediated transformation intestinal epithelium vivo constitute first evidence function role PKC tumorigenesis vivo Interestingly PKC also elevated intestinal tumors formed Apc Min mice Murray et al Oster Leitges determine PKC plays role tumor development Apc Min mice mouse PKC gene Prkci inactivated intestinal epithelium triple transgenic Apc Min Prkci ff villinCre mice Cremediated recombination Apc Min Prkci ff villinCre mice exhibited loss intestinal epithelial PKC expression significant decrease number intestinal tumors compared Apc Min Prkci ff mice harbor intact alleles Prkci gene Murray et al Thus PKC important Apc Min induced intestinal epithelial tumorigenesis indicating role PKC colon tumorigenesis vivo limited Kras mediated tumorsPKC necessary oncogenic Kras mutant APC mediated intestinal tumorigenesis KrasAPCSeveral transgenic models tumorigenesis revealed PKC plays critical promotive role tumorigenesis vivo established mice either kdPKC constitutively active caPKC PKC expressed specifically intestinal epithelium Murray et al Expression either PKC mutant demonstrable effect basal proliferation differentiation colonic epithelium Murray Fields Murray et al However expression caPKC colon increased susceptibility carcinogen azoxymethane AOMinduced formation colonic preneoplastic lesions aberrant crypt foci ACF whereas expression kdPKC significantly inhibited AOMinduced ACF formation Murray et al addition caPKC mice exhibited increase number AOMinduced colon tumors majority tumors mice progressed benign adenoma malignant intramucosal carcinoma Murray et al Similar results obtained vivo model oncogenic Kras mediated colon carcinogenesis Kras LA mouse Johnson et al Expression kdPKC colonic epithelium mice inhibited oncogenic Kras mediated ACF formation Murray et al data demonstrated PKC required oncogenic Kras mediated transformation intestinal epithelium vivo constitute first evidence function role PKC tumorigenesis vivo vivoMurray et al Murray Fields Murray et al Murray et al Murray et al vivoKrasKras LALAJohnson et al KrasMurray et al Krasin vivoin vivoInterestingly PKC also elevated intestinal tumors formed Apc Min mice Murray et al Oster Leitges determine PKC plays role tumor development Apc Min mice mouse PKC gene Prkci inactivated intestinal epithelium triple transgenic Apc Min Prkci ff villinCre mice Cremediated recombination Apc Min Prkci ff villinCre mice exhibited loss intestinal epithelial PKC expression significant decrease number intestinal tumors compared Apc Min Prkci ff mice harbor intact alleles Prkci gene Murray et al Thus PKC important Apc Min induced intestinal epithelial tumorigenesis indicating role PKC colon tumorigenesis vivo limited Kras mediated tumorsApc MinMinMurray et al Oster Leitges Apc MinMinPrkciApc MinMinPrkci ffffvillinCreApc MinMinPrkci ffffvillinCreApc MinMinPrkci ffffPrkciMurray et al Apc MinMinin vivoKrasRole PKC initiation lung tumorigenesis PKC cancer stem cell gene PKC oncogene required maintenance transformed phenotype nonsmall cell lung cancer NSCLC cells Frederick et al Regala et al Regala et al b address whether PKC involved lung tumor development established mouse model oncogenic Kras GD activated Cremediated recombination lung without simultaneous genetic loss mouse PKC gene Prkci Regala et al Genetic loss Prkci dramatically inhibits Kras initiated hyperplasia subsequent lung tumor formation vivo effect correlates defect ability Prkci deficient bronchioalveolar stem cells BASCs undergo Kras mediated expansion morphological transformation vitro vivo Regala et al BASC exhibit stemlike properties thought tumorinitiating cells model Kras mediated lung tumorigenesis Jackson et al Thus Prkci required oncogeneinduced expansion transformation tumorinitiating lung stemlike cells studies suggest PKC may serve critical role cancer stem cell biology Whether PKC plays similar role maintenance cancer stem cell niche human cancers remains important topic future studyRole PKC initiation lung tumorigenesis PKC cancer stem cell gene PKC oncogene required maintenance transformed phenotype nonsmall cell lung cancer NSCLC cells Frederick et al Regala et al Regala et al b address whether PKC involved lung tumor development established mouse model oncogenic Kras GD activated Cremediated recombination lung without simultaneous genetic loss mouse PKC gene Prkci Regala et al Genetic loss Prkci dramatically inhibits Kras initiated hyperplasia subsequent lung tumor formation vivo effect correlates defect ability Prkci deficient bronchioalveolar stem cells BASCs undergo Kras mediated expansion morphological transformation vitro vivo Regala et al BASC exhibit stemlike properties thought tumorinitiating cells model Kras mediated lung tumorigenesis Jackson et al Thus Prkci required oncogeneinduced expansion transformation tumorinitiating lung stemlike cells studies suggest PKC may serve critical role cancer stem cell biology Whether PKC plays similar role maintenance cancer stem cell niche human cancers remains important topic future studyFrederick et al Regala et al aRegala et al bKras GDGDPrkciRegala et al PrkciKrasin vivoPrkciKrasin vitroin vivoRegala et al KrasJackson et al PrkciIV Oncogenic PKC Signaling Mechanisms PKCmediated survival signaling PKC activates multiple survival pathways confer resistance apoptosis induced many stimuli including TNF carcinogens chemotherapeutic agents Figure PKC sufficient mediate antiapoptotic effects BcrAbl via transactivation NFB Jamieson et al Lu et al Interestingly CML cells BcrAbl induces PKC expression RasMekdependent pathway involving functional Elk transcription factor binding site within proximal promoter PKC Gustafson et al Thus BcrAbl appears regulate PKC multiple levels induce chemoresistant phenotype BcrAbl induce PKC expression PKC key effector BcrAblmediated survival signaling PKCmediated survival TNFtreated prostate cancer cells also mediated NFBdependent mechanism prostate cancer cells PKCmediated phosphorylation IK leads activation canonical NFB pathway cell survival Win AcevedoDuncan glioblastoma cells PKCmediated survival appears result PKCinduced attenuation p mitogenactivated protein kinase signaling protects cells cytotoxicity caused chemotherapeutic agents Baldwin et al NSCLC cells ability PKC enhance resistance NNKinduced apoptosis appears mediated Srcdependent activation PKC phosphorylates proapoptotic protein BAD Jin et al Therefore PKC activate multiple signaling pathways promote cell survival different tumor cell types Open separate window Figure Schematic representation key oncogenic PKC signaling pathways PKC resides within several major signaling pathways implicated human cancer PKC activated known oncogenes Ras BcrAbl Src PIK cytokines TNF IL growth factors NGF EGF PKC signals downstream effectors Rac NFB important different aspects transformed phenotype Many components PKCdependent signal pathways mutated often multiple mechanisms ie gene amplification somatic mutation human tumors indicated yellow boxes Arrows indicate flow signaling pathways touching boxes indicate direct binding signaling components Phosphorylation events indicated circled Ps Rac critical downstream effector oncogenic PKC Rho family GTPase Rac activated oncogenic Ras essential Ras mediated transformed growth cellular invasion fibroblasts KhosraviFar et al Qiu et al PKC necessary Ras mediated Rac activation RIE cells Murray et al thus kdPKC blocks oncogenic Ras mediated Rac activation expression constitutively active Rac allele RacV overcomes dnPKCmediated inhibition cellular invasion Murray et al studies placed PKC downstream oncogenic Kras upstream critical Kras effector Rac activates MekErk signaling axis drive transformed growth also mediates cytoskeletal rearrangement involved cellular invasion Murray et al Figure Rac also critical downstream target Kras mediated PKCdependent transformation NSCLC Regala et al PDAC Scotti et al NSCLC PDAC cells KRAS activates PKCRacPakMekErk signaling axis drives transformed growth vitro tumorigenicity vivo Regala et al Scotti et al Interestingly Rac also plays critical role downstream oncogenic PKC NSCLC cells harbor mutant KRAS indicating PKCRac signaling specific mutant KRAS mediated transformation Regala et al Regala et al b Expression RacV reconstituted cellular invasion anchorageindependent growth PKCdeficient NSCLC PDAC cells Mekdependent manner Regala et al Scotti et al Thus Rac critical downstream effector oncogenic PKC multiple cancer cell types restricted tumor cells harboring KRAS mutations role PB domain PKC oncogenic signaling Nterminal regulatory domain aPKCs unique contains PhoxBem PB domain mediates homo heterotypic proteinprotein interactions critical activation intracellular localization Lamark et al Par PB domaincontaining protein binds atypical PKCs via PBPB domain interactions EtienneManneville Hall Wilson et al Par links atypical PKC cell polarity forming complex atypical PKC Rho family GTPase Rac cdc EtienneManneville Hall Joberty et al Lin et al Noda et al Qiu et al Suzuki et al Suzuki et al Since Rac critical downstream effector oncogenic PKC multiple cell types including colon lung pancreas Murray et al Regala et al Scotti et al assessed role PB domain PKC Rac activation NSCLC cell transformation Regala et al Expression PB domain PKC NSCLC cells uncouples PKC Par Rac activation inhibits transformed growth Likewise RNAimediated knock PKC Par Rac inhibits transformed growth cellular invasion NSCLC cancer cells Frederick et al Expression wildtype PKC PKC knock cells restores transformation whereas expression PB domain mutant PKC PKCDA bind Par Frederick et al Similarly expression wild type Par Par knock cells restores transformation whereas expression Par mutants either bind PKC ParKA couple Rac ParCRIB Frederick et al Expression RacV PKC Pardepleted NSCLC cells restores transformed growth cellular invasion Frederick et al PKCPar complex functions activate RacMekErk signaling axis drives transformed growth NSCLC cells Frederick et al studies defined novel PKCPar complex required NSCLC transformation Figure Ect binds activates PKCPar complex identified Rac critical downstream effector oncogenic PKCPar complex key question became complex activate Rac address question utilized proteomics approach identify proteins associate PKCPar complex NSCLC cells Justilien Fields Rho family GTPase guanine nucleotide exchange factor GEF Ect identified prominent component PKCPar complex Fields Justilien Justilien Fields RNAimediated knock Ect inhibits Rac activity blocks transformed growth invasion tumorigenicity NSCLC cells whereas expression RacV restores transformation Ectdeficient cells Justilien Fields Interestingly role Ect NSCLC transformation distinct wellestablished role cytokinesis fact NSCLC cells appear acquired Ectindependent cytokinesis mechanism resembles described fibrosarcoma H cells Kanada et al Rather NSCLC cells Ect mislocalized cytoplasm binds PKCPar complex Knock either PKC Par causes redistribution Ect nucleus loss transformed growth invasion Therefore Ect PKC drive tumor cell proliferation formation oncogenic PKCParEct complex Interestingly Ect gene ECT resides chromosome q close proximity PRKCI Studies primary NSCLC tumors demonstrated PRKCI ECT coamplified overexpressed NSCLC Justilien Fields Thus Ect PKC genetically linked coordinate gene amplification NSCLC tumors biochemically functionally linked NSCLC transformation formation oncogenic PKCParEct complex drives NSCLC cell transformation activating Rac Figure Justilien Fields MMP critical downstream effector oncogenic PKCParRac signaling axis recently carried genomic analysis identify genes whose expression modulated RNAimediated knock PKC NSCLC cells matrix metalloproteinase MMP stromolysin emerged analysis genomic target PKC Frederick et al Depletion PKC Par Rac RNAi inhibits MMP expression NSCLC cells expression exogenous wildtype Par Par knock cells restored MMP expression whereas expression Par mutants either bind PKC Rac indicating role PKCParRac complex MMP expression RNAimediated knock MMP blocks anchorageindependent growth cell invasion NSCLC cells loss transformed growth invasion PKC knock Par knock NSCLC cells rescued addition catalytically active MMP Frederick et al Taken together data defined PKCParRacPakMekErk signaling axis drives anchorageindependent growth invasion NSCLC cells least part induction MMP expression Frederick et al Interestingly analysis primary human lung tumor specimens demonstrated strong correlation PKC MMP expression primary NSCLC tumors suggesting role PKCParRacPakMekErkMMP signaling axis primary human lung cancers Frederick et al molecular mechanism PKCmediated overexpression MMP promotes transformation currently unexplored merits investigation second genomic study conducted metaanalysis gene expression primary lung adenocarcinomas LAC three independent public domain datasets Erdogan et al analysis identified four genes COPB ELF RFC PLS whose expression correlates positively PKC primary LAC tumors three databases QPCR analysis primary LAC samples showed four genes highly overexpressed tumors exhibit strong positive correlation PKC expression Erdogan et al RNAimediated knock PKC LAC cell lines demonstrated PKC regulates expression genes Furthermore RNAimediated knock genes led significant inhibition anchorageindependent growth cellular invasion demonstrating important transformation LAC cells Erdogan et al Finally metaanalysis revealed subsets PKCregulated genes coordinately overexpressed PKC major tumor types including lung squamous cell carcinoma breast colon prostate pancreatic glioblastoma cancers Erdogan et al analysis revealed novel signaling mechanisms participate PKCmediated transformation Figure provide potentially useful biomarkers PKCmediated signaling may serve targets development novel prognostic markers andor therapeutic agentsIV Oncogenic PKC Signaling MechanismsPKCmediated survival signaling PKC activates multiple survival pathways confer resistance apoptosis induced many stimuli including TNF carcinogens chemotherapeutic agents Figure PKC sufficient mediate antiapoptotic effects BcrAbl via transactivation NFB Jamieson et al Lu et al Interestingly CML cells BcrAbl induces PKC expression RasMekdependent pathway involving functional Elk transcription factor binding site within proximal promoter PKC Gustafson et al Thus BcrAbl appears regulate PKC multiple levels induce chemoresistant phenotype BcrAbl induce PKC expression PKC key effector BcrAblmediated survival signaling PKCmediated survival TNFtreated prostate cancer cells also mediated NFBdependent mechanism prostate cancer cells PKCmediated phosphorylation IK leads activation canonical NFB pathway cell survival Win AcevedoDuncan glioblastoma cells PKCmediated survival appears result PKCinduced attenuation p mitogenactivated protein kinase signaling protects cells cytotoxicity caused chemotherapeutic agents Baldwin et al NSCLC cells ability PKC enhance resistance NNKinduced apoptosis appears mediated Srcdependent activation PKC phosphorylates proapoptotic protein BAD Jin et al Therefore PKC activate multiple signaling pathways promote cell survival different tumor cell types Open separate window Figure Schematic representation key oncogenic PKC signaling pathways PKC resides within several major signaling pathways implicated human cancer PKC activated known oncogenes Ras BcrAbl Src PIK cytokines TNF IL growth factors NGF EGF PKC signals downstream effectors Rac NFB important different aspects transformed phenotype Many components PKCdependent signal pathways mutated often multiple mechanisms ie gene amplification somatic mutation human tumors indicated yellow boxes Arrows indicate flow signaling pathways touching boxes indicate direct binding signaling components Phosphorylation events indicated circled PsPKCmediated survival signaling PKC activates multiple survival pathways confer resistance apoptosis induced many stimuli including TNF carcinogens chemotherapeutic agents Figure PKC sufficient mediate antiapoptotic effects BcrAbl via transactivation NFB Jamieson et al Lu et al Interestingly CML cells BcrAbl induces PKC expression RasMekdependent pathway involving functional Elk transcription factor binding site within proximal promoter PKC Gustafson et al Thus BcrAbl appears regulate PKC multiple levels induce chemoresistant phenotype BcrAbl induce PKC expression PKC key effector BcrAblmediated survival signaling PKCmediated survival TNFtreated prostate cancer cells also mediated NFBdependent mechanism prostate cancer cells PKCmediated phosphorylation IK leads activation canonical NFB pathway cell survival Win AcevedoDuncan glioblastoma cells PKCmediated survival appears result PKCinduced attenuation p mitogenactivated protein kinase signaling protects cells cytotoxicity caused chemotherapeutic agents Baldwin et al NSCLC cells ability PKC enhance resistance NNKinduced apoptosis appears mediated Srcdependent activation PKC phosphorylates proapoptotic protein BAD Jin et al Therefore PKC activate multiple signaling pathways promote cell survival different tumor cell typesFigure Figure Jamieson et al Lu et al Gustafson et al Win AcevedoDuncan Baldwin et al Jin et al Open separate window Figure Schematic representation key oncogenic PKC signaling pathways PKC resides within several major signaling pathways implicated human cancer PKC activated known oncogenes Ras BcrAbl Src PIK cytokines TNF IL growth factors NGF EGF PKC signals downstream effectors Rac NFB important different aspects transformed phenotype Many components PKCdependent signal pathways mutated often multiple mechanisms ie gene amplification somatic mutation human tumors indicated yellow boxes Arrows indicate flow signaling pathways touching boxes indicate direct binding signaling components Phosphorylation events indicated circled PsOpen separate windowOpen separate windowOpen separate windowFigure Schematic representation key oncogenic PKC signaling pathways PKC resides within several major signaling pathways implicated human cancer PKC activated known oncogenes Ras BcrAbl Src PIK cytokines TNF IL growth factors NGF EGF PKC signals downstream effectors Rac NFB important different aspects transformed phenotype Many components PKCdependent signal pathways mutated often multiple mechanisms ie gene amplification somatic mutation human tumors indicated yellow boxes Arrows indicate flow signaling pathways touching boxes indicate direct binding signaling components Phosphorylation events indicated circled PsFigure Figure Schematic representation key oncogenic PKC signaling pathways PKC resides within several major signaling pathways implicated human cancer PKC activated known oncogenes Ras BcrAbl Src PIK cytokines TNF IL growth factors NGF EGF PKC signals downstream effectors Rac NFB important different aspects transformed phenotype Many components PKCdependent signal pathways mutated often multiple mechanisms ie gene amplification somatic mutation human tumors indicated yellow boxes Arrows indicate flow signaling pathways touching boxes indicate direct binding signaling components Phosphorylation events indicated circled PsSchematic representation key oncogenic PKC signaling pathwaysPKC resides within several major signaling pathways implicated human cancer PKC activated known oncogenes Ras BcrAbl Src PIK cytokines TNF IL growth factors NGF EGF PKC signals downstream effectors Rac NFB important different aspects transformed phenotype Many components PKCdependent signal pathways mutated often multiple mechanisms ie gene amplification somatic mutation human tumors indicated yellow boxes Arrows indicate flow signaling pathways touching boxes indicate direct binding signaling components Phosphorylation events indicated circled PsRac critical downstream effector oncogenic PKC Rho family GTPase Rac activated oncogenic Ras essential Ras mediated transformed growth cellular invasion fibroblasts KhosraviFar et al Qiu et al PKC necessary Ras mediated Rac activation RIE cells Murray et al thus kdPKC blocks oncogenic Ras mediated Rac activation expression constitutively active Rac allele RacV overcomes dnPKCmediated inhibition cellular invasion Murray et al studies placed PKC downstream oncogenic Kras upstream critical Kras effector Rac activates MekErk signaling axis drive transformed growth also mediates cytoskeletal rearrangement involved cellular invasion Murray et al Figure Rac also critical downstream target Kras mediated PKCdependent transformation NSCLC Regala et al PDAC Scotti et al NSCLC PDAC cells KRAS activates PKCRacPakMekErk signaling axis drives transformed growth vitro tumorigenicity vivo Regala et al Scotti et al Interestingly Rac also plays critical role downstream oncogenic PKC NSCLC cells harbor mutant KRAS indicating PKCRac signaling specific mutant KRAS mediated transformation Regala et al Regala et al b Expression RacV reconstituted cellular invasion anchorageindependent growth PKCdeficient NSCLC PDAC cells Mekdependent manner Regala et al Scotti et al Thus Rac critical downstream effector oncogenic PKC multiple cancer cell types restricted tumor cells harboring KRAS mutationsRac critical downstream effector oncogenic PKC Rho family GTPase Rac activated oncogenic Ras essential Ras mediated transformed growth cellular invasion fibroblasts KhosraviFar et al Qiu et al PKC necessary Ras mediated Rac activation RIE cells Murray et al thus kdPKC blocks oncogenic Ras mediated Rac activation expression constitutively active Rac allele RacV overcomes dnPKCmediated inhibition cellular invasion Murray et al studies placed PKC downstream oncogenic Kras upstream critical Kras effector Rac activates MekErk signaling axis drive transformed growth also mediates cytoskeletal rearrangement involved cellular invasion Murray et al Figure Rac also critical downstream target Kras mediated PKCdependent transformation NSCLC Regala et al PDAC Scotti et al NSCLC PDAC cells KRAS activates PKCRacPakMekErk signaling axis drives transformed growth vitro tumorigenicity vivo Regala et al Scotti et al Interestingly Rac also plays critical role downstream oncogenic PKC NSCLC cells harbor mutant KRAS indicating PKCRac signaling specific mutant KRAS mediated transformation Regala et al Regala et al b Expression RacV reconstituted cellular invasion anchorageindependent growth PKCdeficient NSCLC PDAC cells Mekdependent manner Regala et al Scotti et al Thus Rac critical downstream effector oncogenic PKC multiple cancer cell types restricted tumor cells harboring KRAS mutationsRasRasKhosraviFar et al Qiu et al RasMurray et al RasMurray et al KrasKrasMurray et al Figure Figure KrasRegala et al aScotti et al KRASin vitroin vivoRegala et al aScotti et al KRASKRASRegala et al aRegala et al bRegala et al aScotti et al KRASThe role PB domain PKC oncogenic signaling Nterminal regulatory domain aPKCs unique contains PhoxBem PB domain mediates homo heterotypic proteinprotein interactions critical activation intracellular localization Lamark et al Par PB domaincontaining protein binds atypical PKCs via PBPB domain interactions EtienneManneville Hall Wilson et al Par links atypical PKC cell polarity forming complex atypical PKC Rho family GTPase Rac cdc EtienneManneville Hall Joberty et al Lin et al Noda et al Qiu et al Suzuki et al Suzuki et al Since Rac critical downstream effector oncogenic PKC multiple cell types including colon lung pancreas Murray et al Regala et al Scotti et al assessed role PB domain PKC Rac activation NSCLC cell transformation Regala et al Expression PB domain PKC NSCLC cells uncouples PKC Par Rac activation inhibits transformed growth Likewise RNAimediated knock PKC Par Rac inhibits transformed growth cellular invasion NSCLC cancer cells Frederick et al Expression wildtype PKC PKC knock cells restores transformation whereas expression PB domain mutant PKC PKCDA bind Par Frederick et al Similarly expression wild type Par Par knock cells restores transformation whereas expression Par mutants either bind PKC ParKA couple Rac ParCRIB Frederick et al Expression RacV PKC Pardepleted NSCLC cells restores transformed growth cellular invasion Frederick et al PKCPar complex functions activate RacMekErk signaling axis drives transformed growth NSCLC cells Frederick et al studies defined novel PKCPar complex required NSCLC transformation Figure role PB domain PKC oncogenic signaling Nterminal regulatory domain aPKCs unique contains PhoxBem PB domain mediates homo heterotypic proteinprotein interactions critical activation intracellular localization Lamark et al Par PB domaincontaining protein binds atypical PKCs via PBPB domain interactions EtienneManneville Hall Wilson et al Par links atypical PKC cell polarity forming complex atypical PKC Rho family GTPase Rac cdc EtienneManneville Hall Joberty et al Lin et al Noda et al Qiu et al Suzuki et al Suzuki et al Since Rac critical downstream effector oncogenic PKC multiple cell types including colon lung pancreas Murray et al Regala et al Scotti et al assessed role PB domain PKC Rac activation NSCLC cell transformation Regala et al Expression PB domain PKC NSCLC cells uncouples PKC Par Rac activation inhibits transformed growth Likewise RNAimediated knock PKC Par Rac inhibits transformed growth cellular invasion NSCLC cancer cells Frederick et al Expression wildtype PKC PKC knock cells restores transformation whereas expression PB domain mutant PKC PKCDA bind Par Frederick et al Similarly expression wild type Par Par knock cells restores transformation whereas expression Par mutants either bind PKC ParKA couple Rac ParCRIB Frederick et al Expression RacV PKC Pardepleted NSCLC cells restores transformed growth cellular invasion Frederick et al PKCPar complex functions activate RacMekErk signaling axis drives transformed growth NSCLC cells Frederick et al studies defined novel PKCPar complex required NSCLC transformation Figure Lamark et al EtienneManneville Hall Wilson et al EtienneManneville Hall Joberty et al Lin et al Noda et al Qiu et al Suzuki et al Suzuki et al Murray et al Regala et al aScotti et al Regala et al aFrederick et al Frederick et al Frederick et al Frederick et al Frederick et al Figure Figure Ect binds activates PKCPar complex identified Rac critical downstream effector oncogenic PKCPar complex key question became complex activate Rac address question utilized proteomics approach identify proteins associate PKCPar complex NSCLC cells Justilien Fields Rho family GTPase guanine nucleotide exchange factor GEF Ect identified prominent component PKCPar complex Fields Justilien Justilien Fields RNAimediated knock Ect inhibits Rac activity blocks transformed growth invasion tumorigenicity NSCLC cells whereas expression RacV restores transformation Ectdeficient cells Justilien Fields Interestingly role Ect NSCLC transformation distinct wellestablished role cytokinesis fact NSCLC cells appear acquired Ectindependent cytokinesis mechanism resembles described fibrosarcoma H cells Kanada et al Rather NSCLC cells Ect mislocalized cytoplasm binds PKCPar complex Knock either PKC Par causes redistribution Ect nucleus loss transformed growth invasion Therefore Ect PKC drive tumor cell proliferation formation oncogenic PKCParEct complex Interestingly Ect gene ECT resides chromosome q close proximity PRKCI Studies primary NSCLC tumors demonstrated PRKCI ECT coamplified overexpressed NSCLC Justilien Fields Thus Ect PKC genetically linked coordinate gene amplification NSCLC tumors biochemically functionally linked NSCLC transformation formation oncogenic PKCParEct complex drives NSCLC cell transformation activating Rac Figure Justilien Fields Ect binds activates PKCPar complex identified Rac critical downstream effector oncogenic PKCPar complex key question became complex activate Rac address question utilized proteomics approach identify proteins associate PKCPar complex NSCLC cells Justilien Fields Rho family GTPase guanine nucleotide exchange factor GEF Ect identified prominent component PKCPar complex Fields Justilien Justilien Fields RNAimediated knock Ect inhibits Rac activity blocks transformed growth invasion tumorigenicity NSCLC cells whereas expression RacV restores transformation Ectdeficient cells Justilien Fields Interestingly role Ect NSCLC transformation distinct wellestablished role cytokinesis fact NSCLC cells appear acquired Ectindependent cytokinesis mechanism resembles described fibrosarcoma H cells Kanada et al Rather NSCLC cells Ect mislocalized cytoplasm binds PKCPar complex Knock either PKC Par causes redistribution Ect nucleus loss transformed growth invasion Therefore Ect PKC drive tumor cell proliferation formation oncogenic PKCParEct complex Interestingly Ect gene ECT resides chromosome q close proximity PRKCI Studies primary NSCLC tumors demonstrated PRKCI ECT coamplified overexpressed NSCLC Justilien Fields Thus Ect PKC genetically linked coordinate gene amplification NSCLC tumors biochemically functionally linked NSCLC transformation formation oncogenic PKCParEct complex drives NSCLC cell transformation activating Rac Figure Justilien Fields Justilien Fields Fields Justilien Justilien Fields Justilien Fields Kanada et al ECTPRKCIPRKCIECTJustilien Fields Figure Figure Justilien Fields MMP critical downstream effector oncogenic PKCParRac signaling axis recently carried genomic analysis identify genes whose expression modulated RNAimediated knock PKC NSCLC cells matrix metalloproteinase MMP stromolysin emerged analysis genomic target PKC Frederick et al Depletion PKC Par Rac RNAi inhibits MMP expression NSCLC cells expression exogenous wildtype Par Par knock cells restored MMP expression whereas expression Par mutants either bind PKC Rac indicating role PKCParRac complex MMP expression RNAimediated knock MMP blocks anchorageindependent growth cell invasion NSCLC cells loss transformed growth invasion PKC knock Par knock NSCLC cells rescued addition catalytically active MMP Frederick et al Taken together data defined PKCParRacPakMekErk signaling axis drives anchorageindependent growth invasion NSCLC cells least part induction MMP expression Frederick et al Interestingly analysis primary human lung tumor specimens demonstrated strong correlation PKC MMP expression primary NSCLC tumors suggesting role PKCParRacPakMekErkMMP signaling axis primary human lung cancers Frederick et al molecular mechanism PKCmediated overexpression MMP promotes transformation currently unexplored merits investigation second genomic study conducted metaanalysis gene expression primary lung adenocarcinomas LAC three independent public domain datasets Erdogan et al analysis identified four genes COPB ELF RFC PLS whose expression correlates positively PKC primary LAC tumors three databases QPCR analysis primary LAC samples showed four genes highly overexpressed tumors exhibit strong positive correlation PKC expression Erdogan et al RNAimediated knock PKC LAC cell lines demonstrated PKC regulates expression genes Furthermore RNAimediated knock genes led significant inhibition anchorageindependent growth cellular invasion demonstrating important transformation LAC cells Erdogan et al Finally metaanalysis revealed subsets PKCregulated genes coordinately overexpressed PKC major tumor types including lung squamous cell carcinoma breast colon prostate pancreatic glioblastoma cancers Erdogan et al analysis revealed novel signaling mechanisms participate PKCmediated transformation Figure provide potentially useful biomarkers PKCmediated signaling may serve targets development novel prognostic markers andor therapeutic agentsMMP critical downstream effector oncogenic PKCParRac signaling axis recently carried genomic analysis identify genes whose expression modulated RNAimediated knock PKC NSCLC cells matrix metalloproteinase MMP stromolysin emerged analysis genomic target PKC Frederick et al Depletion PKC Par Rac RNAi inhibits MMP expression NSCLC cells expression exogenous wildtype Par Par knock cells restored MMP expression whereas expression Par mutants either bind PKC Rac indicating role PKCParRac complex MMP expression RNAimediated knock MMP blocks anchorageindependent growth cell invasion NSCLC cells loss transformed growth invasion PKC knock Par knock NSCLC cells rescued addition catalytically active MMP Frederick et al Taken together data defined PKCParRacPakMekErk signaling axis drives anchorageindependent growth invasion NSCLC cells least part induction MMP expression Frederick et al Interestingly analysis primary human lung tumor specimens demonstrated strong correlation PKC MMP expression primary NSCLC tumors suggesting role PKCParRacPakMekErkMMP signaling axis primary human lung cancers Frederick et al molecular mechanism PKCmediated overexpression MMP promotes transformation currently unexplored merits investigationFrederick et al Frederick et al Frederick et al Frederick et al second genomic study conducted metaanalysis gene expression primary lung adenocarcinomas LAC three independent public domain datasets Erdogan et al analysis identified four genes COPB ELF RFC PLS whose expression correlates positively PKC primary LAC tumors three databases QPCR analysis primary LAC samples showed four genes highly overexpressed tumors exhibit strong positive correlation PKC expression Erdogan et al RNAimediated knock PKC LAC cell lines demonstrated PKC regulates expression genes Furthermore RNAimediated knock genes led significant inhibition anchorageindependent growth cellular invasion demonstrating important transformation LAC cells Erdogan et al Finally metaanalysis revealed subsets PKCregulated genes coordinately overexpressed PKC major tumor types including lung squamous cell carcinoma breast colon prostate pancreatic glioblastoma cancers Erdogan et al analysis revealed novel signaling mechanisms participate PKCmediated transformation Figure provide potentially useful biomarkers PKCmediated signaling may serve targets development novel prognostic markers andor therapeutic agentsErdogan et al Erdogan et al Erdogan et al Erdogan et al Figure Figure V PKC Therapeutic Target Treatment Cancer PBPB domain interaction PKC Par highly specific required oncogenic PKCParRacMMP signaling axis mediates anchorageindependent growth invasion human NSCLC cells vitro tumorigenicity vivo Frederick et al Therefore reasoned interaction attractive target development novel mechanismbased therapeutics treatment NSCLC Using novel fluorescence resonance energy transfer FRETbased assay identified small molecular weight compounds disrupt PBPB domain interaction PKC Par StallingsMann et al Among potent inhibitors identified goldcontaining compounds aurothioglucose ATG aurothiomalate ATM FDAapproved treatments rheumatoid arthritis Messori Marcon ATG ATM exhibit dosedependent inhibition PKCPar binding IC StallingsMann et al Treatment NSCLC cells compounds inhibits PKCmediated Rac activation blocks anchorageindependent growth NSCLC cells vitro tumorigenicity vivo StallingsMann et al inhibition rescued expression RacV indicating ATM targets interaction PKC Par couples PKC Rac StallingsMann et al precise mechanism action ATG ATM RA still unknown however proposed mechanism action formation goldcysteine adducts target cellular proteins Bratt et al Jeon et al Pia Rigobello et al Yamashita et al PB domain atypical PKCs contains unique cysteine residue Cys within conserved OPR PC AID OPCA motif crystal structure PKCPar complex resides binding interface PKC Par Hirano et al Lamark et al Mutation Cys isoleucine CI valine CV amino acids frequently reside position PB domains preserves Par binding makes PKC resistant inhibitory effects ATM Par binding vitro Erdogan et al Expression CI PKC mutant NSCLC cells supports transformed growth renders cells resistant inhibitory effects ATM transformed growth Erdogan et al Thus ATM inhibits PKCPar interactions vitro vivo blocks NSCLC cell transformation targeting Cys within PB domain PKC Given clinical potential ATM therapeutic agent assessed inhibitory efficacy ATM transformed growth cell lines representing major subtypes lung cancer including lung adenocarcinoma LAC lung squamous cell carcinoma LSCC large cell carcinoma LCC small cell lung carcinoma SCLC Regala et al ATM potently inhibited anchorageindependent growth lines tested IC ranging nM lung cancer cell lines clustered highly sensitive ATM IC relatively insensitive ATM IC Interestingly ATM sensitivity correlate tumor subtype KRAS mutation status sensitivity panel standard chemotherapeutic agents frequently used treat lung cancer patients including cisplatin placitaxel gemcitabine Regala et al Rather elevated PKC expression major molecular characteristic exhibited lung cancer cells responsive ATM Regala et al Consistent vitro observations ATM inhibits tumorigenicity sensitive insensitive lung cell tumors vivo plasma drug concentrations consistent ATM IC cell lines vitro Furthermore measurements plasma drug concentrations demonstrated sensitive well insensitive cell lines exhibit antitumor response ATM plasma levels routinely achieved RA patients undergoing ATM therapy Regala et al Thus ATM exhibits antitumor activity major lung cancer subtypes particularly tumor cells express high levels PKC PKC expression profiling revealed significant subset primary NSCLC tumors express PKC level associated ATM sensitivity vitro Regala et al Therefore PKC expression profiling lung tumor samples may useful identifying lung cancer patients likely respond ATM therapy addition fact PKC overexpressed many tumor types see Table suggest ATM may effective treatment option tumor types well Several phase phase II clinical trials currently accruing Mayo Clinic determine appropriate dosing regimen ATM assess antitumor activity ATM alone combination targeted therapeutic agents NSCLC ovarian cancer pancreatic cancerV PKC Therapeutic Target Treatment CancerThe PBPB domain interaction PKC Par highly specific required oncogenic PKCParRacMMP signaling axis mediates anchorageindependent growth invasion human NSCLC cells vitro tumorigenicity vivo Frederick et al Therefore reasoned interaction attractive target development novel mechanismbased therapeutics treatment NSCLCin vitroin vivoFrederick et al Using novel fluorescence resonance energy transfer FRETbased assay identified small molecular weight compounds disrupt PBPB domain interaction PKC Par StallingsMann et al Among potent inhibitors identified goldcontaining compounds aurothioglucose ATG aurothiomalate ATM FDAapproved treatments rheumatoid arthritis Messori Marcon ATG ATM exhibit dosedependent inhibition PKCPar binding IC StallingsMann et al Treatment NSCLC cells compounds inhibits PKCmediated Rac activation blocks anchorageindependent growth NSCLC cells vitro tumorigenicity vivo StallingsMann et al inhibition rescued expression RacV indicating ATM targets interaction PKC Par couples PKC Rac StallingsMann et al StallingsMann et al Messori Marcon StallingsMann et al vitroin vivoStallingsMann et al StallingsMann et al precise mechanism action ATG ATM RA still unknown however proposed mechanism action formation goldcysteine adducts target cellular proteins Bratt et al Jeon et al Pia Rigobello et al Yamashita et al PB domain atypical PKCs contains unique cysteine residue Cys within conserved OPR PC AID OPCA motif crystal structure PKCPar complex resides binding interface PKC Par Hirano et al Lamark et al Mutation Cys isoleucine CI valine CV amino acids frequently reside position PB domains preserves Par binding makes PKC resistant inhibitory effects ATM Par binding vitro Erdogan et al Expression CI PKC mutant NSCLC cells supports transformed growth renders cells resistant inhibitory effects ATM transformed growth Erdogan et al Thus ATM inhibits PKCPar interactions vitro vivo blocks NSCLC cell transformation targeting Cys within PB domain PKCBratt et al Jeon et al Pia Rigobello et al Yamashita et al Hirano et al Lamark et al vitroErdogan et al Erdogan et al vitroin vivoGiven clinical potential ATM therapeutic agent assessed inhibitory efficacy ATM transformed growth cell lines representing major subtypes lung cancer including lung adenocarcinoma LAC lung squamous cell carcinoma LSCC large cell carcinoma LCC small cell lung carcinoma SCLC Regala et al ATM potently inhibited anchorageindependent growth lines tested IC ranging nM lung cancer cell lines clustered highly sensitive ATM IC relatively insensitive ATM IC Interestingly ATM sensitivity correlate tumor subtype KRAS mutation status sensitivity panel standard chemotherapeutic agents frequently used treat lung cancer patients including cisplatin placitaxel gemcitabine Regala et al Rather elevated PKC expression major molecular characteristic exhibited lung cancer cells responsive ATM Regala et al Consistent vitro observations ATM inhibits tumorigenicity sensitive insensitive lung cell tumors vivo plasma drug concentrations consistent ATM IC cell lines vitro Furthermore measurements plasma drug concentrations demonstrated sensitive well insensitive cell lines exhibit antitumor response ATM plasma levels routinely achieved RA patients undergoing ATM therapy Regala et al Thus ATM exhibits antitumor activity major lung cancer subtypes particularly tumor cells express high levels PKC PKC expression profiling revealed significant subset primary NSCLC tumors express PKC level associated ATM sensitivity vitro Regala et al Therefore PKC expression profiling lung tumor samples may useful identifying lung cancer patients likely respond ATM therapy addition fact PKC overexpressed many tumor types see Table suggest ATM may effective treatment option tumor types well Several phase phase II clinical trials currently accruing Mayo Clinic determine appropriate dosing regimen ATM assess antitumor activity ATM alone combination targeted therapeutic agents NSCLC ovarian cancer pancreatic cancerRegala et al KRASRegala et al Regala et al vitroin vivoin vitroRegala et al vitroRegala et al Table Table andandSummaryFuture Directions Accumulating evidence demonstrates PKC oncogene frequently targeted genetic alteration many major forms human cancer Tables Functional data indicate PKC required transformed phenotype NSCLC pancreatic ovarian prostate colon brain cancer cells Future studies required determine whether PKC also oncogene cancers Studies PKC using genetically defined models tumorigenesis revealed critical role PKC multiple stages tumorigenesis including tumor initiation progression metastasis Recent studies genetic model lung adenocarcinoma suggest role PKC transformation lung cancer stem cells studies important implications therapeutic use ATM particularly future studies validate PKC important gene critical cancer stem cell niche Significant progress made determining molecular mechanisms PKC drives transformed phenotype particularly central role played oncogenic PKCPar complex transformed growth invasion several PKCdependent survival pathways chemoresistance Future studies required determine composition dynamics PKCPar complex mechanisms oncogenic signaling complex regulated Likewise better understanding critical downstream effectors PKC various human tumor types holds promise identification novel prognostic surrogate markers oncogenic PKC activity may clinically useful ongoing clinical trials ATM studies also hold promise revealing novel therapeutic targets Similarly complete understanding signaling mechanisms Kras possibly oncogenes regulate PKC expression human tumors may reveal new therapeutic intervention strategies Ultimately ongoing future clinical trials required establish usefulness ATM antitumor agent allow validation potential surrogate markers predictors therapeutic response PKCdirected therapy identified preclinical modelsSummaryFuture DirectionsAccumulating evidence demonstrates PKC oncogene frequently targeted genetic alteration many major forms human cancer Tables Functional data indicate PKC required transformed phenotype NSCLC pancreatic ovarian prostate colon brain cancer cells Future studies required determine whether PKC also oncogene cancers Studies PKC using genetically defined models tumorigenesis revealed critical role PKC multiple stages tumorigenesis including tumor initiation progression metastasis Recent studies genetic model lung adenocarcinoma suggest role PKC transformation lung cancer stem cells studies important implications therapeutic use ATM particularly future studies validate PKC important gene critical cancer stem cell niche Significant progress made determining molecular mechanisms PKC drives transformed phenotype particularly central role played oncogenic PKCPar complex transformed growth invasion several PKCdependent survival pathways chemoresistance Future studies required determine composition dynamics PKCPar complex mechanisms oncogenic signaling complex regulated Likewise better understanding critical downstream effectors PKC various human tumor types holds promise identification novel prognostic surrogate markers oncogenic PKC activity may clinically useful ongoing clinical trials ATM studies also hold promise revealing novel therapeutic targets Similarly complete understanding signaling mechanisms Kras possibly oncogenes regulate PKC expression human tumors may reveal new therapeutic intervention strategies Ultimately ongoing future clinical trials required establish usefulness ATM antitumor agent allow validation potential surrogate markers predictors therapeutic response PKCdirected therapy identified preclinical modelsTables Tables andandKrasAcknowledgments authors wish thank members Fields Murray laboratories key contributions data described review authors apologize colleagues whose important contributions area cited though attempted cite much relevant literature possible space limitations made comprehensive citation impossible Work laboratories discussed article supported grants APF National Institutes Health CA American Lung AssociationLUNGevity V Foundation Cancer Research James Esther King Biomedical Research Program Mayo Foundation NRM National Institutes Health CA Mayo Clinic SPORE Pancreatic Cancer Career Development award P CA NR MurrayAcknowledgmentsThe authors wish thank members Fields Murray laboratories key contributions data described review authors apologize colleagues whose important contributions area cited though attempted cite much relevant literature possible space limitations made comprehensive citation impossible Work laboratories discussed article supported grants APF National Institutes Health CA American Lung AssociationLUNGevity V Foundation Cancer Research James Esther King Biomedical Research Program Mayo Foundation NRM National Institutes Health CA Mayo Clinic SPORE Pancreatic Cancer Career Development award P CA NR MurrayThe authors wish thank members Fields Murray laboratories key contributions data described review authors apologize colleagues whose important contributions area cited though attempted cite much relevant literature possible space limitations made comprehensive citation impossible Work laboratories discussed article supported grants APF National Institutes Health CA American Lung AssociationLUNGevity V Foundation Cancer Research James Esther King Biomedical Research Program Mayo Foundation NRM National Institutes Health CA Mayo Clinic SPORE Pancreatic Cancer Career Development award P CA NR MurrayReferences Baldwin RM GarrattLalonde Parolin DA Krzyzanowski PM Andrade Lorimer IA Protection glioblastoma cells cisplatin cytotoxicity via protein kinase Ciotamediated attenuation p MAP kinase signaling Oncogene PubMed Google Scholar Baldwin RM Parolin DAE Lorimer IAJ Regulation glioblastoma cell invasion PKCiota RhoB Oncogene PubMed Google Scholar Balsara BR Sonoda G du Manoir Siegfried JM Gabrielson E Testa JR Comparative genomic hybridization analysis detects frequent often highlevel overrepresentation DNA sequences q p p q human nonsmall cell lung carcinomas Cancer Res PubMed Google Scholar Bedi Barber JP Bedi GC elDeiry WS Sidransky Vala MS Akhtar AJ Hilton J Jones RJ BCRABLmediated inhibition apoptosis delay GM transition DNA damage mechanism resistance multiple anticancer agents Blood PubMed Google Scholar Bjorkoy G Perander Overvatn Johansen Reversion Ras phosphatidylcholinehydrolyzing phospholipase Cmediated transformation NIH cells dominant interfering mutant protein kinase C lambda accompanied loss constitutive nuclear mitogenactivated protein kinaseextracellular signalregulated kinase activity J Biol Chem PubMed Google Scholar Brass N Racz Heckel Remberger K Sybrecht GW Meese EU Amplification genes BCHE SLCA squamous cell carcinoma lung Cancer Res PubMed Google Scholar Brass N Ukena Remberger K Mack U Sybrecht GW Meese EU DNA amplification chromosome qq squamous cell carcinoma lung detected reverse chromosome painting Eur J Cancer PubMed Google Scholar Bratt J Belcher J Vercellotti GM Palmblad J Effects antirheumatic gold salts NFkappa B mobilization tumour necrosis factoralpha TNFalphainduced neutrophildependent cytotoxicity human endothelial cells Clin Exp Immunol PMC free article PubMed Google Scholar Castagna Takai Kaibuchi K Sano K Kikkawa U Nishizuka Direct activation calciumactivated phospholipiddependent protein kinase tumorpromoting phorbol esters J Biol Chem PubMed Google Scholar Chalmers AD Pambos Mason J Lang Wylie C Papalopulu N aPKC Crumbs Lgl control apicobasal polarity early vertebrate development Development PubMed Google Scholar Coghlan MP Chou MM Carpenter CL Atypical protein kinases Clambda zeta associate GTPbinding protein Cdc mediate stress fiber loss Mol Cell Biol PMC free article PubMed Google Scholar Dempsey EC Newton AC MochlyRosen Fields AP Reyland Insel PA Protein kinase C isozymes regulation diverse cell responses J Physiol PubMed Google Scholar DiazMeco MT Lozano J Municio MM Berra E Frutos Sanz L Moscat J Evidence vitro vivo interaction Ras protein kinase C zeta J Biol Chem PubMed Google Scholar Du GS Wang JM Lu JX Li Q CQ Du JT Zou SQ Expression PaPKCiota Ecadherin betacatenin related invasion metastasis hepatocellular carcinoma Ann Surg Oncol PubMed Google Scholar Dyrskjot L Kruhoffer Thykjaer Marcussen N Jensen JL Moller K Orntoft TF Gene expression urinary bladder common carcinoma situ gene expression signature exists disregarding histopathological classification Cancer Res PubMed Google Scholar Eder Sui X Rosen DG Nolden LK Cheng KW Lahad JP KangoSingh Lu KH Warneke CL Atkinson EN Bedrosian Keyomarsi K Kuo Wl Gray JW Yin JCP Liu J Halder G Mills GB Atypical PKCiota contributes poor prognosis loss apicalbasal polarity Cyclin E overexpression ovarian cancer PNAS PMC free article PubMed Google Scholar Erdogan E Klee EW Thompson EA Fields AP Metaanalysis oncogenic protein kinase Ciota signaling lung adenocarcinoma Clin Cancer Res PMC free article PubMed Google Scholar Erdogan E Lamark StallingsMann Lee J Pellecchia Thompson EA Johansen Fields AP Aurothiomalate inhibits transformed growth targeting PB domain protein kinase Ciota J Biol Chem PubMed Google Scholar EtienneManneville Hall Cell polarity Par aPKC cytoskeletal crosstalk Curr Opin Cell Biol PubMed Google Scholar Fields AP Gustafson WC Protein kinase C disease cancer Methods Mol Biol PubMed Google Scholar Fields AP Justilien V guanine nucleotide exchange factor GEF Ect oncogene human cancer Adv Enzyme Regul PMC free article PubMed Google Scholar Fields AP Murray NR Protein kinase C isozymes therapeutic targets treatment human cancers Adv Enzyme Regul PMC free article PubMed Google Scholar Frederick LA Matthews JA Jamieson L Justilien V Thompson EA Radisky DC Fields AP Matrix metalloproteinase critical effector protein kinase CiotaParalphamediated lung cancer Oncogene PMC free article PubMed Google Scholar Ginos Page GP Michalowicz BS Patel KJ Volker SE Pambuccian SE Ondrey FG Adams GL Gaffney PM Identification gene expression signature associated recurrent disease squamous cell carcinoma head neck Cancer Res PubMed Google Scholar GokmenPolar Fields AP Mapping molecular determinant protein kinase C betaII isozyme function J Biol Chem PubMed Google Scholar Gumz ML Zou H Kreinest PA Childs AC Belmonte LS LeGrand SN Wu KJ Luxon BA Sinha Parker Sun LZ Ahlquist DA Wood CG Copland JA Secreted frizzledrelated protein loss contributes tumor phenotype clear cell renal cell carcinoma Clin Cancer Res PubMed Google Scholar Gustafson WC Ray Jamieson L Thompson EA Brasier AR Fields AP BcrAbl regulates protein kinase Ciota PKCiota transcription via Elk site PKCiota promoter J Biol Chem PubMed Google Scholar Heselmeyer K Macville Schrock E Blegen H Hellstrom AC Shah K Auer G Ried Advancedstage cervical carcinomas defined recurrent pattern chromosomal aberrations revealing high genetic instability consistent gain chromosome arm q Genes Chromosomes Cancer PubMed Google Scholar Hirano Yoshinaga Ogura K Yokochi Noda Sumimoto H Inagaki F Solution structure atypical protein kinase C PB domain mode interaction ZIPp MEK J Biol Chem PubMed Google Scholar Ishiguro H Akimoto K Nagashima Kojima Sasaki IshiguroImagawa Nakaigawa N Ohno Kubota Uemura H aPKClambdaiota promotes growth prostate cancer cells autocrine manner transcriptional activation interleukin Proc Natl Acad Sci U PMC free article PubMed Google Scholar Jackson EL Willis N Mercer K Bronson RT Crowley Montoya R Jacks Tuveson DA Analysis lung tumor initiation progression using conditional expression oncogenic Kras Genes Dev PMC free article PubMed Google Scholar Jamieson L Carpenter L Biden TJ Fields AP Protein kinase Ciota activity necessary BcrAblmediated resistance druginduced apoptosis J Biol Chem PubMed Google Scholar Jansen AP Verwiebe EG Dreckschmidt NE Wheeler DL Oberley TD Verma AK Protein kinase Cepsilon transgenic mice unique model metastatic squamous cell carcinoma Cancer Res PubMed Google Scholar Jeon KI Jeong JY Jue DM Thiolreactive metal compounds inhibit NFkappa B activation blocking kappa B kinase J Immunol PubMed Google Scholar Jin Z Xin Deng X Survival function protein kinase Ciota novel nitrosamine methylnitrosaminopyridylbutanoneactivated bad kinase J Biol Chem PubMed Google Scholar Joberty G Petersen C Gao L Macara IG cellpolarity protein Par links Par atypical protein kinase C Cdc Nat Cell Biol PubMed Google Scholar Johnson L Mercer K Greenbaum Bronson RT Crowley Tuveson DA Jacks Somatic activation Kras oncogene causes early onset lung cancer mice Nature PubMed Google Scholar Justilien V Fields AP Ect links PKCiotaParalpha complex Rac activation cellular transformation Oncogene PMC free article PubMed Google Scholar Kampfer Windegger Hochholdinger F Schwaiger W Pestell RG Baier G Grunicke HH Uberall F Protein kinase C isoforms involved transcriptional activation cyclin transforming HaRas J Biol Chem PubMed Google Scholar Kanada Nagasaki Uyeda TQ Novel functions Ect polar lamellipodia formation polarity maintenance contractile ringindependent cytokinesis adherent cells Mol Biol Cell PMC free article PubMed Google Scholar KhosraviFar R Solski PA Clark GJ Kinch MS Der CJ Activation Rac RhoA mitogenactivated protein kinases required Ras transformation Mol Cell Biol PMC free article PubMed Google Scholar Kikkawa U Takai Tanaka Miyake R Nishizuka Protein kinase C possible receptor protein tumorpromoting phorbol esters J Biol Chem PubMed Google Scholar Klimstra DS Longnecker DS Kras mutations pancreatic ductal proliferative lesions J Pathol PMC free article PubMed Google Scholar Kojima Akimoto K Nagashima Ishiguro H Shirai Chishima Ichikawa Ishikawa Sasaki Kubota Inayama Aoki Ohno Shimada H overexpression altered localization atypical protein kinase C lambdaiota breast cancer correlates pathologic type tumors Hum Pathol PubMed Google Scholar Lamark Perander Outzen H Kristiansen K Overvatn Michaelsen E Bjorkoy G Johansen Interaction codes within family mammalian Phox Bemp domaincontaining proteins J Biol Chem PubMed Google Scholar Landi MT Dracheva Rotunno Figueroa JD Liu H Dasgupta Mann FE Fukuoka J Hames Bergen AW Murphy SE Yang P Pesatori AC Consonni Bertazzi PA Wacholder Shih JH Caporaso NE Jen J Gene expression signature cigarette smoking role lung adenocarcinoma development survival PLoS ONE e PMC free article PubMed Google Scholar Lee J Kotliarova Kotliarov Li Su Q Donin NM Pastorino Purow BW Christopher N Zhang W Park JK Fine HA Tumor stem cells derived glioblastomas cultured bFGF EGF closely mirror phenotype genotype primary tumors serumcultured cell lines Cancer Cell PubMed Google Scholar Li Q Wang JM Liu C Xiao BL Lu JX Zou SQ Correlation aPKCiota Ecadherin expression invasion prognosis cholangiocarcinoma Hepatobiliary Pancreat Dis Int PubMed Google Scholar Lin Edwards Fawcett JP Mbamalu G Scott JD Pawson mammalian PARPAR complex implicated CdcRac aPKC signalling cell polarity Nat Cell Biol PubMed Google Scholar Lin Smith LT Smiraglia DJ KazhiyurMannar R Lang JC Schuller DE Kornacker K Wenger R Plass C DNA copy number gains head neck squamous cell carcinoma Oncogene PubMed Google Scholar Lu Jamieson L Brasier AR Fields AP NFkappaBRelA transactivation required atypical protein kinase C iotamediated cell survival Oncogene PubMed Google Scholar Messori L Marcon G Gold complexes treatment rheumatoid arthritis Met Ions Biol Syst PubMed Google Scholar Mischak H Goodnight JA Kolch W MartinyBaron G Schaechtle C Kazanietz MG Blumberg PM Pierce JH Mushinski JF Overexpression protein kinase Cdelta epsilon NIH cells induces opposite effects growth morphology anchorage dependence tumorigenicity J Biol Chem PubMed Google Scholar Murray NR Davidson LA Chapkin RS Gustafson WC Schattenberg DG Fields AP Overexpression protein kinase C betaII induces colonic hyperproliferation increased sensitivity colon carcinogenesis J Cell Biol PMC free article PubMed Google Scholar Murray NR Fields AP Atypical protein kinase C iota protects human leukemia cells druginduced apoptosis J Biol Chem PubMed Google Scholar Murray NR Jamieson L Yu W Zhang J GokmenPolar Sier Anastasiadis P Gatalica Z Thompson EA Fields AP Protein kinase Ciota required Ras transformation colon carcinogenesis vivo J Cell Biol PMC free article PubMed Google Scholar Murray NR Weems J Braun U Leitges Fields AP Protein kinase C betaII PKCiotalambda collaborating partners colon cancer promotion progression Cancer Res PMC free article PubMed Google Scholar Noda Takeya R Ohno Naito Ito Sumimoto H Human homologues Caenorhabditis elegans cell polarity protein PAR adaptor links small GTPases Rac Cdc atypical protein kinase C Genes Cells PubMed Google Scholar Oster H Leitges Protein kinase C alpha PKCzeta suppresses intestinal tumor formation ApcMin mice Cancer Res PubMed Google Scholar Patel R Win H Desai Patel K Matthews JA AcevedoDuncan Involvement PKCiota glioma proliferation Cell Prolif PMC free article PubMed Google Scholar Pia Rigobello Messori L Marcon G Agostina Cinellu Bragadin Folda Scutari G Bindoli Gold complexes inhibit mitochondrial thioredoxin reductase consequences mitochondrial functions J Inorg Biochem PubMed Google Scholar Qiu RG Abo Steven Martin G human homolog C elegans polarity determinant Par links Rac Cdc PKCzeta signaling cell transformation Curr Biol PubMed Google Scholar Qiu RG Chen J Kirn McCormick F Symons essential role Rac Ras transformation Nature PubMed Google Scholar Racz Brass N Heckel Pahl Remberger K Meese E Expression analysis genes qq involved frequent amplification squamous cell lung carcinoma Eur J Cancer PubMed Google Scholar Regala RP Davis RK Kunz Khoor Leitges Fields AP Atypical protein kinase Ciota required bronchioalveolar stem cell expansion lung tumorigenesis Cancer Res PMC free article PubMed Google Scholar Regala RP Thompson EA Fields AP Atypical protein kinase C iota expression aurothiomalate sensitivity human lung cancer cells Cancer Res PMC free article PubMed Google Scholar Regala RP Weems C Jamieson L Copland JA Thompson EA Fields AP Atypical protein kinase Ciota plays critical role human lung cancer cell growth tumorigenicity J Biol Chem PubMed Google Scholar Regala RP Weems C Jamieson L Khoor Edell ES Lohse CM Fields AP Atypical protein kinase C iota oncogene human nonsmall cell lung cancer Cancer Res b PubMed Google Scholar Reyland Protein kinase C isoforms Multifunctional regulators cell life death Front Biosci PMC free article PubMed Google Scholar Richardson AL Wang ZC De Nicolo Lu X Brown Miron Liao X Iglehart JD Livingston DM Ganesan X chromosomal abnormalities basallike human breast cancer Cancer Cell PubMed Google Scholar SanchezCarbayo Socci ND Lozano J Saint F CordonCardo C Defining molecular profiles poor outcome patients invasive bladder cancer using oligonucleotide microarrays J Clin Oncol PubMed Google Scholar Scotti ML Bamlet W Smyrk TC Fields AP Murray NR Protein kinase C iota required pancreatic cancer cell transformed growth tumorigenesis Cancer Res PMC free article PubMed Google Scholar Segara Biankin AV Kench JG Langusch CC Dawson AC Skalicky DA Gotley DC Coleman MJ Sutherland RL Henshall SM Expression HOXB retinoic acid signaling target pancreatic cancer pancreatic intraepithelial neoplasia Clin Cancer Res PubMed Google Scholar Singh B Stoffel Gogineni Poluri Pfister DG Shaha AR Pathak Bosl G CordonCardo C Shah JP Rao PH Amplification q locus associated progression invasive cancer negative prognostic factor head neck squamous cell carcinomas J Pathol PMC free article PubMed Google Scholar Slattery ML Anderson K Curtin K K Schaffer Edwards Samowitz W Lifestyle factors Kiras mutations colon cancer tumors Mutat Res PubMed Google Scholar Snaddon J Parkinson EK Craft JA Bartholomew C Fulton R Detection functional PTEN lipid phosphatase protein enzyme activity squamous cell carcinomas head neck despite loss heterozygosity locus Br J Cancer PMC free article PubMed Google Scholar StallingsMann Jamieson L Regala RP Weems C Murray NR Fields AP novel smallmolecule inhibitor protein kinase Ciota blocks transformed growth nonsmallcell lung cancer cells Cancer Res PubMed Google Scholar Sugita Tanaka N Davidson Sekiya VarellaGarcia West J Drabkin HA Gemmill RM Molecular definition small amplification domain within q tumors cervix ovary lung Cancer Genet Cytogenet PubMed Google Scholar Suzuki Akimoto K Ohno Protein kinase C lambdaiota PKClambdaiota PKC isotype essential development multicellular organisms J Biochem Tokyo PubMed Google Scholar Suzuki Yamanaka Hirose Manabe N Mizuno K Shimizu Akimoto K Izumi Ohnishi Ohno Atypical protein kinase C involved evolutionarily conserved par protein complex plays critical role establishing epitheliaspecific junctional structures J Cell Biol PMC free article PubMed Google Scholar Takagawa R Akimoto K Ichikawa Akiyama H Kojima Ishiguro H Inayama Aoki Kunisaki C Endo Nagashima Ohno High expression atypical protein kinase C lambdaiota gastric cancer prognostic factor recurrence Ann Surg Oncol PubMed Google Scholar Takayama Ohi Hayashi Miyanishi K Nobuoka Nakajima Satoh Takimoto R Kato J Sakamaki Niitsu Analysis Kras APC betacatenin aberrant crypt foci sporadic adenoma cancer familial adenomatous polyposis Gastroenterology PubMed Google Scholar Talantov Mazumder Yu JX Briggs Jiang Backus J Atkins Wang Novel genes associated malignant melanoma benign melanocytic lesions Clin Cancer Res PubMed Google Scholar Uberall F Hellbert K Kampfer Maly K Villunger Spitaler Mwanjewe J BaierBitterlich G Baier G Grunicke HH Evidence atypical protein kinase Clambda atypical protein kinase Czeta participate Rasmediated reorganization Factin cytoskeleton J Cell Biol PMC free article PubMed Google Scholar Valk PJ Verhaak RG Beijen Erpelinck CA Barjesteh van Waalwijk van DoornKhosrovani Boer JM Beverloo HB Moorhouse MJ van der Spek PJ Lowenberg B Delwel R Prognostically useful geneexpression profiles acute myeloid leukemia N Engl J Med PubMed Google Scholar Wallace TA Prueitt RL Yi Howe TM Gillespie JW Yfantis HG Stephens RM Caporaso NE Loffredo CA Ambs Tumor immunobiological differences prostate cancer AfricanAmerican EuropeanAmerican men Cancer Res PubMed Google Scholar Weichert W Gekeler V Denkert C Dietel Hauptmann Protein kinase C isoform expression ovarian carcinoma correlates indicators poor prognosis Int J Oncol PubMed Google Scholar Wilson MI Gill DJ Perisic Quinn MT Williams RL PB domainmediated heterodimerization NADPH oxidase signaling complexes atypical protein kinase C Par p Mol Cell PubMed Google Scholar Win HY AcevedoDuncan Atypical protein kinase C phosphorylates IKKalphabeta transformed nonmalignant malignant prostate cell survival Cancer Lett PubMed Google Scholar Wurmbach E Chen YB Khitrov G Zhang W Roayaie Schwartz Fiel Thung Mazzaferro V Bruix J Bottinger E Friedman Waxman Llovet JM Genomewide molecular profiles HCVinduced dysplasia hepatocellular carcinoma Hepatology PubMed Google Scholar Yamashita Ashino Oshima Kawamura Ohuchi K Takayanagi Inhibition TPAinduced NFkappaB nuclear translocation production PGE antirheumatic gold compounds J Pharm Pharmacol PubMed Google Scholar Yang YL Chu JY Luo ML Wu YP Zhang Feng YB Shi ZZ Xu X Han YL Cai Dong JT Zhan QM Wu Wang MR Amplification PRKCI located q associated lymph node metastasis esophageal squamous cell carcinoma Genes Chromosomes Cancer PubMed Google Scholar Ye H Yu Temam Ziober BL Wang J Schwartz JL Mao L Wong DT Zhou X Transcriptomic dissection tongue squamous cell carcinoma BMC Genomics PMC free article PubMed Google Scholar Zhang L Huang J Yang N Liang Barchetti Giannakakis Cadungog MG OBrienJenkins Massobrio Roby KF Katsaros Gimotty P Butzow R Weber BL Coukos G Integrative genomic analysis protein kinase C PKC family identifies PKCiota biomarker potential oncogene ovarian carcinoma Cancer Res PubMed Google Scholar ReferencesBaldwin RM GarrattLalonde Parolin DA Krzyzanowski PM Andrade Lorimer IA Protection glioblastoma cells cisplatin cytotoxicity via protein kinase Ciotamediated attenuation p MAP kinase signaling Oncogene PubMed Google Scholar Baldwin RM Parolin DAE Lorimer IAJ Regulation glioblastoma cell invasion PKCiota RhoB Oncogene PubMed Google Scholar Balsara BR Sonoda G du Manoir Siegfried JM Gabrielson E Testa JR Comparative genomic hybridization analysis detects frequent often highlevel overrepresentation DNA sequences q p p q human nonsmall cell lung carcinomas Cancer Res PubMed Google Scholar Bedi Barber JP Bedi GC elDeiry WS Sidransky Vala MS Akhtar AJ Hilton J Jones RJ BCRABLmediated inhibition apoptosis delay GM transition DNA damage mechanism resistance multiple anticancer agents Blood PubMed Google Scholar Bjorkoy G Perander Overvatn Johansen Reversion Ras phosphatidylcholinehydrolyzing phospholipase Cmediated transformation NIH cells dominant interfering mutant protein kinase C lambda accompanied loss constitutive nuclear mitogenactivated protein kinaseextracellular signalregulated kinase activity J Biol Chem PubMed Google Scholar Brass N Racz Heckel Remberger K Sybrecht GW Meese EU Amplification genes BCHE SLCA squamous cell carcinoma lung Cancer Res PubMed Google Scholar Brass N Ukena Remberger K Mack U Sybrecht GW Meese EU DNA amplification chromosome qq squamous cell carcinoma lung detected reverse chromosome painting Eur J Cancer PubMed Google Scholar Bratt J Belcher J Vercellotti GM Palmblad J Effects antirheumatic gold salts NFkappa B mobilization tumour necrosis factoralpha TNFalphainduced neutrophildependent cytotoxicity human endothelial cells Clin Exp Immunol PMC free article PubMed Google Scholar Castagna Takai Kaibuchi K Sano K Kikkawa U Nishizuka Direct activation calciumactivated phospholipiddependent protein kinase tumorpromoting phorbol esters J Biol Chem PubMed Google Scholar Chalmers AD Pambos Mason J Lang Wylie C Papalopulu N aPKC Crumbs Lgl control apicobasal polarity early vertebrate development Development PubMed Google Scholar Coghlan MP Chou MM Carpenter CL Atypical protein kinases Clambda zeta associate GTPbinding protein Cdc mediate stress fiber loss Mol Cell Biol PMC free article PubMed Google Scholar Dempsey EC Newton AC MochlyRosen Fields AP Reyland Insel PA Protein kinase C isozymes regulation diverse cell responses J Physiol PubMed Google Scholar DiazMeco MT Lozano J Municio MM Berra E Frutos Sanz L Moscat J Evidence vitro vivo interaction Ras protein kinase C zeta J Biol Chem PubMed Google Scholar Du GS Wang JM Lu JX Li Q CQ Du JT Zou SQ Expression PaPKCiota Ecadherin betacatenin related invasion metastasis hepatocellular carcinoma Ann Surg Oncol PubMed Google Scholar Dyrskjot L Kruhoffer Thykjaer Marcussen N Jensen JL Moller K Orntoft TF Gene expression urinary bladder common carcinoma situ gene expression signature exists disregarding histopathological classification Cancer Res PubMed Google Scholar Eder Sui X Rosen DG Nolden LK Cheng KW Lahad JP KangoSingh Lu KH Warneke CL Atkinson EN Bedrosian Keyomarsi K Kuo Wl Gray JW Yin JCP Liu J Halder G Mills GB Atypical PKCiota contributes poor prognosis loss apicalbasal polarity Cyclin E overexpression ovarian cancer PNAS PMC free article PubMed Google Scholar Erdogan E Klee EW Thompson EA Fields AP Metaanalysis oncogenic protein kinase Ciota signaling lung adenocarcinoma Clin Cancer Res PMC free article PubMed Google Scholar Erdogan E Lamark StallingsMann Lee J Pellecchia Thompson EA Johansen Fields AP Aurothiomalate inhibits transformed growth targeting PB domain protein kinase Ciota J Biol Chem PubMed Google Scholar EtienneManneville Hall Cell polarity Par aPKC cytoskeletal crosstalk Curr Opin Cell Biol PubMed Google Scholar Fields AP Gustafson WC Protein kinase C disease cancer Methods Mol Biol PubMed Google Scholar Fields AP Justilien V guanine nucleotide exchange factor GEF Ect oncogene human cancer Adv Enzyme Regul PMC free article PubMed Google Scholar Fields AP Murray NR Protein kinase C isozymes therapeutic targets treatment human cancers Adv Enzyme Regul PMC free article PubMed Google Scholar Frederick LA Matthews JA Jamieson L Justilien V Thompson EA Radisky DC Fields AP Matrix metalloproteinase critical effector protein kinase CiotaParalphamediated lung cancer Oncogene PMC free article PubMed Google Scholar Ginos Page GP Michalowicz BS Patel KJ Volker SE Pambuccian SE Ondrey FG Adams GL Gaffney PM Identification gene expression signature associated recurrent disease squamous cell carcinoma head neck Cancer Res PubMed Google Scholar GokmenPolar Fields AP Mapping molecular determinant protein kinase C betaII isozyme function J Biol Chem PubMed Google Scholar Gumz ML Zou H Kreinest PA Childs AC Belmonte LS LeGrand SN Wu KJ Luxon BA Sinha Parker Sun LZ Ahlquist DA Wood CG Copland JA Secreted frizzledrelated protein loss contributes tumor phenotype clear cell renal cell carcinoma Clin Cancer Res PubMed Google Scholar Gustafson WC Ray Jamieson L Thompson EA Brasier AR Fields AP BcrAbl regulates protein kinase Ciota PKCiota transcription via Elk site PKCiota promoter J Biol Chem PubMed Google Scholar Heselmeyer K Macville Schrock E Blegen H Hellstrom AC Shah K Auer G Ried Advancedstage cervical carcinomas defined recurrent pattern chromosomal aberrations revealing high genetic instability consistent gain chromosome arm q Genes Chromosomes Cancer PubMed Google Scholar Hirano Yoshinaga Ogura K Yokochi Noda Sumimoto H Inagaki F Solution structure atypical protein kinase C PB domain mode interaction ZIPp MEK J Biol Chem PubMed Google Scholar Ishiguro H Akimoto K Nagashima Kojima Sasaki IshiguroImagawa Nakaigawa N Ohno Kubota Uemura H aPKClambdaiota promotes growth prostate cancer cells autocrine manner transcriptional activation interleukin Proc Natl Acad Sci U PMC free article PubMed Google Scholar Jackson EL Willis N Mercer K Bronson RT Crowley Montoya R Jacks Tuveson DA Analysis lung tumor initiation progression using conditional expression oncogenic Kras Genes Dev PMC free article PubMed Google Scholar Jamieson L Carpenter L Biden TJ Fields AP Protein kinase Ciota activity necessary BcrAblmediated resistance druginduced apoptosis J Biol Chem PubMed Google Scholar Jansen AP Verwiebe EG Dreckschmidt NE Wheeler DL Oberley TD Verma AK Protein kinase Cepsilon transgenic mice unique model metastatic squamous cell carcinoma Cancer Res PubMed Google Scholar Jeon KI Jeong JY Jue DM Thiolreactive metal compounds inhibit NFkappa B activation blocking kappa B kinase J Immunol PubMed Google Scholar Jin Z Xin Deng X Survival function protein kinase Ciota novel nitrosamine methylnitrosaminopyridylbutanoneactivated bad kinase J Biol Chem PubMed Google Scholar Joberty G Petersen C Gao L Macara IG cellpolarity protein Par links Par atypical protein kinase C Cdc Nat Cell Biol PubMed Google Scholar Johnson L Mercer K Greenbaum Bronson RT Crowley Tuveson DA Jacks Somatic activation Kras oncogene causes early onset lung cancer mice Nature PubMed Google Scholar Justilien V Fields AP Ect links PKCiotaParalpha complex Rac activation cellular transformation Oncogene PMC free article PubMed Google Scholar Kampfer Windegger Hochholdinger F Schwaiger W Pestell RG Baier G Grunicke HH Uberall F Protein kinase C isoforms involved transcriptional activation cyclin transforming HaRas J Biol Chem PubMed Google Scholar Kanada Nagasaki Uyeda TQ Novel functions Ect polar lamellipodia formation polarity maintenance contractile ringindependent cytokinesis adherent cells Mol Biol Cell PMC free article PubMed Google Scholar KhosraviFar R Solski PA Clark GJ Kinch MS Der CJ Activation Rac RhoA mitogenactivated protein kinases required Ras transformation Mol Cell Biol PMC free article PubMed Google Scholar Kikkawa U Takai Tanaka Miyake R Nishizuka Protein kinase C possible receptor protein tumorpromoting phorbol esters J Biol Chem PubMed Google Scholar Klimstra DS Longnecker DS Kras mutations pancreatic ductal proliferative lesions J Pathol PMC free article PubMed Google Scholar Kojima Akimoto K Nagashima Ishiguro H Shirai Chishima Ichikawa Ishikawa Sasaki Kubota Inayama Aoki Ohno Shimada H overexpression altered localization atypical protein kinase C lambdaiota breast cancer correlates pathologic type tumors Hum Pathol PubMed Google Scholar Lamark Perander Outzen H Kristiansen K Overvatn Michaelsen E Bjorkoy G Johansen Interaction codes within family mammalian Phox Bemp domaincontaining proteins J Biol Chem PubMed Google Scholar Landi MT Dracheva Rotunno Figueroa JD Liu H Dasgupta Mann FE Fukuoka J Hames Bergen AW Murphy SE Yang P Pesatori AC Consonni Bertazzi PA Wacholder Shih JH Caporaso NE Jen J Gene expression signature cigarette smoking role lung adenocarcinoma development survival PLoS ONE e PMC free article PubMed Google Scholar Lee J Kotliarova Kotliarov Li Su Q Donin NM Pastorino Purow BW Christopher N Zhang W Park JK Fine HA Tumor stem cells derived glioblastomas cultured bFGF EGF closely mirror phenotype genotype primary tumors serumcultured cell lines Cancer Cell PubMed Google Scholar Li Q Wang JM Liu C Xiao BL Lu JX Zou SQ Correlation aPKCiota Ecadherin expression invasion prognosis cholangiocarcinoma Hepatobiliary Pancreat Dis Int PubMed Google Scholar Lin Edwards Fawcett JP Mbamalu G Scott JD Pawson mammalian PARPAR complex implicated CdcRac aPKC signalling cell polarity Nat Cell Biol PubMed Google Scholar Lin Smith LT Smiraglia DJ KazhiyurMannar R Lang JC Schuller DE Kornacker K Wenger R Plass C DNA copy number gains head neck squamous cell carcinoma Oncogene PubMed Google Scholar Lu Jamieson L Brasier AR Fields AP NFkappaBRelA transactivation required atypical protein kinase C iotamediated cell survival Oncogene PubMed Google Scholar Messori L Marcon G Gold complexes treatment rheumatoid arthritis Met Ions Biol Syst PubMed Google Scholar Mischak H Goodnight JA Kolch W MartinyBaron G Schaechtle C Kazanietz MG Blumberg PM Pierce JH Mushinski JF Overexpression protein kinase Cdelta epsilon NIH cells induces opposite effects growth morphology anchorage dependence tumorigenicity J Biol Chem PubMed Google Scholar Murray NR Davidson LA Chapkin RS Gustafson WC Schattenberg DG Fields AP Overexpression protein kinase C betaII induces colonic hyperproliferation increased sensitivity colon carcinogenesis J Cell Biol PMC free article PubMed Google Scholar Murray NR Fields AP Atypical protein kinase C iota protects human leukemia cells druginduced apoptosis J Biol Chem PubMed Google Scholar Murray NR Jamieson L Yu W Zhang J GokmenPolar Sier Anastasiadis P Gatalica Z Thompson EA Fields AP Protein kinase Ciota required Ras transformation colon carcinogenesis vivo J Cell Biol PMC free article PubMed Google Scholar Murray NR Weems J Braun U Leitges Fields AP Protein kinase C betaII PKCiotalambda collaborating partners colon cancer promotion progression Cancer Res PMC free article PubMed Google Scholar Noda Takeya R Ohno Naito Ito Sumimoto H Human homologues Caenorhabditis elegans cell polarity protein PAR adaptor links small GTPases Rac Cdc atypical protein kinase C Genes Cells PubMed Google Scholar Oster H Leitges Protein kinase C alpha PKCzeta suppresses intestinal tumor formation ApcMin mice Cancer Res PubMed Google Scholar Patel R Win H Desai Patel K Matthews JA AcevedoDuncan Involvement PKCiota glioma proliferation Cell Prolif PMC free article PubMed Google Scholar Pia Rigobello Messori L Marcon G Agostina Cinellu Bragadin Folda Scutari G Bindoli Gold complexes inhibit mitochondrial thioredoxin reductase consequences mitochondrial functions J Inorg Biochem PubMed Google Scholar Qiu RG Abo Steven Martin G human homolog C elegans polarity determinant Par links Rac Cdc PKCzeta signaling cell transformation Curr Biol PubMed Google Scholar Qiu RG Chen J Kirn McCormick F Symons essential role Rac Ras transformation Nature PubMed Google Scholar Racz Brass N Heckel Pahl Remberger K Meese E Expression analysis genes qq involved frequent amplification squamous cell lung carcinoma Eur J Cancer PubMed Google Scholar Regala RP Davis RK Kunz Khoor Leitges Fields AP Atypical protein kinase Ciota required bronchioalveolar stem cell expansion lung tumorigenesis Cancer Res PMC free article PubMed Google Scholar Regala RP Thompson EA Fields AP Atypical protein kinase C iota expression aurothiomalate sensitivity human lung cancer cells Cancer Res PMC free article PubMed Google Scholar Regala RP Weems C Jamieson L Copland JA Thompson EA Fields AP Atypical protein kinase Ciota plays critical role human lung cancer cell growth tumorigenicity J Biol Chem PubMed Google Scholar Regala RP Weems C Jamieson L Khoor Edell ES Lohse CM Fields AP Atypical protein kinase C iota oncogene human nonsmall cell lung cancer Cancer Res b PubMed Google Scholar Reyland Protein kinase C isoforms Multifunctional regulators cell life death Front Biosci PMC free article PubMed Google Scholar Richardson AL Wang ZC De Nicolo Lu X Brown Miron Liao X Iglehart JD Livingston DM Ganesan X chromosomal abnormalities basallike human breast cancer Cancer Cell PubMed Google Scholar SanchezCarbayo Socci ND Lozano J Saint F CordonCardo C Defining molecular profiles poor outcome patients invasive bladder cancer using oligonucleotide microarrays J Clin Oncol PubMed Google Scholar Scotti ML Bamlet W Smyrk TC Fields AP Murray NR Protein kinase C iota required pancreatic cancer cell transformed growth tumorigenesis Cancer Res PMC free article PubMed Google Scholar Segara Biankin AV Kench JG Langusch CC Dawson AC Skalicky DA Gotley DC Coleman MJ Sutherland RL Henshall SM Expression HOXB retinoic acid signaling target pancreatic cancer pancreatic intraepithelial neoplasia Clin Cancer Res PubMed Google Scholar Singh B Stoffel Gogineni Poluri Pfister DG Shaha AR Pathak Bosl G CordonCardo C Shah JP Rao PH Amplification q locus associated progression invasive cancer negative prognostic factor head neck squamous cell carcinomas J Pathol PMC free article PubMed Google Scholar Slattery ML Anderson K Curtin K K Schaffer Edwards Samowitz W Lifestyle factors Kiras mutations colon cancer tumors Mutat Res PubMed Google Scholar Snaddon J Parkinson EK Craft JA Bartholomew C Fulton R Detection functional PTEN lipid phosphatase protein enzyme activity squamous cell carcinomas head neck despite loss heterozygosity locus Br J Cancer PMC free article PubMed Google Scholar StallingsMann Jamieson L Regala RP Weems C Murray NR Fields AP novel smallmolecule inhibitor protein kinase Ciota blocks transformed growth nonsmallcell lung cancer cells Cancer Res PubMed Google Scholar Sugita Tanaka N Davidson Sekiya VarellaGarcia West J Drabkin HA Gemmill RM Molecular definition small amplification domain within q tumors cervix ovary lung Cancer Genet Cytogenet PubMed Google Scholar Suzuki Akimoto K Ohno Protein kinase C lambdaiota PKClambdaiota PKC isotype essential development multicellular organisms J Biochem Tokyo PubMed Google Scholar Suzuki Yamanaka Hirose Manabe N Mizuno K Shimizu Akimoto K Izumi Ohnishi Ohno Atypical protein kinase C involved evolutionarily conserved par protein complex plays critical role establishing epitheliaspecific junctional structures J Cell Biol PMC free article PubMed Google Scholar Takagawa R Akimoto K Ichikawa Akiyama H Kojima Ishiguro H Inayama Aoki Kunisaki C Endo Nagashima Ohno High expression atypical protein kinase C lambdaiota gastric cancer prognostic factor recurrence Ann Surg Oncol PubMed Google Scholar Takayama Ohi Hayashi Miyanishi K Nobuoka Nakajima Satoh Takimoto R Kato J Sakamaki Niitsu Analysis Kras APC betacatenin aberrant crypt foci sporadic adenoma cancer familial adenomatous polyposis Gastroenterology PubMed Google Scholar Talantov Mazumder Yu JX Briggs Jiang Backus J Atkins Wang Novel genes associated malignant melanoma benign melanocytic lesions Clin Cancer Res PubMed Google Scholar Uberall F Hellbert K Kampfer Maly K Villunger Spitaler Mwanjewe J BaierBitterlich G Baier G Grunicke HH Evidence atypical protein kinase Clambda atypical protein kinase Czeta participate Rasmediated reorganization Factin cytoskeleton J Cell Biol PMC free article PubMed Google Scholar Valk PJ Verhaak RG Beijen Erpelinck CA Barjesteh van Waalwijk van DoornKhosrovani Boer JM Beverloo HB Moorhouse MJ van der Spek PJ Lowenberg B Delwel R Prognostically useful geneexpression profiles acute myeloid leukemia N Engl J Med PubMed Google Scholar Wallace TA Prueitt RL Yi Howe TM Gillespie JW Yfantis HG Stephens RM Caporaso NE Loffredo CA Ambs Tumor immunobiological differences prostate cancer AfricanAmerican EuropeanAmerican men Cancer Res PubMed Google Scholar Weichert W Gekeler V Denkert C Dietel Hauptmann Protein kinase C isoform expression ovarian carcinoma correlates indicators poor prognosis Int J Oncol PubMed Google Scholar Wilson MI Gill DJ Perisic Quinn MT Williams RL PB domainmediated heterodimerization NADPH oxidase signaling complexes atypical protein kinase C Par p Mol Cell PubMed Google Scholar Win HY AcevedoDuncan Atypical protein kinase C phosphorylates IKKalphabeta transformed nonmalignant malignant prostate cell survival Cancer Lett PubMed Google Scholar Wurmbach E Chen YB Khitrov G Zhang W Roayaie Schwartz Fiel Thung Mazzaferro V Bruix J Bottinger E Friedman Waxman Llovet JM Genomewide molecular profiles HCVinduced dysplasia hepatocellular carcinoma Hepatology PubMed Google Scholar Yamashita Ashino Oshima Kawamura Ohuchi K Takayanagi Inhibition TPAinduced NFkappaB nuclear translocation production PGE antirheumatic gold compounds J Pharm Pharmacol PubMed Google Scholar Yang YL Chu JY Luo ML Wu YP Zhang Feng YB Shi ZZ Xu X Han YL Cai Dong JT Zhan QM Wu Wang MR Amplification PRKCI located q associated lymph node metastasis esophageal squamous cell carcinoma Genes Chromosomes Cancer PubMed Google Scholar Ye H Yu Temam Ziober BL Wang J Schwartz JL Mao L Wong DT Zhou X Transcriptomic dissection tongue squamous cell carcinoma BMC Genomics PMC free article PubMed Google Scholar Zhang L Huang J Yang N Liang Barchetti Giannakakis Cadungog MG OBrienJenkins Massobrio Roby KF Katsaros Gimotty P Butzow R Weber BL Coukos G Integrative genomic analysis protein kinase C PKC family identifies PKCiota biomarker potential oncogene ovarian carcinoma Cancer Res PubMed Google Scholar Baldwin RM GarrattLalonde Parolin DA Krzyzanowski PM Andrade Lorimer IA Protection glioblastoma cells cisplatin cytotoxicity via protein kinase Ciotamediated attenuation p MAP kinase signaling Oncogene PubMed Google Scholar Baldwin RM Parolin DAE Lorimer IAJ Regulation glioblastoma cell invasion PKCiota RhoB Oncogene PubMed Google Scholar Balsara BR Sonoda G du Manoir Siegfried JM Gabrielson E Testa JR Comparative genomic hybridization analysis detects frequent often highlevel overrepresentation DNA sequences q p p q human nonsmall cell lung carcinomas Cancer Res PubMed Google Scholar Bedi Barber JP Bedi GC elDeiry WS Sidransky Vala MS Akhtar AJ Hilton J Jones RJ BCRABLmediated inhibition apoptosis delay GM transition DNA damage mechanism resistance multiple anticancer agents Blood PubMed Google Scholar Bjorkoy G Perander Overvatn Johansen Reversion Ras phosphatidylcholinehydrolyzing phospholipase Cmediated transformation NIH cells dominant interfering mutant protein kinase C lambda accompanied loss constitutive nuclear mitogenactivated protein kinaseextracellular signalregulated kinase activity J Biol Chem PubMed Google Scholar Brass N Racz Heckel Remberger K Sybrecht GW Meese EU Amplification genes BCHE SLCA squamous cell carcinoma lung Cancer Res PubMed Google Scholar Brass N Ukena Remberger K Mack U Sybrecht GW Meese EU DNA amplification chromosome qq squamous cell carcinoma lung detected reverse chromosome painting Eur J Cancer PubMed Google Scholar Bratt J Belcher J Vercellotti GM Palmblad J Effects antirheumatic gold salts NFkappa B mobilization tumour necrosis factoralpha TNFalphainduced neutrophildependent cytotoxicity human endothelial cells Clin Exp Immunol PMC free article PubMed Google Scholar Castagna Takai Kaibuchi K Sano K Kikkawa U Nishizuka Direct activation calciumactivated phospholipiddependent protein kinase tumorpromoting phorbol esters J Biol Chem PubMed Google Scholar Chalmers AD Pambos Mason J Lang Wylie C Papalopulu N aPKC Crumbs Lgl control apicobasal polarity early vertebrate development Development PubMed Google Scholar Coghlan MP Chou MM Carpenter CL Atypical protein kinases Clambda zeta associate GTPbinding protein Cdc mediate stress fiber loss Mol Cell Biol PMC free article PubMed Google Scholar Dempsey EC Newton AC MochlyRosen Fields AP Reyland Insel PA Protein kinase C isozymes regulation diverse cell responses J Physiol PubMed Google Scholar DiazMeco MT Lozano J Municio MM Berra E Frutos Sanz L Moscat J Evidence vitro vivo interaction Ras protein kinase C zeta J Biol Chem PubMed Google Scholar Du GS Wang JM Lu JX Li Q CQ Du JT Zou SQ Expression PaPKCiota Ecadherin betacatenin related invasion metastasis hepatocellular carcinoma Ann Surg Oncol PubMed Google Scholar Dyrskjot L Kruhoffer Thykjaer Marcussen N Jensen JL Moller K Orntoft TF Gene expression urinary bladder common carcinoma situ gene expression signature exists disregarding histopathological classification Cancer Res PubMed Google Scholar Eder Sui X Rosen DG Nolden LK Cheng KW Lahad JP KangoSingh Lu KH Warneke CL Atkinson EN Bedrosian Keyomarsi K Kuo Wl Gray JW Yin JCP Liu J Halder G Mills GB Atypical PKCiota contributes poor prognosis loss apicalbasal polarity Cyclin E overexpression ovarian cancer PNAS PMC free article PubMed Google Scholar Erdogan E Klee EW Thompson EA Fields AP Metaanalysis oncogenic protein kinase Ciota signaling lung adenocarcinoma Clin Cancer Res PMC free article PubMed Google Scholar Erdogan E Lamark StallingsMann Lee J Pellecchia Thompson EA Johansen Fields AP Aurothiomalate inhibits transformed growth targeting PB domain protein kinase Ciota J Biol Chem PubMed Google Scholar EtienneManneville Hall Cell polarity Par aPKC cytoskeletal crosstalk Curr Opin Cell Biol PubMed Google Scholar Fields AP Gustafson WC Protein kinase C disease cancer Methods Mol Biol PubMed Google Scholar Fields AP Justilien V guanine nucleotide exchange factor GEF Ect oncogene human cancer Adv Enzyme Regul PMC free article PubMed Google Scholar Fields AP Murray NR Protein kinase C isozymes therapeutic targets treatment human cancers Adv Enzyme Regul PMC free article PubMed Google Scholar Frederick LA Matthews JA Jamieson L Justilien V Thompson EA Radisky DC Fields AP Matrix metalloproteinase critical effector protein kinase CiotaParalphamediated lung cancer Oncogene PMC free article PubMed Google Scholar Ginos Page GP Michalowicz BS Patel KJ Volker SE Pambuccian SE Ondrey FG Adams GL Gaffney PM Identification gene expression signature associated recurrent disease squamous cell carcinoma head neck Cancer Res PubMed Google Scholar GokmenPolar Fields AP Mapping molecular determinant protein kinase C betaII isozyme function J Biol Chem PubMed Google Scholar Gumz ML Zou H Kreinest PA Childs AC Belmonte LS LeGrand SN Wu KJ Luxon BA Sinha Parker Sun LZ Ahlquist DA Wood CG Copland JA Secreted frizzledrelated protein loss contributes tumor phenotype clear cell renal cell carcinoma Clin Cancer Res PubMed Google Scholar Gustafson WC Ray Jamieson L Thompson EA Brasier AR Fields AP BcrAbl regulates protein kinase Ciota PKCiota transcription via Elk site PKCiota promoter J Biol Chem PubMed Google Scholar Heselmeyer K Macville Schrock E Blegen H Hellstrom AC Shah K Auer G Ried Advancedstage cervical carcinomas defined recurrent pattern chromosomal aberrations revealing high genetic instability consistent gain chromosome arm q Genes Chromosomes Cancer PubMed Google Scholar Hirano Yoshinaga Ogura K Yokochi Noda Sumimoto H Inagaki F Solution structure atypical protein kinase C PB domain mode interaction ZIPp MEK J Biol Chem PubMed Google Scholar Ishiguro H Akimoto K Nagashima Kojima Sasaki IshiguroImagawa Nakaigawa N Ohno Kubota Uemura H aPKClambdaiota promotes growth prostate cancer cells autocrine manner transcriptional activation interleukin Proc Natl Acad Sci U PMC free article PubMed Google Scholar Jackson EL Willis N Mercer K Bronson RT Crowley Montoya R Jacks Tuveson DA Analysis lung tumor initiation progression using conditional expression oncogenic Kras Genes Dev PMC free article PubMed Google Scholar Jamieson L Carpenter L Biden TJ Fields AP Protein kinase Ciota activity necessary BcrAblmediated resistance druginduced apoptosis J Biol Chem PubMed Google Scholar Jansen AP Verwiebe EG Dreckschmidt NE Wheeler DL Oberley TD Verma AK Protein kinase Cepsilon transgenic mice unique model metastatic squamous cell carcinoma Cancer Res PubMed Google Scholar Jeon KI Jeong JY Jue DM Thiolreactive metal compounds inhibit NFkappa B activation blocking kappa B kinase J Immunol PubMed Google Scholar Jin Z Xin Deng X Survival function protein kinase Ciota novel nitrosamine methylnitrosaminopyridylbutanoneactivated bad kinase J Biol Chem PubMed Google Scholar Joberty G Petersen C Gao L Macara IG cellpolarity protein Par links Par atypical protein kinase C Cdc Nat Cell Biol PubMed Google Scholar Johnson L Mercer K Greenbaum Bronson RT Crowley Tuveson DA Jacks Somatic activation Kras oncogene causes early onset lung cancer mice Nature PubMed Google Scholar Justilien V Fields AP Ect links PKCiotaParalpha complex Rac activation cellular transformation Oncogene PMC free article PubMed Google Scholar Kampfer Windegger Hochholdinger F Schwaiger W Pestell RG Baier G Grunicke HH Uberall F Protein kinase C isoforms involved transcriptional activation cyclin transforming HaRas J Biol Chem PubMed Google Scholar Kanada Nagasaki Uyeda TQ Novel functions Ect polar lamellipodia formation polarity maintenance contractile ringindependent cytokinesis adherent cells Mol Biol Cell PMC free article PubMed Google Scholar KhosraviFar R Solski PA Clark GJ Kinch MS Der CJ Activation Rac RhoA mitogenactivated protein kinases required Ras transformation Mol Cell Biol PMC free article PubMed Google Scholar Kikkawa U Takai Tanaka Miyake R Nishizuka Protein kinase C possible receptor protein tumorpromoting phorbol esters J Biol Chem PubMed Google Scholar Klimstra DS Longnecker DS Kras mutations pancreatic ductal proliferative lesions J Pathol PMC free article PubMed Google Scholar Kojima Akimoto K Nagashima Ishiguro H Shirai Chishima Ichikawa Ishikawa Sasaki Kubota Inayama Aoki Ohno Shimada H overexpression altered localization atypical protein kinase C lambdaiota breast cancer correlates pathologic type tumors Hum Pathol PubMed Google Scholar Lamark Perander Outzen H Kristiansen K Overvatn Michaelsen E Bjorkoy G Johansen Interaction codes within family mammalian Phox Bemp domaincontaining proteins J Biol Chem PubMed Google Scholar Landi MT Dracheva Rotunno Figueroa JD Liu H Dasgupta Mann FE Fukuoka J Hames Bergen AW Murphy SE Yang P Pesatori AC Consonni Bertazzi PA Wacholder Shih JH Caporaso NE Jen J Gene expression signature cigarette smoking role lung adenocarcinoma development survival PLoS ONE e PMC free article PubMed Google Scholar Lee J Kotliarova Kotliarov Li Su Q Donin NM Pastorino Purow BW Christopher N Zhang W Park JK Fine HA Tumor stem cells derived glioblastomas cultured bFGF EGF closely mirror phenotype genotype primary tumors serumcultured cell lines Cancer Cell PubMed Google Scholar Li Q Wang JM Liu C Xiao BL Lu JX Zou SQ Correlation aPKCiota Ecadherin expression invasion prognosis cholangiocarcinoma Hepatobiliary Pancreat Dis Int PubMed Google Scholar Lin Edwards Fawcett JP Mbamalu G Scott JD Pawson mammalian PARPAR complex implicated CdcRac aPKC signalling cell polarity Nat Cell Biol PubMed Google Scholar Lin Smith LT Smiraglia DJ KazhiyurMannar R Lang JC Schuller DE Kornacker K Wenger R Plass C DNA copy number gains head neck squamous cell carcinoma Oncogene PubMed Google Scholar Lu Jamieson L Brasier AR Fields AP NFkappaBRelA transactivation required atypical protein kinase C iotamediated cell survival Oncogene PubMed Google Scholar Messori L Marcon G Gold complexes treatment rheumatoid arthritis Met Ions Biol Syst PubMed Google Scholar Mischak H Goodnight JA Kolch W MartinyBaron G Schaechtle C Kazanietz MG Blumberg PM Pierce JH Mushinski JF Overexpression protein kinase Cdelta epsilon NIH cells induces opposite effects growth morphology anchorage dependence tumorigenicity J Biol Chem PubMed Google Scholar Murray NR Davidson LA Chapkin RS Gustafson WC Schattenberg DG Fields AP Overexpression protein kinase C betaII induces colonic hyperproliferation increased sensitivity colon carcinogenesis J Cell Biol PMC free article PubMed Google Scholar Murray NR Fields AP Atypical protein kinase C iota protects human leukemia cells druginduced apoptosis J Biol Chem PubMed Google Scholar Murray NR Jamieson L Yu W Zhang J GokmenPolar Sier Anastasiadis P Gatalica Z Thompson EA Fields AP Protein kinase Ciota required Ras transformation colon carcinogenesis vivo J Cell Biol PMC free article PubMed Google Scholar Murray NR Weems J Braun U Leitges Fields AP Protein kinase C betaII PKCiotalambda collaborating partners colon cancer promotion progression Cancer Res PMC free article PubMed Google Scholar Noda Takeya R Ohno Naito Ito Sumimoto H Human homologues Caenorhabditis elegans cell polarity protein PAR adaptor links small GTPases Rac Cdc atypical protein kinase C Genes Cells PubMed Google Scholar Oster H Leitges Protein kinase C alpha PKCzeta suppresses intestinal tumor formation ApcMin mice Cancer Res PubMed Google Scholar Patel R Win H Desai Patel K Matthews JA AcevedoDuncan Involvement PKCiota glioma proliferation Cell Prolif PMC free article PubMed Google Scholar Pia Rigobello Messori L Marcon G Agostina Cinellu Bragadin Folda Scutari G Bindoli Gold complexes inhibit mitochondrial thioredoxin reductase consequences mitochondrial functions J Inorg Biochem PubMed Google Scholar Qiu RG Abo Steven Martin G human homolog C elegans polarity determinant Par links Rac Cdc PKCzeta signaling cell transformation Curr Biol PubMed Google Scholar Qiu RG Chen J Kirn McCormick F Symons essential role Rac Ras transformation Nature PubMed Google Scholar Racz Brass N Heckel Pahl Remberger K Meese E Expression analysis genes qq involved frequent amplification squamous cell lung carcinoma Eur J Cancer PubMed Google Scholar Regala RP Davis RK Kunz Khoor Leitges Fields AP Atypical protein kinase Ciota required bronchioalveolar stem cell expansion lung tumorigenesis Cancer Res PMC free article PubMed Google Scholar Regala RP Thompson EA Fields AP Atypical protein kinase C iota expression aurothiomalate sensitivity human lung cancer cells Cancer Res PMC free article PubMed Google Scholar Regala RP Weems C Jamieson L Copland JA Thompson EA Fields AP Atypical protein kinase Ciota plays critical role human lung cancer cell growth tumorigenicity J Biol Chem PubMed Google Scholar Regala RP Weems C Jamieson L Khoor Edell ES Lohse CM Fields AP Atypical protein kinase C iota oncogene human nonsmall cell lung cancer Cancer Res b PubMed Google Scholar Reyland Protein kinase C isoforms Multifunctional regulators cell life death Front Biosci PMC free article PubMed Google Scholar Richardson AL Wang ZC De Nicolo Lu X Brown Miron Liao X Iglehart JD Livingston DM Ganesan X chromosomal abnormalities basallike human breast cancer Cancer Cell PubMed Google Scholar SanchezCarbayo Socci ND Lozano J Saint F CordonCardo C Defining molecular profiles poor outcome patients invasive bladder cancer using oligonucleotide microarrays J Clin Oncol PubMed Google Scholar Scotti ML Bamlet W Smyrk TC Fields AP Murray NR Protein kinase C iota required pancreatic cancer cell transformed growth tumorigenesis Cancer Res PMC free article PubMed Google Scholar Segara Biankin AV Kench JG Langusch CC Dawson AC Skalicky DA Gotley DC Coleman MJ Sutherland RL Henshall SM Expression HOXB retinoic acid signaling target pancreatic cancer pancreatic intraepithelial neoplasia Clin Cancer Res PubMed Google Scholar Singh B Stoffel Gogineni Poluri Pfister DG Shaha AR Pathak Bosl G CordonCardo C Shah JP Rao PH Amplification q locus associated progression invasive cancer negative prognostic factor head neck squamous cell carcinomas J Pathol PMC free article PubMed Google Scholar Slattery ML Anderson K Curtin K K Schaffer Edwards Samowitz W Lifestyle factors Kiras mutations colon cancer tumors Mutat Res PubMed Google Scholar Snaddon J Parkinson EK Craft JA Bartholomew C Fulton R Detection functional PTEN lipid phosphatase protein enzyme activity squamous cell carcinomas head neck despite loss heterozygosity locus Br J Cancer PMC free article PubMed Google Scholar StallingsMann Jamieson L Regala RP Weems C Murray NR Fields AP novel smallmolecule inhibitor protein kinase Ciota blocks transformed growth nonsmallcell lung cancer cells Cancer Res PubMed Google Scholar Sugita Tanaka N Davidson Sekiya VarellaGarcia West J Drabkin HA Gemmill RM Molecular definition small amplification domain within q tumors cervix ovary lung Cancer Genet Cytogenet PubMed Google Scholar Suzuki Akimoto K Ohno Protein kinase C lambdaiota PKClambdaiota PKC isotype essential development multicellular organisms J Biochem Tokyo PubMed Google Scholar Suzuki Yamanaka Hirose Manabe N Mizuno K Shimizu Akimoto K Izumi Ohnishi Ohno Atypical protein kinase C involved evolutionarily conserved par protein complex plays critical role establishing epitheliaspecific junctional structures J Cell Biol PMC free article PubMed Google Scholar Takagawa R Akimoto K Ichikawa Akiyama H Kojima Ishiguro H Inayama Aoki Kunisaki C Endo Nagashima Ohno High expression atypical protein kinase C lambdaiota gastric cancer prognostic factor recurrence Ann Surg Oncol PubMed Google Scholar Takayama Ohi Hayashi Miyanishi K Nobuoka Nakajima Satoh Takimoto R Kato J Sakamaki Niitsu Analysis Kras APC betacatenin aberrant crypt foci sporadic adenoma cancer familial adenomatous polyposis Gastroenterology PubMed Google Scholar Talantov Mazumder Yu JX Briggs Jiang Backus J Atkins Wang Novel genes associated malignant melanoma benign melanocytic lesions Clin Cancer Res PubMed Google Scholar Uberall F Hellbert K Kampfer Maly K Villunger Spitaler Mwanjewe J BaierBitterlich G Baier G Grunicke HH Evidence atypical protein kinase Clambda atypical protein kinase Czeta participate Rasmediated reorganization Factin cytoskeleton J Cell Biol PMC free article PubMed Google Scholar Valk PJ Verhaak RG Beijen Erpelinck CA Barjesteh van Waalwijk van DoornKhosrovani Boer JM Beverloo HB Moorhouse MJ van der Spek PJ Lowenberg B Delwel R Prognostically useful geneexpression profiles acute myeloid leukemia N Engl J Med PubMed Google Scholar Wallace TA Prueitt RL Yi Howe TM Gillespie JW Yfantis HG Stephens RM Caporaso NE Loffredo CA Ambs Tumor immunobiological differences prostate cancer AfricanAmerican EuropeanAmerican men Cancer Res PubMed Google Scholar Weichert W Gekeler V Denkert C Dietel Hauptmann Protein kinase C isoform expression ovarian carcinoma correlates indicators poor prognosis Int J Oncol PubMed Google Scholar Wilson MI Gill DJ Perisic Quinn MT Williams RL PB domainmediated heterodimerization NADPH oxidase signaling complexes atypical protein kinase C Par p Mol Cell PubMed Google Scholar Win HY AcevedoDuncan Atypical protein kinase C phosphorylates IKKalphabeta transformed nonmalignant malignant prostate cell survival Cancer Lett PubMed Google Scholar Wurmbach E Chen YB Khitrov G Zhang W Roayaie Schwartz Fiel Thung Mazzaferro V Bruix J Bottinger E Friedman Waxman Llovet JM Genomewide molecular profiles HCVinduced dysplasia hepatocellular carcinoma Hepatology PubMed Google Scholar Yamashita Ashino Oshima Kawamura Ohuchi K Takayanagi Inhibition TPAinduced NFkappaB nuclear translocation production PGE antirheumatic gold compounds J Pharm Pharmacol PubMed Google Scholar Yang YL Chu JY Luo ML Wu YP Zhang Feng YB Shi ZZ Xu X Han YL Cai Dong JT Zhan QM Wu Wang MR Amplification PRKCI located q associated lymph node metastasis esophageal squamous cell carcinoma Genes Chromosomes Cancer PubMed Google Scholar Ye H Yu Temam Ziober BL Wang J Schwartz JL Mao L Wong DT Zhou X Transcriptomic dissection tongue squamous cell carcinoma BMC Genomics PMC free article PubMed Google Scholar Zhang L Huang J Yang N Liang Barchetti Giannakakis Cadungog MG OBrienJenkins Massobrio Roby KF Katsaros Gimotty P Butzow R Weber BL Coukos G Integrative genomic analysis protein kinase C PKC family identifies PKCiota biomarker potential oncogene ovarian carcinoma Cancer Res PubMed Google Scholar Baldwin RM GarrattLalonde Parolin DA Krzyzanowski PM Andrade Lorimer IA Protection glioblastoma cells cisplatin cytotoxicity via protein kinase Ciotamediated attenuation p MAP kinase signaling Oncogene PubMed Google Scholar Baldwin RM GarrattLalonde Parolin DA Krzyzanowski PM Andrade Lorimer IA Protection glioblastoma cells cisplatin cytotoxicity via protein kinase Ciotamediated attenuation p MAP kinase signaling Oncogene PubMed Google Scholar Oncogene Oncogene PubMed Google Scholar Google ScholarBaldwin RM Parolin DAE Lorimer IAJ Regulation glioblastoma cell invasion PKCiota RhoB Oncogene PubMed Google Scholar Baldwin RM Parolin DAE Lorimer IAJ Regulation glioblastoma cell invasion PKCiota RhoB Oncogene PubMed Google Scholar Oncogene Oncogene PubMed Google Scholar Google ScholarBalsara BR Sonoda G du Manoir Siegfried JM Gabrielson E Testa JR Comparative genomic hybridization analysis detects frequent often highlevel overrepresentation DNA sequences q p p q human nonsmall cell lung carcinomas Cancer Res PubMed Google Scholar Balsara BR Sonoda G du Manoir Siegfried JM Gabrielson E Testa JR Comparative genomic hybridization analysis detects frequent often highlevel overrepresentation DNA sequences q p p q human nonsmall cell lung carcinomas Cancer Res PubMed Google Scholar Cancer Res Cancer Res PubMed Google Scholar Google ScholarBedi Barber JP Bedi GC elDeiry WS Sidransky Vala MS Akhtar AJ Hilton J Jones RJ BCRABLmediated inhibition apoptosis delay GM transition DNA damage mechanism resistance multiple anticancer agents Blood PubMed Google Scholar Bedi Barber JP Bedi GC elDeiry WS Sidransky Vala MS Akhtar AJ Hilton J Jones RJ BCRABLmediated inhibition apoptosis delay GM transition DNA damage mechanism resistance multiple anticancer agents Blood PubMed Google Scholar Blood Blood PubMed Google Scholar Google ScholarBjorkoy G Perander Overvatn Johansen Reversion Ras phosphatidylcholinehydrolyzing phospholipase Cmediated transformation NIH cells dominant interfering mutant protein kinase C lambda accompanied loss constitutive nuclear mitogenactivated protein kinaseextracellular signalregulated kinase activity J Biol Chem PubMed Google Scholar Bjorkoy G Perander Overvatn Johansen Reversion Ras phosphatidylcholinehydrolyzing phospholipase Cmediated transformation NIH cells dominant interfering mutant protein kinase C lambda accompanied loss constitutive nuclear mitogenactivated protein kinaseextracellular signalregulated kinase activity J Biol Chem PubMed Google Scholar J Biol Chem J Biol Chem PubMed Google Scholar Google ScholarBrass N Racz Heckel Remberger K Sybrecht GW Meese EU Amplification genes BCHE SLCA squamous cell carcinoma lung Cancer Res PubMed Google Scholar Brass N Racz Heckel Remberger K Sybrecht GW Meese EU Amplification genes BCHE SLCA squamous cell carcinoma lung Cancer Res PubMed Google Scholar Cancer Res Cancer Res PubMed Google Scholar Google ScholarBrass N Ukena Remberger K Mack U Sybrecht GW Meese EU DNA amplification chromosome qq squamous cell carcinoma lung detected reverse chromosome painting Eur J Cancer PubMed Google Scholar Brass N Ukena Remberger K Mack U Sybrecht GW Meese EU DNA amplification chromosome qq squamous cell carcinoma lung detected reverse chromosome painting Eur J Cancer PubMed Google Scholar Eur J Cancer Eur J Cancer APubMed Google Scholar Google ScholarBratt J Belcher J Vercellotti GM Palmblad J Effects antirheumatic gold salts NFkappa B mobilization tumour necrosis factoralpha TNFalphainduced neutrophildependent cytotoxicity human endothelial cells Clin Exp Immunol PMC free article PubMed Google Scholar Bratt J Belcher J Vercellotti GM Palmblad J Effects antirheumatic gold salts NFkappa B mobilization tumour necrosis factoralpha TNFalphainduced neutrophildependent cytotoxicity human endothelial cells Clin Exp Immunol PMC free article PubMed Google Scholar Clin Exp Immunol Clin Exp Immunol PMC free article PMC free articlePubMed Google Scholar Google ScholarCastagna Takai Kaibuchi K Sano K Kikkawa U Nishizuka Direct activation calciumactivated phospholipiddependent protein kinase tumorpromoting phorbol esters J Biol Chem PubMed Google Scholar Castagna Takai Kaibuchi K Sano K Kikkawa U Nishizuka Direct activation calciumactivated phospholipiddependent protein kinase tumorpromoting phorbol esters J Biol Chem PubMed Google Scholar J Biol Chem J Biol Chem PubMed Google Scholar Google ScholarChalmers AD Pambos Mason J Lang Wylie C Papalopulu N aPKC Crumbs Lgl control apicobasal polarity early vertebrate development Development PubMed Google Scholar Chalmers AD Pambos Mason J Lang Wylie C Papalopulu N aPKC Crumbs Lgl control apicobasal polarity early vertebrate development Development PubMed Google Scholar Development Development PubMed Google Scholar Google ScholarCoghlan MP Chou MM Carpenter CL Atypical protein kinases Clambda zeta associate GTPbinding protein Cdc mediate stress fiber loss Mol Cell Biol PMC free article PubMed Google Scholar Coghlan MP Chou MM Carpenter CL Atypical protein kinases Clambda zeta associate GTPbinding protein Cdc mediate stress fiber loss Mol Cell Biol PMC free article PubMed Google Scholar Mol Cell Biol Mol Cell Biol PMC free article PMC free articlePubMed Google Scholar Google ScholarDempsey EC Newton AC MochlyRosen Fields AP Reyland Insel PA Protein kinase C isozymes regulation diverse cell responses J Physiol PubMed Google Scholar Dempsey EC Newton AC MochlyRosen Fields AP Reyland Insel PA Protein kinase C isozymes regulation diverse cell responses J Physiol PubMed Google Scholar J Physiol LLAm J Physiol PubMed Google Scholar Google ScholarDiazMeco MT Lozano J Municio MM Berra E Frutos Sanz L Moscat J Evidence vitro vivo interaction Ras protein kinase C zeta J Biol Chem PubMed Google Scholar DiazMeco MT Lozano J Municio MM Berra E Frutos Sanz L Moscat J Evidence vitro vivo interaction Ras protein kinase C zeta J Biol Chem PubMed Google Scholar J Biol Chem J Biol Chem PubMed Google Scholar Google ScholarDu GS Wang JM Lu JX Li Q CQ Du JT Zou SQ Expression PaPKCiota Ecadherin betacatenin related invasion metastasis hepatocellular carcinoma Ann Surg Oncol PubMed Google Scholar Du GS Wang JM Lu JX Li Q CQ Du JT Zou SQ Expression PaPKCiota Ecadherin betacatenin related invasion metastasis hepatocellular carcinoma Ann Surg Oncol PubMed Google Scholar Ann Surg Oncol Ann Surg Oncol PubMed Google Scholar Google ScholarDyrskjot L Kruhoffer Thykjaer Marcussen N Jensen JL Moller K Orntoft TF Gene expression urinary bladder common carcinoma situ gene expression signature exists disregarding histopathological classification Cancer Res PubMed Google Scholar Dyrskjot L Kruhoffer Thykjaer Marcussen N Jensen JL Moller K Orntoft TF Gene expression urinary bladder common carcinoma situ gene expression signature exists disregarding histopathological classification Cancer Res PubMed Google Scholar Cancer Res Cancer Res PubMed Google Scholar Google ScholarEder Sui X Rosen DG Nolden LK Cheng KW Lahad JP KangoSingh Lu KH Warneke CL Atkinson EN Bedrosian Keyomarsi K Kuo Wl Gray JW Yin JCP Liu J Halder G Mills GB Atypical PKCiota contributes poor prognosis loss apicalbasal polarity Cyclin E overexpression ovarian cancer PNAS PMC free article PubMed Google Scholar Eder Sui X Rosen DG Nolden LK Cheng KW Lahad JP KangoSingh Lu KH Warneke CL Atkinson EN Bedrosian Keyomarsi K Kuo Wl Gray JW Yin JCP Liu J Halder G Mills GB Atypical PKCiota contributes poor prognosis loss apicalbasal polarity Cyclin E overexpression ovarian cancer PNAS PMC free article PubMed Google Scholar PNAS PNAS PMC free article PMC free articlePubMed Google Scholar Google ScholarErdogan E Klee EW Thompson EA Fields AP Metaanalysis oncogenic protein kinase Ciota signaling lung adenocarcinoma Clin Cancer Res PMC free article PubMed Google Scholar Erdogan E Klee EW Thompson EA Fields AP Metaanalysis oncogenic protein kinase Ciota signaling lung adenocarcinoma Clin Cancer Res PMC free article PubMed Google Scholar Clin Cancer Res Clin Cancer Res PMC free article PMC free articlePubMed Google Scholar Google ScholarErdogan E Lamark StallingsMann Lee J Pellecchia Thompson EA Johansen Fields AP Aurothiomalate inhibits transformed growth targeting PB domain protein kinase Ciota J Biol Chem PubMed Google Scholar Erdogan E Lamark StallingsMann Lee J Pellecchia Thompson EA Johansen Fields AP Aurothiomalate inhibits transformed growth targeting PB domain protein kinase Ciota J Biol Chem PubMed Google Scholar J Biol Chem J Biol Chem PubMed Google Scholar Google ScholarEtienneManneville Hall Cell polarity Par aPKC cytoskeletal crosstalk Curr Opin Cell Biol PubMed Google Scholar EtienneManneville Hall Cell polarity Par aPKC cytoskeletal crosstalk Curr Opin Cell Biol PubMed Google Scholar Curr Opin Cell Biol Curr Opin Cell Biol PubMed Google Scholar Google ScholarFields AP Gustafson WC Protein kinase C disease cancer Methods Mol Biol PubMed Google Scholar Fields AP Gustafson WC Protein kinase C disease cancer Methods Mol Biol PubMed Google Scholar Methods Mol Biol Methods Mol Biol PubMed Google Scholar Google ScholarFields AP Justilien V guanine nucleotide exchange factor GEF Ect oncogene human cancer Adv Enzyme Regul PMC free article PubMed Google Scholar Fields AP Justilien V guanine nucleotide exchange factor GEF Ect oncogene human cancer Adv Enzyme Regul PMC free article PubMed Google Scholar Adv Enzyme Regul Adv Enzyme Regul PMC free article PMC free articlePubMed Google Scholar Google ScholarFields AP Murray NR Protein kinase C isozymes therapeutic targets treatment human cancers Adv Enzyme Regul PMC free article PubMed Google Scholar Fields AP Murray NR Protein kinase C isozymes therapeutic targets treatment human cancers Adv Enzyme Regul PMC free article PubMed Google Scholar Adv Enzyme Regul Adv Enzyme Regul PMC free article PMC free articlePubMed Google Scholar Google ScholarFrederick LA Matthews JA Jamieson L Justilien V Thompson EA Radisky DC Fields AP Matrix metalloproteinase critical effector protein kinase CiotaParalphamediated lung cancer Oncogene PMC free article PubMed Google Scholar Frederick LA Matthews JA Jamieson L Justilien V Thompson EA Radisky DC Fields AP Matrix metalloproteinase critical effector protein kinase CiotaParalphamediated lung cancer Oncogene PMC free article PubMed Google Scholar Oncogene Oncogene PMC free article PMC free articlePubMed Google Scholar Google ScholarGinos Page GP Michalowicz BS Patel KJ Volker SE Pambuccian SE Ondrey FG Adams GL Gaffney PM Identification gene expression signature associated recurrent disease squamous cell carcinoma head neck Cancer Res PubMed Google Scholar Ginos Page GP Michalowicz BS Patel KJ Volker SE Pambuccian SE Ondrey FG Adams GL Gaffney PM Identification gene expression signature associated recurrent disease squamous cell carcinoma head neck Cancer Res PubMed Google Scholar Cancer Res Cancer Res PubMed Google Scholar Google ScholarGokmenPolar Fields AP Mapping molecular determinant protein kinase C betaII isozyme function J Biol Chem PubMed Google Scholar GokmenPolar Fields AP Mapping molecular determinant protein kinase C betaII isozyme function J Biol Chem PubMed Google Scholar J Biol Chem J Biol Chem PubMed Google Scholar Google ScholarGumz ML Zou H Kreinest PA Childs AC Belmonte LS LeGrand SN Wu KJ Luxon BA Sinha Parker Sun LZ Ahlquist DA Wood CG Copland JA Secreted frizzledrelated protein loss contributes tumor phenotype clear cell renal cell carcinoma Clin Cancer Res PubMed Google Scholar Gumz ML Zou H Kreinest PA Childs AC Belmonte LS LeGrand SN Wu KJ Luxon BA Sinha Parker Sun LZ Ahlquist DA Wood CG Copland JA Secreted frizzledrelated protein loss contributes tumor phenotype clear cell renal cell carcinoma Clin Cancer Res PubMed Google Scholar Clin Cancer Res Clin Cancer Res PubMed Google Scholar Google ScholarGustafson WC Ray Jamieson L Thompson EA Brasier AR Fields AP BcrAbl regulates protein kinase Ciota PKCiota transcription via Elk site PKCiota promoter J Biol Chem PubMed Google Scholar Gustafson WC Ray Jamieson L Thompson EA Brasier AR Fields AP BcrAbl regulates protein kinase Ciota PKCiota transcription via Elk site PKCiota promoter J Biol Chem PubMed Google Scholar J Biol Chem J Biol Chem PubMed Google Scholar Google ScholarHeselmeyer K Macville Schrock E Blegen H Hellstrom AC Shah K Auer G Ried Advancedstage cervical carcinomas defined recurrent pattern chromosomal aberrations revealing high genetic instability consistent gain chromosome arm q Genes Chromosomes Cancer PubMed Google Scholar Heselmeyer K Macville Schrock E Blegen H Hellstrom AC Shah K Auer G Ried Advancedstage cervical carcinomas defined recurrent pattern chromosomal aberrations revealing high genetic instability consistent gain chromosome arm q Genes Chromosomes Cancer PubMed Google Scholar Genes Chromosomes Cancer Genes Chromosomes Cancer PubMed Google Scholar Google ScholarHirano Yoshinaga Ogura K Yokochi Noda Sumimoto H Inagaki F Solution structure atypical protein kinase C PB domain mode interaction ZIPp MEK J Biol Chem PubMed Google Scholar Hirano Yoshinaga Ogura K Yokochi Noda Sumimoto H Inagaki F Solution structure atypical protein kinase C PB domain mode interaction ZIPp MEK J Biol Chem PubMed Google Scholar J Biol Chem J Biol Chem PubMed Google Scholar Google ScholarIshiguro H Akimoto K Nagashima Kojima Sasaki IshiguroImagawa Nakaigawa N Ohno Kubota Uemura H aPKClambdaiota promotes growth prostate cancer cells autocrine manner transcriptional activation interleukin Proc Natl Acad Sci U PMC free article PubMed Google Scholar Ishiguro H Akimoto K Nagashima Kojima Sasaki IshiguroImagawa Nakaigawa N Ohno Kubota Uemura H aPKClambdaiota promotes growth prostate cancer cells autocrine manner transcriptional activation interleukin Proc Natl Acad Sci U PMC free article PubMed Google Scholar Proc Natl Acad Sci U Proc Natl Acad Sci U PMC free article PMC free articlePubMed Google Scholar Google ScholarJackson EL Willis N Mercer K Bronson RT Crowley Montoya R Jacks Tuveson DA Analysis lung tumor initiation progression using conditional expression oncogenic Kras Genes Dev PMC free article PubMed Google Scholar Jackson EL Willis N Mercer K Bronson RT Crowley Montoya R Jacks Tuveson DA Analysis lung tumor initiation progression using conditional expression oncogenic Kras Genes Dev PMC free article PubMed Google Scholar Genes Dev Genes Dev PMC free article PMC free articlePubMed Google Scholar Google ScholarJamieson L Carpenter L Biden TJ Fields AP Protein kinase Ciota activity necessary BcrAblmediated resistance druginduced apoptosis J Biol Chem PubMed Google Scholar Jamieson L Carpenter L Biden TJ Fields AP Protein kinase Ciota activity necessary BcrAblmediated resistance druginduced apoptosis J Biol Chem PubMed Google Scholar J Biol Chem J Biol Chem PubMed Google Scholar Google ScholarJansen AP Verwiebe EG Dreckschmidt NE Wheeler DL Oberley TD Verma AK Protein kinase Cepsilon transgenic mice unique model metastatic squamous cell carcinoma Cancer Res PubMed Google Scholar Jansen AP Verwiebe EG Dreckschmidt NE Wheeler DL Oberley TD Verma AK Protein kinase Cepsilon transgenic mice unique model metastatic squamous cell carcinoma Cancer Res PubMed Google Scholar Cancer Res Cancer Res PubMed Google Scholar Google ScholarJeon KI Jeong JY Jue DM Thiolreactive metal compounds inhibit NFkappa B activation blocking kappa B kinase J Immunol PubMed Google Scholar Jeon KI Jeong JY Jue DM Thiolreactive metal compounds inhibit NFkappa B activation blocking kappa B kinase J Immunol PubMed Google Scholar J Immunol J Immunol PubMed Google Scholar Google ScholarJin Z Xin Deng X Survival function protein kinase Ciota novel nitrosamine methylnitrosaminopyridylbutanoneactivated bad kinase J Biol Chem PubMed Google Scholar Jin Z Xin Deng X Survival function protein kinase Ciota novel nitrosamine methylnitrosaminopyridylbutanoneactivated bad kinase J Biol Chem PubMed Google Scholar J Biol Chem J Biol Chem PubMed Google Scholar Google ScholarJoberty G Petersen C Gao L Macara IG cellpolarity protein Par links Par atypical protein kinase C Cdc Nat Cell Biol PubMed Google Scholar Joberty G Petersen C Gao L Macara IG cellpolarity protein Par links Par atypical protein kinase C Cdc Nat Cell Biol PubMed Google Scholar Nat Cell Biol Nat Cell Biol PubMed Google Scholar Google ScholarJohnson L Mercer K Greenbaum Bronson RT Crowley Tuveson DA Jacks Somatic activation Kras oncogene causes early onset lung cancer mice Nature PubMed Google Scholar Johnson L Mercer K Greenbaum Bronson RT Crowley Tuveson DA Jacks Somatic activation Kras oncogene causes early onset lung cancer mice Nature PubMed Google Scholar Nature Nature PubMed Google Scholar Google ScholarJustilien V Fields AP Ect links PKCiotaParalpha complex Rac activation cellular transformation Oncogene PMC free article PubMed Google Scholar Justilien V Fields AP Ect links PKCiotaParalpha complex Rac activation cellular transformation Oncogene PMC free article PubMed Google Scholar Oncogene Oncogene PMC free article PMC free articlePubMed Google Scholar Google ScholarKampfer Windegger Hochholdinger F Schwaiger W Pestell RG Baier G Grunicke HH Uberall F Protein kinase C isoforms involved transcriptional activation cyclin transforming HaRas J Biol Chem PubMed Google Scholar Kampfer Windegger Hochholdinger F Schwaiger W Pestell RG Baier G Grunicke HH Uberall F Protein kinase C isoforms involved transcriptional activation cyclin transforming HaRas J Biol Chem PubMed Google Scholar J Biol Chem J Biol Chem PubMed Google Scholar Google ScholarKanada Nagasaki Uyeda TQ Novel functions Ect polar lamellipodia formation polarity maintenance contractile ringindependent cytokinesis adherent cells Mol Biol Cell PMC free article PubMed Google Scholar Kanada Nagasaki Uyeda TQ Novel functions Ect polar lamellipodia formation polarity maintenance contractile ringindependent cytokinesis adherent cells Mol Biol Cell PMC free article PubMed Google Scholar Mol Biol Cell Mol Biol Cell PMC free article PMC free articlePubMed Google Scholar Google ScholarKhosraviFar R Solski PA Clark GJ Kinch MS Der CJ Activation Rac RhoA mitogenactivated protein kinases required Ras transformation Mol Cell Biol PMC free article PubMed Google Scholar KhosraviFar R Solski PA Clark GJ Kinch MS Der CJ Activation Rac RhoA mitogenactivated protein kinases required Ras transformation Mol Cell Biol PMC free article PubMed Google Scholar Mol Cell Biol Mol Cell Biol PMC free article PMC free articlePubMed Google Scholar Google ScholarKikkawa U Takai Tanaka Miyake R Nishizuka Protein kinase C possible receptor protein tumorpromoting phorbol esters J Biol Chem PubMed Google Scholar Kikkawa U Takai Tanaka Miyake R Nishizuka Protein kinase C possible receptor protein tumorpromoting phorbol esters J Biol Chem PubMed Google Scholar J Biol Chem J Biol Chem PubMed Google Scholar Google ScholarKlimstra DS Longnecker DS Kras mutations pancreatic ductal proliferative lesions J Pathol PMC free article PubMed Google Scholar Klimstra DS Longnecker DS Kras mutations pancreatic ductal proliferative lesions J Pathol PMC free article PubMed Google Scholar J Pathol J Pathol PMC free article PMC free articlePubMed Google Scholar Google ScholarKojima Akimoto K Nagashima Ishiguro H Shirai Chishima Ichikawa Ishikawa Sasaki Kubota Inayama Aoki Ohno Shimada H overexpression altered localization atypical protein kinase C lambdaiota breast cancer correlates pathologic type tumors Hum Pathol PubMed Google Scholar Kojima Akimoto K Nagashima Ishiguro H Shirai Chishima Ichikawa Ishikawa Sasaki Kubota Inayama Aoki Ohno Shimada H overexpression altered localization atypical protein kinase C lambdaiota breast cancer correlates pathologic type tumors Hum Pathol PubMed Google Scholar Hum Pathol Hum Pathol PubMed Google Scholar Google ScholarLamark Perander Outzen H Kristiansen K Overvatn Michaelsen E Bjorkoy G Johansen Interaction codes within family mammalian Phox Bemp domaincontaining proteins J Biol Chem PubMed Google Scholar Lamark Perander Outzen H Kristiansen K Overvatn Michaelsen E Bjorkoy G Johansen Interaction codes within family mammalian Phox Bemp domaincontaining proteins J Biol Chem PubMed Google Scholar J Biol Chem J Biol Chem PubMed Google Scholar Google ScholarLandi MT Dracheva Rotunno Figueroa JD Liu H Dasgupta Mann FE Fukuoka J Hames Bergen AW Murphy SE Yang P Pesatori AC Consonni Bertazzi PA Wacholder Shih JH Caporaso NE Jen J Gene expression signature cigarette smoking role lung adenocarcinoma development survival PLoS ONE e PMC free article PubMed Google Scholar Landi MT Dracheva Rotunno Figueroa JD Liu H Dasgupta Mann FE Fukuoka J Hames Bergen AW Murphy SE Yang P Pesatori AC Consonni Bertazzi PA Wacholder Shih JH Caporaso NE Jen J Gene expression signature cigarette smoking role lung adenocarcinoma development survival PLoS ONE e PMC free article PubMed Google Scholar PLoS ONE ePLoS ONE PMC free article PMC free articlePubMed Google Scholar Google ScholarLee J Kotliarova Kotliarov Li Su Q Donin NM Pastorino Purow BW Christopher N Zhang W Park JK Fine HA Tumor stem cells derived glioblastomas cultured bFGF EGF closely mirror phenotype genotype primary tumors serumcultured cell lines Cancer Cell PubMed Google Scholar Lee J Kotliarova Kotliarov Li Su Q Donin NM Pastorino Purow BW Christopher N Zhang W Park JK Fine HA Tumor stem cells derived glioblastomas cultured bFGF EGF closely mirror phenotype genotype primary tumors serumcultured cell lines Cancer Cell PubMed Google Scholar Cancer Cell Cancer Cell PubMed Google Scholar Google ScholarLi Q Wang JM Liu C Xiao BL Lu JX Zou SQ Correlation aPKCiota Ecadherin expression invasion prognosis cholangiocarcinoma Hepatobiliary Pancreat Dis Int PubMed Google Scholar Li Q Wang JM Liu C Xiao BL Lu JX Zou SQ Correlation aPKCiota Ecadherin expression invasion prognosis cholangiocarcinoma Hepatobiliary Pancreat Dis Int PubMed Google Scholar Hepatobiliary Pancreat Dis Int Hepatobiliary Pancreat Dis Int PubMed Google Scholar Google ScholarLin Edwards Fawcett JP Mbamalu G Scott JD Pawson mammalian PARPAR complex implicated CdcRac aPKC signalling cell polarity Nat Cell Biol PubMed Google Scholar Lin Edwards Fawcett JP Mbamalu G Scott JD Pawson mammalian PARPAR complex implicated CdcRac aPKC signalling cell polarity Nat Cell Biol PubMed Google Scholar Nat Cell Biol Nat Cell Biol PubMed Google Scholar Google ScholarLin Smith LT Smiraglia DJ KazhiyurMannar R Lang JC Schuller DE Kornacker K Wenger R Plass C DNA copy number gains head neck squamous cell carcinoma Oncogene PubMed Google Scholar Lin Smith LT Smiraglia DJ KazhiyurMannar R Lang JC Schuller DE Kornacker K Wenger R Plass C DNA copy number gains head neck squamous cell carcinoma Oncogene PubMed Google Scholar Oncogene Oncogene PubMed Google Scholar Google ScholarLu Jamieson L Brasier AR Fields AP NFkappaBRelA transactivation required atypical protein kinase C iotamediated cell survival Oncogene PubMed Google Scholar Lu Jamieson L Brasier AR Fields AP NFkappaBRelA transactivation required atypical protein kinase C iotamediated cell survival Oncogene PubMed Google Scholar Oncogene Oncogene PubMed Google Scholar Google ScholarMessori L Marcon G Gold complexes treatment rheumatoid arthritis Met Ions Biol Syst PubMed Google Scholar Messori L Marcon G Gold complexes treatment rheumatoid arthritis Met Ions Biol Syst PubMed Google Scholar Met Ions Biol Syst Met Ions Biol Syst PubMed Google Scholar Google ScholarMischak H Goodnight JA Kolch W MartinyBaron G Schaechtle C Kazanietz MG Blumberg PM Pierce JH Mushinski JF Overexpression protein kinase Cdelta epsilon NIH cells induces opposite effects growth morphology anchorage dependence tumorigenicity J Biol Chem PubMed Google Scholar Mischak H Goodnight JA Kolch W MartinyBaron G Schaechtle C Kazanietz MG Blumberg PM Pierce JH Mushinski JF Overexpression protein kinase Cdelta epsilon NIH cells induces opposite effects growth morphology anchorage dependence tumorigenicity J Biol Chem PubMed Google Scholar J Biol Chem J Biol Chem PubMed Google Scholar Google ScholarMurray NR Davidson LA Chapkin RS Gustafson WC Schattenberg DG Fields AP Overexpression protein kinase C betaII induces colonic hyperproliferation increased sensitivity colon carcinogenesis J Cell Biol PMC free article PubMed Google Scholar Murray NR Davidson LA Chapkin RS Gustafson WC Schattenberg DG Fields AP Overexpression protein kinase C betaII induces colonic hyperproliferation increased sensitivity colon carcinogenesis J Cell Biol PMC free article PubMed Google Scholar J Cell Biol J Cell Biol PMC free article PMC free articlePubMed Google Scholar Google ScholarMurray NR Fields AP Atypical protein kinase C iota protects human leukemia cells druginduced apoptosis J Biol Chem PubMed Google Scholar Murray NR Fields AP Atypical protein kinase C iota protects human leukemia cells druginduced apoptosis J Biol Chem PubMed Google Scholar J Biol Chem J Biol Chem PubMed Google Scholar Google ScholarMurray NR Jamieson L Yu W Zhang J GokmenPolar Sier Anastasiadis P Gatalica Z Thompson EA Fields AP Protein kinase Ciota required Ras transformation colon carcinogenesis vivo J Cell Biol PMC free article PubMed Google Scholar Murray NR Jamieson L Yu W Zhang J GokmenPolar Sier Anastasiadis P Gatalica Z Thompson EA Fields AP Protein kinase Ciota required Ras transformation colon carcinogenesis vivo J Cell Biol PMC free article PubMed Google Scholar J Cell Biol J Cell Biol PMC free article PMC free articlePubMed Google Scholar Google ScholarMurray NR Weems J Braun U Leitges Fields AP Protein kinase C betaII PKCiotalambda collaborating partners colon cancer promotion progression Cancer Res PMC free article PubMed Google Scholar Murray NR Weems J Braun U Leitges Fields AP Protein kinase C betaII PKCiotalambda collaborating partners colon cancer promotion progression Cancer Res PMC free article PubMed Google Scholar Cancer Res Cancer Res PMC free article PMC free articlePubMed Google Scholar Google ScholarNoda Takeya R Ohno Naito Ito Sumimoto H Human homologues Caenorhabditis elegans cell polarity protein PAR adaptor links small GTPases Rac Cdc atypical protein kinase C Genes Cells PubMed Google Scholar Noda Takeya R Ohno Naito Ito Sumimoto H Human homologues Caenorhabditis elegans cell polarity protein PAR adaptor links small GTPases Rac Cdc atypical protein kinase C Genes Cells PubMed Google Scholar Genes Cells Genes Cells PubMed Google Scholar Google ScholarOster H Leitges Protein kinase C alpha PKCzeta suppresses intestinal tumor formation ApcMin mice Cancer Res PubMed Google Scholar Oster H Leitges Protein kinase C alpha PKCzeta suppresses intestinal tumor formation ApcMin mice Cancer Res PubMed Google Scholar Cancer Res Cancer Res PubMed Google Scholar Google ScholarPatel R Win H Desai Patel K Matthews JA AcevedoDuncan Involvement PKCiota glioma proliferation Cell Prolif PMC free article PubMed Google Scholar Patel R Win H Desai Patel K Matthews JA AcevedoDuncan Involvement PKCiota glioma proliferation Cell Prolif PMC free article PubMed Google Scholar Cell Prolif Cell Prolif PMC free article PMC free articlePubMed Google Scholar Google ScholarPia Rigobello Messori L Marcon G Agostina Cinellu Bragadin Folda Scutari G Bindoli Gold complexes inhibit mitochondrial thioredoxin reductase consequences mitochondrial functions J Inorg Biochem PubMed Google Scholar Pia Rigobello Messori L Marcon G Agostina Cinellu Bragadin Folda Scutari G Bindoli Gold complexes inhibit mitochondrial thioredoxin reductase consequences mitochondrial functions J Inorg Biochem PubMed Google Scholar J Inorg Biochem J Inorg Biochem PubMed Google Scholar Google ScholarQiu RG Abo Steven Martin G human homolog C elegans polarity determinant Par links Rac Cdc PKCzeta signaling cell transformation Curr Biol PubMed Google Scholar Qiu RG Abo Steven Martin G human homolog C elegans polarity determinant Par links Rac Cdc PKCzeta signaling cell transformation Curr Biol PubMed Google Scholar Curr Biol Curr Biol PubMed Google Scholar Google ScholarQiu RG Chen J Kirn McCormick F Symons essential role Rac Ras transformation Nature PubMed Google Scholar Qiu RG Chen J Kirn McCormick F Symons essential role Rac Ras transformation Nature PubMed Google Scholar Nature Nature PubMed Google Scholar Google ScholarRacz Brass N Heckel Pahl Remberger K Meese E Expression analysis genes qq involved frequent amplification squamous cell lung carcinoma Eur J Cancer PubMed Google Scholar Racz Brass N Heckel Pahl Remberger K Meese E Expression analysis genes qq involved frequent amplification squamous cell lung carcinoma Eur J Cancer PubMed Google Scholar Eur J Cancer Eur J Cancer PubMed Google Scholar Google ScholarRegala RP Davis RK Kunz Khoor Leitges Fields AP Atypical protein kinase Ciota required bronchioalveolar stem cell expansion lung tumorigenesis Cancer Res PMC free article PubMed Google Scholar Regala RP Davis RK Kunz Khoor Leitges Fields AP Atypical protein kinase Ciota required bronchioalveolar stem cell expansion lung tumorigenesis Cancer Res PMC free article PubMed Google Scholar Cancer Res Cancer Res PMC free article PMC free articlePubMed Google Scholar Google ScholarRegala RP Thompson EA Fields AP Atypical protein kinase C iota expression aurothiomalate sensitivity human lung cancer cells Cancer Res PMC free article PubMed Google Scholar Regala RP Thompson EA Fields AP Atypical protein kinase C iota expression aurothiomalate sensitivity human lung cancer cells Cancer Res PMC free article PubMed Google Scholar Cancer Res Cancer Res PMC free article PMC free articlePubMed Google Scholar Google ScholarRegala RP Weems C Jamieson L Copland JA Thompson EA Fields AP Atypical protein kinase Ciota plays critical role human lung cancer cell growth tumorigenicity J Biol Chem PubMed Google Scholar Regala RP Weems C Jamieson L Copland JA Thompson EA Fields AP Atypical protein kinase Ciota plays critical role human lung cancer cell growth tumorigenicity J Biol Chem PubMed Google Scholar J Biol Chem J Biol Chem PubMed Google Scholar Google ScholarRegala RP Weems C Jamieson L Khoor Edell ES Lohse CM Fields AP Atypical protein kinase C iota oncogene human nonsmall cell lung cancer Cancer Res b PubMed Google Scholar Regala RP Weems C Jamieson L Khoor Edell ES Lohse CM Fields AP Atypical protein kinase C iota oncogene human nonsmall cell lung cancer Cancer Res b PubMed Google Scholar Cancer Res b Cancer Res PubMed Google Scholar Google ScholarReyland Protein kinase C isoforms Multifunctional regulators cell life death Front Biosci PMC free article PubMed Google Scholar Reyland Protein kinase C isoforms Multifunctional regulators cell life death Front Biosci PMC free article PubMed Google Scholar Front Biosci Front Biosci PMC free article PMC free articlePubMed Google Scholar Google ScholarRichardson AL Wang ZC De Nicolo Lu X Brown Miron Liao X Iglehart JD Livingston DM Ganesan X chromosomal abnormalities basallike human breast cancer Cancer Cell PubMed Google Scholar Richardson AL Wang ZC De Nicolo Lu X Brown Miron Liao X Iglehart JD Livingston DM Ganesan X chromosomal abnormalities basallike human breast cancer Cancer Cell PubMed Google Scholar Cancer Cell Cancer Cell PubMed Google Scholar Google ScholarSanchezCarbayo Socci ND Lozano J Saint F CordonCardo C Defining molecular profiles poor outcome patients invasive bladder cancer using oligonucleotide microarrays J Clin Oncol PubMed Google Scholar SanchezCarbayo Socci ND Lozano J Saint F CordonCardo C Defining molecular profiles poor outcome patients invasive bladder cancer using oligonucleotide microarrays J Clin Oncol PubMed Google Scholar J Clin Oncol J Clin Oncol PubMed Google Scholar Google ScholarScotti ML Bamlet W Smyrk TC Fields AP Murray NR Protein kinase C iota required pancreatic cancer cell transformed growth tumorigenesis Cancer Res PMC free article PubMed Google Scholar Scotti ML Bamlet W Smyrk TC Fields AP Murray NR Protein kinase C iota required pancreatic cancer cell transformed growth tumorigenesis Cancer Res PMC free article PubMed Google Scholar Cancer Res Cancer Res PMC free article PMC free articlePubMed Google Scholar Google ScholarSegara Biankin AV Kench JG Langusch CC Dawson AC Skalicky DA Gotley DC Coleman MJ Sutherland RL Henshall SM Expression HOXB retinoic acid signaling target pancreatic cancer pancreatic intraepithelial neoplasia Clin Cancer Res PubMed Google Scholar Segara Biankin AV Kench JG Langusch CC Dawson AC Skalicky DA Gotley DC Coleman MJ Sutherland RL Henshall SM Expression HOXB retinoic acid signaling target pancreatic cancer pancreatic intraepithelial neoplasia Clin Cancer Res PubMed Google Scholar Clin Cancer Res Clin Cancer Res PubMed Google Scholar Google ScholarSingh B Stoffel Gogineni Poluri Pfister DG Shaha AR Pathak Bosl G CordonCardo C Shah JP Rao PH Amplification q locus associated progression invasive cancer negative prognostic factor head neck squamous cell carcinomas J Pathol PMC free article PubMed Google Scholar Singh B Stoffel Gogineni Poluri Pfister DG Shaha AR Pathak Bosl G CordonCardo C Shah JP Rao PH Amplification q locus associated progression invasive cancer negative prognostic factor head neck squamous cell carcinomas J Pathol PMC free article PubMed Google Scholar J Pathol J Pathol PMC free article PMC free articlePubMed Google Scholar Google ScholarSlattery ML Anderson K Curtin K K Schaffer Edwards Samowitz W Lifestyle factors Kiras mutations colon cancer tumors Mutat Res PubMed Google Scholar Slattery ML Anderson K Curtin K K Schaffer Edwards Samowitz W Lifestyle factors Kiras mutations colon cancer tumors Mutat Res PubMed Google Scholar Mutat Res Mutat Res PubMed Google Scholar Google ScholarSnaddon J Parkinson EK Craft JA Bartholomew C Fulton R Detection functional PTEN lipid phosphatase protein enzyme activity squamous cell carcinomas head neck despite loss heterozygosity locus Br J Cancer PMC free article PubMed Google Scholar Snaddon J Parkinson EK Craft JA Bartholomew C Fulton R Detection functional PTEN lipid phosphatase protein enzyme activity squamous cell carcinomas head neck despite loss heterozygosity locus Br J Cancer PMC free article PubMed Google Scholar Br J Cancer Br J Cancer PMC free article PMC free articlePubMed Google Scholar Google ScholarStallingsMann Jamieson L Regala RP Weems C Murray NR Fields AP novel smallmolecule inhibitor protein kinase Ciota blocks transformed growth nonsmallcell lung cancer cells Cancer Res PubMed Google Scholar StallingsMann Jamieson L Regala RP Weems C Murray NR Fields AP novel smallmolecule inhibitor protein kinase Ciota blocks transformed growth nonsmallcell lung cancer cells Cancer Res PubMed Google Scholar Cancer Res Cancer Res PubMed Google Scholar Google ScholarSugita Tanaka N Davidson Sekiya VarellaGarcia West J Drabkin HA Gemmill RM Molecular definition small amplification domain within q tumors cervix ovary lung Cancer Genet Cytogenet PubMed Google Scholar Sugita Tanaka N Davidson Sekiya VarellaGarcia West J Drabkin HA Gemmill RM Molecular definition small amplification domain within q tumors cervix ovary lung Cancer Genet Cytogenet PubMed Google Scholar Cancer Genet Cytogenet Cancer Genet Cytogenet PubMed Google Scholar Google ScholarSuzuki Akimoto K Ohno Protein kinase C lambdaiota PKClambdaiota PKC isotype essential development multicellular organisms J Biochem Tokyo PubMed Google Scholar Suzuki Akimoto K Ohno Protein kinase C lambdaiota PKClambdaiota PKC isotype essential development multicellular organisms J Biochem Tokyo PubMed Google Scholar J Biochem Tokyo J Biochem Tokyo PubMed Google Scholar Google ScholarSuzuki Yamanaka Hirose Manabe N Mizuno K Shimizu Akimoto K Izumi Ohnishi Ohno Atypical protein kinase C involved evolutionarily conserved par protein complex plays critical role establishing epitheliaspecific junctional structures J Cell Biol PMC free article PubMed Google Scholar Suzuki Yamanaka Hirose Manabe N Mizuno K Shimizu Akimoto K Izumi Ohnishi Ohno Atypical protein kinase C involved evolutionarily conserved par protein complex plays critical role establishing epitheliaspecific junctional structures J Cell Biol PMC free article PubMed Google Scholar J Cell Biol J Cell Biol PMC free article PMC free articlePubMed Google Scholar Google ScholarTakagawa R Akimoto K Ichikawa Akiyama H Kojima Ishiguro H Inayama Aoki Kunisaki C Endo Nagashima Ohno High expression atypical protein kinase C lambdaiota gastric cancer prognostic factor recurrence Ann Surg Oncol PubMed Google Scholar Takagawa R Akimoto K Ichikawa Akiyama H Kojima Ishiguro H Inayama Aoki Kunisaki C Endo Nagashima Ohno High expression atypical protein kinase C lambdaiota gastric cancer prognostic factor recurrence Ann Surg Oncol PubMed Google Scholar Ann Surg Oncol Ann Surg Oncol PubMed Google Scholar Google ScholarTakayama Ohi Hayashi Miyanishi K Nobuoka Nakajima Satoh Takimoto R Kato J Sakamaki Niitsu Analysis Kras APC betacatenin aberrant crypt foci sporadic adenoma cancer familial adenomatous polyposis Gastroenterology PubMed Google Scholar Takayama Ohi Hayashi Miyanishi K Nobuoka Nakajima Satoh Takimoto R Kato J Sakamaki Niitsu Analysis Kras APC betacatenin aberrant crypt foci sporadic adenoma cancer familial adenomatous polyposis Gastroenterology PubMed Google Scholar Gastroenterology Gastroenterology PubMed Google Scholar Google ScholarTalantov Mazumder Yu JX Briggs Jiang Backus J Atkins Wang Novel genes associated malignant melanoma benign melanocytic lesions Clin Cancer Res PubMed Google Scholar Talantov Mazumder Yu JX Briggs Jiang Backus J Atkins Wang Novel genes associated malignant melanoma benign melanocytic lesions Clin Cancer Res PubMed Google Scholar Clin Cancer Res Clin Cancer Res PubMed Google Scholar Google ScholarUberall F Hellbert K Kampfer Maly K Villunger Spitaler Mwanjewe J BaierBitterlich G Baier G Grunicke HH Evidence atypical protein kinase Clambda atypical protein kinase Czeta participate Rasmediated reorganization Factin cytoskeleton J Cell Biol PMC free article PubMed Google Scholar Uberall F Hellbert K Kampfer Maly K Villunger Spitaler Mwanjewe J BaierBitterlich G Baier G Grunicke HH Evidence atypical protein kinase Clambda atypical protein kinase Czeta participate Rasmediated reorganization Factin cytoskeleton J Cell Biol PMC free article PubMed Google Scholar J Cell Biol J Cell Biol PMC free article PMC free articlePubMed Google Scholar Google ScholarValk PJ Verhaak RG Beijen Erpelinck CA Barjesteh van Waalwijk van DoornKhosrovani Boer JM Beverloo HB Moorhouse MJ van der Spek PJ Lowenberg B Delwel R Prognostically useful geneexpression profiles acute myeloid leukemia N Engl J Med PubMed Google Scholar Valk PJ Verhaak RG Beijen Erpelinck CA Barjesteh van Waalwijk van DoornKhosrovani Boer JM Beverloo HB Moorhouse MJ van der Spek PJ Lowenberg B Delwel R Prognostically useful geneexpression profiles acute myeloid leukemia N Engl J Med PubMed Google Scholar N Engl J Med N Engl J Med PubMed Google Scholar Google ScholarWallace TA Prueitt RL Yi Howe TM Gillespie JW Yfantis HG Stephens RM Caporaso NE Loffredo CA Ambs Tumor immunobiological differences prostate cancer AfricanAmerican EuropeanAmerican men Cancer Res PubMed Google Scholar Wallace TA Prueitt RL Yi Howe TM Gillespie JW Yfantis HG Stephens RM Caporaso NE Loffredo CA Ambs Tumor immunobiological differences prostate cancer AfricanAmerican EuropeanAmerican men Cancer Res PubMed Google Scholar Cancer Res Cancer Res PubMed Google Scholar Google ScholarWeichert W Gekeler V Denkert C Dietel Hauptmann Protein kinase C isoform expression ovarian carcinoma correlates indicators poor prognosis Int J Oncol PubMed Google Scholar Weichert W Gekeler V Denkert C Dietel Hauptmann Protein kinase C isoform expression ovarian carcinoma correlates indicators poor prognosis Int J Oncol PubMed Google Scholar Int J Oncol Int J Oncol PubMed Google Scholar Google ScholarWilson MI Gill DJ Perisic Quinn MT Williams RL PB domainmediated heterodimerization NADPH oxidase signaling complexes atypical protein kinase C Par p Mol Cell PubMed Google Scholar Wilson MI Gill DJ Perisic Quinn MT Williams RL PB domainmediated heterodimerization NADPH oxidase signaling complexes atypical protein kinase C Par p Mol Cell PubMed Google Scholar Mol Cell Mol Cell PubMed Google Scholar Google ScholarWin HY AcevedoDuncan Atypical protein kinase C phosphorylates IKKalphabeta transformed nonmalignant malignant prostate cell survival Cancer Lett PubMed Google Scholar Win HY AcevedoDuncan Atypical protein kinase C phosphorylates IKKalphabeta transformed nonmalignant malignant prostate cell survival Cancer Lett PubMed Google Scholar Cancer Lett Cancer Lett PubMed Google Scholar Google ScholarWurmbach E Chen YB Khitrov G Zhang W Roayaie Schwartz Fiel Thung Mazzaferro V Bruix J Bottinger E Friedman Waxman Llovet JM Genomewide molecular profiles HCVinduced dysplasia hepatocellular carcinoma Hepatology PubMed Google Scholar Wurmbach E Chen YB Khitrov G Zhang W Roayaie Schwartz Fiel Thung Mazzaferro V Bruix J Bottinger E Friedman Waxman Llovet JM Genomewide molecular profiles HCVinduced dysplasia hepatocellular carcinoma Hepatology PubMed Google Scholar Hepatology Hepatology PubMed Google Scholar Google ScholarYamashita Ashino Oshima Kawamura Ohuchi K Takayanagi Inhibition TPAinduced NFkappaB nuclear translocation production PGE antirheumatic gold compounds J Pharm Pharmacol PubMed Google Scholar Yamashita Ashino Oshima Kawamura Ohuchi K Takayanagi Inhibition TPAinduced NFkappaB nuclear translocation production PGE antirheumatic gold compounds J Pharm Pharmacol PubMed Google Scholar J Pharm Pharmacol J Pharm Pharmacol PubMed Google Scholar Google ScholarYang YL Chu JY Luo ML Wu YP Zhang Feng YB Shi ZZ Xu X Han YL Cai Dong JT Zhan QM Wu Wang MR Amplification PRKCI located q associated lymph node metastasis esophageal squamous cell carcinoma Genes Chromosomes Cancer PubMed Google Scholar Yang YL Chu JY Luo ML Wu YP Zhang Feng YB Shi ZZ Xu X Han YL Cai Dong JT Zhan QM Wu Wang MR Amplification PRKCI located q associated lymph node metastasis esophageal squamous cell carcinoma Genes Chromosomes Cancer PubMed Google Scholar Genes Chromosomes Cancer Genes Chromosomes Cancer PubMed Google Scholar Google ScholarYe H Yu Temam Ziober BL Wang J Schwartz JL Mao L Wong DT Zhou X Transcriptomic dissection tongue squamous cell carcinoma BMC Genomics PMC free article PubMed Google Scholar Ye H Yu Temam Ziober BL Wang J Schwartz JL Mao L Wong DT Zhou X Transcriptomic dissection tongue squamous cell carcinoma BMC Genomics PMC free article PubMed Google Scholar BMC Genomics BMC Genomics PMC free article PMC free articlePubMed Google Scholar Google ScholarZhang L Huang J Yang N Liang Barchetti Giannakakis Cadungog MG OBrienJenkins Massobrio Roby KF Katsaros Gimotty P Butzow R Weber BL Coukos G Integrative genomic analysis protein kinase C PKC family identifies PKCiota biomarker potential oncogene ovarian carcinoma Cancer Res PubMed Google Scholar Zhang L Huang J Yang N Liang Barchetti Giannakakis Cadungog MG OBrienJenkins Massobrio Roby KF Katsaros Gimotty P Butzow R Weber BL Coukos G Integrative genomic analysis protein kinase C PKC family identifies PKCiota biomarker potential oncogene ovarian carcinoma Cancer Res PubMed Google Scholar Cancer Res Cancer Res PubMed Google Scholar Google Scholar Formats PubReader PDF K Actions Cite Collections Add Collections Create new collection Add existing collection Name collection Name must less characters Choose collection Unable load collection due error Please try Add Cancel Share Permalink Copy RESOURCES Similar articles Cited articles Links NCBI Databases Formats PubReader PDF K Actions Cite Collections Add Collections Create new collection Add existing collection Name collection Name must less characters Choose collection Unable load collection due error Please try Add Cancel Share Permalink Copy RESOURCES Similar articles Cited articles Links NCBI Databases Formats PubReader PDF K Formats PubReader PDF K PubReaderPubReaderPDF KPDF K Actions Cite Collections Add Collections Create new collection Add existing collection Name collection Name must less characters Choose collection Unable load collection due error Please try Add Cancel Actions Cite Collections Add Collections Create new collection Add existing collection Name collection Name must less characters Choose collection Unable load collection due error Please try Add Cancel Cite Cite Cite Collections Add Collections Create new collection Add existing collection Name collection Name must less characters Choose collection Unable load collection due error Please try Add Cancel Collections Add Collections Create new collection Add existing collection Name collection Name must less characters Choose collection Unable load collection due error Please try Add Cancel Collections Collections Add Collections Create new collection Add existing collection Name collection Name must less characters Choose collection Unable load collection due error Please try Add Cancel Add Collections Create new collection Add existing collection Name collection Name must less characters Choose collection Unable load collection due error Please try Add Cancel Add Collections Create new collection Add existing collection Name collection Name must less characters Choose collection Unable load collection due error Please try Add Cancel Create new collection Add existing collection Name collection Name must less characters Choose collection Unable load collection due error Please try Add Cancel Create new collection Add existing collection Create new collection Add existing collection Create new collection Create new collection Add existing collection Add existing collection Name collection Name must less characters Choose collection Unable load collection due error Please try Name collection Name must less characters Name collection Name must less characters Choose collection Unable load collection due error Please try Choose collection Unable load collection due error Please try Please try Add Cancel Add Cancel Share Permalink Copy Share Permalink Copy Permalink Copy Permalink Copy Permalink Copy Permalink Copy Copy Copy RESOURCES Similar articles Cited articles Links NCBI Databases RESOURCES Similar articles Cited articles Links NCBI Databases Similar articles Similar articles Similar articles Cited articles Cited articles Cited articles Links NCBI Databases Links NCBI Databases Links NCBI Databases